
<html lang="en"     class="pb-page"  data-request-id="8f332d3d-6371-40eb-90f4-98074e849f7b"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/jm300438j;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2012.55.issue-12;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Identification of Imidazo-Pyrrolopyridines as Novel and Potent JAK1 Inhibitors" /></meta><meta name="dc.Creator" content="Janusz J.  Kulagowski" /></meta><meta name="dc.Creator" content="Wade  Blair" /></meta><meta name="dc.Creator" content="Richard J.  Bull" /></meta><meta name="dc.Creator" content="Christine  Chang" /></meta><meta name="dc.Creator" content="Gauri  Deshmukh" /></meta><meta name="dc.Creator" content="Hazel J.  Dyke" /></meta><meta name="dc.Creator" content="Charles  Eigenbrot" /></meta><meta name="dc.Creator" content="Nico  Ghilardi" /></meta><meta name="dc.Creator" content="Paul  Gibbons" /></meta><meta name="dc.Creator" content="Trevor K.  Harrison" /></meta><meta name="dc.Creator" content="Peter R.  Hewitt" /></meta><meta name="dc.Creator" content="Marya  Liimatta" /></meta><meta name="dc.Creator" content="Christopher A.  Hurley" /></meta><meta name="dc.Creator" content="Adam  Johnson" /></meta><meta name="dc.Creator" content="Tony  Johnson" /></meta><meta name="dc.Creator" content="Jane R.  Kenny" /></meta><meta name="dc.Creator" content="Pawan  Bir Kohli" /></meta><meta name="dc.Creator" content="Robert J.  Maxey" /></meta><meta name="dc.Creator" content="Rohan  Mendonca" /></meta><meta name="dc.Creator" content="Kyle  Mortara" /></meta><meta name="dc.Creator" content="Jeremy  Murray" /></meta><meta name="dc.Creator" content="Raman  Narukulla" /></meta><meta name="dc.Creator" content="Steven  Shia" /></meta><meta name="dc.Creator" content="Micah  Steffek" /></meta><meta name="dc.Creator" content="Savita  Ubhayakar" /></meta><meta name="dc.Creator" content="Mark  Ultsch" /></meta><meta name="dc.Creator" content="Anne  van Abbema" /></meta><meta name="dc.Creator" content="Stuart I.  Ward" /></meta><meta name="dc.Creator" content="Bohdan  Waszkowycz" /></meta><meta name="dc.Creator" content="Mark  Zak" /></meta><meta name="dc.Description" content="A therapeutic rationale is proposed for the treatment of inflammatory diseases, such as rheumatoid arthritis (RA), by specific targeting of the JAK1 pathway. Examination of the preferred binding co..." /></meta><meta name="Description" content="A therapeutic rationale is proposed for the treatment of inflammatory diseases, such as rheumatoid arthritis (RA), by specific targeting of the JAK1 pathway. Examination of the preferred binding co..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 11, 2012" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm300438j" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2012 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm300438j" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm300438j" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm300438j" /></link>
        
    
    

<title>Identification of Imidazo-Pyrrolopyridines as Novel and Potent JAK1 Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm300438j" /></meta><meta property="og:title" content="Identification of Imidazo-Pyrrolopyridines as Novel and Potent JAK1 Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/large/jm-2012-00438j_0026.jpeg" /></meta><meta property="og:description" content="A therapeutic rationale is proposed for the treatment of inflammatory diseases, such as rheumatoid arthritis (RA), by specific targeting of the JAK1 pathway. Examination of the preferred binding conformation of clinically effective, pan-JAK inhibitor 1 led to identification of a novel, tricyclic hinge binding scaffold 3. Exploration of SAR through a series of cycloamino and cycloalkylamino analogues demonstrated this template to be highly tolerant of substitution, with a predisposition to moderate selectivity for the JAK1 isoform over JAK2. This study culminated in the identification of subnanomolar JAK1 inhibitors such as 22 and 49, having excellent cell potency, good rat pharmacokinetic characteristics, and excellent kinase selectivity. Determination of the binding modes of the series in JAK1 and JAK2 by X-ray crystallography supported the design of analogues to enhance affinity and selectivity." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm300438j"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm300438j">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-13/achre4.2021.54.issue-13/20210706/achre4.2021.54.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-6/amrcda.2021.2.issue-6/20210625/amrcda.2021.2.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-6/aabmcb.2021.4.issue-6/20210621/aabmcb.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-6/aaembp.2021.3.issue-6/20210622/aaembp.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-6/aaemcq.2021.4.issue-6/20210628/aaemcq.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-26/aamick.2021.13.issue-26/20210707/aamick.2021.13.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-6/aanmf6.2021.4.issue-6/20210625/aanmf6.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-13/accacs.2021.11.issue-13/20210702/accacs.2021.11.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-6/acscii.2021.7.issue-6/20210623/acscii.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-6/acbcct.2021.16.issue-6/20210618/acbcct.2021.16.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-3/achsc5.2021.28.issue-3/20210524/achsc5.2021.28.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-13/acncdm.2021.12.issue-13/20210707/acncdm.2021.12.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-6/aesccq.2021.5.issue-6/20210617/aesccq.2021.5.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-5/afsthl.2021.1.issue-5/20210618/afsthl.2021.1.issue-5.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-6/amlccd.2021.10.issue-6/20210615/amlccd.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-6/ancac3.2021.15.issue-6/20210622/ancac3.2021.15.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-27/acsodf.2021.6.issue-27/20210713/acsodf.2021.6.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-6/apchd5.2021.8.issue-6/20210616/apchd5.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-6/ascefj.2021.6.issue-6/20210625/ascefj.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-27/ascecg.2021.9.issue-27/20210712/ascecg.2021.9.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-6/asbcd6.2021.10.issue-6/20210618/asbcd6.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-27/ancham.2021.93.issue-27/20210713/ancham.2021.93.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-27/bichaw.2021.60.issue-27/20210713/bichaw.2021.60.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-6/bcches.2021.32.issue-6/20210616/bcches.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-24/cgeabj.2021.99.issue-24/20210628-01/cgeabj.2021.99.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-6/crtoec.2021.34.issue-6/20210621/crtoec.2021.34.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-12/chreay.2021.121.issue-12/20210623/chreay.2021.121.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-13/cmatex.2021.33.issue-13/20210713/cmatex.2021.33.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-13/enfuem.2021.35.issue-13/20210701/enfuem.2021.35.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-13/esthag.2021.55.issue-13/20210706/esthag.2021.55.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-26/iecred.2021.60.issue-26/20210707/iecred.2021.60.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-13/inocaj.2021.60.issue-13/20210705/inocaj.2021.60.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-6/jaaucr.2021.1.issue-6/20210628/jaaucr.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-26/jafcau.2021.69.issue-26/20210707/jafcau.2021.69.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-6/jcisd8.2021.61.issue-6/20210628/jcisd8.2021.61.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/jmcmar.2021.64.issue-13/20210708/jmcmar.2021.64.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-6/jnprdf.2021.84.issue-6/20210625/jnprdf.2021.84.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-13/joceah.2021.86.issue-13/20210702/joceah.2021.86.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-26/jpcafh.2021.125.issue-26/20210708/jpcafh.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-26/jpcbfk.2021.125.issue-26/20210708/jpcbfk.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-26/jpccck.2021.125.issue-26/20210708/jpccck.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-26/jpclcd.2021.12.issue-26/20210708/jpclcd.2021.12.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-26/jacsat.2021.143.issue-26/20210707/jacsat.2021.143.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-27/langd5.2021.37.issue-27/20210713/langd5.2021.37.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-13/mamobx.2021.54.issue-13/20210713/mamobx.2021.54.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-12/nalefd.2021.21.issue-12/20210623/nalefd.2021.21.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-13/orlef7.2021.23.issue-13/20210702/orlef7.2021.23.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-6/oprdfk.2021.25.issue-6/20210618/oprdfk.2021.25.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-13/orgnd7.2021.40.issue-13/20210712/orgnd7.2021.40.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm300438j&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm300438j&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm300438j&amp;href=/doi/10.1021/jm300438j" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2012</span><span class="cit-fg-volume">, 55</span><span class="cit-fg-issue">, 12</span><span class="cit-fg-pageRange">, 5901-5921</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/55/12" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm3003747" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm300488m" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Identification of Imidazo-Pyrrolopyridines as Novel and Potent JAK1 Inhibitors</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Janusz+J.++Kulagowski">Janusz J. Kulagowski</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wade++Blair">Wade Blair</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Richard+J.++Bull">Richard J. Bull</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christine++Chang">Christine Chang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gauri++Deshmukh">Gauri Deshmukh</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hazel+J.++Dyke">Hazel J. Dyke</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Charles++Eigenbrot">Charles Eigenbrot</a></span><span class="author-xref-symbol author-aff-symbol"><sup>○</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nico++Ghilardi">Nico Ghilardi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul++Gibbons">Paul Gibbons</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Trevor+K.++Harrison">Trevor K. Harrison</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peter+R.++Hewitt">Peter R. Hewitt</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marya++Liimatta">Marya Liimatta</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher+A.++Hurley">Christopher A. Hurley</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Adam++Johnson">Adam Johnson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tony++Johnson">Tony Johnson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jane+R.++Kenny">Jane R. Kenny</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pawan++Bir+Kohli">Pawan Bir Kohli</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert+J.++Maxey">Robert J. Maxey</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rohan++Mendonca">Rohan Mendonca</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kyle++Mortara">Kyle Mortara</a></span><span class="author-xref-symbol author-aff-symbol"><sup>○</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jeremy++Murray">Jeremy Murray</a></span><span class="author-xref-symbol author-aff-symbol"><sup>○</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Raman++Narukulla">Raman Narukulla</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Steven++Shia">Steven Shia</a></span><span class="author-xref-symbol author-aff-symbol"><sup>○</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Micah++Steffek">Micah Steffek</a></span><span class="author-xref-symbol author-aff-symbol"><sup>○</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Savita++Ubhayakar">Savita Ubhayakar</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mark++Ultsch">Mark Ultsch</a></span><span class="author-xref-symbol author-aff-symbol"><sup>○</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anne++van+Abbema">Anne van Abbema</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stuart+I.++Ward">Stuart I. Ward</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bohdan++Waszkowycz">Bohdan Waszkowycz</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mark++Zak">Mark Zak</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>†</sup>Departments of Medicinal Chemistry and <sup>‡</sup>Computer Aided Drug Design, Argenta, 8/9 Spire Green Centre, Harlow CM19 5TR, United Kingdom</span></div><div class="aff-info" id="aff2"><span class="aff-text"><sup>§</sup>Departments of Biochemical and Cellular Pharmacology, <sup>∥</sup>Discovery Chemistry, <sup>⊥</sup>Drug Metabolism and Pharmacokinetics, <sup>#</sup>Immunology, and <sup>○</sup>Structural Biology, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div><div class="corresp-info"><strong>*</strong>Tel: +44 1279 645624. Fax: +44 1279 645646. E-mail: <a href="/cdn-cgi/l/email-protection#b3d9d2ddc6c0c99dd8c6dfd2d4dcc4c0d8daf3d4dfc3d4"><span class="__cf_email__" data-cfemail="d1bbb0bfa4a2abffbaa4bdb0b6bea6a2bab891b6bda1b6">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm300438j&amp;href=/doi/10.1021%2Fjm300438j" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2012</span></span><span class="cit-volume">, 55</span><span class="cit-issue">, 12</span><span class="cit-pageRange">, 5901–5921</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 16, 2012</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>29 March 2012</li><li><span class="item_label"><b>Published</b> online</span>11 June 2012</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 28 June 2012</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm300438j" title="DOI URL">https://doi.org/10.1021/jm300438j</a></div><div class="article_header-article-copyright"><strong>Copyright © 2012 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5901%26pageCount%3D21%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DJanusz%2BJ.%2BKulagowski%252C%2BWade%2BBlair%252C%2BRichard%2BJ.%2BBull%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D55%26issueNum%3D12%26contentID%3Djm300438j%26title%3DIdentification%2Bof%2BImidazo-Pyrrolopyridines%2Bas%2BNovel%2Band%2BPotent%2BJAK1%2BInhibitors%26numPages%3D21%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5921%26publicationDate%3DJune%2B2012">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm300438j"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">5553</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">72</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm300438j" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Identification of Imidazo-Pyrrolopyridines as Novel and Potent JAK1 Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Janusz&quot;,&quot;last_name&quot;:&quot;J. Kulagowski&quot;},{&quot;first_name&quot;:&quot;Wade&quot;,&quot;last_name&quot;:&quot;Blair&quot;},{&quot;first_name&quot;:&quot;Richard&quot;,&quot;last_name&quot;:&quot;J. Bull&quot;},{&quot;first_name&quot;:&quot;Christine&quot;,&quot;last_name&quot;:&quot;Chang&quot;},{&quot;first_name&quot;:&quot;Gauri&quot;,&quot;last_name&quot;:&quot;Deshmukh&quot;},{&quot;first_name&quot;:&quot;Hazel&quot;,&quot;last_name&quot;:&quot;J. Dyke&quot;},{&quot;first_name&quot;:&quot;Charles&quot;,&quot;last_name&quot;:&quot;Eigenbrot&quot;},{&quot;first_name&quot;:&quot;Nico&quot;,&quot;last_name&quot;:&quot;Ghilardi&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;Gibbons&quot;},{&quot;first_name&quot;:&quot;Trevor&quot;,&quot;last_name&quot;:&quot;K. Harrison&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;R. Hewitt&quot;},{&quot;first_name&quot;:&quot;Marya&quot;,&quot;last_name&quot;:&quot;Liimatta&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;A. Hurley&quot;},{&quot;first_name&quot;:&quot;Adam&quot;,&quot;last_name&quot;:&quot;Johnson&quot;},{&quot;first_name&quot;:&quot;Tony&quot;,&quot;last_name&quot;:&quot;Johnson&quot;},{&quot;first_name&quot;:&quot;Jane&quot;,&quot;last_name&quot;:&quot;R. Kenny&quot;},{&quot;first_name&quot;:&quot;Pawan&quot;,&quot;last_name&quot;:&quot;Bir Kohli&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;J. Maxey&quot;},{&quot;first_name&quot;:&quot;Rohan&quot;,&quot;last_name&quot;:&quot;Mendonca&quot;},{&quot;first_name&quot;:&quot;Kyle&quot;,&quot;last_name&quot;:&quot;Mortara&quot;},{&quot;first_name&quot;:&quot;Jeremy&quot;,&quot;last_name&quot;:&quot;Murray&quot;},{&quot;first_name&quot;:&quot;Raman&quot;,&quot;last_name&quot;:&quot;Narukulla&quot;},{&quot;first_name&quot;:&quot;Steven&quot;,&quot;last_name&quot;:&quot;Shia&quot;},{&quot;first_name&quot;:&quot;Micah&quot;,&quot;last_name&quot;:&quot;Steffek&quot;},{&quot;first_name&quot;:&quot;Savita&quot;,&quot;last_name&quot;:&quot;Ubhayakar&quot;},{&quot;first_name&quot;:&quot;Mark&quot;,&quot;last_name&quot;:&quot;Ultsch&quot;},{&quot;first_name&quot;:&quot;Anne&quot;,&quot;last_name&quot;:&quot;van Abbema&quot;},{&quot;first_name&quot;:&quot;Stuart&quot;,&quot;last_name&quot;:&quot;I. Ward&quot;},{&quot;first_name&quot;:&quot;Bohdan&quot;,&quot;last_name&quot;:&quot;Waszkowycz&quot;},{&quot;first_name&quot;:&quot;Mark&quot;,&quot;last_name&quot;:&quot;Zak&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2012&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;11&quot;,&quot;issue&quot;:&quot;12&quot;,&quot;volume&quot;:&quot;55&quot;,&quot;pages&quot;:&quot;5901-5921&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm300438j&quot;},&quot;abstract&quot;:&quot;A therapeutic rationale is proposed for the treatment of inflammatory diseases, such as rheumatoid arthritis (RA), by specific targeting of the JAK1 pathway. Examination of the preferred binding conformation of clinically effective, pan-JAK inhibitor 1 led to identification of a novel, tricyclic hinge binding scaffold 3. Exploration of SAR through a series of cycloamino and cycloalkylamino analogues demonstrated this template to be highly tolerant of substitution, with a predisposition to moderate selectivity for the JAK1 isoform over JAK2. This study culminated in the identification of subnanomolar JAK1 inhibitors such as 22 and 49, having excellent cell potency, good rat pharmacokinetic characteristics, and excellent kinase selectivity. Determination of the binding modes of the series in JAK1 and JAK2 by X-ray crystallography supported the design of analogues to enhance affinity and selectivity.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300438j&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300438j" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300438j&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300438j" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300438j&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300438j" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm300438j&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300438j&amp;href=/doi/10.1021/jm300438j" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm300438j" /></input><a href="/doi/pdf/10.1021/jm300438j" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm300438j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm300438j%26sid%3Dliteratum%253Aachs%26pmid%3D22591402%26genre%3Darticle%26aulast%3DKulagowski%26date%3D2012%26atitle%3DIdentification%2Bof%2BImidazo-Pyrrolopyridines%2Bas%2BNovel%2Band%2BPotent%2BJAK1%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D55%26issue%3D12%26spage%3D5901%26epage%3D5921%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290676" title="Substituents">Substituents</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291870" title="Piperidines">Piperidines</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/55/12" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jmcmar.2012.55.issue-12/production/jmcmar.2012.55.issue-12.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/medium/jm-2012-00438j_0026.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/large/jm-2012-00438j_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300438j&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">A therapeutic rationale is proposed for the treatment of inflammatory diseases, such as rheumatoid arthritis (RA), by specific targeting of the JAK1 pathway. Examination of the preferred binding conformation of clinically effective, pan-JAK inhibitor <b>1</b> led to identification of a novel, tricyclic hinge binding scaffold <b>3</b>. Exploration of SAR through a series of cycloamino and cycloalkylamino analogues demonstrated this template to be highly tolerant of substitution, with a predisposition to moderate selectivity for the JAK1 isoform over JAK2. This study culminated in the identification of subnanomolar JAK1 inhibitors such as <b>22</b> and <b>49</b>, having excellent cell potency, good rat pharmacokinetic characteristics, and excellent kinase selectivity. Determination of the binding modes of the series in JAK1 and JAK2 by X-ray crystallography supported the design of analogues to enhance affinity and selectivity.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec articleNote"><h4><span>▽</span> Author Present Address</h4><p class="last">Department of Infectious Disease, MedImmune, Gaithersburg, Maryland, United States.</p></div><div class="extra-info-sec articleNote"><h4><span>⧫</span> Author Present Address</h4><p class="last">Cancer Research UK Drug Discovery Unit, Paterson Institute for Cancer Research, University of Manchester, Wilmslow Road, Manchester M20 4BX, United Kingdom.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84644" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84644" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The Janus protein tyrosine kinases (JAK1, JAK2, JAK3, and TYK2) mediate intracellular signaling of numerous cytokines and thereby play critical roles in a variety of biological processes, including hematopoiesis and the regulation of immune and inflammatory responses.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> JAKs constitutively associatewith cytoplasmic motifs in the intracellular domain of cytokine receptors and are activated upon ligand induced receptor homo- or heterodimerization, which results in the immediate phosphorylation of tyrosine residues within the cytoplasmic domain of the receptors. These phosphotyrosines then serve as docking sites for cytoplasmic signal transducer and activator of transcription (STAT) proteins. Upon recruitment to the receptor complex, STATs become phosphorylated by the JAKs, which allow them to dimerize and travel to the cellular nucleus, where they act as transcription factors.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a></div><div class="NLM_p">Biochemical and genetic studies have shown that JAK1 is the most broadly used JAK, as it is involved in the signaling of the gamma common (γ<sub>c</sub>), beta common (β<sub>c</sub>), gp130, type I and type II interferon, IL-6, and IL-10 subfamilies of cytokines.<a onclick="showRef(event, 'cit1a ref3'); return false;" href="javascript:void(0);" class="ref cit1a ref3">(1a, 3)</a>JAK2 utilization is more restricted and generally associated with receptors that function as homodimers, such as the erythropoietin (EPO) and growth hormone receptors, among others. Consistent with its role in EPO signaling, mice lacking the JAK2 gene die of anemia,<a onclick="showRef(event, 'cit2a'); return false;" href="javascript:void(0);" class="ref cit2a">(2a)</a> while a gain-of-function mutation in the JAK2 gene (<i>JAK2</i><sup><i>V617F</i></sup>) results in polycythemia vera and other myeloproliferative disorders (MPD) in humans.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Similar to JAK1 and JAK2, TYK2 is also widely expressed and activated by numerous cytokines. In contrast to JAK1 and JAK2, however, deficiency in TYK2 is not lethal, suggesting that TYK2 might be more dispensable than JAK1 and JAK2. While TYK2-deficient mice show no gross abnormalities in the absence of challenge, TYK2-deficient humans suffer from hyper IgE syndrome but are otherwise viable.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Finally, JAK3 is the only JAK family member with a restricted expression pattern and function, being localized in lymphoid tissue.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> This protein associates exclusively with the γ<sub>c</sub> chain, and in both humans and mice, JAK3 deficiency phenocopies γ<sub>c</sub> deficiency, resulting in X-linked severe combined immunodeficiency (X-SCID) due to complete abrogation of IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21 signaling.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a></div><div class="NLM_p">Owing to its restriction to the γ<sub>c</sub> subfamily of cytokines, JAK3 has long been viewed as an attractive therapeutic target for the treatment of certain immune system indications (e.g., transplant rejection and rheumatoid arthritis (RA)).<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7, 8)</a> Initially described as a JAK3 specific inhibitor,<a onclick="showRef(event, 'cit8b'); return false;" href="javascript:void(0);" class="ref cit8b">(8b)</a> the small molecule tofacitinib (<b>1</b>, CP-690,550; Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) is now in advanced clinical testing and has demonstrated efficacy against RA, psoriasis, Crohn’s disease, kidney transplant rejection, and ulcerative colitis.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> It has recently become clear that <b>1</b> is not as specific as initially thought for JAK3, but rather is a potent pan-JAK inhibitor (<i>K</i><sub>i</sub> = 0.68, 0.99, 0.24, and 4.39 nM for JAK1, JAK2, JAK3, and TYK2, respectively).<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Multiple inhibitors targeting JAK2 are also undergoing clinical evaluation against MPDs, and several have exhibited promising results.<a onclick="showRef(event, 'ref4 ref11'); return false;" href="javascript:void(0);" class="ref ref4 ref11">(4, 11)</a> Of these agents, ruxolitinib (<b>2</b>, INCB018424; Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) was approved in 2011 for the treatment of myelofibrosis,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> and the compound has also demonstrated efficacy in the RA setting.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> The reported potency of ruxolitinib (<b>2</b>) for JAK3 is far weaker than its inhibitory activity toward the other JAK family members (IC<sub>50</sub> = 3.3, 2.8, 428, and 19 nM for JAK1, JAK2, JAK3, and TYK2, respectively),<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> suggesting that the compound’s clinical efficacy against RA is unlikely to be driven by inhibition of the JAK3 isoform. Furthermore, a recent report claims that for cytokine signaling mediated through γ<sub>c</sub>-containing receptors, the JAK1 pathway is dominant over JAK3.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/medium/jm-2012-00438j_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/large/jm-2012-00438j_0002.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. JAK inhibitors in advanced clinical evaluation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/large/jm-2012-00438j_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300438j&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Both <b>1</b> and <b>2</b> are potent inhibitors of JAK1 and JAK2, but differ in their potency for JAK3 and TYK2. Since both have exhibited activity against RA, we hypothesized that this property was a result of JAK1 inhibition as a result of the following considerations. First, while IL-6 stimulation activates JAK1, JAK2, and TYK2, cells taken from JAK1 knockout mice exhibit substantially reduced levels of responsiveness when compared to those from wild-type animals.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> In contrast, comparable activities toward IL-6 are observed between wild-type and knockout mice in the case of both JAK2<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> and TYK2.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Second, tocilizumab, an IL-6R-specific, neutralizing humanized monoclonal antibody, has shown impressive clinical efficacy in the treatment of RA.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Furthermore, JAK1 rather than JAK2 participates in the signaling of pathophysiologically relevant γ<sub>c</sub> cytokines, including IL-15, neutralization of which also results in improvement of RA.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div><div class="NLM_p last">Anemia has been observed in some patients during clinical evaluation of both <b>1</b><a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> and <b>2</b>.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> As noted above, both compounds exhibit potent JAK2 inhibitory activity, and a link between JAK2 deficiency and anemia has been demonstrated in mice.<a onclick="showRef(event, 'cit22a ref23'); return false;" href="javascript:void(0);" class="ref cit22a ref23">(22a, 23)</a> Therefore, we reasoned that a JAK1 selective, JAK2 sparing inhibitor would constitute an ideal therapeutic agent to target inflammatory disorders such as RA.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Herein we describe the identification and characterization of a novel series of tricyclic JAK inhibitors along with our initial efforts at achieving the desired JAK1/JAK2 selectivity profile within this chemotype.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17272" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17272" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Molecular modeling studies previously performed on compound <b>1</b> indicated that a staggered, <i>anti</i>-periplanar conformation (<i>anti</i>-<b>1</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>), in which the <i>N</i>-methyl group points toward the pyrrole ring, is energetically favored over the alternate rotational isomer (<i>syn</i>-<b>1</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Furthermore, a single crystal X-ray structure determination of a closely related derivative indicated this compound also exists in a similar staggered conformation.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> In contrast, an X-ray cocrystal structure of <b>1</b> bound to JAK1 clearly showed the piperidine moiety residing in an eclipsed, <i>syn</i>-periplanar orientation to the bicyclic ring system (<i>syn</i>-<b>1</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> These observations suggested the use of a tricyclic template to rigidify the inhibitor structure in a manner that would closely mimic the compound <b>1</b> rotamer that was preferred for JAK1 binding. We elected to explore this possibility by introducing an imidazole ring into the bicyclic inhibitor design, giving rise to an imidazo-pyrrolopyridine scaffold (e.g., <b>3</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/medium/jm-2012-00438j_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/large/jm-2012-00438j_0003.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Generation of tricyclic inhibitor scaffold <b>3</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/large/jm-2012-00438j_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300438j&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">At the outset of this work, it was reasoned that, in order to be considered potential drug candidates, any new compounds should possess levels of biochemical and functional JAK1 potency comparable to <b>1</b>. Specifically, the goal was to achieve at least low single-digit and, preferably, subnanomolar biochemical activity, with a cellular EC<sub>50</sub> value ideally less than 100 nM. However, the degree of selectivity for JAK1 over JAK2 that would be required to impart therapeutic benefit relative to <b>1</b> was unclear. The observation of reduced hemoglobin levels at higher (>5 mg BID) doses of <b>1</b> during a recent clinical trial was attributed by the authors to possible effects on hematopoiesis through inhibition of JAK2.<a onclick="showRef(event, 'cit21b'); return false;" href="javascript:void(0);" class="ref cit21b">(21b)</a> This led us to surmise that a relatively modest degree of selectivity for JAK1 over JAK2, perhaps on the order of 10-fold, may be sufficient to provide a suitable therapeutic window.</div><div class="NLM_p">To the best of our knowledge, no account of how JAK1 selectivity may be achieved has thus far been disclosed, although compounds with this profile have been described in recent patent applications.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Moreover, a compound (GLPG0634; structure undisclosed), reported to be JAK1 selective (IC<sub>50</sub> = 10, 28, 810, and 116 nM for JAK1, JAK2, JAK3, and TYK2, respectively),<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> has recently demonstrated efficacy against RA with a good safety profile in an early phase II trial.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Furthermore, diamino-1,2,4-triazoles structurally related to JNJ-7706621 (IC<sub>50</sub> = 39, 1700, 950, and 39 nM for JAK1, JAK2, JAK3, and TYK2, respectively) have been reported to also be selective for JAK1 and TYK2 over the other JAK isoforms,<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> although the reference compound is known to be somewhat promiscuous against a variety of other kinases.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a></div><div class="NLM_p">In our biochemical assays,<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> compound <b>1</b> was confirmed to be a potent, pan-JAK inhibitor with some selectivity over TYK2 (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Gratifyingly, the racemic tricyclic molecule <b>4</b> displayed similar inhibitory properties when tested against the same enzymes. Equally striking was the observation that, while <b>5</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>), an <i>N</i>-benzyl-containing compound related to <b>1</b>, was several hundred-fold less potent, the corresponding tricyclic inhibitor <b>6</b> suffered only an order of magnitude loss in activity. These observations suggested that the tricyclic imidazo-pyrrolopyridine scaffold could possess a divergent and productive SAR when compared to pyrrolopyrimidine-containing inhibitors such as <b>1</b>. Simplification of <b>4</b> by the removal of the piperidinyl methyl group afforded <b>7</b>, which maintained excellent JAK1 potency.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. JAK Isoform Inhibitory Activities of Heterocycloamine Derivatives of <b>3</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/medium/jm-2012-00438j_0005.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/medium/jm-2012-00438j_0006.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Arithmetic mean of at least 3 separate determinations (<i>n</i> ≥ 3).<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">Not applicable.</p></div></div><div></div></div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/medium/jm-2012-00438j_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/large/jm-2012-00438j_0004.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Synthetic precursor to <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/large/jm-2012-00438j_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300438j&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Encouraged by these preliminary results, we sought alternatives to the distinctive cyanoacetamide substituent present in <b>1</b>, <b>4</b>, and <b>7</b>. Capitalizing on the favorable results observed for <b>6</b>, we examined different ring systems that retained the <i>N</i>-benzyl group (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). The subtle contribution to JAK binding of the piperidinyl methyl group present in <b>6</b> was demonstrated by the <i>des</i>-methyl analogue <b>8</b> (2–6-fold loss in potency across the four isoforms), while <b>9</b> confirmed that the (<i>R</i>)-piperidine configuration favored JAK1 activity. Replacement of the piperidine in <b>8</b> with the corresponding <i>N</i>-benzyl pyrrolidine and azetidine had minimal impact on inhibitory potency across the four JAK family enzymes in our testing panel (<b>10</b> and <b>11</b>, respectively). However, incorporation of an achiral 4-substituted piperidine into the tricyclic inhibitor design (<b>12</b>) resulted in a dramatic increase in JAK potency relative to the 3-substituted piperidines <b>8</b> and <b>9</b>.</div><div class="NLM_p">Having identified compounds such as <b>7</b> and <b>12</b> with encouraging JAK inhibitory potency, further optimization of this novel series of tricyclic JAK inhibitors was undertaken. Following the determination of enzyme activity against all four isoforms, compounds were assessed for cellular potency and selectivity. Since the general pattern of isoform activity displayed in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, namely higher inhibition at JAK1 and JAK2 than at JAK3 and TYK2, was maintained in subsequent examples, further discussion of biochemical potency against the latter two enzymes will be omitted for the purpose of brevity. JAK1 enzyme (biochemical) selectivity is expressed as the ratio: JAK2 (<i>K</i><sub>i</sub>)/JAK1 (<i>K</i><sub>i</sub>). With regard to cellular potency, it was considered desirable to determine both JAK1 and JAK2 cellular activity in the same cell line, in order to circumvent any issues arising from differences in response between alternate cell types. In TF-1 cells, IL-6 stimulation leads to STAT3 phosphorylation predominantly through involvement of JAK1, whereas EPO stimulation elaborates phospho-STAT5 in a JAK2 dependent fashion.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> By analogy to enzyme selectivity, quoted cell selectivities are the ratios of pSTAT5 EC<sub>50</sub> over pSTAT3 EC<sub>50</sub>. Compounds were also routinely evaluated for metabolic stability by incubation with human liver microsomes. Reference standard <b>1</b> exhibited excellent cell potency in the IL-6-driven pSTAT3 cell assay (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Despite having comparable JAK1 biochemical potency, tricyclic analogue <b>7</b> exhibited somewhat weaker cell potency, but equivalent microsomal stability to <b>1</b>. Although having somewhat reduced activity for JAK1 relative to <b>7</b>, <b>12</b> proved more potent in the JAK1-pSTAT3 cellular assay. However, <i>in vitro</i> turnover in human microsomes was observed to be higher for <b>12</b> than that noted for <b>7</b>. Despite this shortcoming, the 4-piperidinyl regioisomer was selected for further optimization, on the basis that a cyanoacetyl substituent was not required, as demonstrated by the excellent JAK1 enzyme potency of <b>12</b>, and the fact that this positional isomer was less stereochemically complex by virtue of not possessing a chiral center. Reasoning that the high <i>in vitro</i> clearance observed with <b>12</b> was due to the presence of a lipophilic benzyl group, efforts were undertaken to address this liability. Unsubstituted piperidine <b>13</b> suffered a significant loss in JAK1 inhibitory activity, with a concomitant loss in cellular potency. Introduction of polarity into <b>12</b> in the form of a pyrimidine (<b>14</b>) maintained comparable inhibitory activity, while concurrently reducing degradation in human microsomal preparations. These improvements unfortunately came at the expense of cellular potency when compared to the less polar <b>12</b>. The cyanoacyl substituent present in <b>1</b>, <b>4</b>, and <b>7</b> was significantly less successful when introduced in the context of the 4-piperidine (<b>15</b>), especially in terms of cellular activity. A benzoyl 4-piperidine substituent likewise proved to be a poor replacement for benzyl (<b>16</b>). No JAK1 potency advantage was offered by a simple alkyl amide (<b>17</b>), although JAK1 enzyme potency was maintained relative to <b>12</b> and <b>14</b> with sulfonamide <b>19</b> and, to a lesser extent, <b>18</b>. Interestingly, substitution of the 4-piperidine with a simple alkyl group, as in <b>20</b>, was highly detrimental to activity. However, functionalization of the alkyl group with electron-withdrawing moieties proved to be a particularly successful strategy, with both JAK1 enzyme and cell potency being restored in the trifluoroethyl analogue <b>21</b>. Within this series of compounds, cyanoethyl derivative <b>22</b> encompassed the optimum overall balance of properties, with excellent cell potency and high <i>in vitro</i> metabolic stability.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. <i>In Vitro</i> Properties of 4-Piperidinyl Derivatives of <b>3</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/medium/jm-2012-00438j_0007.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/medium/jm-2012-00438j_0008.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">Arithmetic mean of at least 3 separate determinations (<i>n</i> ≥ 3).</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">Biochemical selectivity for JAK1 over JAK2 (JAK2 <i>K</i><sub>i</sub>/JAK1 <i>K</i><sub>i</sub>).</p></div><div class="footnote" id="t2fn3"><sup>Table c</sup><p class="last">pSTAT3-IL6 JAK1 driven TF-1 cell-based assay.</p></div><div class="footnote" id="t2fn4"><sup>Table d</sup><p class="last">Cell-based selectivity for JAK1 over JAK2 (pSTAT5-EPO EC<sub>50</sub>/pSTAT3-IL6 EC<sub>50</sub>).</p></div><div class="footnote" id="t2fn5"><sup>Table e</sup><p class="last">Half-life in the presence of <i>in vitro</i> preparations of human liver microsomes.</p></div><div class="footnote" id="t2fn6"><sup>Table f</sup><p class="last">From ref <a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">35</a>.</p></div><div class="footnote" id="t2fn7"><sup>Table g</sup><p class="last">Not determined.</p></div><div class="footnote" id="t2fn8"><sup>Table h</sup><p class="last">Single, more active enantiomer; absolute configuration was assigned arbitrarily.</p></div></div><div></div></div><div class="NLM_p">Some general observations on the tricyclic compounds discussed thus far warrant comment. 4-Piperidine tolerated a wide range of subtituents; the varied chemotypes contained in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> span only a 100-fold range in JAK1 inhibitory activity. The tricyclic scaffold also appeared to have an intrinsic preference for JAK1; nearly all of the compounds displayed a very modest but consistent selectivity for this isoform over JAK2 in the biochemical assays. Furthermore, excellentJAK1-pSTAT3 cell potency was achievable with the tricyclic inhibitors. Cell and biochemical selectivities were in good agreement for the most part, with perhaps a subtle enhancement of the former relative to the latter, as observed also with <b>1</b>. Derivatization of the piperidine with dimethyl glycine (<b>23</b>) resulted in some loss in enzyme activity, but an improvement in biochemical selectivity, when compared to the isosteric amide (<b>17</b>). This characteristic was observed with other derivatives bearing a basic center in this vicinity, with cyclization (<b>24</b>–<b>27</b>) generally offering some benefit to both biochemical potency and selectivity. For instance, proline derivative <b>26</b> displayed a 17-fold preference for JAK1 over JAK2. Possible reasons for the enhanced selectivity observed with compounds incorporating a basic, pendent substituent are discussed in more detail below. Unfortunately, despite possessing intriguing levels of selectivity, progression of this subset of compounds was precluded by a persistent inability to achieve required levels of inhibitory activity, leading to commensurately poor cellular potency.</div><div class="NLM_p">With the aim of enhancing binding interactions by exploiting potential lipophilic contacts between the piperidine ring and protein residues located under the P-loop (see discussion of crystallographic studies below), each position on the ring was sequentially probed with a methyl group. Incorporation of a methyl group in both <i>cis</i> and <i>trans</i> dispositions at either the 2- or 3-positions on the piperidine ring provided no significant benefit (data not shown); however, a distinct trend emerged when this substituent was located at the 4-position (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Although this change generally reduced JAK1 enzyme potency relative to the corresponding unmethylated counterparts, the extent was dramatically dependent on <i>N</i>-substitution. Thus, sulfonamide <b>30</b> was equipotent to its unmethylated analogue <b>19</b>, whereas <b>32</b> suffered a 50-fold reduction in activity when compared to <b>22</b>. However, in each case, biochemical selectivity over JAK2 was improved relative to the unsubstituted example, although this effect was variable, ranging from 3-fold for <b>32</b> to 16-fold for <b>28</b>. The general reduction in activity observed on methylation of the piperidine also translated to the cellular assay; of the compounds tested, only <b>30</b> displayed moderate potency.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. <i>In Vitro</i> Properties of 4-Methylated Piperidinyl Derivatives of <b>3</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/medium/jm-2012-00438j_0009.gif" alt="" id="fx5" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/medium/jm-2012-00438j_0010.gif" alt="" id="fx6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">Mean of at least 3 separate determinations (<i>n</i> ≥ 3).</p></div><div class="footnote" id="t3fn2"><sup>Table b</sup><p class="last">Biochemical selectivity for JAK1 over JAK2 (JAK2 <i>K</i><sub>i</sub>/JAK1 <i>K</i><sub>i</sub>).</p></div><div class="footnote" id="t3fn3"><sup>Table c</sup><p class="last">pSTAT3-IL6 JAK1 driven TF-1 cell-based assay.</p></div><div class="footnote" id="t3fn4"><sup>Table d</sup><p class="last">Cell-based selectivity for JAK1 over JAK2 (pSTAT5-EPO EC<sub>50</sub>/pSTAT3-IL6 EC<sub>50</sub>).</p></div><div class="footnote" id="t3fn5"><sup>Table e</sup><p class="last">Half-life in the presence of <i>in vitro</i> preparations of human liver microsomes.</p></div></div><div></div></div><div class="NLM_p">In an effort to improve further upon the properties of the compounds described thus far, a series of substituted cyclohexylamines was also explored. For structural simplicity, and by analogy with the findings from an evaluation of piperidine SAR, attention in this case was focused on the 1,4 disubstituted regioisomer. Additionally, a selection of <i>cis</i> and <i>trans</i> stereoisomeric pairs was examined in order to establish stereochemical preference.</div><div class="NLM_p">Although identical JAK1 inhibitory activity was exhibited by <i>tert</i>-butyl carbamates <b>33</b> and <b>34</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>), a marginal preference for the <i>trans</i> over <i>cis</i> isomer was observed in the case of the unsubstituted amine (<b>35</b> and <b>36</b>, respectively). However, this trend was far more pronounced in the morpholine substituted pair, with the <i>trans</i> isomer <b>37</b> significantly more potent than the <i>cis</i> isomer <b>38</b>. The <i>trans</i> diastereomer also possessed superior cell potency in the case of the <i>t</i>-butyl carbamate (<b>33</b>, <b>34</b>) and morpholine (<b>37</b>, <b>38</b>) pairs, although not for amines <b>35</b> and <b>36</b>. Indeed, both latter compounds displayed very similar profiles, having moderate biochemical and cell potencies, but high (12-fold) JAK1 cellular selectivites. However, further evaluation of <b>35</b> indicated that this compound had poor rat pharmacokinetic characteristics (see below).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. <i>In Vitro</i> Properties of Cycloalkylamine Derivatives of <b>3</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/medium/jm-2012-00438j_0011.gif" alt="" id="fx7" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/medium/jm-2012-00438j_0012.gif" alt="" id="fx8" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>Table a</sup><p class="last">Relative stereochemistry of substituents on the cyclohexane or cyclopentane ring.</p></div><div class="footnote" id="t4fn2"><sup>Table b</sup><p class="last">Mean of at least 3 separate determinations (<i>n</i> ≥ 3).</p></div><div class="footnote" id="t4fn3"><sup>Table c</sup><p class="last">Biochemical selectivity for JAK1 over JAK2 (JAK2 <i>K</i><sub>i</sub>/JAK1 <i>K</i><sub>i</sub>).</p></div><div class="footnote" id="t4fn4"><sup>Table d</sup><p class="last">pSTAT3-IL6 JAK1 driven TF-1 cell-based assay.</p></div><div class="footnote" id="t4fn5"><sup>Table e</sup><p class="last">Cell-based selectivity for JAK1 over JAK2 (pSTAT5-EPO EC<sub>50</sub>/pSTAT3-IL6 EC<sub>50</sub>).</p></div><div class="footnote" id="t4fn6"><sup>Table f</sup><p class="last">Half-life in the presence of <i>in vitro</i> preparations of human liver microsomes.</p></div><div class="footnote" id="t4fn7"><sup>Table g</sup><p class="last">Not determined.</p></div><div class="footnote" id="t4fn8"><sup>Table h</sup><p class="last">Racemic.</p></div><div class="footnote" id="t4fn9"><sup>Table i</sup><p class="last">Single, more active enantiomer; absolute configuration was assigned arbitrarily.</p></div></div><div></div></div><div class="NLM_p">Derivatization of <b>35</b> provided a range of substituents broadly comparable to those applied to the piperidines in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>. Similar tolerance of a broad range of substitution was also observed with the examples listed in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>. Amide <b>39</b>, amines <b>40</b>–<b>42</b>, and sulphonamide <b>43</b> all possessed single or low double digit nanomolar potency for JAK1 but with variable cellular selectivities. Although having a compelling pharmacological profile, carbamate <b>33</b> displayed only moderate microsomal stability. Reasoning <b>33</b> was compromised by its high lipophilicity (logD<sub>7.2</sub> 3.2), we sought to address this issue by preparing the corresponding methyl analogue <b>44</b> (logD<sub>7.2</sub> 1.9). While this change dramatically improved metabolic stability, it proved detrimental to both enzyme and cell potency and selectivity, relative to <b>33</b>. Interestingly, <i>N</i>-methylation of the carbamate (<b>45</b>) had minimal impact on potency but appeared to abolish both biochemical and cell selectivity. Seeking to reduce hydrophobicity further, the cycloalkyl moiety was truncated to a cyclopentyl ring. Racemic <i>trans</i> derivative <b>46</b> (logD<sub>7.2</sub> 1.2) displayed a 3-fold improvement in JAK1 biochemical activity over <b>44</b>, with a similar enhancement in cell potency. Further improvement in cell potency and selectivity was realized on reinstatement of a <i>t</i>-butyl carbamate (<b>47</b>) but with no penalty in metabolic stability relative to <b>46</b>. The corresponding <i>cis</i> analogue <b>48</b> was less successful, both in terms of potency and stability. Resolution of <b>47</b> provided <b>49</b> as the more active enantiomer. With subnanomolar enzyme activity against JAK1, this compound also proved to have excellent potency in the pSTAT3 cell assay, with an overall profile comparable to that of <b>1</b>. However, in contrast to the potent but unselective <b>1</b>, compound <b>49</b> displayed moderate selectivity for the JAK1 isoform over JAK2, both in biochemical and cell-based assays, in addition to a superior microsomal stability profile.</div><div class="NLM_p">Selected compounds were subjected to more stringent evaluation, including pharmacokinetic profiling in rat and determination of off-target selectivity (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). <i>In vivo</i> plasma clearance following IV dose was high for all compounds. This was unlikely to be as a result of extensive tissue distribution since the volume of distribution for most examples was moderate, save for compounds <b>12</b> and <b>35</b>, for which the much higher values were presumably a reflection of their overtly basic nature. Despite high clearance, reasonable plasma exposure was achieved following PO dose for some compounds, depending on the balance of properties. A similar profile was previously reported for <b>1</b>.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> The poor oral exposure of <b>7</b> was in keeping with low MDCK apparent permeability, which likely resulted from a combination of low lipophilicity (logD) and high polarity (TPSA). In contrast, <i>N</i>-benzyl piperidine <b>12</b> exhibited excellent permeability, but its high lipophilicity and low polarity resulted in high <i>in vitro</i> turnover, with correspondingly high <i>in vivo</i> clearance, culminating in a very poor rat PK profile. These results suggested that an appropriate balance between logD and TPSA was required in order to achieve an appropriate level of permeability with perhaps some modulation of clearance in support of a favorable PK profile. Compounds <b>19</b>, <b>30</b>, and <b>41</b> possessed near identical logD and TPSA values (intermediate between those of <b>7</b> and <b>12</b>) and consequently displayed similar permeability. The PK characteristics of all three compounds showed a substantial improvement over those of <b>7</b> and <b>12</b>, with <b>19</b> and <b>30</b> in particular having good exposure and oral bioavailabilty. Although having comparable and moderate TPSA, <b>22</b> and <b>35</b> exhibited widely disparate PK parameters. The higher lipophilicity of <b>22</b> conveyed an excellent overall profile, whereas that of <b>35</b> was compromised by its remarkably low logD and poor apparent permeability, despite having lower clearance. Likewise, although both <b>12</b> and <b>49</b> are very lipophilic, this potential liability is offset to some extent by the significantly higher polarity of the latter, resulting in <b>49</b> having very favorable PK properties.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Physicochemical, <i>in Vitro</i>, and Rat Pharmacokinetic Properties of Selected Compounds</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="5" align="center"><i>in vivo</i> rat PK<a class="ref internalNav" href="#t5fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Ex</th><th class="colsep0 rowsep0" align="center">logD<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">TPSA (Å<sup>2</sup>)</th><th class="colsep0 rowsep0" align="center">MDCK A:B P<sub>app</sub> (×10<sup>–6</sup>cm/s)<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">rat Hep. T<sub>1/2</sub> (h)<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">CL (mL/min/kg)<a class="ref internalNav" href="#t5fn6" aria-label="f">f</a></th><th class="colsep0 rowsep0" align="center">AUC (μM·h)<a class="ref internalNav" href="#t5fn7" aria-label="g">g</a></th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>max</sub> (μM)<a class="ref internalNav" href="#t5fn8" aria-label="h">h</a></th><th class="colsep0 rowsep0" align="center">Vss (L/kg)<a class="ref internalNav" href="#t5fn9" aria-label="i">i</a></th><th class="colsep0 rowsep0" align="center">F (%)<a class="ref internalNav" href="#t5fn10" aria-label="j">j</a></th><th class="colsep0 rowsep0" align="center">kinase select. (>50% inhib.)<a class="ref internalNav" href="#t5fn5" aria-label="e">e</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1<a class="ref internalNav" href="#t5fn11" aria-label="k">k</a></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">88</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">62</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.7</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">27</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">7</td><td class="colsep0 rowsep0" align="left">0.39</td><td class="colsep0 rowsep0" align="left">90</td><td class="colsep0 rowsep0" align="left">0.3</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">85</td><td class="colsep0 rowsep0" align="left">0.3</td><td class="colsep0 rowsep0" align="left">0.05</td><td class="colsep0 rowsep0" align="left">1.87</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">2/183</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">2.90</td><td class="colsep0 rowsep0" align="left">49</td><td class="colsep0 rowsep0" align="left">32.3</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">170</td><td class="colsep0 rowsep0" align="left"><a class="ref internalNav" href="#t5fn12" aria-label="l">l</a>BLQ</td><td class="colsep0 rowsep0" align="left">0.04</td><td class="colsep0 rowsep0" align="left">6.39</td><td class="colsep0 rowsep0" align="left"><1</td><td class="colsep0 rowsep0" align="left">1/50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">1.04</td><td class="colsep0 rowsep0" align="left">83</td><td class="colsep0 rowsep0" align="left">1.2</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">45</td><td class="colsep0 rowsep0" align="left">2.3</td><td class="colsep0 rowsep0" align="left">2.9</td><td class="colsep0 rowsep0" align="left">1.46</td><td class="colsep0 rowsep0" align="left">36</td><td class="colsep0 rowsep0" align="left">1/50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">1.72</td><td class="colsep0 rowsep0" align="left">73</td><td class="colsep0 rowsep0" align="left">8.2</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">96</td><td class="colsep0 rowsep0" align="left">1.6</td><td class="colsep0 rowsep0" align="left">1.8</td><td class="colsep0 rowsep0" align="left">2.37</td><td class="colsep0 rowsep0" align="left">48</td><td class="colsep0 rowsep0" align="left">0/50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">1.14</td><td class="colsep0 rowsep0" align="left">83</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">82</td><td class="colsep0 rowsep0" align="left">2.3</td><td class="colsep0 rowsep0" align="left">0.8</td><td class="colsep0 rowsep0" align="left">2.72</td><td class="colsep0 rowsep0" align="left">74</td><td class="colsep0 rowsep0" align="left">3/50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="left">–0.44</td><td class="colsep0 rowsep0" align="left">72</td><td class="colsep0 rowsep0" align="left">0.2</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">65</td><td class="colsep0 rowsep0" align="left">0.22</td><td class="colsep0 rowsep0" align="left">0.02</td><td class="colsep0 rowsep0" align="left">13.9</td><td class="colsep0 rowsep0" align="left"><1</td><td class="colsep0 rowsep0" align="left">8/50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="left">0.97</td><td class="colsep0 rowsep0" align="left">82</td><td class="colsep0 rowsep0" align="left">1.5</td><td class="colsep0 rowsep0" align="left">9.8</td><td class="colsep0 rowsep0" align="left">120</td><td class="colsep0 rowsep0" align="left">0.7</td><td class="colsep0 rowsep0" align="left">0.6</td><td class="colsep0 rowsep0" align="left">3.96</td><td class="colsep0 rowsep0" align="left">28</td><td class="colsep0 rowsep0" align="left">5/50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>49</b></td><td class="colsep0 rowsep0" align="left">2.99</td><td class="colsep0 rowsep0" align="left">84</td><td class="colsep0 rowsep0" align="left">11.2</td><td class="colsep0 rowsep0" align="left">2.2</td><td class="colsep0 rowsep0" align="left">140</td><td class="colsep0 rowsep0" align="left">1.3</td><td class="colsep0 rowsep0" align="left">1.1</td><td class="colsep0 rowsep0" align="left">2.53</td><td class="colsep0 rowsep0" align="left">73</td><td class="colsep0 rowsep0" align="left">0/50</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Measured at pH 7.2.</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">Apparent permeability in MDCK transwell culture, A:B apical to basolateral.</p></div><div class="footnote" id="t5fn3"><sup>c</sup><p class="last"><i>In vitro</i> stability in cryopreserved rat hepatocytes.</p></div><div class="footnote" id="t5fn4"><sup>d</sup><p class="last">Normalized to 5 mg/kg <i>po</i>, 1 mg/kg <i>iv</i>.</p></div><div class="footnote" id="t5fn5"><sup>e</sup><p class="last">Number of enzymes inhibited >50% out of a panel of 183 or 50 non-JAK kinases, at a test concentration of 100 × JAK1 <i>K</i><sub>i</sub>.</p></div><div class="footnote" id="t5fn6"><sup>f</sup><p class="last">Plasma clearance following <i>iv</i> dosing.</p></div><div class="footnote" id="t5fn7"><sup>g</sup><p class="last">Plasma area under the curve following <i>po</i> dosing.</p></div><div class="footnote" id="t5fn8"><sup>h</sup><p class="last">Maximal plasma concentration following <i>po</i> dosing.</p></div><div class="footnote" id="t5fn9"><sup>i</sup><p class="last">Volume of distribution at steady state.</p></div><div class="footnote" id="t5fn10"><sup>j</sup><p class="last">Oral bioavailability.</p></div><div class="footnote" id="t5fn11"><sup>k</sup><p class="last">Data taken from ref <a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a>.</p></div><div class="footnote" id="t5fn12"><sup>l</sup><p class="last">Below the level of quantification.</p></div></div></div><div class="NLM_p last">To assess pan-kinase selectivity, compounds were screened at a concentration 100-fold higher than their JAK1 <i>K</i><sub>i</sub> against a commercial panel of 50 (183 in the case of <b>7</b>) kinases. Compounds were scored by the number of proteins showing >50% inhibition. On this basis, <b>7</b>, <b>22</b>, and <b>49</b> proved to have excellent selectivity against non-JAK kinases, while <b>35</b> and <b>41</b> were less selective.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">X-ray Crystallographic Studies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20480" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20480" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">X-ray crystallography proved useful in establishing the binding mode of various members of the imidazo-pyrrolopyridine series and interpreting SAR trends across the JAK isoforms. The X-ray structures of <b>1</b> bound to all four JAK isoforms have been reported in the literature.<a onclick="showRef(event, 'ref27 ref36'); return false;" href="javascript:void(0);" class="ref ref27 ref36">(27, 36)</a> Consistent with its pan-JAK activity, <b>1</b> exhibits a similar binding mode to all four JAK isoforms. A high degree of sequence homology exists between JAK1 and JAK2 within the ATP-binding site (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). Amino acids in close contact to the ligand are conserved or show modest changes (e.g., JAK1 Phe958 → JAK2 Tyr931 on the hinge region). More significant differences arise in solvent-exposed residues at the periphery of the binding site, including Arg879 → Gln853, Glu966 → Asp939, and Lys965 → Arg938. Although there are several changes to P-loop residues (e.g., Glu883 → Lys857, His885 → Asn859), the side chains point away from the ligand and hence are not likely to be amenable for the design of direct hydrogen bonding contacts. The high degree of homology suggested that improvement of selectivity for JAK1 over JAK2 would not be a trivial task.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/medium/jm-2012-00438j_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/large/jm-2012-00438j_0013.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Comparison of the X-ray structures of <b>1</b> complexed with JAK1 (white carbon atoms; PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3EYG">3EYG</a><a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a>) and JAK2 (cyan carbon atoms; PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3FUP">3FUP</a>), showing the conserved binding mode of the ligand and the overall similarity in tertiary structure of the JAK isoforms. The phosphate-binding loop (P-loop), activation loop (A-loop), and hinge region are labeled. Residue differences between JAK1 and JAK2 that are located close to the ATP-binding site are shown in thin stick format. Residue numbers refer to JAK1. Figure was generated with Pymol.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/large/jm-2012-00438j_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300438j&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As desired in the original design, the binding mode of <b>1</b> is conserved in tricyclic analogue <b>7</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). The pyrrolopyridine ring system of <b>7</b> binds to the hinge region (JAK1 residues Glu957 and Leu959) in a way similar to that of the pyrrolopyrimidine core of <b>1</b>. The piperidine ring binds to a small lipophilic pocket adjacent to Leu1010 (on the C-terminal wall), while the cyanoacetate group is directed deep under the P-loop. The nitrile does not form any direct hydrogen bonds but may make favorable electrostatic interactions with the peptide backbone of the P-loop (e.g., the carbonyl carbon of Gly887) and the catalytic Lys908. The tight contacts of this group under the P-loop may explain the loss of potency for bulkier groups in this position on the 3-piperidine core (e.g., <b>8</b>). Transfer of the cyanoacetate to the 4-piperidine core (<b>15</b>) results in a loss of activity: molecular modeling studies suggest the acetonitrile group of <b>15</b> points along a different vector compared to <b>7</b> and hence is unable to bind as tightly under the P-loop.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/medium/jm-2012-00438j_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/large/jm-2012-00438j_0014.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Comparison of the X-ray structures of <b>1</b> complexed with JAK1 (white carbon atoms; PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3EYG">3EYG</a><a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a>) and <b>7</b> complexed with a JAK2 triple mutant (green carbon atoms) showing the conserved binding mode. The phosphate-binding loop (P-loop), activation loop (A-loop), and hinge region are labeled. Residue numbers refer to JAK1. Figure generated with Pymol.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/large/jm-2012-00438j_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300438j&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In general, crystallographic studies revealed that small<i>N</i>-substituents on the 4-piperidinyl core sit loosely between the P-loop and the C-terminal lobe, close to residues associated with the binding of the phosphate of ATP, such as Asn1008 and Asp1021 in JAK1. Larger substituents on the 4-piperidinyl, such as the benzyl group of <b>12</b>, were observed to be oriented toward the P-loop but caused some displacement of the P-loop compared with <b>1</b> and <b>7</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>). The observation that <i>N</i>-substituents on the 4-piperidine are bound loosely along the relatively spacious cleft between the P-loop and the C-terminal lobe may explain why a fairly wide range of substituents is tolerated at this position (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/medium/jm-2012-00438j_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/large/jm-2012-00438j_0015.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Comparison of the X-ray structures of <b>7</b> (green carbon atoms) and <b>12</b> (orange carbon atoms), both complexed with a JAK2 triple mutant, highlighting movement of the P-loop to accommodate the benzyl substituent of <b>12</b>. Residue labels refer to JAK1 numbering.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/large/jm-2012-00438j_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300438j&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p"><i>N</i>-Substitution of the 4-piperidine core with acetylamino groups (<b>23</b>–<b>27</b>) results in a general decrease in inhibitory activity for JAK1 but a gain in selectivity over JAK2. These groups are observed crystallographically to extend toward the bulk solvent between the edge of the P-loop and the C-terminal lobe. The SAR of these basic substituents may be modulated by electrostatic interactions with neighboring residues on the surface of the protein. The presence of several basic amino acids in this region on the C-terminal lobe (e.g., JAK1 Lys965, Arg1007) may impair the JAK1 potency of <b>23</b>–<b>27</b> due to electrostatic repulsion: the guanidine group of Arg1007 is located approximately 5 Å from the pyrrolidine nitrogen of <b>26</b>. Computational modeling studies (described in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>) were used to compare the binding of <b>26</b> to JAK1 and several single residue mutants of JAK1 mimicking the corresponding residue changes in JAK2. These calculations suggested that the residue difference between Glu883 (JAK1) and Lys857 (JAK2) may drive the selectivity of <b>26</b> and similar molecules for JAK1 over JAK2. A visual comparison of the vacuum electrostatic potential of JAK1 to that of the <i>in silico</i> JAK1-E883K mutant illustrates this distinction: the increased positive electrostatic potential in the mutant is repulsive toward the positively charged pyrrolidine moiety on <b>26</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>). This is also consistent with the observation that other basic analogues, similar to <b>26</b>, are disfavored to a greater extent in JAK2 than in JAK1.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/medium/jm-2012-00438j_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/large/jm-2012-00438j_0016.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Electrostatic potential representations for the X-ray structure of <b>26</b> bound to JAK1 (left) and an <i>in silico</i> model of <b>26</b> bound to a JAK1-E883K mutant (right). Ligands are displayed in stick format with green carbon atoms. Surfaces colored by electrostatic potential from red (negative) to blue (positive). A similar orientation of each protein is shown. Surfaces and images were generated with Pymol’s protein contact potential algorithm which approximates the potential that would be felt by a point-charge one solvent radius above the protein surface (Schrödinger, Inc.).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/large/jm-2012-00438j_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300438j&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Methylation at the 4-position of the 4-piperidinyl group (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) may have an effect on the SAR either by a direct interaction with the protein or by stabilization of the ligand conformation. The piperidinyl group is capable of adopting several low energy conformations with respect to the tricyclic core, due to rotation around the bond between the piperidine and the imidazo ring of the tricycle. In X-ray structures of 3-piperidinyl analogues, including <b>1</b>, the hydrogen atom at the 3-position of the piperdinyl moiety (i.e., that on the carbon atom at the point of attachment of the piperidinyl ring to the tricycle) is directed toward the pyrrolo ring of the hinge binder; this conformation allows the <i>N</i>-substituent to be directed under the P-loop. In the 4-piperidinyl series, a broader range of piperidine rotamers is observed crystallographically, presumably influenced to some extent by the binding interactions of substituents on the piperidinyl ring. Thus, methylation on the4-position may serve to stabilize or destabilize specific conformations of the piperidine (e.g., due to steric interactions with the pyrrolo ring of the hinge binder) and thereby influence the binding interactions of substituents on the piperidinyl ring, as well as modulate direct lipophilic contacts between the piperidinyl ring and the C-terminal wall (e.g., Leu1010) (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>).</div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/medium/jm-2012-00438j_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/large/jm-2012-00438j_0017.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Comparison of the X-ray structures of <b>12</b> in JAK2 triple mutant (orange carbon atoms) and <b>30</b> in JAK1 (white carbon atoms), highlighting different piperidine rotamers due to 4-methylation in <b>30</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/large/jm-2012-00438j_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300438j&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">X-ray structures also revealed that the piperidinyl ring of <b>30</b> adopted different rotamers when bound in JAK1 and JAK2; the latter was associated with significant movement of the P-loop into the binding site in order to maximize contacts with the inhibitor (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>). This difference in protein conformation may be an experimental artifact, possibly due to crystal packing contacts which were present in JAK2 but absent in JAK1; it was also noted that the electron density for the P-loop was less complete for the JAK1 complex. The significant shift in the ligand binding mode might have been expected to result in a much greater difference in potency between JAK1 and JAK2, and was not observed for similar inhibitors. However, it is also worth noting that there are several residue differences between JAK1 and JAK2 along the P-loop; although these side chains are directed away from the ligand-binding site, it is possible that they may affect the flexibility of the P-loop such that different low-energy conformations may be accessed by JAK1 compared with JAK2.</div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/medium/jm-2012-00438j_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/large/jm-2012-00438j_0018.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Comparison of the X-ray structures of <b>30</b> bound to JAK1 (white carbon atoms) and JAK2 (cyan carbon atoms), highlighting a shift in the binding mode and significant movement of the P-loop.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/large/jm-2012-00438j_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300438j&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In general, compounds in the cyclohexyl and cyclopentyl series (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>) were observed to bind similarly to the piperidinyl series. As may be expected, substituents on the cyclopentyl ring are directed along a vector intermediate between the vectors presented by the 3-piperidinyl and the 4-piperidinyl rings, and hence may show somewhat different trends in SAR. For example, the relatively bulky carbamate substituent of <b>49</b> lies along the groove between the P-loop and the C-terminal wall, forming a single direct hydrogen bond to the protein to Asp1021 (Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>).</div><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/medium/jm-2012-00438j_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/large/jm-2012-00438j_0019.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Comparison of the X-ray structures of <b>7</b> bound to JAK2 triple mutant (green carbon atoms) and <b>49</b> bound to JAK1 (white carbon atoms) to demonstrate the different vectors adopted by the substituents on the 3-piperidinyl and cyclopentyl rings, respectively. A potential hydrogen bond is highlighted between <b>49</b> and D1021 (yellow dotted line).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/large/jm-2012-00438j_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300438j&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46873" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46873" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Protection of 4-chloro-7-azaindole <b>50</b><a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> with benzenesulfonyl chloride provided <b>51</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>), which was regioselectively nitrated at the 5-position using tetrabutylammonium nitrate in the presence of trifluoroacetic anhydride.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> S<sub>N</sub>Ar displacement of chloride in key intermediate <b>52</b> with amines <b>53a</b>–<b>f</b> afforded <b>54a</b>–<b>f</b>. Amine <b>53a</b> was prepared according to the published procedure.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Iron-mediated reduction<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> followed by cyclization proceeded uneventfully, and the product was deprotected under basic conditions to give the compounds shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> (<b>6</b>, <b>8</b>–<b>10</b>, and<b> 12</b>). In the case of azetidine <b>11</b>, the precursor <i>t</i>-butyl carbamate was deprotected using TFA and the resulting secondary amine reductively alkylated with benzaldehyde. Transfer hydrogenolysis of the <i>N</i>-benzyl groups of <b>6</b> and <b>8</b>, with subsequent cyanoacetylation provided <b>4</b> and <b>7</b>, respectively.</div><figure id="sch1" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/medium/jm-2012-00438j_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/large/jm-2012-00438j_0020.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Preparation of Heterocycloamine Derivatives of <b>3</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/large/jm-2012-00438j_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300438j&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) PhSO<sub>2</sub>Cl, DMAP (cat.), NEt<sub>3</sub>, DCM, rt, overnight, 83%; (ii) <i>n</i>-Bu<sub>4</sub>N<sup>+</sup>NO<sub>3</sub><sup>–</sup>, TFAA, DCM, −5 °C-rt, overnight, 79%; (iii) R′NH<sub>2</sub>, EtN(<i>i</i>-Pr)<sub>2</sub>, <i>i</i>-PrOH, 120 °C in microwave, 11–20 min, 80–100%; (iv) Fe, NH<sub>4</sub>Cl, EtOH, H<sub>2</sub>O, reflux, 70–99%; (v) (EtO)<sub>3</sub>CH, <i>p</i>-TsOH (cat.), PhMe, reflux, 18 h, 81–100%; (vi) NaOH, MeOH, H<sub>2</sub>O, rt, 7 h, 72–98%; (vii) Pd(OH)<sub>2</sub> on C, NH<sub>4</sub>HCO<sub>2</sub>, MeOH, reflux; (viii) NCCH<sub>2</sub>CO<sub>2</sub>H, HOBT, DMAP, EDCl, DCM, rt, 24 h, 11–48% 2 steps; (ix) Pd on C, H<sub>2</sub>, THF; (x) TFA, DCM, 94%, then PhCHO, Na(OAc)<sub>3</sub>BH, AcOH, DCE, MeOH, rt, 91%.</p></p></figure><div class="NLM_p">Hydrogenolysis of <b>12</b> provided <b>13</b>, which was derivatized under standard conditions (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>) to give the compounds in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>.</div><figure id="sch2" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/medium/jm-2012-00438j_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/large/jm-2012-00438j_0021.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Preparation of 4-Piperidinyl Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/large/jm-2012-00438j_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300438j&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) Pd(OH)<sub>2</sub> on C, NH<sub>4</sub>HCO<sub>2</sub>, MeOH, reflux, 52%; (ii) Na(OAc)<sub>3</sub>BH, AcOH, DCE, MeOH, rt, 57–68%; (iii) <b>15</b>, <b>16</b>, X = OH HOBT, DMAP, EDCl, DCM, rt, 32–57%; <b>17</b>, X = Cl NEt<sub>3</sub>, DCM, rt, 52%; <b>23</b>, <b>25</b>–<b>27</b>, X = OH HATU, EtN(<i>i</i>-Pr)<sub>2</sub>, DMF; <b>24</b>, then TFA, DCM, then HCHO, Na(OAc)<sub>3</sub>BH, AcOH, DCE; (iv) EtN(<i>i</i>-Pr)<sub>2</sub>, DMF, THF, 13–18%; (v) NEt<sub>3</sub>, DCM, DMF, rt, 46%; (vi) EtOH, reflux, 87%.</p></p></figure><div class="NLM_p">Piperidine derivatives bearing a 4-methyl group were prepared in accordance with the sequence depicted in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>. Curtius rearrangement of commercially available Boc-protected piperidine carboxylate <b>55</b> in the presence of benzyl alcohol afforded bis carbamate <b>56</b>. Selective deprotection gave amine <b>57</b>, which required significantly more forcing conditions than those employed previously to react with <b>52</b> on account of its hindered nature. Manipulation of the adduct in a manner analogous to that described above gave <b>58</b>, which on deprotection furnished <b>28</b>. Derivatization of the piperidine provided the other compounds listed in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>.</div><figure id="sch3" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/medium/jm-2012-00438j_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/large/jm-2012-00438j_0022.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Preparation of 4-Methyl Piperidinyl Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/large/jm-2012-00438j_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300438j&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) Ph<sub>2</sub>P(O)N<sub>3</sub>, NEt<sub>3</sub>, PhCH<sub>2</sub>OH, PhMe, reflux; (ii) Pd on C, H<sub>2</sub>, EtOH, 47% 2 steps; (iii) <b>52</b>, EtN(<i>i</i>-Pr)<sub>2</sub>, <i>i</i>-PrOH, reflux, 65 h, 79%; (iv) Fe, NH<sub>4</sub>Cl, MeOH, H<sub>2</sub>O, reflux, 84%; (v) (EtO)<sub>3</sub>CH, <i>p</i>-TsOH (cat.), PhMe, reflux, 86%; (vi) NaOH, MeOH, H<sub>2</sub>O, rt, 98%; (vii) TFA, DCM, rt, 98%; (viii) pyrimidine-5-carboxaldehyde, Na(OAc)<sub>3</sub>BH, AcOH, mol. sieves, DCE, rt, 47%; (ix) MeSO<sub>2</sub>Cl, NEt<sub>3</sub>, DCM, rt, 58%; (x) TfOCH<sub>2</sub>CF<sub>3</sub>, NEt<sub>3</sub>, DCM, DMF, rt, 87%; (xi) acrylonitrile, EtOH, reflux, 57%.</p></p></figure><div class="NLM_p">Synthesis of cyclohexylamine derivatives <b>33</b>, <b>35</b>, and <b>39</b>–<b>45</b> followed an analogous process (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>), starting with monoprotected <i>trans</i>-cyclohexyl-1,4-diamine <b>59</b>. Compounds <b>34</b> and <b>36</b> were prepared in a fashion corresponding to that of <b>33</b> and <b>35</b>, respectively, only using the <i>cis</i> diastereomer of <b>59</b>.</div><figure id="sch4" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/medium/jm-2012-00438j_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/large/jm-2012-00438j_0023.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Preparation of 4-Cyclohexylamine Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/large/jm-2012-00438j_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300438j&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) <b>52</b>, EtN(<i>i</i>-Pr)<sub>2</sub>, <i>i</i>-PrOH, reflux, 1 h, 80%; (ii) Fe, NH<sub>4</sub>Cl, MeOH, H<sub>2</sub>O, reflux, 80%; (iii) (EtO)<sub>3</sub>CH, <i>p</i>-TsOH (cat.), PhMe, reflux, 88%; (iv) NaOH, MeOH, THF, rt, 81%; (v) TFA, DCM, rt, 1 h, 95%; (vi) <b>62</b>, <i>iso</i>butyryl chloride, EtN(<i>i</i>-Pr)<sub>2</sub>, DMAP, DCM, rt, then NaOH, MeOH, rt, 30%; (vii) <b>62</b>, cyclopropylcarboxaldehyde, Na(OAc)<sub>3</sub>BH, MeOH, rt, then NaOH, MeOH, rt, 44%; (viii) <b>35</b>, acrylonitrile, EtOH, reflux, 36%; (ix) <b>35</b>, 3-cyanobenzaldehyde, Na(OAc)<sub>3</sub>BH, AcOH, mol. sieves, DCE, rt, 24%; (x) <b>35</b>, MeSO<sub>2</sub>Cl, NEt<sub>3</sub>, DCM, rt, 38%; (xi) <b>62</b>, 4-nitrophenyl chloroformate, pyridine,0 °C, then NaOMe, MeOH, 100 °C in microwave, 10 min, 24%; (xii) <b>62</b>, Ac<sub>2</sub>O, HCO<sub>2</sub>H, THF, then BH<sub>3</sub>-THF, THF, 80 °C 86%; (xiii) methyl chloroformate, EtN(<i>i</i>-Pr)<sub>2</sub>, DCM, then NaOH, THF, MeOH, H<sub>2</sub>O, rt, 55%.</p></p></figure><div class="NLM_p">Morpholine derivatives <b>37</b> and <b>38</b> were prepared (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>) by reductive amination of cyclohexanone <b>65</b> with morpholine, followed by separation of diastereomers <b>66</b> and subsequent deprotection. Compound <b>65</b> arose through oxidation of alcohol <b>64</b>, itself obtained through a process analogous to that described previously, starting with amino alcohol <b>63</b>,</div><figure id="sch5" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/medium/jm-2012-00438j_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/large/jm-2012-00438j_0024.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Preparation of Morpholine Derivatives <b>37</b> and <b>38</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/large/jm-2012-00438j_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300438j&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) <b>52</b>, EtN(<i>i</i>-Pr)<sub>2</sub>, <i>i</i>-PrOH, reflux, 2 h, quant.; (ii) Fe, NH<sub>4</sub>Cl, EtOH, H<sub>2</sub>O, reflux, 2 h, 52%; (iii) (EtO)<sub>3</sub>CH, AcOH, 110 °C, 0. 25 h, then rt, 82%; (iv) Dess–Martin periodinane, DCM, 0 °C-rt, 89%; (v) morpholine, Na(OAc)<sub>3</sub>BH, AcOH, THF, rt, 20 h, then chromatographic separation, <i>trans</i>: 19%, <i>cis</i>: 23%; (vi) NaOH, MeOH, H<sub>2</sub>O, <i>trans</i>, 67%.</p></p></figure><div class="NLM_p">The preparation of cyclopentylamine derivatives <b>47</b>–<b>49</b> is described in Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>. Palladium-mediated reduction of bicyclic hydroxylamine <b>67</b><a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> followed by N–O bond cleavage with Raney nickel<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> afforded protected <i>cis</i> amino alcohol <b>68</b>. Mesylation, azide displacement<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> and subsequent reduction gave <i>trans</i> diamine derivative <b>70</b>. This was progressed as previously described to sulfonyl-protected tricycle <b>72</b>, which gave <b>47</b> on basic hydrolysis. This was subjected to SFC resolution, giving <b>49</b> as the more active enantiomer. Conversely, <b>73</b> was prepared by sequential reaction of <b>72</b> with TFA and methyl chloroformate, followed by hydrolysis as before to <b>46</b>. The <i>cis</i>-diastereomer <b>48</b> was synthesized in a manner analogous to that for <b>47</b>, following Mitsunobu inversion of <b>68</b> to <b>69</b>.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></div><figure id="sch6" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/medium/jm-2012-00438j_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/large/jm-2012-00438j_0025.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Preparation of Cyclopentylamine Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/large/jm-2012-00438j_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300438j&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) Pd on C, H<sub>2</sub>, EtOH, 97%; (ii) Raney Ni, H<sub>2</sub>, EtOH, 75%; (iii) diisopropyl azodicarboxylate, PPh<sub>3</sub>, AcOH, THF, 0 °C-rt, then NaOH, MeOH, THF, H<sub>2</sub>O, rt, 76% 2 steps; (iv) MsCl, Et<sub>3</sub>N, acetone, 0 °C, 98%; (v) NaN<sub>3</sub>, DMF, H<sub>2</sub>O, 100 °C, 77–97%; (vi) PPh<sub>3</sub>, THF, H<sub>2</sub>O, 55 °C, 87–91%; (vii) <b>52</b>, EtN(<i>i</i>-Pr)<sub>2</sub>, <i>i</i>-PrOH, 120 °C in microwave, 10 min, 87%-quant. ; (viii) Fe, NH<sub>4</sub>Cl, EtOH, H<sub>2</sub>O, reflux, 70%; (ix) (EtO)<sub>3</sub>CH, <i>p</i>-TsOH (cat.), PhMe, reflux, 77%; (x) TFA, DCM, rt, 86%; (xi) MeO<sub>2</sub>CCl, EtN(<i>i</i>-Pr)<sub>2</sub>, DCM, quant.; (xii) NaOH, THF, MeOH, H<sub>2</sub>O, 89%; (xiii) SFC resolution.</p></p></figure></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36405" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36405" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Taking account of reported clinical experience with pan-JAK inhibitors and the important role of IL-6 in mediating inflammatory response, it was postulated that selective modulation of the JAK1 signaling pathway represented a valid strategy for the potential treatment of pro-inflammatory conditions such as RA. A significant, recent increase in patent applications claiming kinase inhibitors with selectivity for the JAK1 isoform would suggest this to be an emerging area of interest.</div><div class="NLM_p">A novel, imidazo-pyrrolopyridine hinge-binding scaffold was identified which appeared to possess an innate preference for JAK1 over the other JAK isoforms. While the selectivities quoted are undeniably subtle, they are nonetheless consistent, with virtually all of the compounds within this series showing some degree of JAK1 preference, in contrast to the structurally related, bicyclic inhibitor <b>1</b>. Since such a profile was unexpected, attention was taken to ensure accuracy of reported data. As noted elsewhere, all quoted biochemical and cellular data are the mean of at least three separate experiments; furthermore, on average, the coefficient of variation was less than 0.35 and 0.5 times the mean for biochemical and cell assays, respectively. Moreover, good agreement was generally observed between the selectivity in both biochemical and cellular assays for any given compound. A further feature of this series was the excellent JAK1 inhibitory activity displayed by the majority of examples. The accommodation of a wide variety of chemotypes allowed for ready modulation of physicochemical properties, thereby providing the means for achieving good correlation between biochemical and cell potencies, and favorable rat pharmacokinetic characteristics.</div><div class="NLM_p last">X-ray crystallography proved valuable for confirming the general binding mode of the series and also demonstrated the subtle differences in binding contacts achievable by changes to substitution patterns. In particular, structural information was useful in guiding the design of analogues toward regions of the protein that may be expected to yield improvements in affinity and selectivity. Further optimization of this series, particularly with regard to improving selectivity and demonstrating <i>in vivo</i> activity in a relevant model of inflammatory disease, will be disclosed elsewhere.</div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77144" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77144" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> General Methods</h3><div class="NLM_p">Commercial reagents and solvents were used as supplied. Use of ethanol as reaction solvent refers to industrial methylated spirit. Moisture or oxygen sensitive reactions were conducted under an atmosphere of argon or nitrogen gas. Chemical and optical (where applicable) purities were >95% for all final compounds as assessed by quantitative HPLC with DAD UV detection and chiral SFC analysis, respectively. Further details on the analytical conditions used for individual compounds may be found in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>. <sup>1</sup>H NMR spectra were recorded at ambient temperature using Varian Unity Inova or Bruker Avance DRX400 instruments operating at the indicated frequencies. Chemical shifts were expressed in ppm relative to an internal standard, tetramethylsilane (ppm = 0.00). The following abbreviations were used: br = broad signal, s = singlet, d = doublet, dd = doublet of doublets, t = triplet, q = quartet, p = pentet, and m = multiplet. Microwave experiments were carried out using a Biotage Initiator 2.0 (400 W MAGNETRON) which uses a single-mode resonator and dynamic field tuning.</div><div class="NLM_p">Strong cation exchange chromatography was performed using Biotage Isolute SCX-2 columns. Silica gel chromatography was performed using medium-pressure liquid chromatography (MPLC) on a CombiFlash Companion (Teledyne Isco) with RediSep normal phase silica gel (35–60 μm) columns and UV detection at 254 nm.</div><div class="NLM_p last">Reverse phase high performance liquid chromatography (HPLC) was used to purify compounds where indicated. Unless otherwise indicated, the conditions were elution on a Phenomenex Gemini C18 column (250 × 21.2 mm, 5 μm) as stationary phase and using mobile phase indicated, operating at a 18 mL/min flow rate using a Gilson UV/vis −155 dual channel detector and Gilson GX-271 automated liquid handler.</div></div><div id="sec6_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> JAK Enzyme Assays</h3><div class="NLM_p last">The activity of the isolated JAK1, JAK2, or TYK2 kinase domain was measured by monitoring the phosphorylation of a peptide derived from JAK3 (Val-Ala-Leu-Val-Asp-Gly-Tyr-Phe-Arg-Leu-Thr-Thr) fluorescently labeled on the N-terminus with 5-carboxyfluorescein using the Caliper LabChip technology (Caliper Life Sciences, Hopkinton, MA). Alternatively, the activity of the isolated JAK3 kinase domain was measured by monitoring the phosphorylation of a different peptide derived from JAK3 (Leu-Pro-Leu-Asp-Lys-Asp-Tyr-Tyr-Val-Val-Arg) fluorescently labeled on the N-terminus with 5-carboxyfluorescein using the same Caliper LabChip technology. To determine inhibition constants (<i>K</i><sub>i</sub>), compounds were diluted serially in DMSO and added to 50 μL kinase reactions containing 1.5 nM purified JAK1, 0.2 nM purified JAK2, 5 nM purified JAK3, or 1 nM purified TYK2 enzyme, 100 mM HEPES buffer (pH 7.2), 0.015% Brij-35, 1.5 μM peptide substrate, 25 μM ATP (5 μM ATP in the case of JAK3), 10 mM MgCl<sub>2</sub>, and 4 mM DTT at a final DMSO concentration of 2%. Reactions were incubated at 22 °C in 384-well polypropylene microtiter plates for 30 min and then stopped by the addition of 25 μL of an EDTA containing solution (100 mM HEPES buffer pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM. After termination of the kinase reaction, the proportion of phosphorylated product was determined as a fraction of total peptide substrate using the Caliper LabChip 3000 according to the manufacturer’s specifications. <i>K</i><sub>i</sub> values were then determined using the Morrison tight binding model.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a></div></div><div id="sec6_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> JAK Cellular Assays</h3><div class="NLM_p last">The activities of compounds were determined in cell-based assays that are designed to measure JAK-dependent STAT phosphorylation. TF-1 cells were obtained from the American Type Culture Collection (ATCC; Manassas, VA). TF-1 cells were starved overnight in OptiMEM medium with 0.5% Charcoal/Dextran stripped fetal bovine serum (FBS), 0.1 mM nonessential amino acids (NEAA), 1 mM sodium pyruvate, and without phenol red at 37 °C. Compounds were serially diluted in DMSO and incubated for 20 min at 37 °C with TF-1 cells in 384-well microtiter plates in RPMI-1640 at a final cell density of 100,000 cells per well and a final DMSO concentration of 0.2%. Human recombinant cytokines, IL-6 (30 ng/mL), or EPO (10 U/mL) were then added at the final concentrations indicated to the microtiter plates containing the TF-1 cells, and compound and the plates were incubated for 30–45 min at 37 °C. Compound-mediated effects on STAT3 (IL-6) or STAT5 (EPO) phosphorylation were then measured in the lysates of cells using the Meso Scale Discovery (MSD) technology (Gaithersburg, Maryland) according to the manufacturer’s protocol. EC<sub>50</sub> values were determined as the concentration of compound required for 50% inhibition of STAT phosphorylation relative to that measured for the DMSO control.</div></div><div id="sec6_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 4-Chloro-1-phenylsulfonyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>51</b>)</h3><div class="NLM_p last">A stirred suspension of 4-chloro-7-azaindole (<b>50</b>; 1.00 g, 6.55 mmol) in (DCM) 50 mL was treated with DMAP (80.0 mg, 0.66 mmol), triethylamine (1.36 mL, 9.83 mmol), and benzenesulfonyl chloride (0.93 mL, 7.21 mmol) at ambient temperature. The mixture was left to stand overnight. After dilution with DCM, the reaction mixture was washed with 1 M aqueous HCl solution, saturated sodium hydrogen carbonate solution, water, and brine, dried with sodium sulfate, and concentrated under vacuum to give a brown solid. Trituration (diethyl ether) afforded 1.59 g (83%) of <b>51</b> as a beige solid. LCMS (Method 2, ESI): RT = 4.48 min, m+H = 293.3. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 8.31 (d, <i>J</i> = 5.3 Hz, 1 H), 8.18 (m, 2 H), 7.8 (d, <i>J</i> = 4.1 Hz, 1 H), 7.58 (m, 1 H), 7.49 (m, 1 H), 7.20 (d, <i>J</i> = 5.3 Hz, 1 H), 6.71 (d, <i>J</i> = 4.1 Hz, 1 H).</div></div><div id="sec6_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 4-Chloro-5-nitro-1-phenylsulfonyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>52</b>)</h3><div class="NLM_p last">Tetrabutylammonium nitrate (381 mg, 1.25 mmol) dissolved in DCM (5 mL) was added dropwise to a stirred solution of <b>51</b> (293 mg, 1.00 mmol) in DCM (5 mL) at −5 °C. Trifluoroacetic anhydride (180 μL, 1.29 mmol) was added while maintaining the reaction temperature below 0 °C. The mixture was then stirred at−5 °C for 30 min and ambient temperature for 5 h. TLC indicated incomplete reaction; therefore, 0.25 equiv each of tetrabutylammonium nitrate and trifluoroacetic anhydride were added and the resulting mixture left to stand for 18 h at ambient temperature. DCM was added, and the mixture washed with water, dried with sodium sulfate, and concentrated under vacuum to give a yellow solid. Purification by column chromatography on silica gel (gradient: 0 to 25% ethyl acetate in cyclohexane) gave 266 mg (79%) of <b>52</b> as a white solid. LCMS (Method 2, ESI): RT = 4.57 min, m+H = 338.4. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 9.00 (s, 1 H), 8.21 (m, 2 H), 7.94 (d, <i>J</i> = 4.1 Hz, 1 H), 7.66 (t, <i>J</i> = 7.5 Hz, 1 H), 7.55 (t, <i>J</i> = 7.8 Hz, 2 H), 6.87 (d, <i>J</i> = 4.1 Hz, 1 H).</div></div><div id="sec6_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> (±)-<i>cis</i>-<i>N</i>-[4-Methyl-1-(phenylmethyl)-piperidin-3-yl]-5-nitro-1-(phenylsulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-amine (<b>54a</b>)</h3><div class="NLM_p last">A mixture of <b>52</b> (692 mg, 2.05 mmol), (±)-<i>cis</i>-4-methyl-1-(phenylmethyl)-piperidin-3-ylamine (460 mg, 2.25 mmol), and <i>N,N</i>-diisopropylethylamine (1.25 mL, 7.2 mmol) in 2-propanol was heated at 95 °C for 2 h. The reaction mixture was cooled, and the yellow precipitate that formed was isolated by filtration and dried <i>in vacuo</i> to afford 940 mg (90%) of <b>54a</b>. LCMS (Method 3, ESI): RT = 2.61 min, m+H = 506.2.</div></div><div id="sec6_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> (±)-<i>cis</i>-1-[4-Methyl-1-(phenylmethyl)-piperidin-3-yl]-1,6-dihydro-imidazo[4,5-<i>d</i>]pyrrolo[2,3-b]pyridine (<b>6</b>)</h3><div id="sec600" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> Step 1: (±)-<i>cis</i>-<i>N</i><sup>4</sup>-[4-Methyl-1-(phenylmethyl)-piperidin-3-yl]-1-(phenylsulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-4,5-diamine</h4><div class="NLM_p last">A mixture of <b>54a</b> (940 mg, 1.86 mmol), iron powder (∼325 mesh, 415 mg, 7.44 mmol), and ammonium chloride (597 mg, 11.16 mmol) in a methanol/water mixture (3:1, 64 mL) was heated at reflux for 4 h. The cooled mixture was filtered through Celite and washed with methanol. The filtrate was concentrated under vacuum and the residue obtained partitioned between saturated aqueous sodium bicarbonate and DCM. The aqueous phase was extracted twice with DCM. The combined extracts were washed with brine, dried (sodium sulfate), and concentrated under vacuum. Purification by column chromatography on silica gel (gradient: 0 to 5% [2 M ammonia in methanol] in DCM) afforded 620 mg (70%) of (±)-<i>cis</i>-<i>N</i><sup><i>4</i></sup>-[4-methyl-1-(phenylmethyl)-piperidin-3-yl]-1-(phenylsulfonyl)-1<i>H</i>-pyrrolo[2,3-b]pyridine-4,5-diamine as a white foam. LCMS (Method 3, ESI): RT = 2.16 min, m+H = 476.1.</div></div><div id="sec601" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> Step 2: (±)-<i>cis</i>-1-[4-Methyl-1-(phenylmethyl)-piperidin-3-yl]-6-(phenylsulfonyl)-1,6-dihydro-imidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridine</h4><div class="NLM_p last">A mixture of (±)-<i>cis</i>-<i>N</i><sup><i>4</i></sup>-[4-methyl-1-(phenylmethyl)-piperidin-3-yl]-1-(phenylsulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-4,5-diamine (420 mg, 0.90 mmol), triethyl orthoformate (375 μL, 2.25 mmol), and<i>p</i>-toluenesulfonic acid monohydrate (17.0 mg, 90 μmol) in toluene (25 mL) was heated at reflux for 16 h. After cooling, ethyl acetate was added and the mixture washed with saturated aqueous sodium hydrogen carbonate, water and brine, dried with sodium sulfate, and concentrated under vacuum. Purification by column chromatography on silica gel (gradient: 0 to 4% [2 M ammonia in methanol] in DCM) afforded 356 mg (81%) of (±)-<i>cis</i>-1-[4-methyl-1-(phenylmethyl)-piperidin-3-yl]-6-(phenylsulfonyl)-1,6-dihydro-imidazo[4,5-d]pyrrolo[2,3-<i>b</i>]pyridine as a white foam. LCMS (Method 3, ESI): RT = 2.61 min, m+H = 486.1.</div></div><div id="sec602" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> Step 3: (±)-<i>cis</i>-1-[4-Methyl-1-(phenylmethyl)-piperidin-3-yl]-1,6-dihydro-imidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridine (<b>6</b>)</h4><div class="NLM_p last">A mixture of (±)-<i>cis</i>-1-[4-methyl-1-(phenylmethyl)-piperidin-3-yl]-6-(phenylsulfonyl)-1,6-dihydro-imidazo[4,5-d]pyrrolo[2,3-b]pyridine (356 mg, 0.73 mmol) and 1 M aqueous sodium hydroxide (3.65 mL, 3.65 mmol) in methanol/THF was stirred at room temperature for 64 h. The reaction mixture was concentrated under vacuum, and the residue obtained partitioned between saturated sodium bicarbonate solution and DCM. The aqueous phase was extracted twice with DCM. The combined extracts were washed with brine, dried (sodium sulfate), and concentrated under vacuum to afford 223 mg (89%) of <b>6</b> as a cream colored foam. LCMS (Method 1, ESI): RT 2.39 min, m+H = 346.3. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub><i>6</i></sub>) δ: 11.78 (s, 1 H), 8.91 (s, 1 H), 8.56 (s, 1 H), 7.42 (t, <i>J</i> = 3.0 Hz, 1 H), 7.32–7.34 (m, 4 H), 7.22–7.24 (m, 1 H), 6.87 (dd, <i>J</i> = 3.4, 1.9 Hz, 1 H), 5.04 (d, <i>J</i> = 4.0 Hz, 1 H), 3.56–3.57 (m, 2 H), 3.02–3.06 (m, 2 H), 2.63 (dd, <i>J</i> = 12.1, 3.2 Hz, 1 H), 2.16–2.22 (m, 2 H), 1.53–1.61 (m, 2 H), 0.54 (d, <i>J</i> = 6.8 Hz, 3 H).</div></div></div><div id="sec6_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> (±)-<i>cis</i>-3-(Imidazo[4,5-<i>d</i>]pyrrolo[2,3-b]pyridin-1(6<i>H</i>)-yl)-4-methylpiperidin-1-yl)-3-oxopropanenitrile (<b>4</b>)</h3><div id="sec603" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> Step 1: (±)-<i>cis</i>-1-(4-Methyl-piperidin-3-yl)-1,6-dihydro-imidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridine</h4><div class="NLM_p last">A mixture of <b>6</b> (180 mg, 0.52 mmol), palladium hydroxide (20 wt % on carbon, 37 mg, 0.05 mmol), and ammonium formate (328 mg, 5.2 mmol) in methanol was heated at 60 °C for 24 h. The cooled mixture was filtered through Celite and the filter cake washed with methanol. The filtrate was concentrated under vacuum to afford 110 mg (82%) of (±)-<i>cis</i>-1-(4-methyl-piperidin-3-yl)-1,6-dihydro-imidazo[4,5-<i>d</i>]pyrrolo[2,3-b]pyridine as an off-white solid. LCMS (Method 3, ESI): RT 0.35 min, m+H = 255.9.</div></div><div id="sec604" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> Step 2: (±)-<i>cis</i>-3-(Imidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-1(6<i>H</i>)-yl)-4-methylpiperidin-1-yl)-3-oxopropanenitrile (<b>4</b>)</h4><div class="NLM_p last">A mixture of (±)-<i>cis</i>-4-methyl-piperidin-3-yl)-1,6-dihydro-imidazo[4,5-<i>d</i>]pyrrolo[2,3-b]pyridine (110 mg, 0.43 mmol), cyanoacetic acid (40 mg, 0.47 mmol), HOBt (87 mg, 0.65 mmol), EDCI (167 mg, 0.86 mmol), and DMAP (105 mg, 0.86 mmol) in DCM was stirred at room temperature for 18 h. The reaction mixture was evaporated to dryness and purified by column chromatography on silica gel (gradient: 0 to 6% [2 M ammonia in methanol] in DCM) to give 43 mg (31%) of <b>4</b> as an off-white solid. Further purification by HPLC (gradient: 5–40% acetonitrile containing 0.1% v/v aqueous ammonia in 0.1% v/v aqueous ammonia) afforded 15 mg (11%) of <b>4</b> as a white solid. LCMS (Method 1, ESI): RT 2.14 min, m+H = 323.3. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub><i>6</i></sub>) δ: 11.85 (s, 1 H), 8.59–8.60 (m, 1 H), 8.23–8.59 (m, 1 H), 7.46 (t, <i>J</i> = 3.0 Hz, 1 H), 6.87–6.89 (m, 1 H), 5.08 (d, <i>J</i> =4.7 Hz, 1 H), 4.38–4.40 (m, 2 H), 4.10 (d, <i>J</i> = 18.7 Hz, 1 H), 3.83 (d, <i>J</i> = 20.0 Hz, 1 H), 3.72 (d, <i>J</i> = 14.7 Hz, 1 H), 3.60 (dd, <i>J</i> = 13.8, 3.61 Hz, 1 H), 2.42 (br s, 1 H), 1.71–1.77 (m, 2 H), 0.64 (dd, J = 23.1, 6.83 Hz, 3 H).</div></div></div><div id="sec6_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> <i>N</i>-[1-(Phenylmethyl)-piperidin-4-yl]-5-nitro-1-(phenylsulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-amine (<b>54f</b>)</h3><div class="NLM_p last">A mixture of <b>52</b>(300 mg, 890 μmol), 4-amino-1-benzyl piperidine (203 mg, 1.07 mmol), and diisopropylethylamine (229 μL, 1.34 mmol) in 2-propanol (5 mL) was heated in a microwave reactor at 120 °C for 12 min. The mixture was diluted with DCM and then purified by column chromatography on silica gel (gradient: 0 to 100% ethyl acetate in cyclohexane) to afford 449 mg (100%) of <b>54f</b> as a yellow residue. LCMS (Method 2, ESI): RT = 3.35 min, m+H = 492.6. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 9.10 (s, 1 H), 8.18 (m, 2 H), 7.60 (m, 2 H), 7.51 (m, 2 H), 7.33 (m, 5 H), 6.69 (d, <i>J</i> = 4.2 Hz, 1 H), 4.00 (m, 1 H), 3.58 (m, 2 H), 2.85 (m, 2 H), 2.31 (m, 2 H), 2.11 (m, 2 H), 1.79 (m, 2 H).</div></div><div id="sec6_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 1-[(1-Phenylmethyl)-piperidin-4-yl]-1,6-dihydro-imidazo[4,5-<i>d</i>]pyrrolo[2,3-b]pyridine (<b>12</b>)</h3><div id="sec605" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> Step 1: <i>N</i><sup>4</sup>-[1-(Phenylmethyl)-piperidin-3-yl]-1-phenylsulfonyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-4,5-diamine</h4><div class="NLM_p last">A mixture of <b>54f</b> (442 mg, 890 μmol), iron powder (201 mg, 3.60 mmol), and ammonium chloride (289 mg, 5.39 mmol) in methanol/water (12 mL, 3: 1) was heated at reflux for 4 h. After cooling, the mixture was filtered through Celite, thoroughly washing the filter cake with methanol. The filtrate and washings were combined and concentrated under vacuum. The resulting residue was partitioned between DCM and water, the organic layer dried with sodium sulfate and concentrated under vacuum. Purification by column chromatography on silica gel (gradient: 0 to 10% methanol in DCM) afforded 321 mg (77%) of <i>N</i><sup><i>4</i></sup>-[1-(phenylmethyl)-piperidin-3-yl]-1-phenylsulfonyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-4,5-diamine as an off-white foam. LCMS (Method 2, ESI): RT = 2.55–2.68 min, m+H = 462.5. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 8.12 (m, 2 H), 7.83 (s, 1 H), 7.52 (m, 1 H), 7.44 (m, 3 H), 7.34 (m, 5 H), 6.51 (d, <i>J</i> = 4.2 Hz, 1 H), 4.75 (m, 1 H), 3.69 (m, 3 H), 2.88 (m, 4 H), 2.29 (m, 2 H), 2.06 (m, 2 H), 1.71 (m, 2 H).</div></div><div id="sec606" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> Step 2: 1-[1-(Phenylmethyl)-piperidin-4-yl]-6-(phenylsulfonyl)-1,6-dihydro-imidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridine</h4><div class="NLM_p last">A mixture of <i>N</i><sup><i>4</i></sup>-[1-(phenylmethyl)-piperidin-3-yl]-1-phenylsulfonyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-4,5-diamine (310 mg, 670 μmol), triethyl orthoformate (279 μL, 1.68 mmol), and <i>p</i>-toluenesulfonic acid monohydrate (13 mg, 70 μmol) in toluene (10 mL) was heated to reflux for 2 h. After cooling, ethyl acetate was added and the mixture washed with saturated sodium hydrogen carbonate solution, water, and brine, dried with sodium sulfate, and concentrated under vacuum. Purification by column chromatography on silica gel (gradient: 0 to 10% MeOH in DCM) afforded 360 mg (100%) of 1-[1-(phenylmethyl)-piperidin-4-yl]-6-(phenylsulfonyl)-1,6-dihydro-imidazo[4,5-<i>d</i>]pyrrolo[2,3-b]pyridine as an orange/yellow residue. LCMS (Method 2, ESI): RT = 3.05 min, m+H = 472.5; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 8.91 (s, 1 H), 8.22 (m, 2 H), 8.01 (br s, 1 H), 7.81 (d, <i>J</i> = 4.0 Hz, 1 H), 7.55 (m, 1 H), 7.47 (m, 2 H), 7.37 (m, 5 H), 6.83 (m, 1 H), 4.43 (m, 1 H), 3.62 (m, 2 H), 3.14 (m, 2 H), 2.21 (m, 6 H).</div></div><div id="sec607" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> Step 3: 1-[(1-Phenylmethyl)-piperidin-4-yl]-1,6-dihydro-imidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridine (<b>12</b>)</h4><div class="NLM_p last">A solution of 1-[1-(phenylmethyl)-piperidin-4-yl]-6-(phenylsulfonyl)-1,6-dihydro-imidazo[4,5-<i>d</i>]pyrrolo[2,3-b]pyridine (355 mg, 750 μmol) in methanol (18 mL) was treated with 1 M sodium hydroxide solution (8 mL) and left to stand at ambient temperature for 18 h. The mixture was partially concentrated under vacuum, and the resulting suspension was extracted twice with ethyl acetate. The combined organic extracts were washed with brine, dried with sodium sulfate, and concentrated under vacuum. Purification by column chromatography on silica gel (gradient: 0–10% methanol in DCM) afforded 189 mg (76%) of <b>12</b> as an off-white solid. LCMS (Method 1, ESI): RT = 1.92 min, m+H = 332.2; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub><i>6</i></sub>) δ: 11.85 (br s, 1 H), 8.58 (s, 1 H), 8.31 (s, 1 H), 7.48 (t, <i>J</i> = 3.0 Hz, 1 H), 7.36 (m, 4 H), 7.27 (m, 1 H), 6.75 (dd, <i>J</i> = 3.1, 1.9 Hz, 1 H), 4.57 (m, 1 H), 3.59 (s, 2 H), 3.01 (d, <i>J</i> = 11.3 Hz, 2 H), 2.31 (m, 2 H), 2.14 (m, 4 H).</div></div></div><div id="sec6_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 1-Piperidin-4-yl-1,6-dihydro-imidazo[4,5-d]pyrrolo[2,3-<i>b</i>]pyridine (<b>13</b>)</h3><div class="NLM_p last">A stirred mixture of <b>12</b> (2.68 g, 8.09 mmol), ammonium formate (5.09 g, 80.9 mmol), and palladium hydroxide (20 wt % on carbon, 565 mg, 0.809 mmol) in methanol (150 mL) was heated at reflux for 5 h. Additional ammonium formate (5.09 g, 80.9 mmol) was added and heating continued for 3 h. After cooling, the mixture was filtered through Celite and then concentrated <i>in vacuo</i>. Purification by column chromatography on silica gel (gradient: 0 to 15% [2 M ammonia in methanol] in DCM) and subsequent trituration (diethyl ether) afforded 1.02 g (52%) of <b>13</b> as a beige solid. LCMS (Method 1, ESI): RT = 0.69 min, m+H = 242.2; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub><i>6</i></sub>) δ: 11.84 (s, 1 H), 8.58 (s, 1 H), 8.27 (s, 1 H), 7.46 (t, <i>J</i> = 2.9 Hz, 1 H), 6.78 (dd, <i>J</i> = 3.5, 1.8 Hz, 1 H), 4.61 (m, 1 H), 3.12 (m, 2 H), 2.77 (m, 2 H), 2.09–1.92 (m, 4 H).</div></div><div id="sec6_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 1-(1-Methanesulfonyl-piperidin-4-yl)-1,6-dihydro-imidazo[4,5-d]pyrrolo[2,3-<i>b</i>]pyridine (<b>19</b>)</h3><div class="NLM_p last">To a stirred mixture of <b>13</b>(50.0 mg, 0.21 mmol) in DCM (2 mL), methanesulfonyl chloride (17.0 μL, 0.22 mmol) and triethylamine (57.0 μL, 0.41 mmol) were added sequentially. The mixture was stirred at room temperature for 30 min and then concentrated <i>in vacuo</i>. The resulting residue was triturated (water and then diethyl ether) and air-dried to afford 37.0 mg (55%) of <b>19</b> as a beige solid. LCMS (Method 1, ESI): RT = 2.02 min, m+H = 320.1. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub><i>6</i></sub>) δ: 11.86 (s, 1 H), 8.59 (s, 1 H), 8.34 (s, 1 H), 7.49 (t, <i>J</i> = 2.9 Hz, 1 H), 6.83 (dd, <i>J</i> = 3.1, 1.8 Hz, 1 H), 4.78 (m, 1 H), 3.77 (m, 2 H), 3.16 (m, 2 H), 2.98 (s, 3 H), 2.28–2.12 (m, 4 H).</div></div><div id="sec6_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 4-(Imidazo[4,5-<i>d</i>]pyrrolo[2,3-b]pyridin-1(6<i>H</i>)-yl)-lpiperidin-1-yl)-propanenitrile (<b>22</b>)</h3><div class="NLM_p last">A solution of <b>13</b> (50 mg, 207 μmol) and acrylonitrile (27 μL, 414 μmol) in ethanol (5 mL) was heated at reflux for 5 h. The mixture was concentrated under vacuum and purified by column chromatography on silica gel (gradient: 0 to 10% in methanol in DCM) to afford 53 mg (87%) of <b>22</b> as a white solid. LCMS (Method 1, ESI): RT = 0.75 + 0.87 min, m+H = 295.1. <sup>1</sup>H NMR (DMSO-<i>d</i><sub><i>6</i></sub>) δ: 11.84 (s, 1 H), 8.58 (s, 1 H), 8.32 (s, 1 H), 7.46 (t, <i>J</i> = 3.0 Hz, 1 H), 6.76 (dd, <i>J</i> = 3.4, 1.9 Hz, 1 H), 4.58 (m, 1 H), 3.09 (d, <i>J</i> = 11.4 Hz, 2 H), 2.72 (m, 4 H), 2.37 (td, <i>J</i> = 11.3, 3.3 Hz, 2 H), 2.14 (m, 4 H).</div></div><div id="sec6_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> ((<i>S</i>)-1-Isopropylpyrrolidin-2-yl-[4-(imidazo[4,5-d]pyrrolo[2,3-<i>b</i>]pyridin-1(6<i>H</i>)-yl)-piperidin-1-yl]-methanone (<b>26</b>)</h3><div class="NLM_p last">To a stirred mixture of (<i>S</i>)-1-isopropylpyrrolidine-2-carboxylic acid (31.2 mg, 0.198 mmol), HATU (76 mg, 0.198 mmol), and <i>N,N</i>-diisopropylethylamine (40 μL, 0.247 mmol) in DMF (2 mL) was added <b>13</b> (40 mg, 0.165 mmol), and the resulting mixture was stirred at ambient temperature for 1 h. The reaction mixture was concentrated and purified by column chromatography on silica gel (gradient: 0 to 10% [2 M ammonia in methanol] in DCM) to afford 55 mg (88%) of <b>26</b>. LCMS (Method 1, ESI): RT = 1.57 min, m+H = 381.16. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub><i>6</i></sub>) δ: 11.85 (s, 1 H), 8.57 (s, 1 H), 8.30 (s, 1 H), 7.40 (t, <i>J</i> = 2.9 Hz, 1 H), 6.73 (d, <i>J</i> = 3.3 Hz, 1 H), 4.84 (t, <i>J</i> = 4.1 Hz, 1 H), 4.61 (d, <i>J</i> = 13.6 Hz, 3 H), 2.50–2.45 (m, 4 H), 2.20 (d, <i>J</i> = 12.6 Hz, 3 H), 2.07 (d, <i>J</i> = 3.8 Hz, 1 H), 2.01 (d, <i>J</i> = 12.5 Hz, 3 H), 1.81 (m, 4 H), 1.79 (t, <i>J</i> = 3.6 Hz, 2 H), 1.02 (dd, <i>J</i> = 22.8, 6.42 Hz, 1 H).</div></div><div id="sec6_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 4-Benzyloxycarbonylamino-4-methyl-piperidine-1-carboxylic Acid <i>tert</i>-Butyl Ester (<b>56</b>)</h3><div class="NLM_p last">Compound <b>55</b> (1.0 g, 4.11 mmol), triethylamine (830 μL, 5.96 mmol), and diphenylphosphoroyl azide (1.2 mL, 5.59 mmol) in toluene were stirred at room temperature for 1 h. Benzyl alcohol (2.15 mL, 20.55 mmol) was added, and the reaction stirred at 80 °C for 18 h. The reaction mixture was cooled and concentrated under vacuum. Purification by column chromatography on silica gel (gradient: 0 to 25% ethyl acetate in cyclohexane) afforded 1.79 g of <b>56</b> (contaminated with benzyl alcohol). The material was used in the next step without further purification. LCMS (Method 3, ESI): RT = 3.86 min, m+H = 349.0.</div></div><div id="sec6_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 4-Amino-4-methyl-piperidine-1-carboxylic Acid <i>tert</i>-Butyl Ester (<b>57</b>)</h3><div class="NLM_p last">A solution of <b>56</b> (1.8 g, 5.2 mmol) in ethanol was purged with argon, palladium on carbon (10% Pd content, 550 mg, 0.52 mmol) added, and the reaction mixture stirred under an atmosphere of hydrogen for 18 h. The solids were removed by filtration through Celite washing with ethanol and the filtrate concentrated under vacuum. Purification by column chromatography on silica gel (gradient: 0 to 5% [2 M ammonia in methanol] in DCM) afforded 525 mg (47%) of <b>57</b> as a clear oil. LCMS (Method 3, ESI): RT = 0.31 min, m+H = 214.9; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 3.40–3.42 (m, 4 H), 1.48–1.51 (m, 2 H), 1.46 (s, 9 H), 1.36–1.39 (m, 2 H), 1.14 (s, 3 H).</div></div><div id="sec6_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 4-Methyl-4-(imidazo[4,5-d]pyrrolo[2,3-<i>b</i>]pyridin-1(6<i>H</i>)-yl)-piperidine-1-carboxylic Acid <i>tert</i>-Butyl Ester (<b>58</b>)</h3><div id="sec608" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> Step 1: 4-(5-Nitro-1-phenylsulfonyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-4-ylamino)-4-methyl-piperdine-1-carboxylic Acid <i>tert</i>-Butyl Ester</h4><div class="NLM_p last">A mixture of <b>52</b> (750 mg, 2.23 mmol), <b>57</b> (525 mg, 2.45 mmol), and <i>N,N</i>-diisopropylethylamine (1.36 mL, 7.80 mmol) in 2-propanol was heated at 95 °C for 64 h. The reaction mixture was cooled and the precipitate recovered by filtration. The solid was purified by column chromatography on silica gel (gradient: 0 to 30% ethyl acetate in cyclohexane) to afford 0.91 g (79%) of 4-(5-nitro-1-phenylsulfonyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-4-ylamino)-4-methyl-piperdine-1-carboxylic acid <i>tert</i>-butyl ester as a yellow foam. LCMS (Method 3, ESI): RT = 4.35 min, m+H = 516.2.</div></div><div id="sec609" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> Step 2: 4-(5-Amino-1-phenylsulfonyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-4-ylamino)-4-methyl-piperdine-1-carboxylic Acid <i>tert</i>-Butyl Ester</h4><div class="NLM_p last">A mixture of 4-(5-nitro-1-phenylsulfonyl-1<i>H</i>-pyrrolo[2,3-b]pyridine-4-ylamino)-4-methyl-piperdine-1-carboxylic acid <i>tert</i>-butyl ester (910 mg, 1.76 mmol), iron powder (∼325 mesh, 393 mg, 7.04 mmol) and ammonium chloride (565 mg, 10.56 mmol) in a methanol/water mixture (3:1, 48 mL) was heated at 85 °C for 4 h. The cooled mixture was filtered through Celite washing with methanol. The filtrate was concentrated under vacuum and the residue obtained partitioned between saturated sodium bicarbonate solution and DCM. The aqueous phase was extracted twice with DCM. The combined extracts were washed with brine, dried (sodium sulfate), and concentrated under vacuum to afford a pink residue. Purification by column chromatography on silica gel (gradient: 0 to 4% [2 M ammonia in methanol] in DCM) afforded 720 mg (84%) of 4-(5-amino-1-phenylsulfonyl-1<i>H</i>-pyrrolo[2,3-b]pyridine-4-ylamino)-4-methyl-piperdine-1-carboxylic acid <i>tert</i>-butyl ester as an off-white foam. LCMS (Method 2, ESI): RT = 3.21 min, m+H = 486.3.</div></div><div id="sec610" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> Step 3: 4-[6-Phenylsulfonyl-4-(imidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-1(6<i>H</i>)-yl)]-4-methyl-piperidine-1-carboxylic Acid <i>tert</i>-Butyl Ester</h4><div class="NLM_p last">A mixture of 4-(5-amino-1-phenylsulfonyl-1<i>H</i>-pyrrolo[2,3-b]pyridine-4-ylamino)-4-methyl-piperdine-1-carboxylic acid <i>tert</i>-butyl ester (720 mg, 1.48 mmol), triethyl orthoformate (615 μL, 3.70 mmol), and <i>p</i>-toluenesulfonic acid monohydrate (28.0 mg, 148 μmol) in toluene (50 mL) was heated at reflux for 24 h. After cooling, ethyl acetate was added and the mixture washed with saturated sodium hydrogen carbonate solution, water and brine, dried with sodium sulfate, and concentrated under vacuum. Purification by column chromatography on silica gel (gradient: 0 to 4% [2 M ammonia in methanol] in DCM) afforded 630 mg (86%) of 4-[(6-phenylsulfonyl-4-(imidazo[4,5-<i>d</i>]pyrrolo[2,3-b]pyridin-1(6<i>H</i>)-yl)]-4-methyl-piperidine-1-carboxylic acid <i>tert</i>-butyl ester as an off-white foam. LCMS (Method 2, ESI): RT = 3.54 min, m+H = 496.2.</div></div><div id="sec611" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> Step 4: 4-Methyl-4-(imidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-1(6<i>H</i>)-yl)-piperidine-1-carboxylic Acid <i>tert</i>-Butyl Ester (<b>58</b>)</h4><div class="NLM_p last">A mixture of 4-[(6-phenylsulfonyl-4-(imidazo[4,5-<i>d</i>]pyrrolo[2,3-b]pyridin-1(6<i>H</i>)-yl)]-4-methyl-piperidine-1-carboxylic acid <i>tert</i>-butyl ester (630 mg, 1.27 mmol) and 1 M aqueous sodium hydroxide (6.36 mL, 6.36 mmol) in methanol/THF was stirred at room temperature for 60 h. The reaction mixture was concentrated under vacuum and the residue obtained partitioned between saturated sodium bicarbonate solution and DCM. The aqueous phase was extracted twice with DCM. The combined extracts were washed with brine, dried (sodium sulfate), and concentrated under vacuum to afford 440 mg (98%) of <b>58</b> as an off-white foam. LCMS (Method 1, ESI): RT 3.10 min, m+H = 356.2. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub><i>6</i></sub>) δ: 11.92 (s, 1 H), 8.62 (s, 1 H), 8.34 (s, 1 H), 7.45 (t, <i>J</i> = 3.1 Hz, 1 H), 6.62 (dd, <i>J</i> = 3.5, 1.9 Hz, 1 H), 3.71 (m, 2 H), 3.35 (br s, 2 H), 2.52–2.55 (m, 1 H), 2.04 (d, <i>J</i> = 13.5 Hz, 3 H), 1.85 (s, 3 H), 1.45 (s, 9 H).</div></div></div><div id="sec6_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 1-(4-Methyl-piperidin-4-yl)-1,6-dihydro-imidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridine (<b>28</b>)</h3><div class="NLM_p last">A solution of <b>58</b> (420 mg, 1.18 mmol) and TFA (7 mL) in DCM (28 mL) was stirred at room temperature for 1 h. The reaction mixture was concentrated under vacuum and a portion purified by column chromatography on silica gel (gradient: 0 to 10% [2 M ammonia in methanol] in DCM) to afford 77 mg of <b>28</b> as a white solid. LCMS (Method 1, ESI): RT 1.21 min, m+H = 278.2. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub><i>6</i></sub>) δ: 11.86 (s, 1 H), 8.61 (s, 1 H), 8.31 (s, 1 H), 7.47 (dd, <i>J</i> = 3.4, 2.6 Hz, 1 H), 7.01 (dd, <i>J</i> = 3.5, 1.9 Hz, 1 H), 2.82–2.85 (m, 4 H), 2.55 (dd, <i>J</i> = 13.5, 6.9 Hz, 2 H), 2.37 (br s, 1 H), 1.93–1.97 (m, 2 H), 1.81 (s, 3 H).</div></div><div id="sec6_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 1-(1-Methanesulfonyl-4-methyl-piperidin-4-yl)-1,6-dihydro-imidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridine (<b>30</b>)</h3><div class="NLM_p last">A mixture of <b>28</b>(136 mg, 0.53 mmol), methanesulfonyl chloride (41.5 μL, 0.53 mmol), and triethylamine (88.5 μL, 0.64 mmol) in DCM was stirred at room temperature for 1.5 h. The reaction mixture was washed with saturated sodium hydrogen carbonate solution and brine, dried with sodium sulfate, and concentrated under vacuum. Purification by column chromatography on silica gel (gradient: 0 to 6% [2 M ammonia in methanol] in DCM) afforded 102 mg (58%) of <b>30</b> as a white solid. LCMS (Method 1, ESI): RT 2.19 min, m+H = 334.3. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub><i>6</i></sub>) δ: 11.93 (s, 1 H), 8.63 (s, 1 H), 8.34 (s, 1 H), 7.52 (t, <i>J</i> = 3.1 Hz, 1 H), 6.79 (dd, <i>J</i> = 3.5, 1.9 Hz, 1 H), 3.32 (m, 6 H, includes water solvent peak), 2.92 (s, 3 H), 2.73 (m, 2 H), 2.19 (m, 2 H), 1.85 (s, 3 H).</div></div><div id="sec6_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> <i>trans</i>-[4-(5-Nitro-1-phenylsulfonyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-4-ylamino)-cyclohexyl]-carbamic Acid <i>tert</i>-Butyl Ester (<b>60</b>)</h3><div class="NLM_p last">A mixture of <b>52</b> (1.01 g, 3.0 mmol), <b>59</b> (707 mg, 3.30 mmol), and <i>N,N</i>-diisopropylethylamine (1.80 mL, 10.5 mmol) in 2-propanol was heated at 95 °C for 1 h. The cooled reaction mixture was concentrated under vacuum to afford a yellow residue. Purification by column chromatography on silica gel (gradient: 0 to 10% ethyl acetate in DCM) afforded 1.24 g (80%) of <b>60</b> as a yellow foam. LCMS (Method 3, ESI): RT = 4.13 min, m+H = 516.3.</div></div><div id="sec6_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> <i>trans</i>-[4-(6-Phenylsulfonyl-4-(imidazo[4,5-<i>d</i>]pyrrolo[2,3-b]pyridin-1(6<i>H</i>)-yl)-cyclohexyl]-carbamic Acid <i>tert</i>-Butyl Ester (<b>61</b>)</h3><div id="sec612" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> Step 1: <i>trans</i>-[4-(5-Amino-1-phenylsulfonyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-4-ylamino)-cyclohexyl]-carbamic Acid <i>tert</i>-Butyl Ester</h4><div class="NLM_p last">A mixture of <b>60</b> (1.14 g, 2.21 mmol), iron powder (∼325 mesh, 494 mg, 8.84 mmol), and ammonium chloride (709 mg, 13.26 mmol) in a methanol/water mixture (3:1, 44 mL) was heated at reflux for 4 h. The cooled mixture was filtered through Celite washing with methanol. The filtrate was concentrated under vacuum and the residue obtained partitioned between saturated sodium bicarbonate solution and DCM. The aqueous phase was extracted twice with DCM. The combined extracts were washed with brine, dried (sodium sulfate), and concentrated under vacuum. Purification by column chromatography on silica gel (gradient: 0 to 5% methanol in DCM) afforded 940 mg (88%) of <i>trans</i>-[4-(5-amino-1-phenylsulfonyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-4-ylamino)-cyclohexyl]-carbamic acid <i>tert</i>-butyl ester as an off-white solid. LCMS (Method 3, ESI): RT = 2.65 min, m+H = 486.4.</div></div><div id="sec613" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> Step 2: <i>trans</i>-[4-(6-phenylsulfonyl-4-(imidazo[4,5-<i>d</i>]pyrrolo[2,3-b]pyridin-1(6<i>H</i>)-yl)-cyclohexyl]-carbamic Acid <i>tert</i>-Butyl Ester (<b>61</b>)</h4><div class="NLM_p last">A mixture of <i>trans</i>-[4-(5-amino-1-phenylsulfonyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-4-ylamino)-cyclohexyl]-carbamic acid <i>tert</i>-butyl ester (940 mg, 1.94 mmol), triethyl orthoformate (807 μL, 4.85 mmol), and <i>p</i>-toluenesulfonic acid monohydrate (37.0 mg, 194 μmol) in toluene (25 mL) was heated at reflux for 3.5 h. After cooling, ethyl acetate was added and the mixture washed with saturated sodium hydrogen carbonate solution, water, and brine, dried with sodium sulfate, and concentrated under vacuum. Purification by column chromatography on silica gel (gradient: 0 to 5% [2 M ammonia in methanol] in DCM) afforded 0.81 g (84%) of <b>61</b>. LCMS (Method 3, ESI): RT = 3.47 min, m+H = 496.2. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 8.95 (s, 1 H), 8.23 (dd, <i>J</i> = 7.8, 1.3 Hz, 3 H), 7.85 (d, <i>J</i> = 4.0 Hz, 1 H), 7.55 (m, 1 H), 7.47–7.48 (m, 2 H), 6.75 (d, <i>J</i> = 4.0 Hz, 1 H), 4.40–4.47 (m, 2 H), 3.63 (br s, 1 H), 2.33 (m, 5 H), 1.99 (m, 2 H), 1.47 (s, 9 H).</div></div></div><div id="sec6_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> <i>trans</i>-[4-(Imidazo[4,5-<i>d</i>]pyrrolo[2,3-b]pyridin-1(6<i>H</i>)-yl)-cyclohexyl]-carbamic Acid <i>tert</i>-Butyl Ester (<b>33</b>)</h3><div class="NLM_p last">A mixture of <b>61</b> (810 mg, 1.63 mmol) and 1 M aqueous sodium hydroxide (8.2 mL, 8.2 mmol) in methanol/THF was stirred at room temperature for 18 h. The reaction mixture was concentrated under vacuum and the residue partitioned between saturated sodium bicarbonate solution and DCM. The aqueous phase was extracted twice with DCM. The combined extracts were washed with brine, dried (sodium sulfate), and concentrated under vacuum. Purification by column chromatography on silica gel (gradient: 0 to 6% [2 M ammonia in methanol] in DCM) afforded 470 mg (81%) of <b>33</b> as a white solid. LCMS (Method 1, ESI): RT 3.06 min, m+H = 356.2. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub><i>6</i></sub>) δ: 11.84 (s, 1 H), 8.57 (s, 1 H), 8.28 (s, 1 H), 7.47 (t, <i>J</i> = 3.0 Hz, 1 H), 6.89 (d, <i>J</i> = 7.6 Hz, 1 H), 6.68 (dd, <i>J</i> = 3.4, 1.9 Hz, 1 H), 4.51–4.54 (m, 1 H), 3.43 (br s, 1 H), 2.16 (d, <i>J</i> = 11.7 Hz, 2 H), 2.00 (d, <i>J</i> = 12.4 Hz, 4 H), 1.51–1.56 (m, 2 H), 1.41 (s, 9 H).</div></div><div id="sec6_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> <i>trans</i>-4-(Imidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-1(6<i>H</i>)-yl)-cyclohexylamine (<b>35</b>)</h3><div class="NLM_p last">A mixture of <b>33</b> (442 mg, 1.24 mmol) and TFA (4 mL) in DCM (16 mL) was stirred at room temperature for 1.5 h. The reaction mixture was concentrated under vacuum and the residue purified by chromatography on an SCX-2 column (gradient: 10 to 50% [2 M ammonia in methanol] in DCM) to afford 300 mg (95%) of <b>35</b> as a white solid. LCMS (Method 1, ESI): RT 0.75 min, m+H = 256.1. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub><i>6</i></sub>) δ: 11.84 (br s, 1 H), 8.57 (s, 1 H), 8.26 (s, 1 H), 7.47 (d, <i>J</i> = 3.4 Hz, 1 H), 6.71 (d, <i>J</i> = 3.4 Hz, 1 H), 4.51–4.54 (m, 1 H), 2.73–2.75 (m, 1 H), 2.13 (d, <i>J</i> = 11.7 Hz, 2 H), 1.94–1.98 (m, 4 H), 1.40–1.43 (m, 2 H).</div></div><div id="sec6_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> <i>trans</i>-3-[4-(Imidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-1(6<i>H</i>)-yl)-cyclohexylamino]-propionitrile (<b>41</b>)</h3><div class="NLM_p last">A mixture of acrylonitrile (64.5 μL, 0.98 mmol) and <b>35</b> (50.0 mg, 196 μmol) in ethanol (5.5 mL) was heated at 80 °C for 1 h. After cooling, the solvent was removed under vacuum. The resulting residue was triturated (water and then diethyl ether) and air-dried to afford 22.0 mg (36%) of <b>41</b> as a cream colored solid. LCMS (Method 1, ESI): RT = 1.22 min, m+H = 309.2. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub><i>6</i></sub>) δ: 11.83 (s, 1 H), 8.57 (s, 1 H), 8.26 (s, 1 H), 7.46 (t, <i>J</i> = 2.6 Hz, 1 H), 6.73 (dd, <i>J</i> = 3.1, 1.8 Hz, 1 H), 4.57 (m, 1 H), 2.83 (t, <i>J</i> = 6.6 Hz, 2 H), 2.59 (m, 3 H), 2.17 (m, 2 H), 2.06 (m, 2 H), 1.95 (m, 3 H), 1.40 (m, 2 H).</div></div><div id="sec6_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> (±)-<i>cis</i>-(3-Hydroxy-cyclopentyl)-carbamic Acid <i>tert</i>-Butyl Ester (<b>68</b>)</h3><div class="NLM_p last">A solution of <b>67</b><a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> in ethanol (90 mL) was treated with 10% palladium on carbon (1.0 g, 0.94 mmol palladium) and hydrogenated for 3 days at ambient pressure. More catalyst was added (1.2 g, 1.1 mmol palladium), and the mixture was hydrogenated for a further 24 h. The suspension was filtered through Celite washing with ethanol. The filtrate was concentrated under vacuum to afford 8.86 g (97%) of <b>68</b> as a dark green oil. LCMS (Method 2, ESI): RT = 3.08 min, m+H = 200. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 4.71 (m, 1 H), 4.54 (m, 1 H), 1.87 (m, 3 H), 1.68 (m, 3 H), 1.50 (s, 9 H).</div></div><div id="sec6_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> (±)-<i>trans</i>-(3-Hydroxy-cyclopentyl)-carbamic Acid <i>tert</i>-Butyl Ester (<b>69</b>)</h3><div class="NLM_p last"><i>Step 1:</i> A solution of <b>68</b> (3.00 g, 14.9 mmol) in dry THF (81 mL) at 0 °C under an inert atmosphere was treated with triphenylphosphine (4.30 g, 16.4 mmol) and diisopropylazodicarboxylate (3.50 mL, 17.9 mmol) and the mixture stirred at 0 °C for 10 min. A solution of acetic acid (2.4 mL, 41.8 mmol) in dry THF (18 mL) was added dropwise and the mixture stirred at 0 °C for 20 min, then at ambient temperature overnight. The mixture was concentrated under vacuum and the residue obtained purified by column chromatography on silica gel (gradient: 0 to 30% EtOAc in cyclohexane) to afford 2.87 g (79%) of (±)-<i>trans</i>-acetic acid 3-<i>tert</i>-butoxycarbonylamino-cyclopentyl ester as a white solid. LCMS (Method 2, ESI): RT =3.23 min, no m+H observed. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 5.18 (m, 1 H), 4.46 (br s, 1 H), 4.14 (m, 1 H), 2.12 (m, 3 H), 2.01 (s, 3 H), 1.69 (m, 2 H), 1.44 (s, 9 H), 1.41 (m, 1 H). <i>Step 2</i>: A solution of the preceding material (2.27 g, 11.8 mmol) in methanol (6.8 mL) and THF (6.8 mL) was treated with 4 M aqueous sodium hydroxide solution (6.8 mL, 27.2 mmol) and the mixture stirred at ambient temperature for 1.5 h. The mixture was concentrated under vacuum and the residue obtained partitioned between DCM and brine. The aqueous phase was extracted twice with DCM, and the combined extracts were washed with brine, dried (sodium sulfate), and concentrated under vacuum to afford 2.28 g (96%) of <b>69</b> as a white solid. LCMS (Method 2, ESI): RT = 2.46 min, m+H = 202 (weak), m+H+MeCN = 243. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 4.45 (br s, 1 H), 4.40 (m, 1 H), 4.17 (m, 1 H), 2.21 (m, 1 H), 2.02 (m, 2 H), 1.62 (m, 2 H), 1.44 (s, 9 H), 1.40 (m, 1 H).</div></div><div id="sec6_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> (±)-<i>trans</i>-(3-Amino-cyclopentyl)-carbamic Acid <i>tert</i>-Butyl Ester (<b>70</b>)</h3><div class="NLM_p last"><i>Step 1:</i> A solution of <b>68</b> (2.10 g, 10.4 mmol) in acetone (44 mL) containing triethylamine (2.91 mL, 20.9 mmol) was cooled to 0 °C and treated dropwise with methanesulfonyl chloride (1.21 mL, 15.7 mmol). After 10 min, the mixture was concentrated under vacuum and the residue obtained partitioned between EtOAc and water. The aqueous phase was extracted twice with ethyl acetate, and the combined extracts were washed with 10% aqueous citric acid solution, saturated sodium hydrogen carbonate solution, and brine, dried (sodium sulfate), and concentrated under vacuum to afford 2.88 g (99%) of (±)-<i>cis</i>-methanesulfonic acid 3-<i>tert</i>-butoxycarbonylamino-cyclopentyl ester as a cream colored solid. LCMS (Method 2, ESI): RT = 2.97 min, m+H = 280 (weak), m+H+MeCN = 343. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 5.14 (m, 1 H), 4.72 (br s, 1 H), 4.12 (br s, 1 H), 3.01 (s, 3 H), 2.36 (m, 1 H), 2.11 (m, 2 H), 1.94 (m, 1 H), 1.87 (m, 1 H), 1.70 (m, 1 H), 1.44 (s, 9 H). <i>Step 2</i>: A solution of (±)-<i>cis</i>-methanesulfonic acid 3-<i>tert</i>-butoxycarbonylamino-cyclopentyl ester (2.88 g, 10.3 mmol) in DMF (21 mL) was treated with a solution of sodium azide (0.94 g, 14.5 mmol) in water (3.7 mL), and the reaction mixture was heated at 100 °C for 1 h. The cooled mixture was concentrated under vacuum and the residue obtained partitioned between ethyl acetate and water. The aqueous phase was extracted twice with ethyl acetate, and the combined extracts were washed with water and brine, dried (sodium sulfate), and concentrated under vacuum to afford 2.24 g (96%) of (±)-<i>trans</i>-(3-azido-cyclopentyl)-carbamic acid <i>tert</i>-butyl ester as a yellow oil. LCMS (Method 2, ESI): RT = 3.48 min, no m+H observed, m+H+MeCN = 290. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 4.45 (br s, 1 H), 4.09 (br s, 1 H), 4.03 (m, 1 H), 2.10 (m, 3 H), 1.71 (m, 2 H), 1.44 (m, 10 H). <i>Step 3</i>: A solution of (±)-<i>trans</i>-(3-azido-cyclopentyl)-carbamic acid <i>tert</i>-butyl ester (2.24 g, 9.9 mmol) in THF (90 mL) was treated with water (9 mL) then triphenylphosphine (2.86 g, 10.9 mmol), and the reaction mixture was heated to 55 °C overnight. The cooled mixture was concentrated under vacuum to a solid residue. The solid was triturated with ether and filtered, rinsing with ether. The filtrate was concentrated under vacuum to a yellow oil then triturated with ether as before. The filtrate was concentrated to an orange oil that was purified by column chromatography on silica gel (gradient: 0 to 15% methanol in DCM plus 1% triethylamine) to afford 1.80 g (91%) of <b>70</b> as a white paste that crystallized on standing. LCMS (Method 2, ESI): RT = 0.84 min, m+H = 201. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 4.47 (br s, 1 H), 4.10 (br s, 1 H), 3.46 (m, 1 H), 2.18 (m, 1 H), 2.00 (m, 1 H), 1.72 (t, <i>J</i> = 6.7 Hz, 2 H), 1.44 (s, 9 H), 1.34 (m, 4 H).</div></div><div id="sec6_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> (±)-<i>trans</i>-[3-(6-Phenylsulfonyl-imidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-1(6<i>H</i>)-yl)-cyclopentyl]-carbamic Acid <i>tert</i>-Butyl Ester (<b>72</b>)</h3><div class="NLM_p last"><i>Step 1:</i>A solution of <b>70</b> (1.70 g, 8.5 mmol) in 2-propanol (21 mL) was treated with <i>N,N</i>-diisopropylethylamine (1.60 mL, 9.2 mmol) followed by <b>52</b> (2.39 g, 7.1 mmol), and the mixture was heated at 120 °C for 10 min using microwave irradiation. The cooled reaction mixture was filtered, and the solid was rinsed with 2-propanol and dried under vacuum to afford 3.00 g (84%) of (±)-<i>trans</i>-[3-(5-nitro-1-phenylsulfonyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-ylamino)-cyclopentyl]-carbamic acid <i>tert</i>-butyl ester as a yellow crystalline solid. LCMS (Method 2, ESI): RT = 4.09 min, m+H = 502. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 9.09 (s, 1 H), 9.06 (d, <i>J</i> = 7.0 Hz, 1 H), 8.19 (d, <i>J</i> = 8.0 Hz, 2 H), 7.62 (m, 2 H), 7.52 (t, <i>J</i> = 8.0 Hz, 2 H), 6.84 (d, <i>J</i> = 4.2 Hz, 1 H), 4.58 (m, 2 H), 4.11 (m, 1 H), 2.36 (m, 1 H), 2.25 (m, 1 H), 2.10 (m, 2 H), 1.73 (m, 1 H), 1.62 (m, 1 H), 1.45 (s, 9 H). <i>Step 2</i>: A suspension of (±)-<i>trans</i>-[3-(5-nitro-1-phenylsulfonyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-ylamino)-cyclopentyl]-carbamic acid <i>tert</i>-butyl ester (3.0 g, 6.0 mmol) in ethanol (22 mL) was treated with water (8 mL), ammonium chloride (1.92 g, 35.9 mmol), and iron powder (1.34 g, 24.0 mmol) and the mixture heated at 80 °C for 1.5 h. The cooled reaction mixture was filtered through Celite washing with ethanol/water. The filtrate was concentrated under vacuum and the residue obtained partitioned between DCM and a saturated sodium hydrogen carbonate solution. The aqueous phase was extracted twice with DCM, and the combined extracts were washed with brine, dried (sodium sulfate), and concentrated under vacuum to afford a beige foam. The foam was crystallized from DCM to afford 1.45 g (51%) of (±)-<i>cis</i>-[3-(5-amino-1-phenylsulfonyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-ylamino)-cyclopentyl]-carbamic acid <i>tert</i>-butyl ester as a white solid. LCMS (Method 2, ESI): RT = 2.85 min, m+H = 472. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 8.13 (d, <i>J</i> = 8.1 Hz, 2 H), 7.85 (s, 1 H), 7.54 (tt, <i>J</i> = 7.5, 1.3 Hz, 1 H), 7.45 (m, 3 H), 6.62 (d, <i>J</i> = 4.4 Hz, 1 H), 4.99 (br s, 1 H), 4.56 (br s, 1 H), 4.41 (br s, 1 H), 4.16 (br s, 1 H), 2.24 (m, 2 H, 2.07 (br s, 1 H), 1.88 (m, 1 H), 1.63 (m, 1 H), 1.50 (m, 1 H), 1.44 (s, 9 H). The mother liquor was concentrated under vacuum to a brown foam that was crystallized from DCM to provide a second crop (0.34 g, 12%). The mother liquors from the second crop were concentrated under vacuum to a brown foam. Purification by column chromatography on silica gel (gradient: 0 to 7% methanol in DCM) afforded a further crop of 0.46 g (16%) of product as a white solid. <i>Step 3</i>: A suspension of (±)-<i>cis</i>-[3-(5-amino-1-phenylsulfonyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-ylamino)-cyclopentyl]-carbamic acid <i>tert</i>-butyl ester (1.25 g, 2.7 mmol) in toluene (12.5 mL) was treated with triethyl orthoformate (1.3 mL, 8.0 mmol) followed by <i>p</i>-toluene sulfonic acid monohydrate (50 mg, 0.27 mmol), and the reaction mixture was heated to 100 °C for 1.75 h. The cooled reaction mixture was filtered, and the filter cake was washed with toluene and water and dried to afford a white solid. Purification by column chromatography on silica gel (gradient: 0 to 7% methanol in DCM) afforded 0.90 g (70%) of <b>72</b> as a white solid. LCMS (Method 2, ESI): RT = 3.59 min, m+H = 482. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub><i>6</i></sub>) δ: 8.72 (s, 1 H), 8.49 (s, 1 H), 8.13 (d, <i>J</i> = 8.5 Hz, 2 H), 8.01 (d, <i>J</i> = 4.2 Hz, 1 H), 7.70 (tt, <i>J</i> = 7.7, 1.2 Hz, 1 H), 7.61 (t, <i>J</i> = 8.1 Hz, 2 H), 7.29 (d, <i>J</i> = 4.0 Hz, 1 H), 7.18 (d, <i>J</i> = 4.7 Hz, 1 H), 5.23 (p, <i>J</i> = 7.7 Hz, 1 H), 4.11 (m, 1 H), 2.36 (m, 1 H), 2.29 - 2.08 (m, 3 H), 1.96 (m, 1 H), 1.64 (m, 1 H), 1.40 (s, 9 H).</div></div><div id="sec6_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> (±)-<i>trans</i>-3-(Imidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-1(6<i>H</i>)-yl)-cyclopentyl]-carbamic Acid <i>tert</i>-Butyl Ester (<b>47</b>)</h3><div class="NLM_p last">A suspension of <b>72</b> (300 mg, 0.62 mmol) in methanol (3.2 mL) and THF (3.2 mL) was treated with 2 M aqueous sodium hydroxide solution (1.6 mL, 3.2 mmol), and the mixture was stirred at ambient temperature for 30 min then at 50 °C for 1 h. The mixture was concentrated under vacuum and the residue obtained partitioned between DCM and water. The aqueous phase was extracted with DCM, and the combined extracts were washed with saturated sodium hydrogen carbonate solution, and brine, dried (sodium sulfate), and concentrated under vacuum to afford a yellow glass. This was triturated with ether to give a solid that was collected, washed with ether, and dried to afford 170 mg (80%) of <b>47</b> as an off-white solid. LCMS (Method 1, ESI): RT = 2.93 min, m+H = 342.3.; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub><i>6</i></sub>) δ: 11.83 (s, 1 H), 8.57 (s, 1 H), 8.29 (s, 1 H), 7.47 (t, <i>J</i> = 3.0 Hz, 1 H), 7.20 (d, <i>J</i> = 7.3 Hz, 1 H), 6.83 (dd, <i>J</i> = 3.2, 1.7 Hz, 1 H), 5.24 (q, <i>J</i> = 7.5 Hz, 1 H), 4.13 (m, 1 H), 2.38 (m, 1 H), 2.33 – 2.12 (m, 3 H), 2.03 (m, 1 H), 1.68 (m, 1 H), 1.40 (s, 9 H).</div></div><div id="sec6_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> <i>trans</i>-3-(Imidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-1(6<i>H</i>)-yl)-cyclopentyl]-carbamic Acid <i>tert</i>-Butyl Ester (<b>49</b>)</h3><div class="NLM_p last">Compound <b>47</b> was resolved using SFC (21.2 × 250 mm, 5 μm Chiralpak AD; mobile phase, 35% methanol/65% CO<sub>2</sub>; flow rate, 60 mL/min; detection at 230 nm). LCMS (Method 4, ESI): RT = 0.94 min, m = 341.2.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-3"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i64"><a href="/doi/suppl/10.1021/jm300438j">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82218" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82218" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Details of crystallographic methods and procedures: analytical LCMS methods; experimental LogD measurement procedures; <i>in vitro</i> and <i>in vivo</i> ADME experimental procedures; details of molecular modeling calculations and methods; preparation and characterization of <b>7</b>–<b>11</b>, <b>14</b>–<b>18</b>, <b>20</b>, <b>21</b>, <b>23</b>–<b>25</b>, <b>27</b>, <b>29</b>, <b>31</b>, <b>32</b>, <b>34</b>, <b>36</b>–<b>40</b>, <b>42</b>–<b>46</b>, <b>48</b>, <b>54b</b>–<b>d</b>, <b>54g</b>, <b>62</b>, <b>64</b>–<b>66</b>, <b>71</b>, <b>73</b>, and <b>74</b>. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm300438j/suppl_file/jm300438j_si_001.pdf">jm300438j_si_001.pdf (662.56 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">PDB nos.: 4E6D for <b>7</b> complexed with JAK2TM, 4E6Q for <b>12</b> complexed with JAK2TM, 4E5W for <b>26</b> complexed with JAK1, 4E4L for <b>30</b> complexed with JAK1, 4E4M for <b>30</b> complexed with JAK2, and 4E4N for <b>49</b> complexed with JAK1.</p><div class="testing" data-doi="10.1021/jm300438j" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37754" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37754" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Janusz J. Kulagowski</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Medicinal Chemistry and ‡Computer Aided Drug Design, Argenta, 8/9 Spire Green Centre, Harlow CM19 5TR, United
Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">§Departments of Biochemical and Cellular Pharmacology, ∥Discovery Chemistry, ⊥Drug Metabolism
and Pharmacokinetics, #Immunology, and ○Structural Biology, Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080,
United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#5339323d2620297d38263f32343c2420383a13343f2334"><span class="__cf_email__" data-cfemail="dfb5beb1aaaca5f1b4aab3beb8b0a8acb4b69fb8b3afb8">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wade Blair</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Medicinal Chemistry and ‡Computer Aided Drug Design, Argenta, 8/9 Spire Green Centre, Harlow CM19 5TR, United
Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">§Departments of Biochemical and Cellular Pharmacology, ∥Discovery Chemistry, ⊥Drug Metabolism
and Pharmacokinetics, #Immunology, and ○Structural Biology, Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080,
United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Richard J. Bull</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Medicinal Chemistry and ‡Computer Aided Drug Design, Argenta, 8/9 Spire Green Centre, Harlow CM19 5TR, United
Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">§Departments of Biochemical and Cellular Pharmacology, ∥Discovery Chemistry, ⊥Drug Metabolism
and Pharmacokinetics, #Immunology, and ○Structural Biology, Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080,
United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christine Chang</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Medicinal Chemistry and ‡Computer Aided Drug Design, Argenta, 8/9 Spire Green Centre, Harlow CM19 5TR, United
Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">§Departments of Biochemical and Cellular Pharmacology, ∥Discovery Chemistry, ⊥Drug Metabolism
and Pharmacokinetics, #Immunology, and ○Structural Biology, Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080,
United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gauri Deshmukh</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Medicinal Chemistry and ‡Computer Aided Drug Design, Argenta, 8/9 Spire Green Centre, Harlow CM19 5TR, United
Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">§Departments of Biochemical and Cellular Pharmacology, ∥Discovery Chemistry, ⊥Drug Metabolism
and Pharmacokinetics, #Immunology, and ○Structural Biology, Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080,
United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hazel J. Dyke</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Medicinal Chemistry and ‡Computer Aided Drug Design, Argenta, 8/9 Spire Green Centre, Harlow CM19 5TR, United
Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">§Departments of Biochemical and Cellular Pharmacology, ∥Discovery Chemistry, ⊥Drug Metabolism
and Pharmacokinetics, #Immunology, and ○Structural Biology, Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080,
United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Charles Eigenbrot</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Medicinal Chemistry and ‡Computer Aided Drug Design, Argenta, 8/9 Spire Green Centre, Harlow CM19 5TR, United
Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">§Departments of Biochemical and Cellular Pharmacology, ∥Discovery Chemistry, ⊥Drug Metabolism
and Pharmacokinetics, #Immunology, and ○Structural Biology, Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080,
United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nico Ghilardi</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Medicinal Chemistry and ‡Computer Aided Drug Design, Argenta, 8/9 Spire Green Centre, Harlow CM19 5TR, United
Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">§Departments of Biochemical and Cellular Pharmacology, ∥Discovery Chemistry, ⊥Drug Metabolism
and Pharmacokinetics, #Immunology, and ○Structural Biology, Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080,
United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul Gibbons</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Medicinal Chemistry and ‡Computer Aided Drug Design, Argenta, 8/9 Spire Green Centre, Harlow CM19 5TR, United
Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">§Departments of Biochemical and Cellular Pharmacology, ∥Discovery Chemistry, ⊥Drug Metabolism
and Pharmacokinetics, #Immunology, and ○Structural Biology, Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080,
United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Trevor K. Harrison</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Medicinal Chemistry and ‡Computer Aided Drug Design, Argenta, 8/9 Spire Green Centre, Harlow CM19 5TR, United
Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">§Departments of Biochemical and Cellular Pharmacology, ∥Discovery Chemistry, ⊥Drug Metabolism
and Pharmacokinetics, #Immunology, and ○Structural Biology, Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080,
United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter R. Hewitt</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Medicinal Chemistry and ‡Computer Aided Drug Design, Argenta, 8/9 Spire Green Centre, Harlow CM19 5TR, United
Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">§Departments of Biochemical and Cellular Pharmacology, ∥Discovery Chemistry, ⊥Drug Metabolism
and Pharmacokinetics, #Immunology, and ○Structural Biology, Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080,
United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marya Liimatta</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Medicinal Chemistry and ‡Computer Aided Drug Design, Argenta, 8/9 Spire Green Centre, Harlow CM19 5TR, United
Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">§Departments of Biochemical and Cellular Pharmacology, ∥Discovery Chemistry, ⊥Drug Metabolism
and Pharmacokinetics, #Immunology, and ○Structural Biology, Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080,
United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher A. Hurley</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Medicinal Chemistry and ‡Computer Aided Drug Design, Argenta, 8/9 Spire Green Centre, Harlow CM19 5TR, United
Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">§Departments of Biochemical and Cellular Pharmacology, ∥Discovery Chemistry, ⊥Drug Metabolism
and Pharmacokinetics, #Immunology, and ○Structural Biology, Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080,
United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Adam Johnson</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Medicinal Chemistry and ‡Computer Aided Drug Design, Argenta, 8/9 Spire Green Centre, Harlow CM19 5TR, United
Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">§Departments of Biochemical and Cellular Pharmacology, ∥Discovery Chemistry, ⊥Drug Metabolism
and Pharmacokinetics, #Immunology, and ○Structural Biology, Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080,
United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tony Johnson</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Medicinal Chemistry and ‡Computer Aided Drug Design, Argenta, 8/9 Spire Green Centre, Harlow CM19 5TR, United
Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">§Departments of Biochemical and Cellular Pharmacology, ∥Discovery Chemistry, ⊥Drug Metabolism
and Pharmacokinetics, #Immunology, and ○Structural Biology, Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080,
United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jane R. Kenny</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Medicinal Chemistry and ‡Computer Aided Drug Design, Argenta, 8/9 Spire Green Centre, Harlow CM19 5TR, United
Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">§Departments of Biochemical and Cellular Pharmacology, ∥Discovery Chemistry, ⊥Drug Metabolism
and Pharmacokinetics, #Immunology, and ○Structural Biology, Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080,
United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pawan Bir Kohli</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Medicinal Chemistry and ‡Computer Aided Drug Design, Argenta, 8/9 Spire Green Centre, Harlow CM19 5TR, United
Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">§Departments of Biochemical and Cellular Pharmacology, ∥Discovery Chemistry, ⊥Drug Metabolism
and Pharmacokinetics, #Immunology, and ○Structural Biology, Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080,
United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert J. Maxey</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Medicinal Chemistry and ‡Computer Aided Drug Design, Argenta, 8/9 Spire Green Centre, Harlow CM19 5TR, United
Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">§Departments of Biochemical and Cellular Pharmacology, ∥Discovery Chemistry, ⊥Drug Metabolism
and Pharmacokinetics, #Immunology, and ○Structural Biology, Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080,
United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rohan Mendonca</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Medicinal Chemistry and ‡Computer Aided Drug Design, Argenta, 8/9 Spire Green Centre, Harlow CM19 5TR, United
Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">§Departments of Biochemical and Cellular Pharmacology, ∥Discovery Chemistry, ⊥Drug Metabolism
and Pharmacokinetics, #Immunology, and ○Structural Biology, Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080,
United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kyle Mortara</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Medicinal Chemistry and ‡Computer Aided Drug Design, Argenta, 8/9 Spire Green Centre, Harlow CM19 5TR, United
Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">§Departments of Biochemical and Cellular Pharmacology, ∥Discovery Chemistry, ⊥Drug Metabolism
and Pharmacokinetics, #Immunology, and ○Structural Biology, Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080,
United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeremy Murray</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Medicinal Chemistry and ‡Computer Aided Drug Design, Argenta, 8/9 Spire Green Centre, Harlow CM19 5TR, United
Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">§Departments of Biochemical and Cellular Pharmacology, ∥Discovery Chemistry, ⊥Drug Metabolism
and Pharmacokinetics, #Immunology, and ○Structural Biology, Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080,
United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Raman Narukulla</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Medicinal Chemistry and ‡Computer Aided Drug Design, Argenta, 8/9 Spire Green Centre, Harlow CM19 5TR, United
Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">§Departments of Biochemical and Cellular Pharmacology, ∥Discovery Chemistry, ⊥Drug Metabolism
and Pharmacokinetics, #Immunology, and ○Structural Biology, Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080,
United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steven Shia</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Medicinal Chemistry and ‡Computer Aided Drug Design, Argenta, 8/9 Spire Green Centre, Harlow CM19 5TR, United
Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">§Departments of Biochemical and Cellular Pharmacology, ∥Discovery Chemistry, ⊥Drug Metabolism
and Pharmacokinetics, #Immunology, and ○Structural Biology, Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080,
United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Micah Steffek</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Medicinal Chemistry and ‡Computer Aided Drug Design, Argenta, 8/9 Spire Green Centre, Harlow CM19 5TR, United
Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">§Departments of Biochemical and Cellular Pharmacology, ∥Discovery Chemistry, ⊥Drug Metabolism
and Pharmacokinetics, #Immunology, and ○Structural Biology, Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080,
United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Savita Ubhayakar</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Medicinal Chemistry and ‡Computer Aided Drug Design, Argenta, 8/9 Spire Green Centre, Harlow CM19 5TR, United
Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">§Departments of Biochemical and Cellular Pharmacology, ∥Discovery Chemistry, ⊥Drug Metabolism
and Pharmacokinetics, #Immunology, and ○Structural Biology, Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080,
United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mark Ultsch</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Medicinal Chemistry and ‡Computer Aided Drug Design, Argenta, 8/9 Spire Green Centre, Harlow CM19 5TR, United
Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">§Departments of Biochemical and Cellular Pharmacology, ∥Discovery Chemistry, ⊥Drug Metabolism
and Pharmacokinetics, #Immunology, and ○Structural Biology, Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080,
United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anne van Abbema</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Medicinal Chemistry and ‡Computer Aided Drug Design, Argenta, 8/9 Spire Green Centre, Harlow CM19 5TR, United
Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">§Departments of Biochemical and Cellular Pharmacology, ∥Discovery Chemistry, ⊥Drug Metabolism
and Pharmacokinetics, #Immunology, and ○Structural Biology, Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080,
United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stuart I. Ward</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Medicinal Chemistry and ‡Computer Aided Drug Design, Argenta, 8/9 Spire Green Centre, Harlow CM19 5TR, United
Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">§Departments of Biochemical and Cellular Pharmacology, ∥Discovery Chemistry, ⊥Drug Metabolism
and Pharmacokinetics, #Immunology, and ○Structural Biology, Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080,
United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bohdan Waszkowycz</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Medicinal Chemistry and ‡Computer Aided Drug Design, Argenta, 8/9 Spire Green Centre, Harlow CM19 5TR, United
Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">§Departments of Biochemical and Cellular Pharmacology, ∥Discovery Chemistry, ⊥Drug Metabolism
and Pharmacokinetics, #Immunology, and ○Structural Biology, Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080,
United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mark Zak</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Medicinal Chemistry and ‡Computer Aided Drug Design, Argenta, 8/9 Spire Green Centre, Harlow CM19 5TR, United
Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">§Departments of Biochemical and Cellular Pharmacology, ∥Discovery Chemistry, ⊥Drug Metabolism
and Pharmacokinetics, #Immunology, and ○Structural Biology, Genentech,
Inc., 1 DNA Way, South San Francisco, California 94080,
United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d2318e4690-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i67">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14424" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14424" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We wish to thank Peter Crackett for the provision of intermediates, Russell Scammel, Michael Podmore and Neil Bayliss for analytical support, Erlie Delarosa (hepatocyte stability), and Ning Liu (microsomal stability) for <i>in vitro</i> ADME support, and Peter Dragovich and David Clark for editorial assistance.</p></div><div class="postAsapNotesSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="postAsapNotesSection">Note Added After ASAP Publication</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21450" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21450" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">After this paper was published on the Web June 11, 2012, a change was made to ref 31. The corrected version was reposted June 15, 2012.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i68" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i68"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i69" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i69"> Abbreviations Used</h2><tr><td class="NLM_term">AcOH</td><td class="NLM_def"><p class="first last">Acetic acid</p></td></tr><tr><td class="NLM_term">BME</td><td class="NLM_def"><p class="first last">β-mercaptoethanol</p></td></tr><tr><td class="NLM_term">CDCl<sub>3</sub></td><td class="NLM_def"><p class="first last">deuterated chloroform</p></td></tr><tr><td class="NLM_term">DMSO-<i>d</i><sub><i>6</i></sub></td><td class="NLM_def"><p class="first last">deuterated DMSO</p></td></tr><tr><td class="NLM_term">EDCI</td><td class="NLM_def"><p class="first last">1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride</p></td></tr><tr><td class="NLM_term">HATU</td><td class="NLM_def"><p class="first last">2-(7-aza-1<i>H</i>-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate</p></td></tr><tr><td class="NLM_term">HOBt</td><td class="NLM_def"><p class="first last">hydroxybenzotriazole</p></td></tr><tr><td class="NLM_term">LogD<sub>7.2</sub></td><td class="NLM_def"><p class="first last">log of partition coefficient between octanol and pH<sub>7.2</sub> aqueous buffer</p></td></tr><tr><td class="NLM_term">MCT</td><td class="NLM_def"><p class="first last">methyl cellulose/tween</p></td></tr><tr><td class="NLM_term">MDCK</td><td class="NLM_def"><p class="first last">Madin–Darby canine kidney cells</p></td></tr><tr><td class="NLM_term"><i>P</i><sub>app</sub></td><td class="NLM_def"><p class="first last">apparent permeability</p></td></tr><tr><td class="NLM_term">p-TsOH</td><td class="NLM_def"><p class="first last"><i>para</i>-toluenesulfonic acid</p></td></tr><tr><td class="NLM_term">SCX-2</td><td class="NLM_def"><p class="first last">prepacked Isolute silica-based sorbent with a chemically bonded propylsulfonic acid functional group</p></td></tr><tr><td class="NLM_term">TCEP</td><td class="NLM_def"><p class="first last"><i>tris</i>(2-carboxyethyl)phosphine</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i70">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12635" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12635" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 47 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Song, L.; Schindler, C.</span><span> </span><span class="NLM_article-title">JAK-STAT Signalling</span>. In  <span class="citation_source-book">The Handbook of Cell Signalling</span>. <span class="NLM_edition">2</span>nd ed.; <span class="NLM_contrib-group">Bradshaw, R. A., Dennis, E. A.</span>, Eds.; <span class="NLM_publisher-name">Elsevier Inc.</span>: <span class="NLM_publisher-loc">San Diego, CA</span>,<span class="NLM_x"> </span><span class="NLM_year">2010</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">3</span>, pp  <span class="NLM_fpage">2041</span><span class="NLM_x">–</span> <span class="NLM_lpage">2048</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Fjm300438j&amp;key=10.1016%2FB978-0-12-374145-5.00249-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&pages=2041-2048&author=L.+Song&author=C.+Schindlerauthor=R.+A.+Bradshaw&author=E.+A.+Dennis&title=The+Handbook+of+Cell+Signalling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-374145-5.00249-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-0-12-374145-5.00249-7%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DL.%26atitle%3DJAK-STAT%2520Signalling%26btitle%3DThe%2520Handbook%2520of%2520Cell%2520Signalling%26aulast%3DBradshaw%26aufirst%3DR.%2BA.%26pub%3DElsevier%2520Inc%26date%3D2010%26volume%3D3%26spage%3D2041%26epage%3D2048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Shuai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, B.</span><span> </span><span class="NLM_article-title">Regulation of JAK-STAT Signalling in the Immune System</span> <span class="citation_source-journal">Nat. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">900</span><span class="NLM_x">–</span> <span class="NLM_lpage">911</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Fjm300438j&amp;key=10.1038%2Fnri1226" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Fjm300438j&amp;key=14668806" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Fjm300438j&amp;key=1%3ACAS%3A528%3ADC%252BD3sXptFCltbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=900-911&author=K.+Shuaiauthor=B.+Liu&title=Regulation+of+JAK-STAT+Signalling+in+the+Immune+System"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of JAK-STAT signalling in the immune system</span></div><div class="casAuthors">Shuai, Ke; Liu, Bin</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">900-911</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The cytokine-activated Janus kinase (JAK)-signal transducer and activator of transcription (STAT) pathway has an important role in the control of immune responses.  Dysregulation of JAK-STAT signalling is assocd. with various immune disorders.  The signalling strength kinetics and specificity of the JAK-STAT pathway are modulated at many levels by distinct regulatory proteins.  Here, we review recent studies on the regulation of the JAK-STAT pathway that will enhance our ability to design rational therapeutic strategies for immune diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDG-MzyqAi4bVg90H21EOLACvtfcHk0lis8ETVXFNFgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXptFCltbc%253D&md5=cb04239e0d430052a975e930c656e31d</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1038%2Fnri1226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri1226%26sid%3Dliteratum%253Aachs%26aulast%3DShuai%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DB.%26atitle%3DRegulation%2520of%2520JAK-STAT%2520Signalling%2520in%2520the%2520Immune%2520System%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2003%26volume%3D3%26spage%3D900%26epage%3D911" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Ghoreschi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laurence, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Shea, J. J.</span><span> </span><span class="NLM_article-title">Janus Kinases in Immune Cell Signalling</span> <span class="citation_source-journal">Immunol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">228</span><span class="NLM_x">, </span> <span class="NLM_fpage">273</span><span class="NLM_x">–</span> <span class="NLM_lpage">287</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=16&amp;doi=10.1021%2Fjm300438j&amp;key=10.1111%2Fj.1600-065X.2008.00754.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=8&amp;doi=10.1021%2Fjm300438j&amp;key=19290934" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=32&amp;doi=10.1021%2Fjm300438j&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGls7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=228&publication_year=2009&pages=273-287&author=K.+Ghoreschiauthor=A.+Laurenceauthor=J.+J.+O%E2%80%99Shea&title=Janus+Kinases+in+Immune+Cell+Signalling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1cR"><div class="casContent"><span class="casTitleNuber">1c</span><div class="casTitle"><span class="NLM_cas:atitle">Janus kinases in immune cell signaling</span></div><div class="casAuthors">Ghoreschi, Kamran; Laurence, Arian; O'Shea, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">228</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">273-287</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">1600-065X</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  The Janus family kinases (Jaks), Jak1, Jak2, Jak3, and Tyk2, form one subgroup of the non-receptor protein tyrosine kinases.  They are involved in cell growth, survival, development, and differentiation of a variety of cells but are critically important for immune cells and hematopoietic cells.  Data from exptl. mice and clin. observations have unraveled multiple signaling events mediated by Jaks in innate and adaptive immunity.  Deficiency of Jak3 or Tyk2 results in defined clin. disorders, which are also evident in mouse models.  A striking phenotype assocd. with inactivating Jak3 mutations is severe combined immunodeficiency syndrome, whereas mutation of Tyk2 results in another primary immunodeficiency termed autosomal recessive hyperimmunoglobulin E syndrome.  By contrast, complete deletion of Jak1 or Jak2 in the mouse are not compatible with life and, unsurprisingly, do not have counterparts in human disease.  However, activating mutations of each of the Jaks are found in assocn. with malignant transformation, the most common being gain-of-function mutations of Jak2 in polycythemia vera and other myeloproliferative disorders.  Our existing knowledge on Jak signaling pathways and fundamental work on their biochem. structure and intracellular interactions allow us to develop new strategies for controlling autoimmune diseases or malignancies by developing selective Jak inhibitors, which are now coming into clin. use.  Despite the fact that Jaks were discovered only a little more than a decade ago, at the time of writing there are 20 clin. trials underway testing the safely and efficacy of Jak inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp23ncK0nYqpbVg90H21EOLACvtfcHk0lis8ETVXFNFgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGls7vJ&md5=adc282a9ad381ee18abe57a82c921f65</span></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-065X.2008.00754.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-065X.2008.00754.x%26sid%3Dliteratum%253Aachs%26aulast%3DGhoreschi%26aufirst%3DK.%26aulast%3DLaurence%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26atitle%3DJanus%2520Kinases%2520in%2520Immune%2520Cell%2520Signalling%26jtitle%3DImmunol.%2520Rev.%26date%3D2009%26volume%3D228%26spage%3D273%26epage%3D287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Levy, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darnell, J. E.,  Jr.</span><span> </span><span class="NLM_article-title">STATS: Transcriptional Control and Biological Impact</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">651</span><span class="NLM_x">–</span> <span class="NLM_lpage">662</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Fjm300438j&amp;key=10.1038%2Fnrm909" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Fjm300438j&amp;key=12209125" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Fjm300438j&amp;key=1%3ACAS%3A528%3ADC%252BD38Xmslansrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2002&pages=651-662&author=D.+E.+Levyauthor=J.+E.+Darnell&title=STATS%3A+Transcriptional+Control+and+Biological+Impact"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Stats: transcriptional control and biological impact</span></div><div class="casAuthors">Levy, David E.; Darnell, J. E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">651-662</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Extracellular proteins bound to cell-surface receptors can change nuclear gene expression patterns in minutes, with far-reaching consequences for development, cell growth, and homeostasis.  The signal transducer and activator of transcription (STAT) proteins are among the most well studied of the latent cytoplasmic signal-dependent transcription factor pathways.  In addn. to several roles in normal cell decisions, dysregulation of STAT function contributes to human disease, making the study of these proteins an important topic of current research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGqYF32j262LVg90H21EOLACvtfcHk0lis8ETVXFNFgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xmslansrw%253D&md5=4a04359c59e54b12d8a67efb6ef42e4c</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1038%2Fnrm909&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm909%26sid%3Dliteratum%253Aachs%26aulast%3DLevy%26aufirst%3DD.%2BE.%26aulast%3DDarnell%26aufirst%3DJ.%2BE.%26atitle%3DSTATS%253A%2520Transcriptional%2520Control%2520and%2520Biological%2520Impact%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2002%26volume%3D3%26spage%3D651%26epage%3D662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kisseleva, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braunstein, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schindler, C. W.</span><span> </span><span class="NLM_article-title">Signalling Through the JAK/STAT Pathway, Recent Advances and Future Challenges</span> <span class="citation_source-journal">Gene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2002&pages=1-24&author=T.+Kisselevaauthor=S.+Bhattacharyaauthor=J.+Braunsteinauthor=C.+W.+Schindler&title=Signalling+Through+the+JAK%2FSTAT+Pathway%2C+Recent+Advances+and+Future+Challenges"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKisseleva%26aufirst%3DT.%26aulast%3DBhattacharya%26aufirst%3DS.%26aulast%3DBraunstein%26aufirst%3DJ.%26aulast%3DSchindler%26aufirst%3DC.%2BW.%26atitle%3DSignalling%2520Through%2520the%2520JAK%252FSTAT%2520Pathway%252C%2520Recent%2520Advances%2520and%2520Future%2520Challenges%26jtitle%3DGene%26date%3D2002%26volume%3D285%26spage%3D1%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Schindler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, T.</span><span> </span><span class="NLM_article-title">JAK-STAT Signaling: From Interferons to Cytokines</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">20059</span><span class="NLM_x">–</span> <span class="NLM_lpage">20063</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=20059-20063&author=C.+Schindlerauthor=D.+E.+Levyauthor=T.+Decker&title=JAK-STAT+Signaling%3A+From+Interferons+to+Cytokines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchindler%26aufirst%3DC.%26aulast%3DLevy%26aufirst%3DD.%2BE.%26aulast%3DDecker%26aufirst%3DT.%26atitle%3DJAK-STAT%2520Signaling%253A%2520From%2520Interferons%2520to%2520Cytokines%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D20059%26epage%3D20063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Quintas-Cardama, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kantarjian, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verstovsek, S.</span><span> </span><span class="NLM_article-title">Janus Kinase Inhibitors for the Treatment of Myeloproliferative Neoplasias and Beyond</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">140</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=127-140&author=A.+Quintas-Cardamaauthor=H.+Kantarjianauthor=J.+Cortesauthor=S.+Verstovsek&title=Janus+Kinase+Inhibitors+for+the+Treatment+of+Myeloproliferative+Neoplasias+and+Beyond"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DQuintas-Cardama%26aufirst%3DA.%26aulast%3DKantarjian%26aufirst%3DH.%26aulast%3DCortes%26aufirst%3DJ.%26aulast%3DVerstovsek%26aufirst%3DS.%26atitle%3DJanus%2520Kinase%2520Inhibitors%2520for%2520the%2520Treatment%2520of%2520Myeloproliferative%2520Neoplasias%2520and%2520Beyond%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D127%26epage%3D140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Watford, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Shea, J. J.</span><span> </span><span class="NLM_article-title">Human TYK2 Kinase Deficiency: Another Primary Immunodeficiency Syndrome</span> <span class="citation_source-journal">Immunity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">695</span><span class="NLM_x">–</span> <span class="NLM_lpage">697</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=695-697&author=W.+T.+Watfordauthor=J.+J.+O%E2%80%99Shea&title=Human+TYK2+Kinase+Deficiency%3A+Another+Primary+Immunodeficiency+Syndrome"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWatford%26aufirst%3DW.%2BT.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26atitle%3DHuman%2520TYK2%2520Kinase%2520Deficiency%253A%2520Another%2520Primary%2520Immunodeficiency%2520Syndrome%26jtitle%3DImmunity%26date%3D2006%26volume%3D25%26spage%3D695%26epage%3D697" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">O’Shea, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gadina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, R. D.</span><span> </span><span class="NLM_article-title">Cytokine Signaling in 2002: New Surprises in the Jak/Stat Pathway</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl.</span><span class="NLM_x">) </span> <span class="NLM_fpage">S121</span><span class="NLM_x">–</span> <span class="NLM_lpage">S131</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2002&pages=S121-S131&issue=Suppl.&author=J.+J.+O%E2%80%99Sheaauthor=M.+Gadinaauthor=R.+D.+Schreiber&title=Cytokine+Signaling+in+2002%3A+New+Surprises+in+the+Jak%2FStat+Pathway"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26aulast%3DGadina%26aufirst%3DM.%26aulast%3DSchreiber%26aufirst%3DR.%2BD.%26atitle%3DCytokine%2520Signaling%2520in%25202002%253A%2520New%2520Surprises%2520in%2520the%2520Jak%252FStat%2520Pathway%26jtitle%3DCell%26date%3D2002%26volume%3D109%26issue%3DSuppl%26spage%3DS121%26epage%3DS131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">O’Shea, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borie, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Changelian, P. S.</span><span> </span><span class="NLM_article-title">A New Modality for Immunosuppression: Targeting the JAK/STAT Pathway</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">555</span><span class="NLM_x">–</span> <span class="NLM_lpage">564</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=555-564&author=J.+J.+O%E2%80%99Sheaauthor=M.+Pesuauthor=D.+C.+Borieauthor=P.+S.+Changelian&title=A+New+Modality+for+Immunosuppression%3A+Targeting+the+JAK%2FSTAT+Pathway"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26aulast%3DPesu%26aufirst%3DM.%26aulast%3DBorie%26aufirst%3DD.%2BC.%26aulast%3DChangelian%26aufirst%3DP.%2BS.%26atitle%3DA%2520New%2520Modality%2520for%2520Immunosuppression%253A%2520Targeting%2520the%2520JAK%252FSTAT%2520Pathway%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D555%26epage%3D564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wrobleski, S. T.; Pitts, W. J.</span><span> </span><span class="NLM_article-title">Advances in the Discovery of Small Molecule JAK3 Inhibitors</span>. In  <span class="citation_source-book">Annual Reports in Medicinal Chemistry</span>; <span class="NLM_contrib-group">Macor, J. E.</span>, Ed.: <span class="NLM_publisher-name">Elsevier Inc.</span>: <span class="NLM_publisher-loc">San Diego</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">44</span>, Chapter 12, pp  <span class="NLM_fpage">247</span><span class="NLM_x">–</span> <span class="NLM_lpage">264</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=247-264&author=S.+T.+Wrobleski&author=W.+J.+Pittsauthor=J.+E.+Macor&title=Annual+Reports+in+Medicinal+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DWrobleski%26aufirst%3DS.%2BT.%26atitle%3DAdvances%2520in%2520the%2520Discovery%2520of%2520Small%2520Molecule%2520JAK3%2520Inhibitors%26btitle%3DAnnual%2520Reports%2520in%2520Medicinal%2520Chemistry%26aulast%3DMacor%26aufirst%3DJ.%2BE.%26pub%3DElsevier%2520Inc%26date%3D2009%26volume%3D44%26spage%3D247%26epage%3D264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Changelian, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flanagan, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ball, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kent, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnuson, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzuti, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brissette, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCurdy, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudlacz, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conklyn, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koslov, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strelevitz, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whipple, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munchhof, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doty, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casavant, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blumenkopf, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hines, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lillie, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subramanyam, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shang-Poa, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milici, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beckius, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodworth, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaweco, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beals, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Littman, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zagouras, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magna, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saltarelli, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelms, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Des Etages, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawabata, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finco-Kent, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Si, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paniagua, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holm, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reitz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Shea, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borie, D. C.</span><span> </span><span class="NLM_article-title">Prevention of Organ Allograft Rejection by a Specific Janus Kinase 3 Inhibitor</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">302</span><span class="NLM_x">, </span> <span class="NLM_fpage">875</span><span class="NLM_x">–</span> <span class="NLM_lpage">878</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Fjm300438j&amp;key=10.1126%2Fscience.1087061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=8&amp;doi=10.1021%2Fjm300438j&amp;key=14593182" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Fjm300438j&amp;key=1%3ACAS%3A528%3ADC%252BD3sXos1Cmtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=302&publication_year=2003&pages=875-878&author=P.+S.+Changelianauthor=M.+E.+Flanaganauthor=D.+J.+Ballauthor=C.+R.+Kentauthor=K.+S.+Magnusonauthor=W.+H.+Martinauthor=B.+J.+Rizzutiauthor=P.+S.+Sawyerauthor=B.+D.+Perryauthor=W.+H.+Brissetteauthor=S.+P.+McCurdyauthor=E.+M.+Kudlaczauthor=M.+J.+Conklynauthor=E.+A.+Elliottauthor=E.+R.+Koslovauthor=M.+B.+Fisherauthor=T.+J.+Strelevitzauthor=K.+Yoonauthor=D.+A.+Whippleauthor=J.+Sunauthor=M.+J.+Munchhofauthor=J.+L.+Dotyauthor=J.+M.+Casavantauthor=T.+A.+Blumenkopfauthor=M.+Hinesauthor=M.+F.+Brownauthor=B.+M.+Lillieauthor=C.+Subramanyamauthor=C.+Shang-Poaauthor=A.+J.+Miliciauthor=G.+E.+Beckiusauthor=J.+D.+Moyerauthor=C.+Suauthor=T.+G.+Woodworthauthor=A.+S.+Gawecoauthor=C.+R.+Bealsauthor=B.+H.+Littmanauthor=D.+A.+Fisherauthor=J.+F.+Smithauthor=P.+Zagourasauthor=H.+A.+Magnaauthor=M.+J.+Saltarelliauthor=K.+S.+Johnsonauthor=L.+F.+Nelmsauthor=S.+G.+Des+Etagesauthor=L.+S.+Hayesauthor=T.+T.+Kawabataauthor=D.+Finco-Kentauthor=D.+L.+Bakerauthor=M.+Larsonauthor=M.+S.+Siauthor=R.+Paniaguaauthor=J.+Higginsauthor=B.+Holmauthor=B.+Reitzauthor=Y.+J.+Zhouauthor=R.+E.+Morrisauthor=J.+J.+O%E2%80%99Sheaauthor=D.+C.+Borie&title=Prevention+of+Organ+Allograft+Rejection+by+a+Specific+Janus+Kinase+3+Inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">Prevention of Organ Allograft Rejection by a Specific Janus Kinase 3 Inhibitor</span></div><div class="casAuthors">Changelian, Paul S.; Flanagan, Mark E.; Ball, Douglas J.; Kent, Craig R.; Magnuson, Kelly S.; Martin, William H.; Rizzuti, Bonnie J.; Sawyer, Perry S.; Perry, Bret D.; Brissette, William H.; McCurdy, Sandra P.; Kudlacz, Elizabeth M.; Conklyn, Maryrose J.; Elliott, Eileen A.; Koslov, Erika R.; Fisher, Michael B.; Strelevitz, Timothy J.; Yoon, Kwansik; Whipple, David A.; Sun, Jianmin; Munchhof, Michael J.; Doty, John L.; Casavant, Jeffrey M.; Blumenkopf, Todd A.; Hines, Michael; Brown, Matthew F.; Lillie, Brett M.; Subramanyam, Chakrapani; Chang, Shang-Poa; Milici, Anthony J.; Beckius, Gretchen E.; Moyer, James D.; Su, Chunyan; Woodworth, Thasia G.; Gaweco, Anderson S.; Beals, Chan R.; Littman, Bruce H.; Fisher, Douglas A.; Smith, James F.; Zagouras, Panayiotis; Magna, Holly A.; Saltarelli, Mary J.; Johnson, Kimberly S.; Nelms, Linda F.; Des Etages, Shelley G.; Hayes, Lisa S.; Kawabata, Thomas T.; Finco-Kent, Deborah; Baker, Deanna L.; Larson, Michael; Si, Ming-Sing; Paniagua, Ricardo; Higgins, John; Holm, Bari; Reitz, Bruce; Zhou, Yong-Jie; Morris, Randall E.; O'Shea, John J.; Borie, Dominic C.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">302</span>
        (<span class="NLM_cas:issue">5646</span>),
    <span class="NLM_cas:pages">875-878</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Because of its requirement for signaling by multiple cytokines, Janus kinase 3 (JAK3) is an excellent target for clin. immunosuppression.  The authors report the development of a specific, orally active inhibitor of JAK3, CP-690,550, that significantly prolonged survival in a murine model of heart transplantation and in cynomolgus monkeys receiving kidney transplants.  CP-690,550 treatment was not assocd. with hypertension, hyperlipidemia, or lymphoproliferative disease.  On the basis of these preclin. results, the authors believe JAK3 blockade by CP-690,550 has potential for therapeutically desirable immunosuppression in human organ transplantation and in other clin. settings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNoo8qryWWkbVg90H21EOLACvtfcHk0lgfOaVeZ5fuBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXos1Cmtrg%253D&md5=85b6ea64a6711f95fc28408d42ce9c49</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1126%2Fscience.1087061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1087061%26sid%3Dliteratum%253Aachs%26aulast%3DChangelian%26aufirst%3DP.%2BS.%26aulast%3DFlanagan%26aufirst%3DM.%2BE.%26aulast%3DBall%26aufirst%3DD.%2BJ.%26aulast%3DKent%26aufirst%3DC.%2BR.%26aulast%3DMagnuson%26aufirst%3DK.%2BS.%26aulast%3DMartin%26aufirst%3DW.%2BH.%26aulast%3DRizzuti%26aufirst%3DB.%2BJ.%26aulast%3DSawyer%26aufirst%3DP.%2BS.%26aulast%3DPerry%26aufirst%3DB.%2BD.%26aulast%3DBrissette%26aufirst%3DW.%2BH.%26aulast%3DMcCurdy%26aufirst%3DS.%2BP.%26aulast%3DKudlacz%26aufirst%3DE.%2BM.%26aulast%3DConklyn%26aufirst%3DM.%2BJ.%26aulast%3DElliott%26aufirst%3DE.%2BA.%26aulast%3DKoslov%26aufirst%3DE.%2BR.%26aulast%3DFisher%26aufirst%3DM.%2BB.%26aulast%3DStrelevitz%26aufirst%3DT.%2BJ.%26aulast%3DYoon%26aufirst%3DK.%26aulast%3DWhipple%26aufirst%3DD.%2BA.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DMunchhof%26aufirst%3DM.%2BJ.%26aulast%3DDoty%26aufirst%3DJ.%2BL.%26aulast%3DCasavant%26aufirst%3DJ.%2BM.%26aulast%3DBlumenkopf%26aufirst%3DT.%2BA.%26aulast%3DHines%26aufirst%3DM.%26aulast%3DBrown%26aufirst%3DM.%2BF.%26aulast%3DLillie%26aufirst%3DB.%2BM.%26aulast%3DSubramanyam%26aufirst%3DC.%26aulast%3DShang-Poa%26aufirst%3DC.%26aulast%3DMilici%26aufirst%3DA.%2BJ.%26aulast%3DBeckius%26aufirst%3DG.%2BE.%26aulast%3DMoyer%26aufirst%3DJ.%2BD.%26aulast%3DSu%26aufirst%3DC.%26aulast%3DWoodworth%26aufirst%3DT.%2BG.%26aulast%3DGaweco%26aufirst%3DA.%2BS.%26aulast%3DBeals%26aufirst%3DC.%2BR.%26aulast%3DLittman%26aufirst%3DB.%2BH.%26aulast%3DFisher%26aufirst%3DD.%2BA.%26aulast%3DSmith%26aufirst%3DJ.%2BF.%26aulast%3DZagouras%26aufirst%3DP.%26aulast%3DMagna%26aufirst%3DH.%2BA.%26aulast%3DSaltarelli%26aufirst%3DM.%2BJ.%26aulast%3DJohnson%26aufirst%3DK.%2BS.%26aulast%3DNelms%26aufirst%3DL.%2BF.%26aulast%3DDes%2BEtages%26aufirst%3DS.%2BG.%26aulast%3DHayes%26aufirst%3DL.%2BS.%26aulast%3DKawabata%26aufirst%3DT.%2BT.%26aulast%3DFinco-Kent%26aufirst%3DD.%26aulast%3DBaker%26aufirst%3DD.%2BL.%26aulast%3DLarson%26aufirst%3DM.%26aulast%3DSi%26aufirst%3DM.%2BS.%26aulast%3DPaniagua%26aufirst%3DR.%26aulast%3DHiggins%26aufirst%3DJ.%26aulast%3DHolm%26aufirst%3DB.%26aulast%3DReitz%26aufirst%3DB.%26aulast%3DZhou%26aufirst%3DY.%2BJ.%26aulast%3DMorris%26aufirst%3DR.%2BE.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26aulast%3DBorie%26aufirst%3DD.%2BC.%26atitle%3DPrevention%2520of%2520Organ%2520Allograft%2520Rejection%2520by%2520a%2520Specific%2520Janus%2520Kinase%25203%2520Inhibitor%26jtitle%3DScience%26date%3D2003%26volume%3D302%26spage%3D875%26epage%3D878" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">West, K.</span><span> </span><span class="NLM_article-title">CP-690550, a JAK3 Inhibitor as an Immunosuppressant for the Treatment of Rheumatoid Arthritis, Transplant Rejection, Psoriasis and Other Immune-mediated Disorders</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">491</span><span class="NLM_x">–</span> <span class="NLM_lpage">504</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=491-504&author=K.+West&title=CP-690550%2C+a+JAK3+Inhibitor+as+an+Immunosuppressant+for+the+Treatment+of+Rheumatoid+Arthritis%2C+Transplant+Rejection%2C+Psoriasis+and+Other+Immune-mediated+Disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWest%26aufirst%3DK.%26atitle%3DCP-690550%252C%2520a%2520JAK3%2520Inhibitor%2520as%2520an%2520Immunosuppressant%2520for%2520the%2520Treatment%2520of%2520Rheumatoid%2520Arthritis%252C%2520Transplant%2520Rejection%252C%2520Psoriasis%2520and%2520Other%2520Immune-mediated%2520Disorders%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2009%26volume%3D10%26spage%3D491%26epage%3D504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Verstovsek, S.</span><span> </span><span class="NLM_article-title">Janus-Activated Kinase 2 Inhibitors: A New Era of Targeted Therapies Providing Significant Clinical Benefit for Philadelphia Chromosome–Negative Myeloproliferative Neoplasms</span> <span class="citation_source-journal">J. Clin. Oncology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">781</span><span class="NLM_x">–</span> <span class="NLM_lpage">788</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=16&amp;doi=10.1021%2Fjm300438j&amp;key=10.1200%2FJCO.2010.33.4508" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=8&amp;doi=10.1021%2Fjm300438j&amp;key=21220594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Fjm300438j&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktlelsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=781-788&author=S.+Verstovsek&title=Janus-Activated+Kinase+2+Inhibitors%3A+A+New+Era+of+Targeted+Therapies+Providing+Significant+Clinical+Benefit+for+Philadelphia+Chromosome%E2%80%93Negative+Myeloproliferative+Neoplasms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">Janus-activated kinase 2 inhibitors: a new era of targeted therapies providing significant clinical benefit for Philadelphia chromosome-negative myeloproliferative neoplasms</span></div><div class="casAuthors">Verstovsek, Srdan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">781-788</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">A review covers the role of Janus activated kinase 2 (JAK2) in the pathogenesis of myeloproliferative neoplasm (MPN), including JAK2V617F and JAK2 exon 12 mutations, thrombopoietin receptor mutations, and mutations in the adapter protein LNK.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKong4ZeEVSbVg90H21EOLACvtfcHk0liDaPB7QKjEHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktlelsL4%253D&md5=46cf6565241b648b80031a23da5df9e5</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1200%2FJCO.2010.33.4508&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2010.33.4508%26sid%3Dliteratum%253Aachs%26aulast%3DVerstovsek%26aufirst%3DS.%26atitle%3DJanus-Activated%2520Kinase%25202%2520Inhibitors%253A%2520A%2520New%2520Era%2520of%2520Targeted%2520Therapies%2520Providing%2520Significant%2520Clinical%2520Benefit%2520for%2520Philadelphia%2520Chromosome%25E2%2580%2593Negative%2520Myeloproliferative%2520Neoplasms%26jtitle%3DJ.%2520Clin.%2520Oncology%26date%3D2011%26volume%3D29%26spage%3D781%26epage%3D788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Vijayakrishnan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkataramanan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gulati, P.</span><span> </span><span class="NLM_article-title">Treating Inflammation with the Janus Kinase Inhibitor CP-690,550</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">25</span><span class="NLM_x">–</span> <span class="NLM_lpage">34</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2011&pages=25-34&author=L.+Vijayakrishnanauthor=R.+Venkataramananauthor=P.+Gulati&title=Treating+Inflammation+with+the+Janus+Kinase+Inhibitor+CP-690%2C550"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVijayakrishnan%26aufirst%3DL.%26aulast%3DVenkataramanan%26aufirst%3DR.%26aulast%3DGulati%26aufirst%3DP.%26atitle%3DTreating%2520Inflammation%2520with%2520the%2520Janus%2520Kinase%2520Inhibitor%2520CP-690%252C550%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2011%26volume%3D32%26spage%3D25%26epage%3D34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Meyer, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jesson, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elrick, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funckes-Shippy, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warner, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowty, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramaiah, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabbye, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barks, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kishore, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, D. L.</span><span> </span><span class="NLM_article-title">Anti-Inflammatory Activity and Neutrophil Reductions Mediated by the JAK1/JAK3 Inhibitor, CP-690,550, in Rat Adjuvant-Induced Arthritis</span> <span class="citation_source-journal">J. Inflamm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm300438j&amp;key=10.1186%2F1476-9255-7-41" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm300438j&amp;key=1%3ACAS%3A280%3ADC%252BC3cjnsVWktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2010&pages=41&author=D.+M.+Meyerauthor=M.+I.+Jessonauthor=X.+Liauthor=M.+M.+Elrickauthor=C.+L.+Funckes-Shippyauthor=J.+D.+Warnerauthor=C.+J.+Grossauthor=M.+E.+Dowtyauthor=S.+K.+Ramaiahauthor=J.+L.+Hirschauthor=M.+J.+Sabbyeauthor=J.+L.+Barksauthor=N.+Kishoreauthor=D.+L.+Morris&title=Anti-Inflammatory+Activity+and+Neutrophil+Reductions+Mediated+by+the+JAK1%2FJAK3+Inhibitor%2C+CP-690%2C550%2C+in+Rat+Adjuvant-Induced+Arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-inflammatory activity and neutrophil reductions mediated by the JAK1/JAK3 inhibitor, CP-690,550, in rat adjuvant-induced arthritis</span></div><div class="casAuthors">Meyer Debra M; Jesson Michael I; Li Xiong; Elrick Mollisa M; Funckes-Shippy Christie L; Warner James D; Gross Cindy J; Dowty Martin E; Ramaiah Shashi K; Hirsch Jeffrey L; Saabye Matthew J; Barks Jennifer L; Kishore Nandini; Morris Dale L</div><div class="citationInfo"><span class="NLM_cas:title">Journal of inflammation (London, England)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">41</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  The Janus kinase (JAK) family of tyrosine kinases includes JAK1, JAK2, JAK3 and TYK2, and is required for signaling through Type I and Type II cytokine receptors.  CP-690,550 is a potent and selective JAK inhibitor currently in clinical trials for rheumatoid arthritis (RA) and other autoimmune disease indications.  In RA trials, dose-dependent decreases in neutrophil counts (PBNC) were observed with CP-690,550 treatment.  These studies were undertaken to better understand the relationship between JAK selectivity and PBNC decreases observed with CP-690,550 treatment.  METHODS:  Potency and selectivity of CP-690,550 for mouse, rat and human JAKs was evaluated in a panel of in vitro assays.  The effect of CP-690,550 on granulopoiesis from progenitor cells was also assessed in vitro using colony forming assays.  In vivo the potency of orally administered CP-690,550 on arthritis (paw edema), plasma cytokines, PBNC and bone marrow differentials were evaluated in the rat adjuvant-induced arthritis (AIA) model.  RESULTS:  CP-690,550 potently inhibited signaling through JAK1 and JAK3 with 5-100 fold selectivity over JAK2 in cellular assays, despite inhibiting all four JAK isoforms with nM potency in in vitro enzyme assays.  Dose-dependent inhibition of paw edema was observed in vivo with CP-690,550 treatment.  Plasma cytokines (IL-6 and IL-17), PBNC, and bone marrow myeloid progenitor cells were elevated in the context of AIA disease.  At efficacious exposures, CP-690,550 returned all of these parameters to pre-disease levels.  The plasma concentration of CP-690,550 at efficacious doses was above the in vitro whole blood IC50 of JAK1 and JAK3 inhibition, but not that of JAK2.  CONCLUSION:  Results from this investigation suggest that CP-690,550 is a potent inhibitor of JAK1 and JAK3 with potentially reduced cellular potency for JAK2.  In rat AIA, as in the case of human RA, PBNC were decreased at efficacious exposures of CP-690,550.  Inflammatory end points were similarly reduced, as judged by attenuation of paw edema and cytokines IL-6 and IL-17.  Plasma concentration at these exposures was consistent with inhibition of JAK1 and JAK3 but not JAK2.  Decreases in PBNC following CP-690,550 treatment may thus be related to attenuation of inflammation and are likely not due to suppression of granulopoiesis through JAK2 inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR-l9vqy6452oNpW7w2tapOfW6udTcc2eaLQrc9AArEn7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cjnsVWktA%253D%253D&md5=1190d7c5509fde79a7b56024a3aec9d9</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1186%2F1476-9255-7-41&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1476-9255-7-41%26sid%3Dliteratum%253Aachs%26aulast%3DMeyer%26aufirst%3DD.%2BM.%26aulast%3DJesson%26aufirst%3DM.%2BI.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DElrick%26aufirst%3DM.%2BM.%26aulast%3DFunckes-Shippy%26aufirst%3DC.%2BL.%26aulast%3DWarner%26aufirst%3DJ.%2BD.%26aulast%3DGross%26aufirst%3DC.%2BJ.%26aulast%3DDowty%26aufirst%3DM.%2BE.%26aulast%3DRamaiah%26aufirst%3DS.%2BK.%26aulast%3DHirsch%26aufirst%3DJ.%2BL.%26aulast%3DSabbye%26aufirst%3DM.%2BJ.%26aulast%3DBarks%26aufirst%3DJ.%2BL.%26aulast%3DKishore%26aufirst%3DN.%26aulast%3DMorris%26aufirst%3DD.%2BL.%26atitle%3DAnti-Inflammatory%2520Activity%2520and%2520Neutrophil%2520Reductions%2520Mediated%2520by%2520the%2520JAK1%252FJAK3%2520Inhibitor%252C%2520CP-690%252C550%252C%2520in%2520Rat%2520Adjuvant-Induced%2520Arthritis%26jtitle%3DJ.%2520Inflamm.%26date%3D2010%26volume%3D7%26spage%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lucia, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recchia, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gentile, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bossio, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vigna, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzone, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madeo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morabito, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gigliotti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeStefano, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caruso, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Servillo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franzese, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisconte, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gentile, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morabito, F.</span><span> </span><span class="NLM_article-title">Janus Kinase 2 Inhibitors in Myeloproliferative Disorders</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">59</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2011&pages=41-59&author=E.+Luciaauthor=A.+G.+Recchiaauthor=M.+Gentileauthor=S.+Bossioauthor=E.+Vignaauthor=C.+Mazzoneauthor=A.+Madeoauthor=L.+Morabitoauthor=V.+Gigliottiauthor=L.+DeStefanoauthor=N.+Carusoauthor=P.+Servilloauthor=F.+Franzeseauthor=M.+G.+Bisconteauthor=C.+Gentileauthor=F.+Morabito&title=Janus+Kinase+2+Inhibitors+in+Myeloproliferative+Disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLucia%26aufirst%3DE.%26aulast%3DRecchia%26aufirst%3DA.%2BG.%26aulast%3DGentile%26aufirst%3DM.%26aulast%3DBossio%26aufirst%3DS.%26aulast%3DVigna%26aufirst%3DE.%26aulast%3DMazzone%26aufirst%3DC.%26aulast%3DMadeo%26aufirst%3DA.%26aulast%3DMorabito%26aufirst%3DL.%26aulast%3DGigliotti%26aufirst%3DV.%26aulast%3DDeStefano%26aufirst%3DL.%26aulast%3DCaruso%26aufirst%3DN.%26aulast%3DServillo%26aufirst%3DP.%26aulast%3DFranzese%26aufirst%3DF.%26aulast%3DBisconte%26aufirst%3DM.%2BG.%26aulast%3DGentile%26aufirst%3DC.%26aulast%3DMorabito%26aufirst%3DF.%26atitle%3DJanus%2520Kinase%25202%2520Inhibitors%2520in%2520Myeloproliferative%2520Disorders%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2011%26volume%3D20%26spage%3D41%26epage%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ghoreschi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laurence, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Shea, J. J.</span><span> </span><span class="NLM_article-title">Selectivity and Therapeutic Inhibition of Kinases: To Be or Not To Be?</span> <span class="citation_source-journal">Nat. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">356</span><span class="NLM_x">–</span> <span class="NLM_lpage">360</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=16&amp;doi=10.1021%2Fjm300438j&amp;key=10.1038%2Fni.1701" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=356-360&author=K.+Ghoreschiauthor=A.+Laurenceauthor=J.+J.+O%E2%80%99Shea&title=Selectivity+and+Therapeutic+Inhibition+of+Kinases%3A+To+Be+or+Not+To+Be%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1038%2Fni.1701&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni.1701%26sid%3Dliteratum%253Aachs%26aulast%3DGhoreschi%26aufirst%3DK.%26aulast%3DLaurence%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26atitle%3DSelectivity%2520and%2520Therapeutic%2520Inhibition%2520of%2520Kinases%253A%2520To%2520Be%2520or%2520Not%2520To%2520Be%253F%26jtitle%3DNat.%2520Immunol.%26date%3D2009%26volume%3D4%26spage%3D356%26epage%3D360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Mesa, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasothan, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirkpatrick, P.</span><span> </span><span class="NLM_article-title">Ruxolitinib</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">103</span><span class="NLM_x">–</span> <span class="NLM_lpage">104</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=103-104&author=R.+A.+Mesaauthor=U.+Yasothanauthor=P.+Kirkpatrick&title=Ruxolitinib"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMesa%26aufirst%3DR.%2BA.%26aulast%3DYasothan%26aufirst%3DU.%26aulast%3DKirkpatrick%26aufirst%3DP.%26atitle%3DRuxolitinib%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2012%26volume%3D11%26spage%3D103%26epage%3D104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Moreland, L.</span> <span class="citation_source-book">A Randomized Placebo-Controlled Study of INCB018424, a Selective Janus Kinase 1& 2 (JAK1&2) Inhibitor in Rheumatoid Arthritis (RA)</span>. Annual Scientific Meeting of the American College of Rheumatology, San Francisco, CA, Oct 24–29,<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">; </span>John Wiley & Sons: Chichester, UK; Abstract 714.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=L.+Moreland&title=A+Randomized+Placebo-Controlled+Study+of+INCB018424%2C+a+Selective+Janus+Kinase+1%26+2+%28JAK1%262%29+Inhibitor+in+Rheumatoid+Arthritis+%28RA%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DMoreland%26aufirst%3DL.%26btitle%3DA%2520Randomized%2520Placebo-Controlled%2520Study%2520of%2520INCB018424%252C%2520a%2520Selective%2520Janus%2520Kinase%25201%2526%25202%2520%2528JAK1%25262%2529%2520Inhibitor%2520in%2520Rheumatoid%2520Arthritis%2520%2528RA%2529%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Quintas-Cardama, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaddi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manshouri, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherle, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caulder, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waeltz, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rupar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burn, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Covington, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shepard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodgers, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kantarjian, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridman, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verstovsek, S.</span><span> </span><span class="NLM_article-title">Preclinical Characterization of the Selective JAK1/2 Inhibitor INCB01424: Therapeutic Implications for the Treatment of Myeloproliferative Neoplasms</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">3109</span><span class="NLM_x">–</span> <span class="NLM_lpage">3117</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2010&pages=3109-3117&author=A.+Quintas-Cardamaauthor=K.+Vaddiauthor=P.+Liuauthor=T.+Manshouriauthor=J.+Liauthor=P.+A.+Scherleauthor=E.+Caulderauthor=X.+Wenauthor=Y.+Liauthor=P.+Waeltzauthor=M.+Ruparauthor=T.+Burnauthor=Y.+Loauthor=J.+Kelleyauthor=M.+Covingtonauthor=S.+Shepardauthor=J.+D.+Rodgersauthor=P.+Haleyauthor=H.+Kantarjianauthor=J.+S.+Fridmanauthor=S.+Verstovsek&title=Preclinical+Characterization+of+the+Selective+JAK1%2F2+Inhibitor+INCB01424%3A+Therapeutic+Implications+for+the+Treatment+of+Myeloproliferative+Neoplasms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DQuintas-Cardama%26aufirst%3DA.%26aulast%3DVaddi%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DManshouri%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DScherle%26aufirst%3DP.%2BA.%26aulast%3DCaulder%26aufirst%3DE.%26aulast%3DWen%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DWaeltz%26aufirst%3DP.%26aulast%3DRupar%26aufirst%3DM.%26aulast%3DBurn%26aufirst%3DT.%26aulast%3DLo%26aufirst%3DY.%26aulast%3DKelley%26aufirst%3DJ.%26aulast%3DCovington%26aufirst%3DM.%26aulast%3DShepard%26aufirst%3DS.%26aulast%3DRodgers%26aufirst%3DJ.%2BD.%26aulast%3DHaley%26aufirst%3DP.%26aulast%3DKantarjian%26aufirst%3DH.%26aulast%3DFridman%26aufirst%3DJ.%2BS.%26aulast%3DVerstovsek%26aufirst%3DS.%26atitle%3DPreclinical%2520Characterization%2520of%2520the%2520Selective%2520JAK1%252F2%2520Inhibitor%2520INCB01424%253A%2520Therapeutic%2520Implications%2520for%2520the%2520Treatment%2520of%2520Myeloproliferative%2520Neoplasms%26jtitle%3DBlood%26date%3D2010%26volume%3D115%26spage%3D3109%26epage%3D3117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Haan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rolvering, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raulf, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapp, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Druckes, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thoma, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behrmann, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zerwes, H.-G.</span><span> </span><span class="NLM_article-title">Jak1 Has a Dominant Role over Jak3 in Signal Transduction through γc-Containing Cytokine Receptors</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">314</span><span class="NLM_x">–</span> <span class="NLM_lpage">323</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm300438j&amp;key=10.1016%2Fj.chembiol.2011.01.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm300438j&amp;key=21439476" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm300438j&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvFSrtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=314-323&author=C.+Haanauthor=C.+Rolveringauthor=F.+Raulfauthor=M.+Kappauthor=P.+Druckesauthor=G.+Thomaauthor=I.+Behrmannauthor=H.-G.+Zerwes&title=Jak1+Has+a+Dominant+Role+over+Jak3+in+Signal+Transduction+through+%CE%B3c-Containing+Cytokine+Receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Jak1 Has a Dominant Role over Jak3 in Signal Transduction through γc-Containing Cytokine Receptors</span></div><div class="casAuthors">Haan, Claude; Rolvering, Catherine; Raulf, Friedrich; Kapp, Manuela; Drueckes, Peter; Thoma, Gebhard; Behrmann, Iris; Zerwes, Hans-Guenter</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">314-323</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Genetic deficiency of Jak3 leads to abrogation of signal transduction through the common gamma chain (γc) and thus to immunodeficiency suggesting that specific inhibition of Jak3 kinase may result in immunosuppression.  Jak1 cooperates with Jak3 in signaling through γc-contg. receptors.  Unexpectedly, a Jak3-selective inhibitor was less efficient in abolishing STAT5 phosphorylation than pan-Jak inhibitors.  We therefore explored the roles of Jak1 and Jak3 kinase functionality in signaling using a reconstituted system.  The presence of kinase-inactive Jak1 but not kinase-inactive Jak3 resulted in complete abolishment of STAT5 phosphorylation.  Specific inhibition of the "analog-sensitive" mutant AS-Jak1 but not AS-Jak3 by the ATP-competitive analog 1NM-PP1 abrogated IL-2 signaling, corroborating the data with the selective Jak3 inhibitor.  Jak1 thus plays a dominant role over Jak3 and these data challenge the notion that selective ATP-competitive Jak3 kinase inhibitors will be effective.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUv04vX29Zk7Vg90H21EOLACvtfcHk0lhTl4CK8bKu1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvFSrtrw%253D&md5=0109f316cfe0bee40f80a79f244e6ba5</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2011.01.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2011.01.012%26sid%3Dliteratum%253Aachs%26aulast%3DHaan%26aufirst%3DC.%26aulast%3DRolvering%26aufirst%3DC.%26aulast%3DRaulf%26aufirst%3DF.%26aulast%3DKapp%26aufirst%3DM.%26aulast%3DDruckes%26aufirst%3DP.%26aulast%3DThoma%26aufirst%3DG.%26aulast%3DBehrmann%26aufirst%3DI.%26aulast%3DZerwes%26aufirst%3DH.-G.%26atitle%3DJak1%2520Has%2520a%2520Dominant%2520Role%2520over%2520Jak3%2520in%2520Signal%2520Transduction%2520through%2520%25CE%25B3c-Containing%2520Cytokine%2520Receptors%26jtitle%3DChem.%2520Biol.%26date%3D2011%26volume%3D18%26spage%3D314%26epage%3D323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Rodig, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meraz, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lampe, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riley, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arthur, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheehan, K. C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennica, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, E. M.,  Jr</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, R. D.</span><span> </span><span class="NLM_article-title">Disruption of the JAK1 Gene Demonstrates Obligatory and Nonredundant Roles of the JAKs in Cytokine-Induced Biologic Responses</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">373</span><span class="NLM_x">–</span> <span class="NLM_lpage">383</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1998&pages=373-383&author=S.+J.+Rodigauthor=M.+A.+Merazauthor=J.+M.+Whiteauthor=P.+A.+Lampeauthor=J.+K.+Rileyauthor=C.+D.+Arthurauthor=K.+L.+Kingauthor=K.+C.+F.+Sheehanauthor=L.+Yinauthor=D.+Pennicaauthor=E.+M.+Johnsonauthor=R.+D.+Schreiber&title=Disruption+of+the+JAK1+Gene+Demonstrates+Obligatory+and+Nonredundant+Roles+of+the+JAKs+in+Cytokine-Induced+Biologic+Responses"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRodig%26aufirst%3DS.%2BJ.%26aulast%3DMeraz%26aufirst%3DM.%2BA.%26aulast%3DWhite%26aufirst%3DJ.%2BM.%26aulast%3DLampe%26aufirst%3DP.%2BA.%26aulast%3DRiley%26aufirst%3DJ.%2BK.%26aulast%3DArthur%26aufirst%3DC.%2BD.%26aulast%3DKing%26aufirst%3DK.%2BL.%26aulast%3DSheehan%26aufirst%3DK.%2BC.%2BF.%26aulast%3DYin%26aufirst%3DL.%26aulast%3DPennica%26aufirst%3DD.%26aulast%3DJohnson%26aufirst%3DE.%2BM.%26aulast%3DSchreiber%26aufirst%3DR.%2BD.%26atitle%3DDisruption%2520of%2520the%2520JAK1%2520Gene%2520Demonstrates%2520Obligatory%2520and%2520Nonredundant%2520Roles%2520of%2520the%2520JAKs%2520in%2520Cytokine-Induced%2520Biologic%2520Responses%26jtitle%3DCell%26date%3D1998%26volume%3D93%26spage%3D373%26epage%3D383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Parganas, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stravopodis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Topham, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marine, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teglund, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanin, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bodner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colamonici, O. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Deursen, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosveld, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ihle, J. N.</span><span> </span><span class="NLM_article-title">JAK2 Is Essential for Signaling Through a Variety of Cytokine Receptors</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">385</span><span class="NLM_x">–</span> <span class="NLM_lpage">395</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1998&pages=385-395&author=E.+Parganasauthor=D.+Wangauthor=D.+Stravopodisauthor=D.+J.+Tophamauthor=J.-C.+Marineauthor=S.+Teglundauthor=E.+F.+Vaninauthor=S.+Bodnerauthor=O.+R.+Colamoniciauthor=J.+M.+van+Deursenauthor=G.+Grosveldauthor=J.+N.+Ihle&title=JAK2+Is+Essential+for+Signaling+Through+a+Variety+of+Cytokine+Receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DParganas%26aufirst%3DE.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DStravopodis%26aufirst%3DD.%26aulast%3DTopham%26aufirst%3DD.%2BJ.%26aulast%3DMarine%26aufirst%3DJ.-C.%26aulast%3DTeglund%26aufirst%3DS.%26aulast%3DVanin%26aufirst%3DE.%2BF.%26aulast%3DBodner%26aufirst%3DS.%26aulast%3DColamonici%26aufirst%3DO.%2BR.%26aulast%3Dvan%2BDeursen%26aufirst%3DJ.%2BM.%26aulast%3DGrosveld%26aufirst%3DG.%26aulast%3DIhle%26aufirst%3DJ.%2BN.%26atitle%3DJAK2%2520Is%2520Essential%2520for%2520Signaling%2520Through%2520a%2520Variety%2520of%2520Cytokine%2520Receptors%26jtitle%3DCell%26date%3D1998%26volume%3D93%26spage%3D385%26epage%3D395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Shimoda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyamoto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shibamori, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Numata, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takase, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shibata, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gondo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sekiguchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niho, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, K.</span><span> </span><span class="NLM_article-title">TYK2 Plays a Restricted Role in IFNα Signaling, Although it is Required for IL-12-Mediated T Cell Function</span> <span class="citation_source-journal">Immunity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">561</span><span class="NLM_x">–</span> <span class="NLM_lpage">571</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2000&pages=561-571&author=K.+Shimodaauthor=K.+Katoauthor=K.+Aokiauthor=T.+Matsudaauthor=A.+Miyamotoauthor=M.+Shibamoriauthor=M.+Yamashitaauthor=A.+Numataauthor=K.+Takaseauthor=S.+Kobayashiauthor=S.+Shibataauthor=Y.+Asanoauthor=H.+Gondoauthor=K.+Sekiguchiauthor=K.+Nakayamaauthor=T.+Nakayamaauthor=T.+Okamuraauthor=S.+Okamuraauthor=Y.+Nihoauthor=K.+Nakayama&title=TYK2+Plays+a+Restricted+Role+in+IFN%CE%B1+Signaling%2C+Although+it+is+Required+for+IL-12-Mediated+T+Cell+Function"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShimoda%26aufirst%3DK.%26aulast%3DKato%26aufirst%3DK.%26aulast%3DAoki%26aufirst%3DK.%26aulast%3DMatsuda%26aufirst%3DT.%26aulast%3DMiyamoto%26aufirst%3DA.%26aulast%3DShibamori%26aufirst%3DM.%26aulast%3DYamashita%26aufirst%3DM.%26aulast%3DNumata%26aufirst%3DA.%26aulast%3DTakase%26aufirst%3DK.%26aulast%3DKobayashi%26aufirst%3DS.%26aulast%3DShibata%26aufirst%3DS.%26aulast%3DAsano%26aufirst%3DY.%26aulast%3DGondo%26aufirst%3DH.%26aulast%3DSekiguchi%26aufirst%3DK.%26aulast%3DNakayama%26aufirst%3DK.%26aulast%3DNakayama%26aufirst%3DT.%26aulast%3DOkamura%26aufirst%3DT.%26aulast%3DOkamura%26aufirst%3DS.%26aulast%3DNiho%26aufirst%3DY.%26aulast%3DNakayama%26aufirst%3DK.%26atitle%3DTYK2%2520Plays%2520a%2520Restricted%2520Role%2520in%2520IFN%25CE%25B1%2520Signaling%252C%2520Although%2520it%2520is%2520Required%2520for%2520IL-12-Mediated%2520T%2520Cell%2520Function%26jtitle%3DImmunity%26date%3D2000%26volume%3D13%26spage%3D561%26epage%3D571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Patel, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreland, L. W.</span><span> </span><span class="NLM_article-title">Interleukin-6 Inhibition for Treatment of Rheumatoid Arthritis: A Review of Tocilizumab Therapy</span> <span class="citation_source-journal">Drug Des. Dev. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">263</span><span class="NLM_x">–</span> <span class="NLM_lpage">278</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm300438j&amp;key=10.2147%2FDDDT.S14099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm300438j&amp;key=21116333" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm300438j&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVWks7rO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2010&pages=263-278&author=A.+M.+Patelauthor=L.+W.+Moreland&title=Interleukin-6+Inhibition+for+Treatment+of+Rheumatoid+Arthritis%3A+A+Review+of+Tocilizumab+Therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Interleukin-6 inhibition for treatment of rheumatoid arthritis: a review of tocilizumab therapy</span></div><div class="casAuthors">Patel, Aarat M.; Moreland, Larry W.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Design, Development and Therapy</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">263-278</span>CODEN:
                <span class="NLM_cas:coden">DDDTAQ</span>;
        ISSN:<span class="NLM_cas:issn">1177-8881</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">A review.  The dawn of the biol. era has been an exciting period for clin. research and patient care in rheumatoid arthritis (RA).  Targeted biol. therapies have changed the outcome of this disease and made remission a realistic outcome for many patients.  Tocilizumab (TCZ, Actemra), is a humanized monoclonal antibody against the interleukin 6 receptor and has been approved in many countries for the treatment of moderate to severe RA.  There have been a no. of important clin. trials demonstrating the efficacy of TCZ in active rheumatoid arthritis.  This review summarizes the data on efficacy, patient-reported outcomes, adverse events, and safety from some of these trials.  Current trends in clin. practice will be discussed.  It is difficult to place TCZ and many new medications in the algorithm of treatment at present.  However, the next few years will hopefully reveal their role as we better define abnormal immune processes in individuals with RA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSQBaSb6OpuLVg90H21EOLACvtfcHk0liq1LBeFMQwOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVWks7rO&md5=ec9c2425184f453195e64fe225f66417</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.2147%2FDDDT.S14099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FDDDT.S14099%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DA.%2BM.%26aulast%3DMoreland%26aufirst%3DL.%2BW.%26atitle%3DInterleukin-6%2520Inhibition%2520for%2520Treatment%2520of%2520Rheumatoid%2520Arthritis%253A%2520A%2520Review%2520of%2520Tocilizumab%2520Therapy%26jtitle%3DDrug%2520Des.%2520Dev.%2520Ther.%26date%3D2010%26volume%3D4%26spage%3D263%26epage%3D278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Baslund, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tvede, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danneskiold-Samsoe, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panavi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beurskens, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuuman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van de Winkel, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parren, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gracie, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jongbloed, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liew, F. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McInnes, I. B.</span><span> </span><span class="NLM_article-title">Targeting Interleukin-15 in Patients With Rheumatoid Arthritis: A Proof-of-Concept Study</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">2686</span><span class="NLM_x">–</span> <span class="NLM_lpage">2692</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm300438j&amp;key=10.1002%2Fart.21249" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm300438j&amp;key=16142748" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm300438j&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFeltrjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2005&pages=2686-2692&author=B.+Baslundauthor=N.+Tvedeauthor=B.+Danneskiold-Samsoeauthor=P.+Larssonauthor=G.+Panaviauthor=J.+Petersenauthor=L.+J.+Petersenauthor=F.+J.+Beurskensauthor=J.+Schuumanauthor=J.+G.+van+de+Winkelauthor=P.+W.+Parrenauthor=J.+A.+Gracieauthor=S.+Jongbloedauthor=F.+Y.+Liewauthor=I.+B.+McInnes&title=Targeting+Interleukin-15+in+Patients+With+Rheumatoid+Arthritis%3A+A+Proof-of-Concept+Study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting interleukin-15 in patients with rheumatoid arthritis. A proof-of-concept study</span></div><div class="casAuthors">Baslund, Bo; Tvede, Niels; Danneskiold-Samsoe, Bente; Larsson, Per; Panayi, Gabriel; Petersen, Joergen; Petersen, Lars J.; Beurskens, Frank J. M.; Schuurman, Janine; van de Winkel, Jan G. J.; Parren, Paul W. H. I.; Gracie, J. Alastair; Jongbloed, Sarah; Liew, Foo Y.; McInnes, Iain B.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2686-2692</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective. Interleukin-15 (IL-15) is a proinflammatory, innate response cytokine that mediates pleiotropic effector function in rheumatoid arthritis (RA) inflammatory synovitis.  Our objective was to study the ability of HuMax-IL15, a human IgG1 anti-IL-15 monoclonal antibody, to neutralize exogenous and endogenous IL-15 activity in vitro and to perform a phase I-II dose-escalation trial with HuMax-IL15 in patients with active RA.  Methods. Mononuclear cells from blood and synovial fluid (SF) of RA patients were isolated and cultured in vitro under exptl. conditions involving the addn. of HuMax-IL15.  HuMax-IL15 was administered to 30 RA patients who received no other disease-modifying antirheumatic drugs in a 12-wk, dose-ascending, placebo-controlled, double-blind, phase I-II proof-of-concept study.  Results. In vitro studies showed that HuMax-IL15 suppressed proliferation and induced apoptosis in an IL-15-dependent cell line, BDB2, and was capable of suppressing the release of interferon-γ by synovial fluid mononuclear cell (SFMC) cultures induced by exogenous IL-15.  Furthermore, HuMax-IL15 F(ab')2 fragments suppressed exogenous IL-15-induced CD69 expression in RA peripheral blood mononuclear cells and SFMCs, which indicates that HuMax-IL15 can specifically neutralize several biol. effects of IL-15 in synovial tissue in vitro.  In a phase I-II clin. trial, HuMax-IL15 was well tolerated clin., with no significant effects on T lymphocyte subset and natural killer cell nos.  Substantial improvements in disease activity were obsd. according to the American College of Rheumatol. criteria for 20% improvement (63% of patients), 50% improvement (38%), and 70% improvement (25%).  Conclusion. These clin. data suggest for the first time that IL-15 could represent a novel therapeutic target in RA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogAvhCWrkc8bVg90H21EOLACvtfcHk0liq1LBeFMQwOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFeltrjP&md5=5e9ada4f9e9649a6d048fe68c421d2cb</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1002%2Fart.21249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.21249%26sid%3Dliteratum%253Aachs%26aulast%3DBaslund%26aufirst%3DB.%26aulast%3DTvede%26aufirst%3DN.%26aulast%3DDanneskiold-Samsoe%26aufirst%3DB.%26aulast%3DLarsson%26aufirst%3DP.%26aulast%3DPanavi%26aufirst%3DG.%26aulast%3DPetersen%26aufirst%3DJ.%26aulast%3DPetersen%26aufirst%3DL.%2BJ.%26aulast%3DBeurskens%26aufirst%3DF.%2BJ.%26aulast%3DSchuuman%26aufirst%3DJ.%26aulast%3Dvan%2Bde%2BWinkel%26aufirst%3DJ.%2BG.%26aulast%3DParren%26aufirst%3DP.%2BW.%26aulast%3DGracie%26aufirst%3DJ.%2BA.%26aulast%3DJongbloed%26aufirst%3DS.%26aulast%3DLiew%26aufirst%3DF.%2BY.%26aulast%3DMcInnes%26aufirst%3DI.%2BB.%26atitle%3DTargeting%2520Interleukin-15%2520in%2520Patients%2520With%2520Rheumatoid%2520Arthritis%253A%2520A%2520Proof-of-Concept%2520Study%26jtitle%3DArthritis%2520Rheum.%26date%3D2005%26volume%3D52%26spage%3D2686%26epage%3D2692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Yamaoka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kubo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sonomoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeshima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, Y.</span><span> </span><span class="NLM_article-title">JAK Inhibitor: Tofacitinib, a New Disease Modifying Anti-Rheumatic Drug</span> <span class="citation_source-journal">Inflammation Regener.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">349</span><span class="NLM_x">–</span> <span class="NLM_lpage">353</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=16&amp;doi=10.1021%2Fjm300438j&amp;key=10.2492%2Finflammregen.31.349" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=32&amp;doi=10.1021%2Fjm300438j&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlSrtb%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=349-353&author=K.+Yamaokaauthor=S.+Kuboauthor=K.+Sonomotoauthor=K.+Maeshimaauthor=Y.+Tanaka&title=JAK+Inhibitor%3A+Tofacitinib%2C+a+New+Disease+Modifying+Anti-Rheumatic+Drug"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21aR"><div class="casContent"><span class="casTitleNuber">21a</span><div class="casTitle"><span class="NLM_cas:atitle">JAK inhibitor: tofacitinib, a new disease modifying anti-rheumatic drug</span></div><div class="casAuthors">Yamaoka, Kunihiro; Kubo, Satoshi; Sonomoto, Koshiro; Maeshima, Keisuke; Tanaka, Yoshiya</div><div class="citationInfo"><span class="NLM_cas:title">Inflammation and Regeneration</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">349-353</span>CODEN:
                <span class="NLM_cas:coden">IRNECG</span>;
        ISSN:<span class="NLM_cas:issn">1880-9693</span>.
    
            (<span class="NLM_cas:orgname">Nippon Ensho/Saisei Igakkai</span>)
        </div><div class="casAbstract">Treatment of rheumatoid arthritis (RA) with biol. agents targeting inflammatory cytokines and cell surface mols. such as tumor necrosis factor and Interleukin-6 is generally more efficacious than traditional disease-modifying antirheumatic drugs when combined with MTX.  However, not only do ∼30% of patients poorly respond to treatment but also parenteral mode of administration and expense are issues to be solved.  Recently, a kinase inhibitor targeting Janus kinases (JAKs), has shown high efficacy in active RA in clin. trials.  Among several JAK inhibitors in clin. trials for RA, tofacitinib is a step ahead for use in clin. practice.  Kinase inhibitors are orally available, which is a major advantage over biol. agents, in addn. to being less expensive.  This review describes recent advance in JAK inhibitors for RA and its possible mechanism of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3A1aier6Px7Vg90H21EOLACvtfcHk0liq1LBeFMQwOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlSrtb%252FN&md5=33059f4ce0e6b80984903eb0f0f3e3f9</span></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=10.2492%2Finflammregen.31.349&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2492%252Finflammregen.31.349%26sid%3Dliteratum%253Aachs%26aulast%3DYamaoka%26aufirst%3DK.%26aulast%3DKubo%26aufirst%3DS.%26aulast%3DSonomoto%26aufirst%3DK.%26aulast%3DMaeshima%26aufirst%3DK.%26aulast%3DTanaka%26aufirst%3DY.%26atitle%3DJAK%2520Inhibitor%253A%2520Tofacitinib%252C%2520a%2520New%2520Disease%2520Modifying%2520Anti-Rheumatic%2520Drug%26jtitle%3DInflammation%2520Regener.%26date%3D2011%26volume%3D31%26spage%3D349%26epage%3D353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit21b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Fleischmann, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cutolo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genovese, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanik, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connell, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruben, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnaswami, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallenstein, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkinson, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwillich, S. H.</span><span> </span><span class="NLM_article-title">Phase 2B Dose-Ranging Study of the Oral JAK Inhibitor Tofacitinib (CP-690,550) or Adalimumab Monotherapy Versus Placebo in Patients with Active Rheumatoid Arthritis with an Inadequate Response to DMARDs</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">617</span><span class="NLM_x">–</span> <span class="NLM_lpage">629</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=16&amp;doi=10.1021%2Fjm300438j&amp;key=10.1002%2Fart.33383" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=8&amp;doi=10.1021%2Fjm300438j&amp;key=21952978" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=32&amp;doi=10.1021%2Fjm300438j&amp;key=1%3ACAS%3A528%3ADC%252BC38XivVGjurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2012&pages=617-629&author=R.+Fleischmannauthor=M.+Cutoloauthor=M.+C.+Genoveseauthor=E.+B.+Leeauthor=K.+S.+Kanikauthor=S.+Sadisauthor=C.+A.+Connellauthor=D.+Grubenauthor=S.+Krishnaswamiauthor=G.+Wallensteinauthor=B.+E.+Wilkinsonauthor=S.+H.+Zwillich&title=Phase+2B+Dose-Ranging+Study+of+the+Oral+JAK+Inhibitor+Tofacitinib+%28CP-690%2C550%29+or+Adalimumab+Monotherapy+Versus+Placebo+in+Patients+with+Active+Rheumatoid+Arthritis+with+an+Inadequate+Response+to+DMARDs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21bR"><div class="casContent"><span class="casTitleNuber">21b</span><div class="casTitle"><span class="NLM_cas:atitle">Phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) or adalimumab monotherapy versus placebo in patients with active rheumatoid arthritis with an inadequate response to disease-modifying antirheumatic drugs</span></div><div class="casAuthors">Fleischmann, Roy; Cutolo, Maurizio; Genovese, Mark C.; Lee, Eun Bong; Kanik, Keith S.; Sadis, Seth; Connell, Carol A.; Gruben, David; Krishnaswami, Sriram; Wallenstein, Gene; Wilkinson, Bethanie E.; Zwillich, Samuel H.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">617-629</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective : To compare the efficacy, safety, and tolerability of 5 doses of oral tofacitinib (CP-690,550) or adalimumab monotherapy with placebo for the treatment of active rheumatoid arthritis (RA) in patients with an inadequate response to disease-modifying antirheumatic drugs.  Methods : In this 24-wk, double-blind, phase IIb study, patients with RA (n = 384) were randomized to receive placebo, tofacitinib at 1, 3, 5, 10, or 15 mg administered orally twice a day, or adalimumab at 40 mg injected s.c. every 2 wk (total of 6 injections) followed by oral tofacitinib at 5 mg twice a day for 12 wk.  The primary end point was the responder rate according to the American College of Rheumatol. 20% improvement criteria (ACR20) at week 12.  Results : Treatment with tofacitinib at a dose of ≥3 mg twice a day resulted in a rapid response with significant efficacy when compared to placebo, as indicated by the primary end point (ACR20 response at week 12), achieved in 39.2% (3 mg; P ≤ 0.05), 59.2% (5 mg; P < 0.0001), 70.5% (10 mg; P < 0.0001), and 71.9% (15 mg; P < 0.0001) in the tofacitinib group and 35.9% of patients in the adalimumab group (P = 0.105), compared with 22.0% of patients receiving placebo.  Improvements were sustained at week 24, according to the ACR20, ACR50, and ACR70 response rates as well as classifications of remission according to the 3-variable Disease Activity Score in 28 joints (DAS28) using C-reactive protein and the 4-variable DAS28 using the erythrocyte sedimentation rate.  The most common treatment-emergent adverse events (AEs) in patients across all tofacitinib treatment arms (n = 272) were urinary tract infection (7.7%), diarrhea (4.8%), headache (4.8%), and bronchitis (4.8%).  Conclusion : Tofacitinib monotherapy at ≥3 mg twice a day was efficacious in the treatment of patients with active RA over 24 wk and demonstrated a manageable safety profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuu7Uf_SwBXbVg90H21EOLACvtfcHk0liq1LBeFMQwOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XivVGjurs%253D&md5=99d7be4fd115ffa87410dcbd6c6ea860</span></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=10.1002%2Fart.33383&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.33383%26sid%3Dliteratum%253Aachs%26aulast%3DFleischmann%26aufirst%3DR.%26aulast%3DCutolo%26aufirst%3DM.%26aulast%3DGenovese%26aufirst%3DM.%2BC.%26aulast%3DLee%26aufirst%3DE.%2BB.%26aulast%3DKanik%26aufirst%3DK.%2BS.%26aulast%3DSadis%26aufirst%3DS.%26aulast%3DConnell%26aufirst%3DC.%2BA.%26aulast%3DGruben%26aufirst%3DD.%26aulast%3DKrishnaswami%26aufirst%3DS.%26aulast%3DWallenstein%26aufirst%3DG.%26aulast%3DWilkinson%26aufirst%3DB.%2BE.%26aulast%3DZwillich%26aufirst%3DS.%2BH.%26atitle%3DPhase%25202B%2520Dose-Ranging%2520Study%2520of%2520the%2520Oral%2520JAK%2520Inhibitor%2520Tofacitinib%2520%2528CP-690%252C550%2529%2520or%2520Adalimumab%2520Monotherapy%2520Versus%2520Placebo%2520in%2520Patients%2520with%2520Active%2520Rheumatoid%2520Arthritis%2520with%2520an%2520Inadequate%2520Response%2520to%2520DMARDs%26jtitle%3DArthritis%2520Rheum.%26date%3D2012%26volume%3D64%26spage%3D617%26epage%3D629" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit21c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Kremer, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkinson, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connell, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">French, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez-Reino, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruben, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanik, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnaswami, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pascuala-Ramos, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallenstein, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwillich, S. H.</span><span> </span><span class="NLM_article-title">A Phase 2B Dose-Ranging Study of the Oral JAK Inhibitor Tofacitinib (CP-690,550) Versus Placebo in Combination with Background Methotrexate in Patients with Active Rheumatoid Arthritis and Inadequate Response to Methotrexate Alone</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">970</span><span class="NLM_x">–</span> <span class="NLM_lpage">981</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21c&amp;dbid=16&amp;doi=10.1021%2Fjm300438j&amp;key=10.1002%2Fart.33419" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21c&amp;dbid=8&amp;doi=10.1021%2Fjm300438j&amp;key=22006202" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21c&amp;dbid=32&amp;doi=10.1021%2Fjm300438j&amp;key=1%3ACAS%3A528%3ADC%252BC38XmvVygt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2012&pages=970-981&author=J.+M.+Kremerauthor=S.+Cohenauthor=B.+E.+Wilkinsonauthor=C.+A.+Connellauthor=J.+L.+Frenchauthor=J.+Gomez-Reinoauthor=D.+Grubenauthor=K.+S.+Kanikauthor=S.+Krishnaswamiauthor=V.+Pascuala-Ramosauthor=G.+Wallensteinauthor=S.+H.+Zwillich&title=A+Phase+2B+Dose-Ranging+Study+of+the+Oral+JAK+Inhibitor+Tofacitinib+%28CP-690%2C550%29+Versus+Placebo+in+Combination+with+Background+Methotrexate+in+Patients+with+Active+Rheumatoid+Arthritis+and+Inadequate+Response+to+Methotrexate+Alone"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21cR"><div class="casContent"><span class="casTitleNuber">21c</span><div class="casTitle"><span class="NLM_cas:atitle">A phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) versus placebo in combination with background methotrexate in patients with active rheumatoid arthritis and an inadequate response to methotrexate alone</span></div><div class="casAuthors">Kremer, Joel M.; Cohen, Stanley; Wilkinson, Bethanie E.; Connell, Carol A.; French, Jonathan L.; Gomez-Reino, Juan; Gruben, David; Kanik, Keith S.; Krishnaswami, Sriram; Pascual-Ramos, Virginia; Wallenstein, Gene; Zwillich, Samuel H.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">970-981</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective. To compare the efficacy, safety, and tolerability of 6 dosages of oral tofacitinib (CP-690,550) with placebo for the treatment of active rheumatoid arthritis (RA) in patients receiving a stable background regimen of methotrexate (MTX) who have an inadequate response to MTX monotherapy.  Methods. In this 24-wk, double-blind, phase IIb study, patients with active RA (n = 507) were randomized to receive placebo or tofacitinib (20 mg/day, 1 mg twice daily, 3 mg twice daily, 5 mg twice daily, 10 mg twice daily, or 15 mg twice daily).  All patients continued to receive a stable dosage of MTX.  The primary end point was the American College of Rheumatol. 20% improvement criteria (ACR20) response rate at week 12.  Results. At week 12, ACR20 response rates for patients receiving all tofacitinib dosages ≥3 mg twice daily (52.9% for 3 mg twice daily, 50.7% for 5 mg twice daily, 58.1% for 10 mg twice daily, 56.0% for 15 mg twice daily, and 53.8% for 20 mg/day) were significantly (P ≤ 0.05) greater than those for placebo (33.3%).  Improvements were sustained at week 24 for the ACR20, ACR50, and ACR70 responses, scores for the Health Assessment Questionnaire disability index, the 3-variable Disease Activity Score in 28 joints using the C-reactive protein level (DAS28-CRP), and a 3-variable DAS28-CRP of <2.6.  The most common treatment-emergent adverse events occurring in >10% of patients in any tofacitinib group were diarrhea, upper respiratory tract infection, and headache; 21 patients (4.1%) experienced serious adverse events.  Sporadic increases in transaminase levels, increases in cholesterol and serum creatinine levels, and decreases in neutrophil and Hb levels were obsd.  Conclusion. In patients with active RA in whom the response to MTX has been inadequate, the addn. of tofacitinib at a dosage ≥3 mg twice daily showed sustained efficacy and a manageable safety profile over 24 wk.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGQK92I8twr7Vg90H21EOLACvtfcHk0lg-gbYvpIcDAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmvVygt78%253D&md5=69d74dbdde12d7d1b45fa3d3a413645a</span></div><a href="/servlet/linkout?suffix=cit21c&amp;dbid=16384&amp;doi=10.1002%2Fart.33419&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.33419%26sid%3Dliteratum%253Aachs%26aulast%3DKremer%26aufirst%3DJ.%2BM.%26aulast%3DCohen%26aufirst%3DS.%26aulast%3DWilkinson%26aufirst%3DB.%2BE.%26aulast%3DConnell%26aufirst%3DC.%2BA.%26aulast%3DFrench%26aufirst%3DJ.%2BL.%26aulast%3DGomez-Reino%26aufirst%3DJ.%26aulast%3DGruben%26aufirst%3DD.%26aulast%3DKanik%26aufirst%3DK.%2BS.%26aulast%3DKrishnaswami%26aufirst%3DS.%26aulast%3DPascuala-Ramos%26aufirst%3DV.%26aulast%3DWallenstein%26aufirst%3DG.%26aulast%3DZwillich%26aufirst%3DS.%2BH.%26atitle%3DA%2520Phase%25202B%2520Dose-Ranging%2520Study%2520of%2520the%2520Oral%2520JAK%2520Inhibitor%2520Tofacitinib%2520%2528CP-690%252C550%2529%2520Versus%2520Placebo%2520in%2520Combination%2520with%2520Background%2520Methotrexate%2520in%2520Patients%2520with%2520Active%2520Rheumatoid%2520Arthritis%2520and%2520Inadequate%2520Response%2520to%2520Methotrexate%2520Alone%26jtitle%3DArthritis%2520Rheum.%26date%3D2012%26volume%3D64%26spage%3D970%26epage%3D981" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Jatiani, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, E. P.</span><span> </span><span class="NLM_article-title">JAK/STAT Pathways in Cytokine Signaling and Myeloproliferative Disorders: Approaches for Targeted Therapies</span> <span class="citation_source-journal">Genes Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">979</span><span class="NLM_x">–</span> <span class="NLM_lpage">993</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=16&amp;doi=10.1021%2Fjm300438j&amp;key=10.1177%2F1947601910397187" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=8&amp;doi=10.1021%2Fjm300438j&amp;key=21442038" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=32&amp;doi=10.1021%2Fjm300438j&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisF2nsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=979-993&author=S.+S.+Jatianiauthor=S.+J.+Bakerauthor=L.+R.+Silvermanauthor=E.+P.+Reddy&title=JAK%2FSTAT+Pathways+in+Cytokine+Signaling+and+Myeloproliferative+Disorders%3A+Approaches+for+Targeted+Therapies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22aR"><div class="casContent"><span class="casTitleNuber">22a</span><div class="casTitle"><span class="NLM_cas:atitle">JAK/STAT pathways in cytokine signaling and myeloproliferative disorders: approaches for targeted therapies</span></div><div class="casAuthors">Jatiani, Shashidhar S.; Baker, Stacey J.; Silverman, Lewis R.; Reddy, E. Premkumar</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">979-993</span>CODEN:
                <span class="NLM_cas:coden">GCEAAY</span>;
        ISSN:<span class="NLM_cas:issn">1947-6019</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">A review.  Hematopoiesis is the cumulative result of intricately regulated signaling pathways that are mediated by cytokines and their receptors.  Studies conducted over the past 10 to 15 years have revealed that hematopoietic cytokine receptor signaling is largely mediated by a family of tyrosine kinases termed Janus kinases (JAKs) and their downstream transcription factors, termed STATs (signal transducers and activators of transcription).  Aberrations in these pathways, such as those caused by the recently identified JAK2V617F mutation and translocations of the JAK2 gene, are underlying causes of leukemias and other myeloproliferative disorders.  This review discusses the role of JAK/STAT signaling in normal hematopoiesis as well as genetic abnormalities assocd. with myeloproliferative and myelodisplastic syndromes.  This review also summarizes the status of several small mol. JAK2 inhibitors that are currently at various stages of clin. development Several of these compds. appear to improve the quality of life of patients with myeloproliferative disorders by palliation of disease-related symptoms.  However, to date, these agents do not seem to significantly affect bone marrow fibrosis, alter marrow histopathol., reverse cytopenias, reduce red cell transfusion requirements, or significantly reduce allele burden.  These results suggest the possibility that addnl. mutational events might be assocd. with the development of these neoplasms, and indicate the need for combination therapies as the nature and significance of these addnl. mol. events is better understood.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoG-L7_08PNubVg90H21EOLACvtfcHk0lg-gbYvpIcDAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisF2nsrs%253D&md5=c0837365f2a21a48053b2e8093465848</span></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=10.1177%2F1947601910397187&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1947601910397187%26sid%3Dliteratum%253Aachs%26aulast%3DJatiani%26aufirst%3DS.%2BS.%26aulast%3DBaker%26aufirst%3DS.%2BJ.%26aulast%3DSilverman%26aufirst%3DL.%2BR.%26aulast%3DReddy%26aufirst%3DE.%2BP.%26atitle%3DJAK%252FSTAT%2520Pathways%2520in%2520Cytokine%2520Signaling%2520and%2520Myeloproliferative%2520Disorders%253A%2520Approaches%2520for%2520Targeted%2520Therapies%26jtitle%3DGenes%2520Cancer%26date%3D2010%26volume%3D1%26spage%3D979%26epage%3D993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit22b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Verstovsek, S.; Passamonti, F.; Rambaldi, A.; Barosi, G.; Rosen, P.; Levy, R.; Bradley, E. C.; Schacter, L.; Garrett, W. M.; Vaddi, K.; Contel, N.; Rumi, E.; Gattoni, E.; Cazzola, M.; Kantarjian, H.; Barbui, T.; Vannucchi, A.</span> <span class="citation_source-book">A Phase 2 Study of INCB018424, an Oral, Selective JAK1/JAK2 Inhibitor, in Patients with Advanced Polycythemia Vera (PV) and Essential Thrombocythemia (ET) Refractory to Hydroxyurea</span>; 51st American Society of Hematology Annual Meeting and Exposition, New Orleans, LA, Dec 5–8,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span>American Society of Hematology: Washington, DC; Abstract 311.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=S.+Verstovsek&author=F.+Passamonti&author=A.+Rambaldi&author=G.+Barosi&author=P.+Rosen&author=R.+Levy&author=E.+C.+Bradley&author=L.+Schacter&author=W.+M.+Garrett&author=K.+Vaddi&author=N.+Contel&author=E.+Rumi&author=E.+Gattoni&author=M.+Cazzola&author=H.+Kantarjian&author=T.+Barbui&author=A.+Vannucchi&title=A+Phase+2+Study+of+INCB018424%2C+an+Oral%2C+Selective+JAK1%2FJAK2+Inhibitor%2C+in+Patients+with+Advanced+Polycythemia+Vera+%28PV%29+and+Essential+Thrombocythemia+%28ET%29+Refractory+to+Hydroxyurea"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DVerstovsek%26aufirst%3DS.%26btitle%3DA%2520Phase%25202%2520Study%2520of%2520INCB018424%252C%2520an%2520Oral%252C%2520Selective%2520JAK1%252FJAK2%2520Inhibitor%252C%2520in%2520Patients%2520with%2520Advanced%2520Polycythemia%2520Vera%2520%2528PV%2529%2520and%2520Essential%2520Thrombocythemia%2520%2528ET%2529%2520Refractory%2520to%2520Hydroxyurea%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Neubauer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huffstadt, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfeffer, K.</span><span> </span><span class="NLM_article-title">Jak2 Deficiency Defines an Essential Developmental Checkpoint in Definitive Hematopoiesis</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">397</span><span class="NLM_x">–</span> <span class="NLM_lpage">409</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1998&pages=397-409&author=H.+Neubauerauthor=A.+Cumanoauthor=M.+Mullerauthor=H.+Wuauthor=U.+Huffstadtauthor=K.+Pfeffer&title=Jak2+Deficiency+Defines+an+Essential+Developmental+Checkpoint+in+Definitive+Hematopoiesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNeubauer%26aufirst%3DH.%26aulast%3DCumano%26aufirst%3DA.%26aulast%3DMuller%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DHuffstadt%26aufirst%3DU.%26aulast%3DPfeffer%26aufirst%3DK.%26atitle%3DJak2%2520Deficiency%2520Defines%2520an%2520Essential%2520Developmental%2520Checkpoint%2520in%2520Definitive%2520Hematopoiesis%26jtitle%3DCell%26date%3D1998%26volume%3D93%26spage%3D397%26epage%3D409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Garber, K.</span><span> </span><span class="NLM_article-title">Pfizer’s JAK Inhibitor Sails Through Phase 3 in Rheumatoid Arthritis</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">467</span><span class="NLM_x">–</span> <span class="NLM_lpage">468</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=467-468&author=K.+Garber&title=Pfizer%E2%80%99s+JAK+Inhibitor+Sails+Through+Phase+3+in+Rheumatoid+Arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGarber%26aufirst%3DK.%26atitle%3DPfizer%25E2%2580%2599s%2520JAK%2520Inhibitor%2520Sails%2520Through%2520Phase%25203%2520in%2520Rheumatoid%2520Arthritis%26jtitle%3DNat.%2520Biotechnol.%26date%3D2011%26volume%3D29%26spage%3D467%26epage%3D468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Jiang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghoreschi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deflorian, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perreira, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, D.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leister, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costanzi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Shea, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, J. T.</span><span> </span><span class="NLM_article-title">Examining the Chirality, Conformation and Selective Kinase Inhibition of 3-((3<i>R</i>,4<i>R</i>)-4-methyl-3-(methyl(7H-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile (CP-690,550)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">8012</span><span class="NLM_x">–</span> <span class="NLM_lpage">8018</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801142b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=8012-8018&author=J.+Jiangauthor=K.+Ghoreschiauthor=F.+Deflorianauthor=Z.+Chenauthor=M.+Perreiraauthor=M.+Pesuauthor=J.+Smithauthor=D.-C.+Nguyenauthor=E.+H.+Liuauthor=W.+Leisterauthor=S.+Costanziauthor=J.+J.+O%E2%80%99Sheaauthor=J.+T.+Thomas&title=Examining+the+Chirality%2C+Conformation+and+Selective+Kinase+Inhibition+of+3-%28%283R%2C4R%29-4-methyl-3-%28methyl%287H-pyrrolo%5B2%2C3-d%5Dpyrimidin-4-yl%29amino%29piperidin-1-yl%29-3-oxopropanenitrile+%28CP-690%2C550%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm801142b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801142b%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DGhoreschi%26aufirst%3DK.%26aulast%3DDeflorian%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DPerreira%26aufirst%3DM.%26aulast%3DPesu%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DJ.%26aulast%3DNguyen%26aufirst%3DD.-C.%26aulast%3DLiu%26aufirst%3DE.%2BH.%26aulast%3DLeister%26aufirst%3DW.%26aulast%3DCostanzi%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26aulast%3DThomas%26aufirst%3DJ.%2BT.%26atitle%3DExamining%2520the%2520Chirality%252C%2520Conformation%2520and%2520Selective%2520Kinase%2520Inhibition%2520of%25203-%2528%25283R%252C4R%2529-4-methyl-3-%2528methyl%25287H-pyrrolo%255B2%252C3-d%255Dpyrimidin-4-yl%2529amino%2529piperidin-1-yl%2529-3-oxopropanenitrile%2520%2528CP-690%252C550%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D8012%26epage%3D8018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Flanagan, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blumenkopf, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brissette, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casavant, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shang-Poa, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doty, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hines, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kent, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudlacz, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lillie, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnuson, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCurdy, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munchhof, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strelevitz, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subramanyam, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whipple, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Changelian, P. S.</span><span> </span><span class="NLM_article-title">Discovery of CP-690,550: A Potent and Selective Janus Kinase (JAK) Inhibitor for the Treatment of Autoimmune Diseases and Organ Transplant Rejection</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">8468</span><span class="NLM_x">–</span> <span class="NLM_lpage">8484</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1004286" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm300438j&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVOgt7vP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=8468-8484&author=M.+E.+Flanaganauthor=T.+A.+Blumenkopfauthor=W.+H.+Brissetteauthor=M.+F.+Brownauthor=J.+M.+Casavantauthor=C.+Shang-Poaauthor=J.+L.+Dotyauthor=E.+A.+Elliottauthor=M.+B.+Fisherauthor=M.+Hinesauthor=C.+Kentauthor=E.+M.+Kudlaczauthor=B.+M.+Lillieauthor=K.+S.+Magnusonauthor=S.+P.+McCurdyauthor=M.+J.+Munchhofauthor=B.+D.+Perryauthor=P.+S.+Sawyerauthor=T.+J.+Strelevitzauthor=C.+Subramanyamauthor=J.+Sunauthor=D.+A.+Whippleauthor=P.+S.+Changelian&title=Discovery+of+CP-690%2C550%3A+A+Potent+and+Selective+Janus+Kinase+%28JAK%29+Inhibitor+for+the+Treatment+of+Autoimmune+Diseases+and+Organ+Transplant+Rejection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of CP-690,550: A Potent and Selective Janus Kinase (JAK) Inhibitor for the Treatment of Autoimmune Diseases and Organ Transplant Rejection</span></div><div class="casAuthors">Flanagan, Mark E.; Blumenkopf, Todd A.; Brissette, William H.; Brown, Matthew F.; Casavant, Jeffrey M.; Chang, Shang-Poa; Doty, Jonathan L.; Elliott, Eileen A.; Fisher, Michael B.; Hines, Michael; Kent, Craig; Kudlacz, Elizabeth M.; Lillie, Brett M.; Magnuson, Kelly S.; McCurdy, Sandra P.; Munchhof, Michael J.; Perry, Bret D.; Sawyer, Perry S.; Strelevitz, Timothy J.; Subramanyam, Chakrapani; Sun, Jianmin; Whipple, David A.; Changelian, Paul S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8468-8484</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">There is a crit. need for safer and more convenient treatments for organ transplant rejection and autoimmune disorders such as rheumatoid arthritis.  Janus tyrosine kinases (JAK1, JAK3) are expressed in lymphoid cells and are involved in the signaling of multiple cytokines important for various T cell functions.  Blockade of the JAK1/JAK3-STAT pathway with a small mol. was anticipated to provide therapeutic immunosuppression/immunomodulation.  The Pfizer compd. library was screened against the catalytic domain of JAK3 resulting in the identification of a pyrrolopyrimidine-based series of inhibitors represented by the hexahydrocarbazolyl pyrrolopyrimidine CP-352,664.  Synthetic analogs of CP-352,664 were screened against the JAK enzymes and evaluated in an IL-2 induced T cell blast proliferation assay.  Select compds. were evaluated in rodent efficacy models of allograft rejection and destructive inflammatory arthritis.  Optimization within this chem. series led to identification of the cyanoacetylpiperidinylamino pyrrolopyrimidine CP-690,550, a potential first-in-class JAK inhibitor for treatment of autoimmune diseases and organ transplant rejection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbFS_8DSHkDbVg90H21EOLACvtfcHk0lgaQNoWS3tkRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVOgt7vP&md5=c1d31ce42ab3f1c1f3029c6f4f48df1a</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm1004286&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1004286%26sid%3Dliteratum%253Aachs%26aulast%3DFlanagan%26aufirst%3DM.%2BE.%26aulast%3DBlumenkopf%26aufirst%3DT.%2BA.%26aulast%3DBrissette%26aufirst%3DW.%2BH.%26aulast%3DBrown%26aufirst%3DM.%2BF.%26aulast%3DCasavant%26aufirst%3DJ.%2BM.%26aulast%3DShang-Poa%26aufirst%3DC.%26aulast%3DDoty%26aufirst%3DJ.%2BL.%26aulast%3DElliott%26aufirst%3DE.%2BA.%26aulast%3DFisher%26aufirst%3DM.%2BB.%26aulast%3DHines%26aufirst%3DM.%26aulast%3DKent%26aufirst%3DC.%26aulast%3DKudlacz%26aufirst%3DE.%2BM.%26aulast%3DLillie%26aufirst%3DB.%2BM.%26aulast%3DMagnuson%26aufirst%3DK.%2BS.%26aulast%3DMcCurdy%26aufirst%3DS.%2BP.%26aulast%3DMunchhof%26aufirst%3DM.%2BJ.%26aulast%3DPerry%26aufirst%3DB.%2BD.%26aulast%3DSawyer%26aufirst%3DP.%2BS.%26aulast%3DStrelevitz%26aufirst%3DT.%2BJ.%26aulast%3DSubramanyam%26aufirst%3DC.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DWhipple%26aufirst%3DD.%2BA.%26aulast%3DChangelian%26aufirst%3DP.%2BS.%26atitle%3DDiscovery%2520of%2520CP-690%252C550%253A%2520A%2520Potent%2520and%2520Selective%2520Janus%2520Kinase%2520%2528JAK%2529%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520Autoimmune%2520Diseases%2520and%2520Organ%2520Transplant%2520Rejection%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D8468%26epage%3D8484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Williams, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamert, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walden, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fantino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossjohn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucet, I. S.</span><span> </span><span class="NLM_article-title">Dissecting Specificity in the Janus Kinases: The Structures of JAK-Specific Inhibitors Complexed to the JAK1 and JAK2 Protein Tyrosine Kinase Domain</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">387</span><span class="NLM_x">, </span> <span class="NLM_fpage">219</span><span class="NLM_x">–</span> <span class="NLM_lpage">232</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=387&publication_year=2009&pages=219-232&author=N.+K.+Williamsauthor=R.+S.+Bamertauthor=O.+Patelauthor=C.+Wangauthor=P.+M.+Waldenauthor=E.+Fantinoauthor=J.+Rossjohnauthor=I.+S.+Lucet&title=Dissecting+Specificity+in+the+Janus+Kinases%3A+The+Structures+of+JAK-Specific+Inhibitors+Complexed+to+the+JAK1+and+JAK2+Protein+Tyrosine+Kinase+Domain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DN.%2BK.%26aulast%3DBamert%26aufirst%3DR.%2BS.%26aulast%3DPatel%26aufirst%3DO.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DWalden%26aufirst%3DP.%2BM.%26aulast%3DFantino%26aufirst%3DE.%26aulast%3DRossjohn%26aufirst%3DJ.%26aulast%3DLucet%26aufirst%3DI.%2BS.%26atitle%3DDissecting%2520Specificity%2520in%2520the%2520Janus%2520Kinases%253A%2520The%2520Structures%2520of%2520JAK-Specific%2520Inhibitors%2520Complexed%2520to%2520the%2520JAK1%2520and%2520JAK2%2520Protein%2520Tyrosine%2520Kinase%2520Domain%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2009%26volume%3D387%26spage%3D219%26epage%3D232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="note"><p class="first last">Prior to the commencement of this work, a series of related, imidazolone-containing compounds had been described as JAK3 inhibitors:</p></div><div class="NLM_citation" id="cit28a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Inoue, T.; Tanaka, A.; Nakai, K.; Sasaki, H.; Takahashi, F.; Shirakami, S.; Hatanaka, K.; Nakajima, Y.; Mukoyoshi, K.; Hamaguchi, H.; Kunikawa, S.; Higashi, Y.</span><span> </span><span class="NLM_article-title">Heterocyclic Janus Kinase 3 Inhibitors</span>. WO2007077949,<span class="NLM_x"> </span><span class="NLM_year">2007</span>. <div class="note"><p class="first last">More recently, during the course of this work, patent applications have appeared describing other tricyclic, azaindole-containing scaffolds as JAK inhibitors. These include azaindole annelated by pyrrole, </p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=T.+Inoue&author=A.+Tanaka&author=K.+Nakai&author=H.+Sasaki&author=F.+Takahashi&author=S.+Shirakami&author=K.+Hatanaka&author=Y.+Nakajima&author=K.+Mukoyoshi&author=H.+Hamaguchi&author=S.+Kunikawa&author=Y.+Higashi&title=Heterocyclic+Janus+Kinase+3+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DInoue%26aufirst%3DT.%26atitle%3DHeterocyclic%2520Janus%2520Kinase%25203%2520Inhibitors%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit28b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Shirakami, S.; Nakajima, Y.; Maeda, J.; Tominaga, H.; Yamagishi, H.; Hondo, T.; Inami, M.; Morio, H.; Inoue, T.; Mizutani, T.; Ishioka, H.</span><span> </span><span class="NLM_article-title">Fused Pyrrolopyridine Derivative</span>. WO2010119875,<span class="NLM_x"> </span><span class="NLM_year">2010</span><span class="NLM_x">; </span><div class="note"><p class="first last">by pyrrole, pyrazole, and isoxazole,</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=S.+Shirakami&author=Y.+Nakajima&author=J.+Maeda&author=H.+Tominaga&author=H.+Yamagishi&author=T.+Hondo&author=M.+Inami&author=H.+Morio&author=T.+Inoue&author=T.+Mizutani&author=H.+Ishioka&title=Fused+Pyrrolopyridine+Derivative"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DShirakami%26aufirst%3DS.%26atitle%3DFused%2520Pyrrolopyridine%2520Derivative%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit28c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Wishart, N.; Argiriadi, M.; Calderwood, D. J.; Ericsson, A. M.; Fiamengo, B. A.; Frank, K. E.; Friedman, M.; George, D. M.; Goedken, E. R.; Josephsohn, N. S.; Li, B. C.; Morytko, M. J.; Stewart, K. D.; Voss, J. W.; Wallace, G. A.; Wang, L.; Woller, K. R.</span><span> </span><span class="NLM_article-title">Novel Tricyclic Compounds</span>. WO2009152133,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span><div class="note"><p class="first last">by isothiazole, triazole, and imidazole, as in <b>3</b>,</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=N.+Wishart&author=M.+Argiriadi&author=D.+J.+Calderwood&author=A.+M.+Ericsson&author=B.+A.+Fiamengo&author=K.+E.+Frank&author=M.+Friedman&author=D.+M.+George&author=E.+R.+Goedken&author=N.+S.+Josephsohn&author=B.+C.+Li&author=M.+J.+Morytko&author=K.+D.+Stewart&author=J.+W.+Voss&author=G.+A.+Wallace&author=L.+Wang&author=K.+R.+Woller&title=Novel+Tricyclic+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWishart%26aufirst%3DN.%26atitle%3DNovel%2520Tricyclic%2520Compounds%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit28d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Wishart, N.; Argiriadi, M.; Breinlinger, E. C.; Calderwood, D. J.; Ericsson, A. M.; Fiamengo, B. A.; Frank, K. E.; Friedman, M.; George, D. M.; Goedken, E. R.; Josephsohn, N. S.; Li, B. C.; Morytko, M. J.; Mullen, K. D.; Somal, G.; Stewart, K. D.; Voss, J. W.; Wallace, G. A.; Wang, L.; Woller, K. R.</span><span> </span><span class="NLM_article-title">Novel Tricyclic Compounds</span>. WO2011068899,<span class="NLM_x"> </span><span class="NLM_year">2011</span>. <div class="note"><p class="first last">Tricycles corresponding to <b>3</b> but having distinct substitution and probably employing an alternative hinge-binding mode have recently appeared as JAK2 inhibitors:</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=N.+Wishart&author=M.+Argiriadi&author=E.+C.+Breinlinger&author=D.+J.+Calderwood&author=A.+M.+Ericsson&author=B.+A.+Fiamengo&author=K.+E.+Frank&author=M.+Friedman&author=D.+M.+George&author=E.+R.+Goedken&author=N.+S.+Josephsohn&author=B.+C.+Li&author=M.+J.+Morytko&author=K.+D.+Mullen&author=G.+Somal&author=K.+D.+Stewart&author=J.+W.+Voss&author=G.+A.+Wallace&author=L.+Wang&author=K.+R.+Woller&title=Novel+Tricyclic+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWishart%26aufirst%3DN.%26atitle%3DNovel%2520Tricyclic%2520Compounds%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit28e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Purandare, A. V.; Grebinski, J. W.; Hart, A.; Inghrim, J.; Schroeder, G.; Wan, H.</span><span> </span><span class="NLM_article-title">JAK2 Inhibitors and Their Use for the Treatment of Myeloproliferative Diseases and Cancer</span>. WO2011028864,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=A.+V.+Purandare&author=J.+W.+Grebinski&author=A.+Hart&author=J.+Inghrim&author=G.+Schroeder&author=H.+Wan&title=JAK2+Inhibitors+and+Their+Use+for+the+Treatment+of+Myeloproliferative+Diseases+and+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DPurandare%26aufirst%3DA.%2BV.%26atitle%3DJAK2%2520Inhibitors%2520and%2520Their%2520Use%2520for%2520the%2520Treatment%2520of%2520Myeloproliferative%2520Diseases%2520and%2520Cancer%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="note"><p class="first last">Analogues of <b>1</b> substituted with pendent sulfonamides are described to have binding selectivity for JAK1 over JAK2 and JAK3: </p></div><div class="NLM_citation" id="cit29a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Acker, B. A.; Hartmann, S. J.; Huang, H.-C.; Jacobsen, E. J.; Promo, M. A.; Wolfson, S. G.; Xie, J.</span><span> </span><span class="NLM_article-title">Pyrrolo[2,3-d]pyrimidine Compounds</span>. WO2011045702,<span class="NLM_x"> </span><span class="NLM_year">2011</span><span class="NLM_x">, </span>and</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=B.+A.+Acker&author=S.+J.+Hartmann&author=H.-C.+Huang&author=E.+J.+Jacobsen&author=M.+A.+Promo&author=S.+G.+Wolfson&author=J.+Xie&title=Pyrrolo%5B2%2C3-d%5Dpyrimidine+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAcker%26aufirst%3DB.%2BA.%26atitle%3DPyrrolo%255B2%252C3-d%255Dpyrimidine%2520Compounds%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit29b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Xie, J.; Promo, M. A.; Jacobsen, E. J.; Huang, H.-C.; Maddux, T.</span><span> </span><span class="NLM_article-title">Pyrrolo[2,3-D]pyrimidine Compounds</span>. WO2011075334,<span class="NLM_x"> </span><span class="NLM_year">2011</span>. <div class="note"><p class="first last">Also claimed as JAK1 selective inhibitors are derivatives of <b>2</b>:</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=J.+Xie&author=M.+A.+Promo&author=E.+J.+Jacobsen&author=H.-C.+Huang&author=T.+Maddux&title=Pyrrolo%5B2%2C3-D%5Dpyrimidine+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DJ.%26atitle%3DPyrrolo%255B2%252C3-D%255Dpyrimidine%2520Compounds%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit29c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Huang, T.; Xue, C.-B.; Wang, A.; Kong, L.; Ye, H. F.; Yao, W.; Rodgers, J. D.; Shepard, S.; Wang, H.; Shao, L.; Li, H.-Y.; Li, Q.</span><span> </span><span class="NLM_article-title">Piperidin-4-yl Azetidine Derivatives as JAK1 Inhibitors</span>. WO2011112662,<span class="NLM_x"> </span><span class="NLM_year">2011</span><span class="NLM_x">; </span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=T.+Huang&author=C.-B.+Xue&author=A.+Wang&author=L.+Kong&author=H.+F.+Ye&author=W.+Yao&author=J.+D.+Rodgers&author=S.+Shepard&author=H.+Wang&author=L.+Shao&author=H.-Y.+Li&author=Q.+Li&title=Piperidin-4-yl+Azetidine+Derivatives+as+JAK1+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DT.%26atitle%3DPiperidin-4-yl%2520Azetidine%2520Derivatives%2520as%2520JAK1%2520Inhibitors%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit29d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Rodgers, J. D.; Li, Y.-L.; Shepard, S.; Wang, H.</span><span> </span><span class="NLM_article-title">Heterocyclic Derivatives of Pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines as Janus Kinase Inhibitors</span>. WO2011028685,<span class="NLM_x"> </span><span class="NLM_year">2011</span><span class="NLM_x">; </span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=J.+D.+Rodgers&author=Y.-L.+Li&author=S.+Shepard&author=H.+Wang&title=Heterocyclic+Derivatives+of+Pyrazol-4-yl-pyrrolo%5B2%2C3-d%5Dpyrimidines+as+Janus+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRodgers%26aufirst%3DJ.%2BD.%26atitle%3DHeterocyclic%2520Derivatives%2520of%2520Pyrazol-4-yl-pyrrolo%255B2%252C3-d%255Dpyrimidines%2520as%2520Janus%2520Kinase%2520Inhibitors%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit29e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Li, Y.-L.; Rodgers, J. D.</span><span> </span><span class="NLM_article-title">3-[4-(7<i>H</i>-Pyrrolo[2,3-d]pyrimidin-4-yl)-1<i>H</i>-pyrazol-1-yl]octane- or Heptane-nitrile As JAK Inhibitors</span>. WO2010135621,<span class="NLM_x"> </span><span class="NLM_year">2010</span><span class="NLM_x">, </span><div class="note"><p class="first last">along with a polyaryl macrocycle:</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=Y.-L.+Li&author=J.+D.+Rodgers&title=3-%5B4-%287H-Pyrrolo%5B2%2C3-d%5Dpyrimidin-4-yl%29-1H-pyrazol-1-yl%5Doctane-+or+Heptane-nitrile+As+JAK+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.-L.%26atitle%3D3-%255B4-%25287H-Pyrrolo%255B2%252C3-d%255Dpyrimidin-4-yl%2529-1H-pyrazol-1-yl%255Doctane-%2520or%2520Heptane-nitrile%2520As%2520JAK%2520Inhibitors%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit29f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Combs, A. P.; Sparks, R. B.; Yue, E. W.; Feng, H.; Bower, M. J.; Zhu, W.</span><span> </span><span class="NLM_article-title">Macrocyclic Compounds and Their Use as Kinase Inhibitors</span>. WO2009132202,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=A.+P.+Combs&author=R.+B.+Sparks&author=E.+W.+Yue&author=H.+Feng&author=M.+J.+Bower&author=W.+Zhu&title=Macrocyclic+Compounds+and+Their+Use+as+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCombs%26aufirst%3DA.%2BP.%26atitle%3DMacrocyclic%2520Compounds%2520and%2520Their%2520Use%2520as%2520Kinase%2520Inhibitors%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Van’t Klooster, G.; Van Rompaey, L.; Menet, C.; Namour, F.; Vanhoutte, F.; van der Aar, E.; Clément-Lacroix, P.; Gallien, R.; Nelles, L.; Guérin, C.; Smets, B.; Brys, R.; Feyen, J.; Wigerinck, P.</span> <span class="citation_source-book">Preclinical Pharmacology and Early Clinical Evaluation of GLPG0634, a Selective JAK1 Inhibitor for the Treatment of Rheumatoid Arthritis</span>. EULAR Annual European Congress of Rheumatology, London, May 25–28,<span class="NLM_x"> </span><span class="NLM_year">2011</span><span class="NLM_x">; </span>BMJ Publishing Group Ltd.: London; Abstract 251.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=G.+Van%E2%80%99t+Klooster&author=L.+Van+Rompaey&author=C.+Menet&author=F.+Namour&author=F.+Vanhoutte&author=E.+van+der+Aar&author=P.+Cl%C3%A9ment-Lacroix&author=R.+Gallien&author=L.+Nelles&author=C.+Gu%C3%A9rin&author=B.+Smets&author=R.+Brys&author=J.+Feyen&author=P.+Wigerinck&title=Preclinical+Pharmacology+and+Early+Clinical+Evaluation+of+GLPG0634%2C+a+Selective+JAK1+Inhibitor+for+the+Treatment+of+Rheumatoid+Arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DVan%25E2%2580%2599t%2BKlooster%26aufirst%3DG.%26btitle%3DPreclinical%2520Pharmacology%2520and%2520Early%2520Clinical%2520Evaluation%2520of%2520GLPG0634%252C%2520a%2520Selective%2520JAK1%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520Rheumatoid%2520Arthritis%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span> </span><span class="NLM_article-title">Galapagos' GLPG0634 Shows Excellent Efficacy and Safety in Rheumatoid Arthritis Phase II Study</span>. <span class="NLM_publisher-name">Galapagos NV</span>: <span class="NLM_publisher-loc">Mechelen, Belgium</span>, Press Release November 22,<span class="NLM_x"> </span><span class="NLM_year">2011</span>. Available at <a href="http://www.glpg.com/" class="extLink">http://www.glpg.com/</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Galapagos%27+GLPG0634+Shows+Excellent+Efficacy+and+Safety+in+Rheumatoid+Arthritis+Phase+II+Study.+Galapagos+NV%3A+Mechelen%2C+Belgium%2C+Press+Release+November+22%2C+2011.+Available+at+http%3A%2F%2Fwww.glpg.com%2F."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26atitle%3DGalapagos%2527%2520GLPG0634%2520Shows%2520Excellent%2520Efficacy%2520and%2520Safety%2520in%2520Rheumatoid%2520Arthritis%2520Phase%2520II%2520Study%26pub%3DGalapagos%2520NV%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Malerich, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fine, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klebansky, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanga, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Andrea, A.</span><span> </span><span class="NLM_article-title">Diamino-1,2,4-triazole Derivatives Are Selective Inhibitors of TYK2 and JAK1 Over JAK2 and JAK3</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">7454</span><span class="NLM_x">–</span> <span class="NLM_lpage">7457</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=7454-7457&author=J.+P.+Malerichauthor=J.+S.+Lamauthor=B.+Hartauthor=R.+M.+Fineauthor=B.+Klebanskyauthor=M.+J.+Tangaauthor=A.+D%E2%80%99Andrea&title=Diamino-1%2C2%2C4-triazole+Derivatives+Are+Selective+Inhibitors+of+TYK2+and+JAK1+Over+JAK2+and+JAK3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMalerich%26aufirst%3DJ.%2BP.%26aulast%3DLam%26aufirst%3DJ.%2BS.%26aulast%3DHart%26aufirst%3DB.%26aulast%3DFine%26aufirst%3DR.%2BM.%26aulast%3DKlebansky%26aufirst%3DB.%26aulast%3DTanga%26aufirst%3DM.%2BJ.%26aulast%3DD%25E2%2580%2599Andrea%26aufirst%3DA.%26atitle%3DDiamino-1%252C2%252C4-triazole%2520Derivatives%2520Are%2520Selective%2520Inhibitors%2520of%2520TYK2%2520and%2520JAK1%2520Over%2520JAK2%2520and%2520JAK3%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D7454%26epage%3D7457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Karaman, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrgard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallant, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atteridge, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cicero, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edeen, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faraoni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockhart, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milanov, Z. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallares, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pritchard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wodicka, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinkar, P. P.</span><span> </span><span class="NLM_article-title">A Quantitative Analysis of Kinase Inhibitor Selectivity</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm300438j&amp;key=10.1038%2Fnbt1358" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm300438j&amp;key=18183025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm300438j&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisFGlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2008&pages=127-132&author=M.+W.+Karamanauthor=S.+Herrgardauthor=D.+K.+Treiberauthor=P.+Gallantauthor=C.+E.+Atteridgeauthor=B.+T.+Campbellauthor=K.+W.+Chanauthor=P.+Ciceroauthor=M.+I.+Davisauthor=P.+T.+Edeenauthor=R.+Faraoniauthor=M.+Floydauthor=J.+P.+Huntauthor=D.+J.+Lockhartauthor=Z.+V.+Milanovauthor=M.+J.+Morrisonauthor=G.+Pallaresauthor=H.+K.+Patelauthor=S.+Pritchardauthor=L.+M.+Wodickaauthor=P.+P.+Zarrinkar&title=A+Quantitative+Analysis+of+Kinase+Inhibitor+Selectivity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">A quantitative analysis of kinase inhibitor selectivity</span></div><div class="casAuthors">Karaman, Mazen W.; Herrgard, Sanna; Treiber, Daniel K.; Gallant, Paul; Atteridge, Corey E.; Campbell, Brian T.; Chan, Katrina W.; Ciceri, Pietro; Davis, Mindy I.; Edeen, Philip T.; Faraoni, Raffaella; Floyd, Mark; Hunt, Jeremy P.; Lockhart, Daniel J.; Milanov, Zdravko V.; Morrison, Michael J.; Pallares, Gabriel; Patel, Hitesh K.; Pritchard, Stephanie; Wodicka, Lisa M.; Zarrinkar, Patrick P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">127-132</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets.  The biol. consequences of multikinase activity are poorly defined, and an important step toward understanding the relationship between selectivity, efficacy and safety is the exploration of how inhibitors interact with the human kinome.  The authors present interaction maps for 38 kinase inhibitors across a panel of 317 kinases representing >50% of the predicted human protein kinome.  The data constitute the most comprehensive study of kinase inhibitor selectivity to date and reveal a wide diversity of interaction patterns.  To enable a global anal. of the results, the authors introduce the concept of a selectivity score as a general tool to quantify and differentiate the obsd. interaction patterns.  The authors further investigate the impact of panel size and find that small assay panels do not provide a robust measure of selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiArJSq2_lPrVg90H21EOLACvtfcHk0lgJTJ_KiIqZ-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisFGlsQ%253D%253D&md5=346265d412853ced636ad4128ed8a76f</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1038%2Fnbt1358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt1358%26sid%3Dliteratum%253Aachs%26aulast%3DKaraman%26aufirst%3DM.%2BW.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DGallant%26aufirst%3DP.%26aulast%3DAtteridge%26aufirst%3DC.%2BE.%26aulast%3DCampbell%26aufirst%3DB.%2BT.%26aulast%3DChan%26aufirst%3DK.%2BW.%26aulast%3DCicero%26aufirst%3DP.%26aulast%3DDavis%26aufirst%3DM.%2BI.%26aulast%3DEdeen%26aufirst%3DP.%2BT.%26aulast%3DFaraoni%26aufirst%3DR.%26aulast%3DFloyd%26aufirst%3DM.%26aulast%3DHunt%26aufirst%3DJ.%2BP.%26aulast%3DLockhart%26aufirst%3DD.%2BJ.%26aulast%3DMilanov%26aufirst%3DZ.%2BV.%26aulast%3DMorrison%26aufirst%3DM.%2BJ.%26aulast%3DPallares%26aufirst%3DG.%26aulast%3DPatel%26aufirst%3DH.%2BK.%26aulast%3DPritchard%26aufirst%3DS.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26atitle%3DA%2520Quantitative%2520Analysis%2520of%2520Kinase%2520Inhibitor%2520Selectivity%26jtitle%3DNat.%2520Biotechnol.%26date%3D2008%26volume%3D26%26spage%3D127%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Van Abbema, A.; Kanada, H.; Chang, C.; Bir Kohli, P.; Smith, J.; Barrett, K.; Lewin-Koh, N.; Johnson, A. R.; Ghilardi, N.; Blair, W.</span><span> </span><span class="NLM_article-title">Determination of the JAK-Dependence of Cytokine Pathways Using Small Molecule Inhibitors</span>, unpublished results.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Van+Abbema%2C+A.%3B+Kanada%2C+H.%3B+Chang%2C+C.%3B+Bir+Kohli%2C+P.%3B+Smith%2C+J.%3B+Barrett%2C+K.%3B+Lewin-Koh%2C+N.%3B+Johnson%2C+A.+R.%3B+Ghilardi%2C+N.%3B+Blair%2C+W.+Determination+of+the+JAK-Dependence+of+Cytokine+Pathways+Using+Small+Molecule+Inhibitors%2C+unpublished+results."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BAbbema%26aufirst%3DA.%26atitle%3DDetermination%2520of%2520the%2520JAK-Dependence%2520of%2520Cytokine%2520Pathways%2520Using%2520Small%2520Molecule%2520Inhibitors" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="note"><p class="first last">EC<sub>50</sub> values for compounds that do not achieve at least 50% inhibition at the highest concentration tested (10 μM) in the cell based assays are considered to be noncalculable and are reported as >10 μM. Owing to normal run-to-run variability, some weakly potent compounds achieve >50% inhibition in some, but not all, of the replicate runs. In these cases, we report EC<sub>50</sub> > X, where X is the arithmetic mean of all the individual EC<sub>50</sub> values, both calculable and noncalculable. For example, compound <b>13</b> displayed replicate EC<sub>50</sub> values of 6.3 μM, >10 μM, and >10 μM in the pSTAT5-EPO assay; thus, the average JAK2 cell EC<sub>50</sub> was reported as >8.8 μM, giving a JAK2/JAK1 cell selectivity of >6.3-fold.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Chrencik, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patny, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, I. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korniski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emmons, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinberg, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gormley, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiefer, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leone, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sommers, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tenbrink, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomasselli, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benson, T. E.</span><span> </span><span class="NLM_article-title">Structural and Thermodynamic Characterization of the TYK2 and JAK3 Kinase Domains in Complex with CP690550 and CMP-6</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">400</span><span class="NLM_x">, </span> <span class="NLM_fpage">413</span><span class="NLM_x">–</span> <span class="NLM_lpage">433</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=400&publication_year=2010&pages=413-433&author=J.+E.+Chrencikauthor=A.+Patnyauthor=I.+K.+Leungauthor=B.+Korniskiauthor=T.+L.+Emmonsauthor=T.+Hallauthor=R.+A.+Weinbergauthor=J.+A.+Gormleyauthor=J.+M.+Williamsauthor=J.+E.+Dayauthor=J.+L.+Hirschauthor=J.+R.+Kieferauthor=J.+W.+Leoneauthor=H.+D.+Fischerauthor=C.+D.+Sommersauthor=H.-C.+Huangauthor=E.+J.+Jacobsenauthor=R.+E.+Tenbrinkauthor=A.+G.+Tomasselliauthor=T.+E.+Benson&title=Structural+and+Thermodynamic+Characterization+of+the+TYK2+and+JAK3+Kinase+Domains+in+Complex+with+CP690550+and+CMP-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChrencik%26aufirst%3DJ.%2BE.%26aulast%3DPatny%26aufirst%3DA.%26aulast%3DLeung%26aufirst%3DI.%2BK.%26aulast%3DKorniski%26aufirst%3DB.%26aulast%3DEmmons%26aufirst%3DT.%2BL.%26aulast%3DHall%26aufirst%3DT.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26aulast%3DGormley%26aufirst%3DJ.%2BA.%26aulast%3DWilliams%26aufirst%3DJ.%2BM.%26aulast%3DDay%26aufirst%3DJ.%2BE.%26aulast%3DHirsch%26aufirst%3DJ.%2BL.%26aulast%3DKiefer%26aufirst%3DJ.%2BR.%26aulast%3DLeone%26aufirst%3DJ.%2BW.%26aulast%3DFischer%26aufirst%3DH.%2BD.%26aulast%3DSommers%26aufirst%3DC.%2BD.%26aulast%3DHuang%26aufirst%3DH.-C.%26aulast%3DJacobsen%26aufirst%3DE.%2BJ.%26aulast%3DTenbrink%26aufirst%3DR.%2BE.%26aulast%3DTomasselli%26aufirst%3DA.%2BG.%26aulast%3DBenson%26aufirst%3DT.%2BE.%26atitle%3DStructural%2520and%2520Thermodynamic%2520Characterization%2520of%2520the%2520TYK2%2520and%2520JAK3%2520Kinase%2520Domains%2520in%2520Complex%2520with%2520CP690550%2520and%2520CMP-6%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2010%26volume%3D400%26spage%3D413%26epage%3D433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="note"><p class="first last">As crystallization of JAK1 proved difficult during the early stages of this program, the cocrystalization of several compounds reported below was solved using a JAK2 triple mutant surrogate, in which three residues adjacent to the ligand binding site were mutated to the respective JAK1 residues (i.e., Q853R, Y931F, and D939E using JAK2 numbering) in order to explore potential binding interactions between these residues and the ligand. Later compounds in the series were successfully cocrystalized with wild type JAK1.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit47"><span>The Pymol Molecular Graphics System, version 1.3; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York</span> (<a href="http://www.pymol.org" class="extLink">http://www.pymol.org</a>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+Pymol+Molecular+Graphics+System%2C+version+1.3%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York+%28http%3A%2F%2Fwww.pymol.org%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Pymol%2520Molecular%2520Graphics%2520System%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crockett, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reider, P. A</span><span> </span><span class="NLM_article-title">Practical Synthesis of 2-((1<i>H</i>-Pyrrolo[2,3-b]pyridine-4-yl)methylamino)-5-fluoronicotinic Acid</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">4021</span><span class="NLM_x">–</span> <span class="NLM_lpage">4023</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo0602571" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2006&pages=4021-4023&author=X.+Wangauthor=B.+Zhiauthor=J.+Baumauthor=Y.+Chenauthor=R.+Crockettauthor=L.+Huangauthor=S.+Eisenbergauthor=J.+Ngauthor=R.+Larsenauthor=M.+Martinelliauthor=P.+A+Reider&title=Practical+Synthesis+of+2-%28%281H-Pyrrolo%5B2%2C3-b%5Dpyridine-4-yl%29methylamino%29-5-fluoronicotinic+Acid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjo0602571&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo0602571%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DZhi%26aufirst%3DB.%26aulast%3DBaum%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DCrockett%26aufirst%3DR.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DEisenberg%26aufirst%3DS.%26aulast%3DNg%26aufirst%3DJ.%26aulast%3DLarsen%26aufirst%3DR.%26aulast%3DMartinelli%26aufirst%3DM.%26aulast%3DReider%26aufirst%3DP.%2BA%26atitle%3DPractical%2520Synthesis%2520of%25202-%2528%25281H-Pyrrolo%255B2%252C3-b%255Dpyridine-4-yl%2529methylamino%2529-5-fluoronicotinic%2520Acid%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2006%26volume%3D71%26spage%3D4021%26epage%3D4023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Vanotti, E.; Angelucci, F.; Bargiotti, A.; Brasca, M. G.; Menichincheri, M.</span><span> </span><span class="NLM_article-title">Pyrrolopyridines as Kinase Inhibitors</span>. WO2007054508,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=E.+Vanotti&author=F.+Angelucci&author=A.+Bargiotti&author=M.+G.+Brasca&author=M.+Menichincheri&title=Pyrrolopyridines+as+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DVanotti%26aufirst%3DE.%26atitle%3DPyrrolopyridines%2520as%2520Kinase%2520Inhibitors%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Brown Ripin, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abele, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blumenkopf, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casavant, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doty, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flanagan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koecher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laue, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meltz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munchhof, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pouwer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sha, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teixeira, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vries, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whipple, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilcox, G.</span><span> </span><span class="NLM_article-title">Development of a Scaleable Route for the Production of <i>cis</i>-<i>N</i>-Benzyl-3-methylamino-4-methylpiperidine</span> <span class="citation_source-journal">Org. Process Res. Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">115</span><span class="NLM_x">–</span> <span class="NLM_lpage">120</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2003&pages=115-120&author=D.+H.+Brown+Ripinauthor=S.+Abeleauthor=W.+Caiauthor=T.+Blumenkopfauthor=J.+M.+Casavantauthor=J.+L.+Dotyauthor=M.+Flanaganauthor=C.+Koecherauthor=K.+W.+Laueauthor=K.+McCarthyauthor=C.+Meltzauthor=M.+J.+Munchhofauthor=K.+Pouwerauthor=B.+Shaauthor=J.+Sunauthor=J.+Teixeiraauthor=T.+Vriesauthor=D.+A.+Whippleauthor=G.+Wilcox&title=Development+of+a+Scaleable+Route+for+the+Production+of+cis-N-Benzyl-3-methylamino-4-methylpiperidine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%2BRipin%26aufirst%3DD.%2BH.%26aulast%3DAbele%26aufirst%3DS.%26aulast%3DCai%26aufirst%3DW.%26aulast%3DBlumenkopf%26aufirst%3DT.%26aulast%3DCasavant%26aufirst%3DJ.%2BM.%26aulast%3DDoty%26aufirst%3DJ.%2BL.%26aulast%3DFlanagan%26aufirst%3DM.%26aulast%3DKoecher%26aufirst%3DC.%26aulast%3DLaue%26aufirst%3DK.%2BW.%26aulast%3DMcCarthy%26aufirst%3DK.%26aulast%3DMeltz%26aufirst%3DC.%26aulast%3DMunchhof%26aufirst%3DM.%2BJ.%26aulast%3DPouwer%26aufirst%3DK.%26aulast%3DSha%26aufirst%3DB.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DTeixeira%26aufirst%3DJ.%26aulast%3DVries%26aufirst%3DT.%26aulast%3DWhipple%26aufirst%3DD.%2BA.%26aulast%3DWilcox%26aufirst%3DG.%26atitle%3DDevelopment%2520of%2520a%2520Scaleable%2520Route%2520for%2520the%2520Production%2520of%2520cis-N-Benzyl-3-methylamino-4-methylpiperidine%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2003%26volume%3D7%26spage%3D115%26epage%3D120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Ramadas, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srinivasan, N.</span><span> </span><span class="NLM_article-title">Iron-Ammonium Chloride: A Convenient and Inexpensive Reductant</span> <span class="citation_source-journal">Synth. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">3189</span><span class="NLM_x">–</span> <span class="NLM_lpage">3195</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm300438j&amp;key=10.1080%2F00397919208021132" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm300438j&amp;key=1%3ACAS%3A528%3ADyaK3sXhs1ykt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1992&pages=3189-3195&author=K.+Ramadasauthor=N.+Srinivasan&title=Iron-Ammonium+Chloride%3A+A+Convenient+and+Inexpensive+Reductant"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Iron-ammonium chloride - a convenient and inexpensive reductant</span></div><div class="casAuthors">Ramadas, Krishnamurthy; Srinivasan, Natarajan</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">3189-95</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    </div><div class="casAbstract">The redn. of nitro arom. compds., I (R1 = H, NH2, Me, Cl, R2 = H, NH2, NO2, R3 = H, CH2CN, CH2CO2H, Me, OH, NHAc, Br, Cl, NH2, R4 = NO2), contg. other susceptible groups is reinvestigated to provide a viable economic route from the point of view of quant. transformation, reduced reaction times, and simple work up using iron powder and ammonium chloride soln. in neutral medium.  Thus, using Fe/NH4Cl on I gave I (R4 = NH2) in 67-90% yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqD_QX8c0Gcx7Vg90H21EOLACvtfcHk0lh_A4F2H5a8Ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXhs1ykt7k%253D&md5=7b3830ad2efaf09a30cbff04b89eb32a</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1080%2F00397919208021132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397919208021132%26sid%3Dliteratum%253Aachs%26aulast%3DRamadas%26aufirst%3DK.%26aulast%3DSrinivasan%26aufirst%3DN.%26atitle%3DIron-Ammonium%2520Chloride%253A%2520A%2520Convenient%2520and%2520Inexpensive%2520Reductant%26jtitle%3DSynth.%2520Commun.%26date%3D1992%26volume%3D22%26spage%3D3189%26epage%3D3195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Li, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brogan, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gage, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. J.</span><span> </span><span class="NLM_article-title">Chemoenzymatic Synthesis and Synthetic Application of Enantiopure Aminocyclopentenols: Total Synthesis of Carbocyclic (+)-Uracil Polyoxin C and Its α-Epimer</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">4538</span><span class="NLM_x">–</span> <span class="NLM_lpage">4540</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo0496796" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2004&pages=4538-4540&author=F.+Liauthor=J.+B.+Broganauthor=J.+L.+Gageauthor=D.+Zhangauthor=M.+J.+Miller&title=Chemoenzymatic+Synthesis+and+Synthetic+Application+of+Enantiopure+Aminocyclopentenols%3A+Total+Synthesis+of+Carbocyclic+%28%2B%29-Uracil+Polyoxin+C+and+Its+%CE%B1-Epimer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjo0496796&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo0496796%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DF.%26aulast%3DBrogan%26aufirst%3DJ.%2BB.%26aulast%3DGage%26aufirst%3DJ.%2BL.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DMiller%26aufirst%3DM.%2BJ.%26atitle%3DChemoenzymatic%2520Synthesis%2520and%2520Synthetic%2520Application%2520of%2520Enantiopure%2520Aminocyclopentenols%253A%2520Total%2520Synthesis%2520of%2520Carbocyclic%2520%2528%252B%2529-Uracil%2520Polyoxin%2520C%2520and%2520Its%2520%25CE%25B1-Epimer%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2004%26volume%3D69%26spage%3D4538%26epage%3D4540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Ranganathan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, K. S.</span><span> </span><span class="NLM_article-title">2-Aza-3-oxabicyclo[2.2.1]heptane Hydrochloride: An Exceptionally Versatile Synthon For Carbocyclic Sugars and Nucleosides</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">3347</span><span class="NLM_x">–</span> <span class="NLM_lpage">3362</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1997&pages=3347-3362&author=S.+Ranganathanauthor=K.+S.+George&title=2-Aza-3-oxabicyclo%5B2.2.1%5Dheptane+Hydrochloride%3A+An+Exceptionally+Versatile+Synthon+For+Carbocyclic+Sugars+and+Nucleosides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRanganathan%26aufirst%3DS.%26aulast%3DGeorge%26aufirst%3DK.%2BS.%26atitle%3D2-Aza-3-oxabicyclo%255B2.2.1%255Dheptane%2520Hydrochloride%253A%2520An%2520Exceptionally%2520Versatile%2520Synthon%2520For%2520Carbocyclic%2520Sugars%2520and%2520Nucleosides%26jtitle%3DTetrahedron%26date%3D1997%26volume%3D53%26spage%3D3347%26epage%3D3362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Gregson, M.; Ayres, B. E.; Ewan, G. B.; Ellis, F.; Knight, J.</span><span> </span><span class="NLM_article-title">2,6-Diaminopurine Derivatives</span>. WO199417090,<span class="NLM_x"> </span><span class="NLM_year">1994</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1994&author=M.+Gregson&author=B.+E.+Ayres&author=G.+B.+Ewan&author=F.+Ellis&author=J.+Knight&title=2%2C6-Diaminopurine+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGregson%26aufirst%3DM.%26atitle%3D2%252C6-Diaminopurine%2520Derivatives%26date%3D1994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Erickson, S. D.; Qian, Y.; Tilley, J. W.</span><span> </span><span class="NLM_article-title">Diaminocyclohexane and Diaminocyclopentane Derivatives</span>. WO2008065021,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=S.+D.+Erickson&author=Y.+Qian&author=J.+W.+Tilley&title=Diaminocyclohexane+and+Diaminocyclopentane+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DErickson%26aufirst%3DS.%2BD.%26atitle%3DDiaminocyclohexane%2520and%2520Diaminocyclopentane%2520Derivatives%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Morrison, J. F.</span><span> </span><span class="NLM_article-title">Kinetics of the Reversible Inhibition of Enzyme-Catalyzed Reactions by Tight-binding Inhibitors</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1969</span><span class="NLM_x">, </span> <span class="NLM_volume">185</span><span class="NLM_x">, </span> <span class="NLM_fpage">269</span><span class="NLM_x">–</span> <span class="NLM_lpage">296</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=185&publication_year=1969&pages=269-296&author=J.+F.+Morrison&title=Kinetics+of+the+Reversible+Inhibition+of+Enzyme-Catalyzed+Reactions+by+Tight-binding+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMorrison%26aufirst%3DJ.%2BF.%26atitle%3DKinetics%2520of%2520the%2520Reversible%2520Inhibition%2520of%2520Enzyme-Catalyzed%2520Reactions%2520by%2520Tight-binding%2520Inhibitors%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D1969%26volume%3D185%26spage%3D269%26epage%3D296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit47b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">William, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, J. F.</span><span> </span><span class="NLM_article-title">The Kinetics of Reversible Tight-binding Inhibition</span> <span class="citation_source-journal">Methods Enzymol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">437</span><span class="NLM_x">–</span> <span class="NLM_lpage">467</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1979&pages=437-467&author=J.+W.+Williamauthor=J.+F.+Morrison&title=The+Kinetics+of+Reversible+Tight-binding+Inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilliam%26aufirst%3DJ.%2BW.%26aulast%3DMorrison%26aufirst%3DJ.%2BF.%26atitle%3DThe%2520Kinetics%2520of%2520Reversible%2520Tight-binding%2520Inhibition%26jtitle%3DMethods%2520Enzymol.%26date%3D1979%26volume%3D63%26spage%3D437%26epage%3D467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b','cit1c'],'ref2':['cit2a','cit2b'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8a','cit8b'],'ref9':['cit9a','cit9b','cit9c'],'ref10':['cit10'],'ref11':['cit11a','cit11b'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21a','cit21b','cit21c'],'ref22':['cit22a','cit22b'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28a','cit28b','cit28c','cit28d','cit28e'],'ref29':['cit29a','cit29b','cit29c','cit29d','cit29e','cit29f'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':[],'ref36':['cit36'],'ref37':[],'ref38':['cit47'],'ref39':['cit38'],'ref40':['cit39'],'ref41':['cit40'],'ref42':['cit41'],'ref43':['cit42'],'ref44':['cit43'],'ref45':['cit44'],'ref46':['cit45'],'ref47':['cit47a','cit47b']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 72 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Xuewu Liang, Shuai Tang, Xuyi Liu, Yingluo Liu, Qifu Xu, Xiaomin Wang, Abdusaid Saidahmatov, Chunpu Li, Jiang Wang, Yu Zhou, Yingjie Zhang, Meiyu Geng, Min Huang, <span class="NLM_string-name hlFld-ContribAuthor">Hong Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel Pyrrolo[2,3-d]pyrimidine-based Derivatives as Potent JAK/HDAC Dual Inhibitors for the Treatment of Refractory Solid Tumors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021</strong>, Article ASAP.</span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c02111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c02111%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BNovel%252BPyrrolo%25255B2%25252C3-d%25255Dpyrimidine-based%252BDerivatives%252Bas%252BPotent%252BJAK%25252FHDAC%252BDual%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BRefractory%252BSolid%252BTumors%26aulast%3DLiang%26aufirst%3DXuewu%26date%3D2021%26date%3D2020%26date%3D07122020%26volume%3D0%26issue%3D0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Minjian Yang, Bingzhong Tao, Chengjuan Chen, Wenqiang Jia, Shaolei Sun, Tiantai Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Xiaojian Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Machine Learning Models Based on Molecular Fingerprints and an Extreme Gradient Boosting Method Lead to the Discovery of JAK2 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2019,</strong> <em>59 </em>
                                    (12)
                                     , 5002-5012. <a href="https://doi.org/10.1021/acs.jcim.9b00798" title="DOI URL">https://doi.org/10.1021/acs.jcim.9b00798</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.9b00798&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.9b00798%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DMachine%252BLearning%252BModels%252BBased%252Bon%252BMolecular%252BFingerprints%252Band%252Ban%252BExtreme%252BGradient%252BBoosting%252BMethod%252BLead%252Bto%252Bthe%252BDiscovery%252Bof%252BJAK2%252BInhibitors%26aulast%3DYang%26aufirst%3DMinjian%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D15092019%26date%3D04122019%26date%3D20112019%26volume%3D59%26issue%3D12%26spage%3D5002%26epage%3D5012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zheng Zhao, Lei Xie, <span class="NLM_string-name hlFld-ContribAuthor">Philip E. Bourne</span>. </span><span class="cited-content_cbyCitation_article-title">Structural Insights into Characterizing Binding Sites in Epidermal Growth Factor Receptor Kinase Mutants. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2019,</strong> <em>59 </em>
                                    (1)
                                     , 453-462. <a href="https://doi.org/10.1021/acs.jcim.8b00458" title="DOI URL">https://doi.org/10.1021/acs.jcim.8b00458</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.8b00458&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.8b00458%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DStructural%252BInsights%252Binto%252BCharacterizing%252BBinding%252BSites%252Bin%252BEpidermal%252BGrowth%252BFactor%252BReceptor%252BKinase%252BMutants%26aulast%3DZhao%26aufirst%3DZheng%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D10072018%26date%3D11012019%26date%3D24122018%26volume%3D59%26issue%3D1%26spage%3D453%26epage%3D462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Mark E. Schnute, Mattias Wennerstål, Jennifer Alley, Martin Bengtsson, James R. Blinn, Charles W. Bolten, Timothy Braden, Tomas Bonn, Bo Carlsson, Nicole Caspers, Ming Chen, Chulho Choi, Leon P. Collis, Kimberly Crouse, Mathias Färnegårdh, Kimberly F. Fennell, Susan Fish, Andrew C. Flick, Annika Goos-Nilsson, Hjalmar Gullberg, Peter K. Harris, Steven E. Heasley, Martin Hegen, Alexander E. Hromockyj, Xiao Hu, Bolette Husman, Tomasz Janosik, Peter Jones, Neelu Kaila, Elisabet Kallin, Björn Kauppi, James R. Kiefer, John Knafels, Konrad Koehler, Lars Kruger, Ravi G. Kurumbail, Robert E. Kyne, Jr., Wei Li, Joakim Löfstedt, Scott A. Long, Carol A. Menard, Scot Mente, Dean Messing, Marvin J. Meyers, Lee Napierata, Daniel Nöteberg, Philippe Nuhant, Matthew J. Pelc, Michael J. Prinsen, Patrik Rhönnstad, Eva Backström-Rydin, Johnny Sandberg, Maria Sandström, Falgun Shah, Maria Sjöberg, Aron Sundell, Alexandria P. Taylor, Atli Thorarensen, John I. Trujillo, John D. Trzupek, Ray Unwalla, Felix F. Vajdos, Robin A. Weinberg, David C. Wood, Li Xing, Edouard Zamaratski, Christoph W. Zapf, Yajuan Zhao, Anna Wilhelmsson, <span class="NLM_string-name hlFld-ContribAuthor">Gabriel Berstein</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 3-Cyano-N-(3-(1-isobutyrylpiperidin-4-yl)-1-methyl-4-(trifluoromethyl)-1H-pyrrolo[2,3-b]pyridin-5-yl)benzamide: A Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor-Related Orphan Receptor C2 Inverse Agonist. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (23)
                                     , 10415-10439. <a href="https://doi.org/10.1021/acs.jmedchem.8b00392" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00392</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00392&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00392%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B3-Cyano-N-%2525283-%2525281-isobutyrylpiperidin-4-yl%252529-1-methyl-4-%252528trifluoromethyl%252529-1H-pyrrolo%25255B2%25252C3-b%25255Dpyridin-5-yl%252529benzamide%25253A%252BA%252BPotent%25252C%252BSelective%25252C%252Band%252BOrally%252BBioavailable%252BRetinoic%252BAcid%252BReceptor-Related%252BOrphan%252BReceptor%252BC2%252BInverse%252BAgonist%26aulast%3DSchnute%26aufirst%3DMark%2BE.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D10032018%26date%3D09092018%26date%3D21082018%26volume%3D61%26issue%3D23%26spage%3D10415%26epage%3D10439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Mohamed
S. A. Elsayed, Jeffery J. Nielsen, Sungtae Park, Jeongho Park, Qingyang Liu, Chang H. Kim, Yves Pommier, Keli Agama, Philip S. Low, <span class="NLM_string-name hlFld-ContribAuthor">Mark Cushman</span>. </span><span class="cited-content_cbyCitation_article-title">Application of Sequential Palladium Catalysis for the Discovery of Janus Kinase Inhibitors in the Benzo[c]pyrrolo[2,3-h][1,6]naphthyridin-5-one (BPN) Series. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (23)
                                     , 10440-10462. <a href="https://doi.org/10.1021/acs.jmedchem.8b00510" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00510</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00510&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00510%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DApplication%252Bof%252BSequential%252BPalladium%252BCatalysis%252Bfor%252Bthe%252BDiscovery%252Bof%252BJanus%252BKinase%252BInhibitors%252Bin%252Bthe%252BBenzo%25255Bc%25255Dpyrrolo%25255B2%25252C3-h%25255D%25255B1%25252C6%25255Dnaphthyridin-5-one%252B%252528BPN%252529%252BSeries%26aulast%3DElsayed%26aufirst%3DMohamed%2BS.%2BA.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D31032018%26date%3D21112018%26volume%3D61%26issue%3D23%26spage%3D10440%26epage%3D10462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael L.  Vazquez</span>, <span class="hlFld-ContribAuthor ">Neelu  Kaila</span>, <span class="hlFld-ContribAuthor ">Joseph W.  Strohbach</span>, <span class="hlFld-ContribAuthor ">John D.  Trzupek</span>, <span class="hlFld-ContribAuthor ">Matthew F.  Brown</span>, <span class="hlFld-ContribAuthor ">Mark E.  Flanagan</span>, <span class="hlFld-ContribAuthor ">Mark J.  Mitton-Fry</span>, <span class="hlFld-ContribAuthor ">Timothy A.  Johnson</span>, <span class="hlFld-ContribAuthor ">Ruth E.  TenBrink</span>, <span class="hlFld-ContribAuthor ">Eric P.  Arnold</span>, <span class="hlFld-ContribAuthor ">Arindrajit  Basak</span>, <span class="hlFld-ContribAuthor ">Steven E.  Heasley</span>, <span class="hlFld-ContribAuthor ">Soojin  Kwon</span>, <span class="hlFld-ContribAuthor ">Jonathan  Langille</span>, <span class="hlFld-ContribAuthor ">Mihir D.  Parikh</span>, <span class="hlFld-ContribAuthor ">Sarah H.  Griffin</span>, <span class="hlFld-ContribAuthor ">Jeffrey M.  Casavant</span>, <span class="hlFld-ContribAuthor ">Brian A.  Duclos</span>, <span class="hlFld-ContribAuthor ">Ashley E.  Fenwick</span>, <span class="hlFld-ContribAuthor ">Thomas M.  Harris</span>, <span class="hlFld-ContribAuthor ">Seungil  Han</span>, <span class="hlFld-ContribAuthor ">Nicole  Caspers</span>, <span class="hlFld-ContribAuthor ">Martin E.  Dowty</span>, <span class="hlFld-ContribAuthor ">Xin  Yang</span>, <span class="hlFld-ContribAuthor ">Mary Ellen  Banker</span>, <span class="hlFld-ContribAuthor ">Martin  Hegen</span>, <span class="hlFld-ContribAuthor ">Peter T.  Symanowicz</span>, <span class="hlFld-ContribAuthor ">Li  Li</span>, <span class="hlFld-ContribAuthor ">Lu  Wang</span>, <span class="hlFld-ContribAuthor ">Tsung H.  Lin</span>, <span class="hlFld-ContribAuthor ">Jason  Jussif</span>, <span class="hlFld-ContribAuthor ">James D.  Clark</span>, <span class="hlFld-ContribAuthor ">Jean-Baptiste  Telliez</span>, <span class="hlFld-ContribAuthor ">Ralph P.  Robinson</span>, and <span class="hlFld-ContribAuthor ">Ray  Unwalla</span>  . </span><span class="cited-content_cbyCitation_article-title">Identification of N-{cis-3-[Methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclobutyl}propane-1-sulfonamide (PF-04965842): A Selective JAK1 Clinical Candidate for the Treatment of Autoimmune Diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (3)
                                     , 1130-1152. <a href="https://doi.org/10.1021/acs.jmedchem.7b01598" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01598</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01598%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252BN-%25257Bcis-3-%25255BMethyl%2525287H-pyrrolo%25255B2%25252C3-d%25255Dpyrimidin-4-yl%252529amino%25255Dcyclobutyl%25257Dpropane-1-sulfonamide%252B%252528PF-04965842%252529%25253A%252BA%252BSelective%252BJAK1%252BClinical%252BCandidate%252Bfor%252Bthe%252BTreatment%252Bof%252BAutoimmune%252BDiseases%26aulast%3DVazquez%26aufirst%3DMichael%2BL.%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D30102017%26date%3D23012018%26date%3D08022018%26date%3D03012018%26volume%3D61%26issue%3D3%26spage%3D1130%26epage%3D1152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tony  Siu</span>, <span class="hlFld-ContribAuthor ">Jason  Brubaker</span>, <span class="hlFld-ContribAuthor ">Peter  Fuller</span>, <span class="hlFld-ContribAuthor ">Luis  Torres</span>, <span class="hlFld-ContribAuthor ">Hongbo  Zeng</span>, <span class="hlFld-ContribAuthor ">Joshua  Close</span>, <span class="hlFld-ContribAuthor ">Dawn M.  Mampreian</span>, <span class="hlFld-ContribAuthor ">Feng  Shi</span>, <span class="hlFld-ContribAuthor ">Duan  Liu</span>, <span class="hlFld-ContribAuthor ">Xavier  Fradera</span>, <span class="hlFld-ContribAuthor ">Kevin  Johnson</span>, <span class="hlFld-ContribAuthor ">Nathan  Bays</span>, <span class="hlFld-ContribAuthor ">Elma  Kadic</span>, <span class="hlFld-ContribAuthor ">Fang  He</span>, <span class="hlFld-ContribAuthor ">Peter  Goldenblatt</span>, <span class="hlFld-ContribAuthor ">Lynsey  Shaffer</span>, <span class="hlFld-ContribAuthor ">Sangita B.  Patel</span>, <span class="hlFld-ContribAuthor ">Charles A.  Lesburg</span>, <span class="hlFld-ContribAuthor ">Carla  Alpert</span>, <span class="hlFld-ContribAuthor ">Lauren  Dorosh</span>, <span class="hlFld-ContribAuthor ">Sujal V.  Deshmukh</span>, <span class="hlFld-ContribAuthor ">Hongshi  Yu</span>, <span class="hlFld-ContribAuthor ">Joel  Klappenbach</span>, <span class="hlFld-ContribAuthor ">Fiona  Elwood</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Dinsmore</span>, <span class="hlFld-ContribAuthor ">Rafael  Fernandez</span>, <span class="hlFld-ContribAuthor ">Lily  Moy</span>, and <span class="hlFld-ContribAuthor ">Jonathan R.  Young</span>  . </span><span class="cited-content_cbyCitation_article-title">The Discovery of 3-((4-Chloro-3-methoxyphenyl)amino)-1-((3R,4S)-4-cyanotetrahydro-2H-pyran-3-yl)-1H-pyrazole-4-carboxamide, a Highly Ligand Efficient and Efficacious Janus Kinase 1 Selective Inhibitor with Favorable Pharmacokinetic Properties. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (23)
                                     , 9676-9690. <a href="https://doi.org/10.1021/acs.jmedchem.7b01135" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01135</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01135%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252BDiscovery%252Bof%252B3-%252528%2525284-Chloro-3-methoxyphenyl%252529amino%252529-1-%252528%2525283R%25252C4S%252529-4-cyanotetrahydro-2H-pyran-3-yl%252529-1H-pyrazole-4-carboxamide%25252C%252Ba%252BHighly%252BLigand%252BEfficient%252Band%252BEfficacious%252BJanus%252BKinase%252B1%252BSelective%252BInhibitor%252Bwith%252BFavorable%252BPharmacokinetic%252BProperties%26aulast%3DSiu%26aufirst%3DTony%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D04082017%26date%3D04122017%26date%3D14122017%26date%3D20112017%26volume%3D60%26issue%3D23%26spage%3D9676%26epage%3D9690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ignacio  Aliagas</span>, <span class="hlFld-ContribAuthor ">Raphaëlle  Berger</span>, <span class="hlFld-ContribAuthor ">Kristin  Goldberg</span>, <span class="hlFld-ContribAuthor ">Rachel T.  Nishimura</span>, <span class="hlFld-ContribAuthor ">John  Reilly</span>, <span class="hlFld-ContribAuthor ">Paul  Richardson</span>, <span class="hlFld-ContribAuthor ">Daniel  Richter</span>, <span class="hlFld-ContribAuthor ">Edward C.  Sherer</span>, <span class="hlFld-ContribAuthor ">Brian A.  Sparling</span>, and <span class="hlFld-ContribAuthor ">Marian C.  Bryan</span>  . </span><span class="cited-content_cbyCitation_article-title">Sustainable Practices in Medicinal Chemistry Part 2: Green by Design. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (14)
                                     , 5955-5968. <a href="https://doi.org/10.1021/acs.jmedchem.6b01837" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01837</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01837&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01837%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSustainable%252BPractices%252Bin%252BMedicinal%252BChemistry%252BPart%252B2%25253A%252BGreen%252Bby%252BDesign%26aulast%3DAliagas%26aufirst%3DIgnacio%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D14122016%26date%3D12042017%26date%3D27072017%26date%3D04042017%26volume%3D60%26issue%3D14%26spage%3D5955%26epage%3D5968" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dávid  Bajusz</span>, <span class="hlFld-ContribAuthor ">György G.  Ferenczy</span>, and <span class="hlFld-ContribAuthor ">György M.  Keserű</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Subtype Selective Janus Kinase (JAK) Inhibitors by Structure-Based Virtual Screening. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2016,</strong> <em>56 </em>
                                    (1)
                                     , 234-247. <a href="https://doi.org/10.1021/acs.jcim.5b00634" title="DOI URL">https://doi.org/10.1021/acs.jcim.5b00634</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.5b00634&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.5b00634%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DDiscovery%252Bof%252BSubtype%252BSelective%252BJanus%252BKinase%252B%252528JAK%252529%252BInhibitors%252Bby%252BStructure-Based%252BVirtual%252BScreening%26aulast%3DBajusz%26aufirst%3DD%25C3%25A1vid%26date%3D2016%26date%3D2015%26date%3D2015%26date%3D18102015%26date%3D31122015%26date%3D25012016%26date%3D18122015%26volume%3D56%26issue%3D1%26spage%3D234%26epage%3D247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Davide  Carta</span>, <span class="hlFld-ContribAuthor ">Roberta  Bortolozzi</span>, <span class="hlFld-ContribAuthor ">Ernest  Hamel</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Basso</span>, <span class="hlFld-ContribAuthor ">Stefano  Moro</span>, <span class="hlFld-ContribAuthor ">Giampietro  Viola</span>, and <span class="hlFld-ContribAuthor ">Maria Grazia  Ferlin</span>  . </span><span class="cited-content_cbyCitation_article-title">Novel 3-Substituted 7-Phenylpyrrolo[3,2-f]quinolin-9(6H)-ones as Single Entities with Multitarget Antiproliferative Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (20)
                                     , 7991-8010. <a href="https://doi.org/10.1021/acs.jmedchem.5b00805" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00805</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00805&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00805%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252B3-Substituted%252B7-Phenylpyrrolo%25255B3%25252C2-f%25255Dquinolin-9%2525286H%252529-ones%252Bas%252BSingle%252BEntities%252Bwith%252BMultitarget%252BAntiproliferative%252BActivity%26aulast%3DCarta%26aufirst%3DDavide%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D27052015%26date%3D07102015%26date%3D22102015%26date%3D29092015%26volume%3D58%26issue%3D20%26spage%3D7991%26epage%3D8010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James D.  Clark</span>, <span class="hlFld-ContribAuthor ">Mark E.  Flanagan</span>, and <span class="hlFld-ContribAuthor ">Jean-Baptiste  Telliez</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery and Development of Janus Kinase (JAK) Inhibitors for Inflammatory Diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (12)
                                     , 5023-5038. <a href="https://doi.org/10.1021/jm401490p" title="DOI URL">https://doi.org/10.1021/jm401490p</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm401490p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm401490p%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BDevelopment%252Bof%252BJanus%252BKinase%252B%252528JAK%252529%252BInhibitors%252Bfor%252BInflammatory%252BDiseases%26aulast%3DClark%26aufirst%3DJames%2BD.%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D25092013%26date%3D23012014%26date%3D26062014%26date%3D13012014%26volume%3D57%26issue%3D12%26spage%3D5023%26epage%3D5038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tobias  Klein</span>, <span class="hlFld-ContribAuthor ">Julie  Tucker</span>, <span class="hlFld-ContribAuthor ">Geoffrey A.  Holdgate</span>, <span class="hlFld-ContribAuthor ">Richard A.  Norman</span>, and <span class="hlFld-ContribAuthor ">Alexander L.  Breeze</span>  . </span><span class="cited-content_cbyCitation_article-title">FGFR1 Kinase Inhibitors: Close Regioisomers Adopt Divergent Binding Modes and Display Distinct Biophysical Signatures. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>5 </em>
                                    (2)
                                     , 166-171. <a href="https://doi.org/10.1021/ml4004205" title="DOI URL">https://doi.org/10.1021/ml4004205</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml4004205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml4004205%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DFGFR1%252BKinase%252BInhibitors%25253A%252BClose%252BRegioisomers%252BAdopt%252BDivergent%252BBinding%252BModes%252Band%252BDisplay%252BDistinct%252BBiophysical%252BSignatures%26aulast%3DKlein%26aufirst%3DTobias%26date%3D2014%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D19102013%26date%3D06122013%26date%3D16122013%26date%3D13022014%26date%3D06122013%26volume%3D5%26issue%3D2%26spage%3D166%26epage%3D171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark  Zak</span>, <span class="hlFld-ContribAuthor ">Christopher A.  Hurley</span>, <span class="hlFld-ContribAuthor ">Stuart I.  Ward</span>, <span class="hlFld-ContribAuthor ">Philippe  Bergeron</span>, <span class="hlFld-ContribAuthor ">Kathy  Barrett</span>, <span class="hlFld-ContribAuthor ">Mercedesz  Balazs</span>, <span class="hlFld-ContribAuthor ">Wade S.  Blair</span>, <span class="hlFld-ContribAuthor ">Richard  Bull</span>, <span class="hlFld-ContribAuthor ">Paroma  Chakravarty</span>, <span class="hlFld-ContribAuthor ">Christine  Chang</span>, <span class="hlFld-ContribAuthor ">Peter  Crackett</span>, <span class="hlFld-ContribAuthor ">Gauri  Deshmukh</span>, <span class="hlFld-ContribAuthor ">Jason  DeVoss</span>, <span class="hlFld-ContribAuthor ">Peter S.  Dragovich</span>, <span class="hlFld-ContribAuthor ">Charles  Eigenbrot</span>, <span class="hlFld-ContribAuthor ">Charles  Ellwood</span>, <span class="hlFld-ContribAuthor ">Simon  Gaines</span>, <span class="hlFld-ContribAuthor ">Nico  Ghilardi</span>, <span class="hlFld-ContribAuthor ">Paul  Gibbons</span>, <span class="hlFld-ContribAuthor ">Stefan  Gradl</span>, <span class="hlFld-ContribAuthor ">Peter  Gribling</span>, <span class="hlFld-ContribAuthor ">Chris  Hamman</span>, <span class="hlFld-ContribAuthor ">Eric  Harstad</span>, <span class="hlFld-ContribAuthor ">Peter  Hewitt</span>, <span class="hlFld-ContribAuthor ">Adam  Johnson</span>, <span class="hlFld-ContribAuthor ">Tony  Johnson</span>, <span class="hlFld-ContribAuthor ">Jane R.  Kenny</span>, <span class="hlFld-ContribAuthor ">Michael F. T.  Koehler</span>, <span class="hlFld-ContribAuthor ">Pawan  Bir Kohli</span>, <span class="hlFld-ContribAuthor ">Sharada  Labadie</span>, <span class="hlFld-ContribAuthor ">Wyne P.  Lee</span>, <span class="hlFld-ContribAuthor ">Jiangpeng  Liao</span>, <span class="hlFld-ContribAuthor ">Marya  Liimatta</span>, <span class="hlFld-ContribAuthor ">Rohan  Mendonca</span>, <span class="hlFld-ContribAuthor ">Raman  Narukulla</span>, <span class="hlFld-ContribAuthor ">Rebecca  Pulk</span>, <span class="hlFld-ContribAuthor ">Austin  Reeve</span>, <span class="hlFld-ContribAuthor ">Scott  Savage</span>, <span class="hlFld-ContribAuthor ">Steven  Shia</span>, <span class="hlFld-ContribAuthor ">Micah  Steffek</span>, <span class="hlFld-ContribAuthor ">Savita  Ubhayakar</span>, <span class="hlFld-ContribAuthor ">Anne  van Abbema</span>, <span class="hlFld-ContribAuthor ">Ignacio  Aliagas</span>, <span class="hlFld-ContribAuthor ">Barbara  Avitabile-Woo</span>, <span class="hlFld-ContribAuthor ">Yisong  Xiao</span>, <span class="hlFld-ContribAuthor ">Jing  Yang</span>, and <span class="hlFld-ContribAuthor ">Janusz J.  Kulagowski</span>  . </span><span class="cited-content_cbyCitation_article-title">Identification of C-2 Hydroxyethyl Imidazopyrrolopyridines as Potent JAK1 Inhibitors with Favorable Physicochemical Properties and High Selectivity over JAK2. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (11)
                                     , 4764-4785. <a href="https://doi.org/10.1021/jm4004895" title="DOI URL">https://doi.org/10.1021/jm4004895</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm4004895&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm4004895%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252BC-2%252BHydroxyethyl%252BImidazopyrrolopyridines%252Bas%252BPotent%252BJAK1%252BInhibitors%252Bwith%252BFavorable%252BPhysicochemical%252BProperties%252Band%252BHigh%252BSelectivity%252Bover%252BJAK2%26aulast%3DZak%26aufirst%3DMark%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D04042013%26date%3D31052013%26date%3D13062013%26date%3D09052013%26volume%3D56%26issue%3D11%26spage%3D4764%26epage%3D4785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emily J.  Hanan</span>, <span class="hlFld-ContribAuthor ">Anne  van Abbema</span>, <span class="hlFld-ContribAuthor ">Kathy  Barrett</span>, <span class="hlFld-ContribAuthor ">Wade S.  Blair</span>, <span class="hlFld-ContribAuthor ">Jeff  Blaney</span>, <span class="hlFld-ContribAuthor ">Christine  Chang</span>, <span class="hlFld-ContribAuthor ">Charles  Eigenbrot</span>, <span class="hlFld-ContribAuthor ">Sean  Flynn</span>, <span class="hlFld-ContribAuthor ">Paul  Gibbons</span>, <span class="hlFld-ContribAuthor ">Christopher A.  Hurley</span>, <span class="hlFld-ContribAuthor ">Jane R.  Kenny</span>, <span class="hlFld-ContribAuthor ">Janusz  Kulagowski</span>, <span class="hlFld-ContribAuthor ">Leslie  Lee</span>, <span class="hlFld-ContribAuthor ">Steven R.  Magnuson</span>, <span class="hlFld-ContribAuthor ">Claire  Morris</span>, <span class="hlFld-ContribAuthor ">Jeremy  Murray</span>, <span class="hlFld-ContribAuthor ">Richard M.  Pastor</span>, <span class="hlFld-ContribAuthor ">Tom  Rawson</span>, <span class="hlFld-ContribAuthor ">Michael  Siu</span>, <span class="hlFld-ContribAuthor ">Mark  Ultsch</span>, <span class="hlFld-ContribAuthor ">Aihe  Zhou</span>, <span class="hlFld-ContribAuthor ">Deepak  Sampath</span>, and <span class="hlFld-ContribAuthor ">Joseph P.  Lyssikatos</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Potent and Selective Pyrazolopyrimidine Janus Kinase 2 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (22)
                                     , 10090-10107. <a href="https://doi.org/10.1021/jm3012239" title="DOI URL">https://doi.org/10.1021/jm3012239</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm3012239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm3012239%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BPotent%252Band%252BSelective%252BPyrazolopyrimidine%252BJanus%252BKinase%252B2%252BInhibitors%26aulast%3DHanan%26aufirst%3DEmily%2BJ.%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D22082012%26date%3D24102012%26date%3D26112012%26date%3D12102012%26volume%3D55%26issue%3D22%26spage%3D10090%26epage%3D10107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark  Zak</span>, <span class="hlFld-ContribAuthor ">Rohan  Mendonca</span>, <span class="hlFld-ContribAuthor ">Mercedesz  Balazs</span>, <span class="hlFld-ContribAuthor ">Kathy  Barrett</span>, <span class="hlFld-ContribAuthor ">Philippe  Bergeron</span>, <span class="hlFld-ContribAuthor ">Wade S.  Blair</span>, <span class="hlFld-ContribAuthor ">Christine  Chang</span>, <span class="hlFld-ContribAuthor ">Gauri  Deshmukh</span>, <span class="hlFld-ContribAuthor ">Jason  DeVoss</span>, <span class="hlFld-ContribAuthor ">Peter S.  Dragovich</span>, <span class="hlFld-ContribAuthor ">Charles  Eigenbrot</span>, <span class="hlFld-ContribAuthor ">Nico  Ghilardi</span>, <span class="hlFld-ContribAuthor ">Paul  Gibbons</span>, <span class="hlFld-ContribAuthor ">Stefan  Gradl</span>, <span class="hlFld-ContribAuthor ">Chris  Hamman</span>, <span class="hlFld-ContribAuthor ">Emily J.  Hanan</span>, <span class="hlFld-ContribAuthor ">Eric  Harstad</span>, <span class="hlFld-ContribAuthor ">Peter R.  Hewitt</span>, <span class="hlFld-ContribAuthor ">Christopher A.  Hurley</span>, <span class="hlFld-ContribAuthor ">Tian  Jin</span>, <span class="hlFld-ContribAuthor ">Adam  Johnson</span>, <span class="hlFld-ContribAuthor ">Tony  Johnson</span>, <span class="hlFld-ContribAuthor ">Jane R.  Kenny</span>, <span class="hlFld-ContribAuthor ">Michael F. T.  Koehler</span>, <span class="hlFld-ContribAuthor ">Pawan  Bir Kohli</span>, <span class="hlFld-ContribAuthor ">Janusz J.  Kulagowski</span>, <span class="hlFld-ContribAuthor ">Sharada  Labadie</span>, <span class="hlFld-ContribAuthor ">Jiangpeng  Liao</span>, <span class="hlFld-ContribAuthor ">Marya  Liimatta</span>, <span class="hlFld-ContribAuthor ">Zhonghua  Lin</span>, <span class="hlFld-ContribAuthor ">Patrick J.  Lupardus</span>, <span class="hlFld-ContribAuthor ">Robert J.  Maxey</span>, <span class="hlFld-ContribAuthor ">Jeremy M.  Murray</span>, <span class="hlFld-ContribAuthor ">Rebecca  Pulk</span>, <span class="hlFld-ContribAuthor ">Madeleine  Rodriguez</span>, <span class="hlFld-ContribAuthor ">Scott  Savage</span>, <span class="hlFld-ContribAuthor ">Steven  Shia</span>, <span class="hlFld-ContribAuthor ">Micah  Steffek</span>, <span class="hlFld-ContribAuthor ">Savita  Ubhayakar</span>, <span class="hlFld-ContribAuthor ">Mark  Ultsch</span>, <span class="hlFld-ContribAuthor ">Anne  van Abbema</span>, <span class="hlFld-ContribAuthor ">Stuart I.  Ward</span>, <span class="hlFld-ContribAuthor ">Ling  Xiao</span>, and <span class="hlFld-ContribAuthor ">Yisong  Xiao</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery and Optimization of C-2 Methyl Imidazopyrrolopyridines as Potent and Orally Bioavailable JAK1 Inhibitors with Selectivity over JAK2. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (13)
                                     , 6176-6193. <a href="https://doi.org/10.1021/jm300628c" title="DOI URL">https://doi.org/10.1021/jm300628c</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm300628c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm300628c%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BOptimization%252Bof%252BC-2%252BMethyl%252BImidazopyrrolopyridines%252Bas%252BPotent%252Band%252BOrally%252BBioavailable%252BJAK1%252BInhibitors%252Bwith%252BSelectivity%252Bover%252BJAK2%26aulast%3DZak%26aufirst%3DMark%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D05052012%26date%3D28062012%26date%3D12072012%26date%3D14062012%26volume%3D55%26issue%3D13%26spage%3D6176%26epage%3D6193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pengfei  Xu</span>, <span class="hlFld-ContribAuthor ">Pei  Shen</span>, <span class="hlFld-ContribAuthor ">Hai  Wang</span>, <span class="hlFld-ContribAuthor ">Lian  Qin</span>, <span class="hlFld-ContribAuthor ">Jie  Ren</span>, <span class="hlFld-ContribAuthor ">Qiushuang  Sun</span>, <span class="hlFld-ContribAuthor ">Raoling  Ge</span>, <span class="hlFld-ContribAuthor ">Jinlei  Bian</span>, <span class="hlFld-ContribAuthor ">Yi  Zhong</span>, <span class="hlFld-ContribAuthor ">Zhiyu  Li</span>, <span class="hlFld-ContribAuthor ">JuBo  Wang</span>, <span class="hlFld-ContribAuthor ">Zhixia  Qiu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of imidazopyrrolopyridines derivatives as novel and selective inhibitors of JAK2. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>218 </em>, 113394. <a href="https://doi.org/10.1016/j.ejmech.2021.113394" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113394</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113394&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113394%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bimidazopyrrolopyridines%252Bderivatives%252Bas%252Bnovel%252Band%252Bselective%252Binhibitors%252Bof%252BJAK2%26aulast%3DXu%26aufirst%3DPengfei%26date%3D2021%26volume%3D218%26spage%3D113394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Neelam  Pery</span>, <span class="hlFld-ContribAuthor ">Nayab Batool  Rizvi</span>, <span class="hlFld-ContribAuthor ">Muhammad Imtiaz  Shafiq</span>. </span><span class="cited-content_cbyCitation_article-title">Development of piperidinyl dipyrrrolopyridine-based dual inhibitors of Janus kinase and Bruton’s tyrosine kinase: a potential therapeutic probability to deal with rheumatoid arthritis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Modeling</span><span> <strong>2020,</strong> <em>26 </em>
                                    (9)
                                     <a href="https://doi.org/10.1007/s00894-020-04512-3" title="DOI URL">https://doi.org/10.1007/s00894-020-04512-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00894-020-04512-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00894-020-04512-3%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Modeling%26atitle%3DDevelopment%252Bof%252Bpiperidinyl%252Bdipyrrrolopyridine-based%252Bdual%252Binhibitors%252Bof%252BJanus%252Bkinase%252Band%252BBruton%2525E2%252580%252599s%252Btyrosine%252Bkinase%25253A%252Ba%252Bpotential%252Btherapeutic%252Bprobability%252Bto%252Bdeal%252Bwith%252Brheumatoid%252Barthritis%26aulast%3DPery%26aufirst%3DNeelam%26date%3D2020%26date%3D2020%26volume%3D26%26issue%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Safa  Daoud</span>, <span class="hlFld-ContribAuthor ">Mutasem O.  Taha</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacophore modeling of JAK1: A target infested with activity-cliffs. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Graphics and Modelling</span><span> <strong>2020,</strong> <em>99 </em>, 107615. <a href="https://doi.org/10.1016/j.jmgm.2020.107615" title="DOI URL">https://doi.org/10.1016/j.jmgm.2020.107615</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmgm.2020.107615&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmgm.2020.107615%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Graphics%2520and%2520Modelling%26atitle%3DPharmacophore%252Bmodeling%252Bof%252BJAK1%25253A%252BA%252Btarget%252Binfested%252Bwith%252Bactivity-cliffs%26aulast%3DDaoud%26aufirst%3DSafa%26date%3D2020%26volume%3D99%26spage%3D107615" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ayah  Abdeldayem</span>, <span class="hlFld-ContribAuthor ">Yasir S.  Raouf</span>, <span class="hlFld-ContribAuthor ">Stefan N.  Constantinescu</span>, <span class="hlFld-ContribAuthor ">Richard  Moriggl</span>, <span class="hlFld-ContribAuthor ">Patrick T.  Gunning</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in covalent kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Chemical Society Reviews</span><span> <strong>2020,</strong> <em>49 </em>
                                    (9)
                                     , 2617-2687. <a href="https://doi.org/10.1039/C9CS00720B" title="DOI URL">https://doi.org/10.1039/C9CS00720B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9CS00720B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9CS00720B%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Society%2520Reviews%26atitle%3DAdvances%252Bin%252Bcovalent%252Bkinase%252Binhibitors%26aulast%3DAbdeldayem%26aufirst%3DAyah%26date%3D2020%26date%3D2020%26volume%3D49%26issue%3D9%26spage%3D2617%26epage%3D2687" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bo  Sun</span>, <span class="hlFld-ContribAuthor ">Xiaowen  Liu</span>, <span class="hlFld-ContribAuthor ">Xu  Zheng</span>, <span class="hlFld-ContribAuthor ">Changyuan  Wang</span>, <span class="hlFld-ContribAuthor ">Qiang  Meng</span>, <span class="hlFld-ContribAuthor ">Huijun  Sun</span>, <span class="hlFld-ContribAuthor ">Xiaohong  Shu</span>, <span class="hlFld-ContribAuthor ">Kexin  Liu</span>, <span class="hlFld-ContribAuthor ">Xiuli  Sun</span>, <span class="hlFld-ContribAuthor ">Yanxia  Li</span>, <span class="hlFld-ContribAuthor ">Xiaodong  Ma</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Pyrimidines as Multitarget Protein Tyrosine Kinase Inhibitors for the Treatment of Idiopathic Pulmonary Fibrosis (IPF). </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2020,</strong> <em>15 </em>
                                    (2)
                                     , 182-187. <a href="https://doi.org/10.1002/cmdc.201900606" title="DOI URL">https://doi.org/10.1002/cmdc.201900606</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201900606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201900606%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DNovel%252BPyrimidines%252Bas%252BMultitarget%252BProtein%252BTyrosine%252BKinase%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BIdiopathic%252BPulmonary%252BFibrosis%252B%252528IPF%252529%26aulast%3DSun%26aufirst%3DBo%26date%3D2020%26date%3D2019%26volume%3D15%26issue%3D2%26spage%3D182%26epage%3D187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthias  Gehringer</span>, <span class="hlFld-ContribAuthor ">Michael  Forster</span>. </span><span class="cited-content_cbyCitation_article-title">Covalent Janus Kinase 3 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 225-256. <a href="https://doi.org/10.1007/7355_2020_96" title="DOI URL">https://doi.org/10.1007/7355_2020_96</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2020_96&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2020_96%26sid%3Dliteratum%253Aachs%26atitle%3DCovalent%252BJanus%252BKinase%252B3%252BInhibitors%26aulast%3DGehringer%26aufirst%3DMatthias%26date%3D2020%26date%3D2020%26spage%3D225%26epage%3D256%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DProteinkinase%252BInhibitors%26aulast%3DLaufer%26aufirst%3DStefan%26date%3D2021%26volume%3D36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yang-Heon  Song</span>. </span><span class="cited-content_cbyCitation_article-title">Three Heterocyclic Rings Fused (5-6-5). </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,<a href="https://doi.org/10.1016/B978-0-12-409547-2.14899-1" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.14899-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.14899-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.14899-1%26sid%3Dliteratum%253Aachs%26atitle%3DThree%252BHeterocyclic%252BRings%252BFused%252B%2525285-6-5%252529%26aulast%3DSong%26aufirst%3DYang-Heon%26date%3D2020%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2020%26volume%3Dvol.%25208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elham Y.  Al-Barghouthy</span>, <span class="hlFld-ContribAuthor ">Areej  Abuhammad</span>, <span class="hlFld-ContribAuthor ">Mutasem O.  Taha</span>. </span><span class="cited-content_cbyCitation_article-title">QSAR-guided pharmacophore modeling and subsequent virtual screening identify novel TYK2 inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2019,</strong> <em>28 </em>
                                    (9)
                                     , 1368-1387. <a href="https://doi.org/10.1007/s00044-019-02377-7" title="DOI URL">https://doi.org/10.1007/s00044-019-02377-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-019-02377-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-019-02377-7%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DQSAR-guided%252Bpharmacophore%252Bmodeling%252Band%252Bsubsequent%252Bvirtual%252Bscreening%252Bidentify%252Bnovel%252BTYK2%252Binhibitor%26aulast%3DAl-Barghouthy%26aufirst%3DElham%2BY.%26date%3D2019%26date%3D2019%26volume%3D28%26issue%3D9%26spage%3D1368%26epage%3D1387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stanislav  Andreev</span>, <span class="hlFld-ContribAuthor ">Tatu  Pantsar</span>, <span class="hlFld-ContribAuthor ">Francesco  Ansideri</span>, <span class="hlFld-ContribAuthor ">Mark  Kudolo</span>, <span class="hlFld-ContribAuthor ">Michael  Forster</span>, <span class="hlFld-ContribAuthor ">Dieter  Schollmeyer</span>, <span class="hlFld-ContribAuthor ">Stefan A.  Laufer</span>, <span class="hlFld-ContribAuthor ">Pierre  Koch</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis and Biological Evaluation of 7-Chloro-9H-pyrimido[4,5-b]indole-based Glycogen Synthase Kinase-3β Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (12)
                                     , 2331. <a href="https://doi.org/10.3390/molecules24122331" title="DOI URL">https://doi.org/10.3390/molecules24122331</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24122331&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24122331%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDesign%25252C%252BSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252B7-Chloro-9H-pyrimido%25255B4%25252C5-b%25255Dindole-based%252BGlycogen%252BSynthase%252BKinase-3%2525CE%2525B2%252BInhibitors%26aulast%3DAndreev%26aufirst%3DStanislav%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D12%26spage%3D2331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicolas  Sailliet</span>, <span class="hlFld-ContribAuthor ">Carole  Brosseau</span>, <span class="hlFld-ContribAuthor ">Jean-Michel  Robert</span>, <span class="hlFld-ContribAuthor ">Sophie  Brouard</span>. </span><span class="cited-content_cbyCitation_article-title">Role of JAK inhibitors and immune cells in transplantation. </span><span class="cited-content_cbyCitation_journal-name">Cytokine & Growth Factor Reviews</span><span> <strong>2019,</strong> <em>47 </em>, 62-73. <a href="https://doi.org/10.1016/j.cytogfr.2019.05.002" title="DOI URL">https://doi.org/10.1016/j.cytogfr.2019.05.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cytogfr.2019.05.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cytogfr.2019.05.002%26sid%3Dliteratum%253Aachs%26jtitle%3DCytokine%2520%2526%2520Growth%2520Factor%2520Reviews%26atitle%3DRole%252Bof%252BJAK%252Binhibitors%252Band%252Bimmune%252Bcells%252Bin%252Btransplantation%26aulast%3DSailliet%26aufirst%3DNicolas%26date%3D2019%26volume%3D47%26spage%3D62%26epage%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maaged  Abdullah</span>, <span class="hlFld-ContribAuthor ">Lalitha  Guruprasad</span>. </span><span class="cited-content_cbyCitation_article-title">Computational fragment-based design of Wee1 kinase inhibitors with tricyclic core scaffolds. </span><span class="cited-content_cbyCitation_journal-name">Structural Chemistry</span><span> <strong>2019,</strong> <em>30 </em>
                                    (1)
                                     , 213-226. <a href="https://doi.org/10.1007/s11224-018-1176-3" title="DOI URL">https://doi.org/10.1007/s11224-018-1176-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11224-018-1176-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11224-018-1176-3%26sid%3Dliteratum%253Aachs%26jtitle%3DStructural%2520Chemistry%26atitle%3DComputational%252Bfragment-based%252Bdesign%252Bof%252BWee1%252Bkinase%252Binhibitors%252Bwith%252Btricyclic%252Bcore%252Bscaffolds%26aulast%3DAbdullah%26aufirst%3DMaaged%26date%3D2019%26date%3D2018%26volume%3D30%26issue%3D1%26spage%3D213%26epage%3D226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yifan  Zhou</span>, <span class="hlFld-ContribAuthor ">Xiao  Liu</span>, <span class="hlFld-ContribAuthor ">Youzhi  Zhang</span>, <span class="hlFld-ContribAuthor ">Long  Peng</span>, <span class="hlFld-ContribAuthor ">John Z. H.  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Residue-specific free energy analysis in ligand bindings to JAK2. </span><span class="cited-content_cbyCitation_journal-name">Molecular Physics</span><span> <strong>2018,</strong> <em>116 </em>
                                    (19-20)
                                     , 2633-2641. <a href="https://doi.org/10.1080/00268976.2018.1442596" title="DOI URL">https://doi.org/10.1080/00268976.2018.1442596</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00268976.2018.1442596&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00268976.2018.1442596%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Physics%26atitle%3DResidue-specific%252Bfree%252Benergy%252Banalysis%252Bin%252Bligand%252Bbindings%252Bto%252BJAK2%26aulast%3DZhou%26aufirst%3DYifan%26date%3D2018%26date%3D2018%26volume%3D116%26issue%3D19-20%26spage%3D2633%26epage%3D2641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haneesh  Jasuja</span>, <span class="hlFld-ContribAuthor ">Navriti  Chadha</span>, <span class="hlFld-ContribAuthor ">Pankaj Kumar  Singh</span>, <span class="hlFld-ContribAuthor ">Maninder  Kaur</span>, <span class="hlFld-ContribAuthor ">Malkeet Singh  Bahia</span>, <span class="hlFld-ContribAuthor ">Om  Silakari</span>. </span><span class="cited-content_cbyCitation_article-title">Putative dual inhibitors of Janus kinase 1 and 3 (JAK1/3): Pharmacophore based hierarchical virtual screening. </span><span class="cited-content_cbyCitation_journal-name">Computational Biology and Chemistry</span><span> <strong>2018,</strong> <em>76 </em>, 109-117. <a href="https://doi.org/10.1016/j.compbiolchem.2018.07.009" title="DOI URL">https://doi.org/10.1016/j.compbiolchem.2018.07.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.compbiolchem.2018.07.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.compbiolchem.2018.07.009%26sid%3Dliteratum%253Aachs%26jtitle%3DComputational%2520Biology%2520and%2520Chemistry%26atitle%3DPutative%252Bdual%252Binhibitors%252Bof%252BJanus%252Bkinase%252B1%252Band%252B3%252B%252528JAK1%25252F3%252529%25253A%252BPharmacophore%252Bbased%252Bhierarchical%252Bvirtual%252Bscreening%26aulast%3DJasuja%26aufirst%3DHaneesh%26date%3D2018%26volume%3D76%26spage%3D109%26epage%3D117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuan  Yin</span>, <span class="hlFld-ContribAuthor ">Cheng-Juan  Chen</span>, <span class="hlFld-ContribAuthor ">Ru-Nan  Yu</span>, <span class="hlFld-ContribAuthor ">Zhi-Jian  Wang</span>, <span class="hlFld-ContribAuthor ">Tian-Tai  Zhang</span>, <span class="hlFld-ContribAuthor ">Da-Yong  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based design and synthesis of 1H-pyrazolo[3,4-d]pyrimidin-4-amino derivatives as Janus kinase 3 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (17)
                                     , 4774-4786. <a href="https://doi.org/10.1016/j.bmc.2018.04.005" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.04.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.04.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.04.005%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DStructure-based%252Bdesign%252Band%252Bsynthesis%252Bof%252B1H-pyrazolo%25255B3%25252C4-d%25255Dpyrimidin-4-amino%252Bderivatives%252Bas%252BJanus%252Bkinase%252B3%252Binhibitors%26aulast%3DYin%26aufirst%3DYuan%26date%3D2018%26volume%3D26%26issue%3D17%26spage%3D4774%26epage%3D4786" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rohit B.  Kamble</span>, <span class="hlFld-ContribAuthor ">Gurunath  Suryavanshi</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of key intermediate for (+)-tofacitinib through Co
              III
              (salen)-catalyzed two stereocentered hydrolytic kinetic resolution of (±)-methyl-3-(oxiran-2-yl)butanoate. </span><span class="cited-content_cbyCitation_journal-name">Synthetic Communications</span><span> <strong>2018,</strong> <em>48 </em>
                                    (9)
                                     , 1045-1051. <a href="https://doi.org/10.1080/00397911.2018.1434204" title="DOI URL">https://doi.org/10.1080/00397911.2018.1434204</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00397911.2018.1434204&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00397911.2018.1434204%26sid%3Dliteratum%253Aachs%26jtitle%3DSynthetic%2520Communications%26atitle%3DSynthesis%252Bof%252Bkey%252Bintermediate%252Bfor%252B%252528%25252B%252529-tofacitinib%252Bthrough%252BCo%252BIII%252B%252528salen%252529-catalyzed%252Btwo%252Bstereocentered%252Bhydrolytic%252Bkinetic%252Bresolution%252Bof%252B%252528%2525C2%2525B1%252529-methyl-3-%252528oxiran-2-yl%252529butanoate%26aulast%3DKamble%26aufirst%3DRohit%2BB.%26date%3D2018%26date%3D2018%26volume%3D48%26issue%3D9%26spage%3D1045%26epage%3D1051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Linhong  He</span>, <span class="hlFld-ContribAuthor ">Mingfeng  Shao</span>, <span class="hlFld-ContribAuthor ">Taijin  Wang</span>, <span class="hlFld-ContribAuthor ">Tingxuan  Lan</span>, <span class="hlFld-ContribAuthor ">Chufeng  Zhang</span>, <span class="hlFld-ContribAuthor ">Lijuan  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and SAR study of highly potent, selective, irreversible covalent JAK3 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Molecular Diversity</span><span> <strong>2018,</strong> <em>22 </em>
                                    (2)
                                     , 343-358. <a href="https://doi.org/10.1007/s11030-017-9803-2" title="DOI URL">https://doi.org/10.1007/s11030-017-9803-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11030-017-9803-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11030-017-9803-2%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Diversity%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252BSAR%252Bstudy%252Bof%252Bhighly%252Bpotent%25252C%252Bselective%25252C%252Birreversible%252Bcovalent%252BJAK3%252Binhibitors%26aulast%3DHe%26aufirst%3DLinhong%26date%3D2018%26date%3D2018%26volume%3D22%26issue%3D2%26spage%3D343%26epage%3D358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ramesh  Itteboina</span>, <span class="hlFld-ContribAuthor ">Srilata  Ballu</span>, <span class="hlFld-ContribAuthor ">Sree Kanth  Sivan</span>, <span class="hlFld-ContribAuthor ">Vijjulatha  Manga</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular modeling-driven approach for identification of Janus kinase 1 inhibitors through 3D-QSAR, docking and molecular dynamics simulations. </span><span class="cited-content_cbyCitation_journal-name">Journal of Receptors and Signal Transduction</span><span> <strong>2017,</strong> <em>37 </em>
                                    (5)
                                     , 453-469. <a href="https://doi.org/10.1080/10799893.2017.1328442" title="DOI URL">https://doi.org/10.1080/10799893.2017.1328442</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10799893.2017.1328442&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10799893.2017.1328442%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Receptors%2520and%2520Signal%2520Transduction%26atitle%3DMolecular%252Bmodeling-driven%252Bapproach%252Bfor%252Bidentification%252Bof%252BJanus%252Bkinase%252B1%252Binhibitors%252Bthrough%252B3D-QSAR%25252C%252Bdocking%252Band%252Bmolecular%252Bdynamics%252Bsimulations%26aulast%3DItteboina%26aufirst%3DRamesh%26date%3D2017%26date%3D2017%26volume%3D37%26issue%3D5%26spage%3D453%26epage%3D469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael  Forster</span>, <span class="hlFld-ContribAuthor ">Matthias  Gehringer</span>, <span class="hlFld-ContribAuthor ">Stefan A.  Laufer</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in JAK3 inhibition: Isoform selectivity by covalent cysteine targeting. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (18)
                                     , 4229-4237. <a href="https://doi.org/10.1016/j.bmcl.2017.07.079" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.07.079</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.07.079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.07.079%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DRecent%252Badvances%252Bin%252BJAK3%252Binhibition%25253A%252BIsoform%252Bselectivity%252Bby%252Bcovalent%252Bcysteine%252Btargeting%26aulast%3DForster%26aufirst%3DMichael%26date%3D2017%26volume%3D27%26issue%3D18%26spage%3D4229%26epage%3D4237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Barbara  Morzyk-Ociepa</span>, <span class="hlFld-ContribAuthor ">Ksenia  Szmigiel</span>, <span class="hlFld-ContribAuthor ">Ilona  Turowska-Tyrk</span>, <span class="hlFld-ContribAuthor ">Danuta  Michalska</span>. </span><span class="cited-content_cbyCitation_article-title">X-ray crystal structure, infrared, Raman and density functional studies of 7-azaindole-3-carboxaldehyde. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2017,</strong> <em>1128 </em>, 186-194. <a href="https://doi.org/10.1016/j.molstruc.2016.08.061" title="DOI URL">https://doi.org/10.1016/j.molstruc.2016.08.061</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2016.08.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2016.08.061%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DX-ray%252Bcrystal%252Bstructure%25252C%252Binfrared%25252C%252BRaman%252Band%252Bdensity%252Bfunctional%252Bstudies%252Bof%252B7-azaindole-3-carboxaldehyde%26aulast%3DMorzyk-Ociepa%26aufirst%3DBarbara%26date%3D2017%26volume%3D1128%26spage%3D186%26epage%3D194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hao-Chun  Liao</span>, <span class="hlFld-ContribAuthor ">Biing-Jiun  Uang</span>. </span><span class="cited-content_cbyCitation_article-title">Formal asymmetric synthesis of (+)-tofacitinib. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron: Asymmetry</span><span> <strong>2017,</strong> <em>28 </em>
                                    (1)
                                     , 105-109. <a href="https://doi.org/10.1016/j.tetasy.2016.11.013" title="DOI URL">https://doi.org/10.1016/j.tetasy.2016.11.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetasy.2016.11.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetasy.2016.11.013%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%253A%2520Asymmetry%26atitle%3DFormal%252Basymmetric%252Bsynthesis%252Bof%252B%252528%25252B%252529-tofacitinib%26aulast%3DLiao%26aufirst%3DHao-Chun%26date%3D2017%26volume%3D28%26issue%3D1%26spage%3D105%26epage%3D109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">C. A.  Dendrou</span>, <span class="hlFld-ContribAuthor ">A.  Cortes</span>, <span class="hlFld-ContribAuthor ">L.  Shipman</span>, <span class="hlFld-ContribAuthor ">H. G.  Evans</span>, <span class="hlFld-ContribAuthor ">K. E.  Attfield</span>, <span class="hlFld-ContribAuthor ">L.  Jostins</span>, <span class="hlFld-ContribAuthor ">T.  Barber</span>, <span class="hlFld-ContribAuthor ">G.  Kaur</span>, <span class="hlFld-ContribAuthor ">S. B.  Kuttikkatte</span>, <span class="hlFld-ContribAuthor ">O. A.  Leach</span>, <span class="hlFld-ContribAuthor ">C.  Desel</span>, <span class="hlFld-ContribAuthor ">S. L.  Faergeman</span>, <span class="hlFld-ContribAuthor ">J.  Cheeseman</span>, <span class="hlFld-ContribAuthor ">M. J.  Neville</span>, <span class="hlFld-ContribAuthor ">S.  Sawcer</span>, <span class="hlFld-ContribAuthor ">A.  Compston</span>, <span class="hlFld-ContribAuthor ">A. R.  Johnson</span>, <span class="hlFld-ContribAuthor ">C.  Everett</span>, <span class="hlFld-ContribAuthor ">J. I.  Bell</span>, <span class="hlFld-ContribAuthor ">F.  Karpe</span>, <span class="hlFld-ContribAuthor ">M.  Ultsch</span>, <span class="hlFld-ContribAuthor ">C.  Eigenbrot</span>, <span class="hlFld-ContribAuthor ">G.  McVean</span>, <span class="hlFld-ContribAuthor ">L.  Fugger</span>. </span><span class="cited-content_cbyCitation_article-title">Resolving TYK2 locus genotype-to-phenotype differences in autoimmunity. </span><span class="cited-content_cbyCitation_journal-name">Science Translational Medicine</span><span> <strong>2016,</strong> <em>8 </em>
                                    (363)
                                     , 363ra149-363ra149. <a href="https://doi.org/10.1126/scitranslmed.aag1974" title="DOI URL">https://doi.org/10.1126/scitranslmed.aag1974</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1126/scitranslmed.aag1974&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1126%2Fscitranslmed.aag1974%26sid%3Dliteratum%253Aachs%26jtitle%3DScience%2520Translational%2520Medicine%26atitle%3DResolving%252BTYK2%252Blocus%252Bgenotype-to-phenotype%252Bdifferences%252Bin%252Bautoimmunity%26aulast%3DDendrou%26aufirst%3DC.%2BA.%26date%3D2016%26date%3D2016%26volume%3D8%26issue%3D363%26spage%3D363ra149%26epage%3D363ra149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dávid  Bajusz</span>, <span class="hlFld-ContribAuthor ">György G.  Ferenczy</span>, <span class="hlFld-ContribAuthor ">György M.  Keserű</span>. </span><span class="cited-content_cbyCitation_article-title">Ensemble docking-based virtual screening yields novel spirocyclic JAK1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Graphics and Modelling</span><span> <strong>2016,</strong> <em>70 </em>, 275-283. <a href="https://doi.org/10.1016/j.jmgm.2016.10.014" title="DOI URL">https://doi.org/10.1016/j.jmgm.2016.10.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmgm.2016.10.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmgm.2016.10.014%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Graphics%2520and%2520Modelling%26atitle%3DEnsemble%252Bdocking-based%252Bvirtual%252Bscreening%252Byields%252Bnovel%252Bspirocyclic%252BJAK1%252Binhibitors%26aulast%3DBajusz%26aufirst%3DD%25C3%25A1vid%26date%3D2016%26volume%3D70%26spage%3D275%26epage%3D283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicole L.  Caspers</span>, <span class="hlFld-ContribAuthor ">Seungil  Han</span>, <span class="hlFld-ContribAuthor ">Francis  Rajamohan</span>, <span class="hlFld-ContribAuthor ">Lise R.  Hoth</span>, <span class="hlFld-ContribAuthor ">Kieran F.  Geoghegan</span>, <span class="hlFld-ContribAuthor ">Timothy A.  Subashi</span>, <span class="hlFld-ContribAuthor ">Michael L.  Vazquez</span>, <span class="hlFld-ContribAuthor ">Neelu  Kaila</span>, <span class="hlFld-ContribAuthor ">Ciarán N.  Cronin</span>, <span class="hlFld-ContribAuthor ">Eric  Johnson</span>, <span class="hlFld-ContribAuthor ">Ravi G.  Kurumbail</span>. </span><span class="cited-content_cbyCitation_article-title">Development of a high-throughput crystal structure-determination platform for JAK1 using a novel metal-chelator soaking system. </span><span class="cited-content_cbyCitation_journal-name">Acta Crystallographica Section F Structural Biology Communications</span><span> <strong>2016,</strong> <em>72 </em>
                                    (11)
                                     , 840-845. <a href="https://doi.org/10.1107/S2053230X16016356" title="DOI URL">https://doi.org/10.1107/S2053230X16016356</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1107/S2053230X16016356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1107%2FS2053230X16016356%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Crystallographica%2520Section%2520F%2520Structural%2520Biology%2520Communications%26atitle%3DDevelopment%252Bof%252Ba%252Bhigh-throughput%252Bcrystal%252Bstructure-determination%252Bplatform%252Bfor%252BJAK1%252Busing%252Ba%252Bnovel%252Bmetal-chelator%252Bsoaking%252Bsystem%26aulast%3DCaspers%26aufirst%3DNicole%2BL.%26date%3D2016%26date%3D2016%26volume%3D72%26issue%3D11%26spage%3D840%26epage%3D845" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ramesh  Itteboina</span>, <span class="hlFld-ContribAuthor ">Srilata  Ballu</span>, <span class="hlFld-ContribAuthor ">Sree Kanth  Sivan</span>, <span class="hlFld-ContribAuthor ">Vijjulatha  Manga</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular docking, 3D QSAR and dynamics simulation studies of imidazo-pyrrolopyridines as janus kinase 1 (JAK 1) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Computational Biology and Chemistry</span><span> <strong>2016,</strong> <em>64 </em>, 33-46. <a href="https://doi.org/10.1016/j.compbiolchem.2016.04.009" title="DOI URL">https://doi.org/10.1016/j.compbiolchem.2016.04.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.compbiolchem.2016.04.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.compbiolchem.2016.04.009%26sid%3Dliteratum%253Aachs%26jtitle%3DComputational%2520Biology%2520and%2520Chemistry%26atitle%3DMolecular%252Bdocking%25252C%252B3D%252BQSAR%252Band%252Bdynamics%252Bsimulation%252Bstudies%252Bof%252Bimidazo-pyrrolopyridines%252Bas%252Bjanus%252Bkinase%252B1%252B%252528JAK%252B1%252529%252Binhibitors%26aulast%3DItteboina%26aufirst%3DRamesh%26date%3D2016%26volume%3D64%26spage%3D33%26epage%3D46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maximilien  Murone</span>, <span class="hlFld-ContribAuthor ">Anne  Vaslin Chessex</span>, <span class="hlFld-ContribAuthor ">Antoine  Attinger</span>, <span class="hlFld-ContribAuthor ">Raghuveer  Ramachandra</span>, <span class="hlFld-ContribAuthor ">Shankar J.  Shetty</span>, <span class="hlFld-ContribAuthor ">Girish  Daginakatte</span>, <span class="hlFld-ContribAuthor ">Saumitra  Sengupta</span>, <span class="hlFld-ContribAuthor ">Sivapriya  Marappan</span>, <span class="hlFld-ContribAuthor ">Samiulla  Dhodheri</span>, <span class="hlFld-ContribAuthor ">Stefania  Rigotti</span>, <span class="hlFld-ContribAuthor ">Yogeshwar  Bachhav</span>, <span class="hlFld-ContribAuthor ">Silvano  Brienza</span>, <span class="hlFld-ContribAuthor ">Peter  Traxler</span>, <span class="hlFld-ContribAuthor ">Marc  Lang</span>, <span class="hlFld-ContribAuthor ">Michel  Aguet</span>, <span class="hlFld-ContribAuthor ">Vincent  Zoete</span>, <span class="hlFld-ContribAuthor ">Olivier  Michielin</span>, <span class="hlFld-ContribAuthor ">Courtney  Nicholas</span>, <span class="hlFld-ContribAuthor ">Faye M.  Johnson</span>, <span class="hlFld-ContribAuthor ">Murali  Ramachandra</span>, <span class="hlFld-ContribAuthor ">Andres  McAllister</span>. </span><span class="cited-content_cbyCitation_article-title">Debio 0617B Inhibits Growth of STAT3-Driven Solid Tumors through Combined Inhibition of JAK, SRC, and Class III/V Receptor Tyrosine Kinases. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2016,</strong> <em>15 </em>
                                    (10)
                                     , 2334-2343. <a href="https://doi.org/10.1158/1535-7163.MCT-15-0974" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-15-0974</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-15-0974&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-15-0974%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DDebio%252B0617B%252BInhibits%252BGrowth%252Bof%252BSTAT3-Driven%252BSolid%252BTumors%252Bthrough%252BCombined%252BInhibition%252Bof%252BJAK%25252C%252BSRC%25252C%252Band%252BClass%252BIII%25252FV%252BReceptor%252BTyrosine%252BKinases%26aulast%3DMurone%26aufirst%3DMaximilien%26date%3D2016%26date%3D2016%26volume%3D15%26issue%3D10%26spage%3D2334%26epage%3D2343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hyungmi  Kim</span>, <span class="hlFld-ContribAuthor ">Mi Kyoung  Kim</span>, <span class="hlFld-ContribAuthor ">Hyunah  Choo</span>, <span class="hlFld-ContribAuthor ">Youhoon  Chong</span>. </span><span class="cited-content_cbyCitation_article-title">Novel JAK1-selective benzimidazole inhibitors with enhanced membrane permeability. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (14)
                                     , 3213-3215. <a href="https://doi.org/10.1016/j.bmcl.2016.05.078" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.05.078</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.05.078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.05.078%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DNovel%252BJAK1-selective%252Bbenzimidazole%252Binhibitors%252Bwith%252Benhanced%252Bmembrane%252Bpermeability%26aulast%3DKim%26aufirst%3DHyungmi%26date%3D2016%26volume%3D26%26issue%3D14%26spage%3D3213%26epage%3D3215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emilie  Leroy</span>, <span class="hlFld-ContribAuthor ">Alexandra  Dusa</span>, <span class="hlFld-ContribAuthor ">Didier  Colau</span>, <span class="hlFld-ContribAuthor ">Amir  Motamedi</span>, <span class="hlFld-ContribAuthor ">Xavier  Cahu</span>, <span class="hlFld-ContribAuthor ">Céline  Mouton</span>, <span class="hlFld-ContribAuthor ">Lily J.  Huang</span>, <span class="hlFld-ContribAuthor ">Andrew K.  Shiau</span>, <span class="hlFld-ContribAuthor ">Stefan N.  Constantinescu</span>. </span><span class="cited-content_cbyCitation_article-title">Uncoupling JAK2 V617F activation from cytokine-induced signalling by modulation of JH2 αC helix. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Journal</span><span> <strong>2016,</strong> <em>473 </em>
                                    (11)
                                     , 1579-1591. <a href="https://doi.org/10.1042/BCJ20160085" title="DOI URL">https://doi.org/10.1042/BCJ20160085</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1042/BCJ20160085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1042%2FBCJ20160085%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Journal%26atitle%3DUncoupling%252BJAK2%252BV617F%252Bactivation%252Bfrom%252Bcytokine-induced%252Bsignalling%252Bby%252Bmodulation%252Bof%252BJH2%252B%2525CE%2525B1C%252Bhelix%26aulast%3DLeroy%26aufirst%3DEmilie%26date%3D2016%26date%3D2016%26volume%3D473%26issue%3D11%26spage%3D1579%26epage%3D1591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiaojiao  Xu</span>, <span class="hlFld-ContribAuthor ">Jin  Cai</span>, <span class="hlFld-ContribAuthor ">Junqing  Chen</span>, <span class="hlFld-ContribAuthor ">Xi  Zong</span>, <span class="hlFld-ContribAuthor ">Xuan  Wu</span>, <span class="hlFld-ContribAuthor ">Min  Ji</span>, <span class="hlFld-ContribAuthor ">Peng  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">An Efficient Synthesis of Baricitinib. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Research</span><span> <strong>2016,</strong> <em>40 </em>
                                    (4)
                                     , 205-208. <a href="https://doi.org/10.3184/174751916X14569294811333" title="DOI URL">https://doi.org/10.3184/174751916X14569294811333</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3184/174751916X14569294811333&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3184%2F174751916X14569294811333%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Research%26atitle%3DAn%252BEfficient%252BSynthesis%252Bof%252BBaricitinib%26aulast%3DXu%26aufirst%3DJiaojiao%26date%3D2016%26date%3D2016%26volume%3D40%26issue%3D4%26spage%3D205%26epage%3D208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Satoe  Ishii</span>, <span class="hlFld-ContribAuthor ">Yasutaka  Niwa</span>, <span class="hlFld-ContribAuthor ">Soichiro  Watanabe</span>. </span><span class="cited-content_cbyCitation_article-title">Deoxyfluorination of α- N -phthaloyl cycloalkanones with bis(2-methoxyethyl)aminosulfur trifluoride (Deoxo-Fluor). </span><span class="cited-content_cbyCitation_journal-name">Journal of Fluorine Chemistry</span><span> <strong>2016,</strong> <em>182 </em>, 41-46. <a href="https://doi.org/10.1016/j.jfluchem.2015.12.001" title="DOI URL">https://doi.org/10.1016/j.jfluchem.2015.12.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jfluchem.2015.12.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jfluchem.2015.12.001%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Fluorine%2520Chemistry%26atitle%3DDeoxyfluorination%252Bof%252B%2525CE%2525B1-%252BN%252B-phthaloyl%252Bcycloalkanones%252Bwith%252Bbis%2525282-methoxyethyl%252529aminosulfur%252Btrifluoride%252B%252528Deoxo-Fluor%252529%26aulast%3DIshii%26aufirst%3DSatoe%26date%3D2016%26volume%3D182%26spage%3D41%26epage%3D46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leonid G.  Voskressensky</span>, <span class="hlFld-ContribAuthor ">Olga A.  Storozhenko</span>, <span class="hlFld-ContribAuthor ">Alexey A.  Festa</span>, <span class="hlFld-ContribAuthor ">Victor N.  Khrustalev</span>, <span class="hlFld-ContribAuthor ">Thi Tuyet Anh  Dang</span>, <span class="hlFld-ContribAuthor ">Van Tuyen  Nguyen</span>, <span class="hlFld-ContribAuthor ">Alexey V.  Varlamov</span>. </span><span class="cited-content_cbyCitation_article-title">A novel domino condensation—intramolecular nucleophilic cyclization approach toward annulated imidazo-pyrrolopyridines. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2015,</strong> <em>56 </em>
                                    (46)
                                     , 6475-6477. <a href="https://doi.org/10.1016/j.tetlet.2015.10.003" title="DOI URL">https://doi.org/10.1016/j.tetlet.2015.10.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2015.10.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2015.10.003%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DA%252Bnovel%252Bdomino%252Bcondensation%2525E2%252580%252594intramolecular%252Bnucleophilic%252Bcyclization%252Bapproach%252Btoward%252Bannulated%252Bimidazo-pyrrolopyridines%26aulast%3DVoskressensky%26aufirst%3DLeonid%2BG.%26date%3D2015%26volume%3D56%26issue%3D46%26spage%3D6475%26epage%3D6477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hiroaki  Yamagishi</span>, <span class="hlFld-ContribAuthor ">Shohei  Shirakami</span>, <span class="hlFld-ContribAuthor ">Yutaka  Nakajima</span>, <span class="hlFld-ContribAuthor ">Akira  Tanaka</span>, <span class="hlFld-ContribAuthor ">Fumie  Takahashi</span>, <span class="hlFld-ContribAuthor ">Hisao  Hamaguchi</span>, <span class="hlFld-ContribAuthor ">Keiko  Hatanaka</span>, <span class="hlFld-ContribAuthor ">Ayako  Moritomo</span>, <span class="hlFld-ContribAuthor ">Masamichi  Inami</span>, <span class="hlFld-ContribAuthor ">Yasuyuki  Higashi</span>, <span class="hlFld-ContribAuthor ">Takayuki  Inoue</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 3,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridin-2(1H)-one derivatives as novel JAK inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2015,</strong> <em>23 </em>
                                    (15)
                                     , 4846-4859. <a href="https://doi.org/10.1016/j.bmc.2015.05.028" title="DOI URL">https://doi.org/10.1016/j.bmc.2015.05.028</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2015.05.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2015.05.028%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B3%25252C6-dihydroimidazo%25255B4%25252C5-d%25255Dpyrrolo%25255B2%25252C3-b%25255Dpyridin-2%2525281H%252529-one%252Bderivatives%252Bas%252Bnovel%252BJAK%252Binhibitors%26aulast%3DYamagishi%26aufirst%3DHiroaki%26date%3D2015%26volume%3D23%26issue%3D15%26spage%3D4846%26epage%3D4859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rohit Y.  Sathe</span>, <span class="hlFld-ContribAuthor ">Seema A.  Kulkarni</span>, <span class="hlFld-ContribAuthor ">Raja Natesan  Sella</span>, <span class="hlFld-ContribAuthor ">Thirumurthy  Madhavan</span>. </span><span class="cited-content_cbyCitation_article-title">Computational identification of JAK2 inhibitors: a combined pharmacophore mapping and molecular docking approach. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2015,</strong> <em>24 </em>
                                    (4)
                                     , 1449-1467. <a href="https://doi.org/10.1007/s00044-014-1223-6" title="DOI URL">https://doi.org/10.1007/s00044-014-1223-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-014-1223-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-014-1223-6%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DComputational%252Bidentification%252Bof%252BJAK2%252Binhibitors%25253A%252Ba%252Bcombined%252Bpharmacophore%252Bmapping%252Band%252Bmolecular%252Bdocking%252Bapproach%26aulast%3DSathe%26aufirst%3DRohit%2BY.%26date%3D2015%26date%3D2014%26volume%3D24%26issue%3D4%26spage%3D1449%26epage%3D1467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ignacio  Aliagas</span>, <span class="hlFld-ContribAuthor ">Alberto  Gobbi</span>, <span class="hlFld-ContribAuthor ">Timothy  Heffron</span>, <span class="hlFld-ContribAuthor ">Man-Ling  Lee</span>, <span class="hlFld-ContribAuthor ">Daniel F.  Ortwine</span>, <span class="hlFld-ContribAuthor ">Mark  Zak</span>, <span class="hlFld-ContribAuthor ">S. Cyrus  Khojasteh</span>. </span><span class="cited-content_cbyCitation_article-title">A probabilistic method to report predictions from a human liver microsomes stability QSAR model: a practical tool for drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Journal of Computer-Aided Molecular Design</span><span> <strong>2015,</strong> <em>29 </em>
                                    (4)
                                     , 327-338. <a href="https://doi.org/10.1007/s10822-015-9838-3" title="DOI URL">https://doi.org/10.1007/s10822-015-9838-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10822-015-9838-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10822-015-9838-3%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Computer-Aided%2520Molecular%2520Design%26atitle%3DA%252Bprobabilistic%252Bmethod%252Bto%252Breport%252Bpredictions%252Bfrom%252Ba%252Bhuman%252Bliver%252Bmicrosomes%252Bstability%252BQSAR%252Bmodel%25253A%252Ba%252Bpractical%252Btool%252Bfor%252Bdrug%252Bdiscovery%26aulast%3DAliagas%26aufirst%3DIgnacio%26date%3D2015%26date%3D2015%26volume%3D29%26issue%3D4%26spage%3D327%26epage%3D338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eric R.  Goedken</span>, <span class="hlFld-ContribAuthor ">Maria A.  Argiriadi</span>, <span class="hlFld-ContribAuthor ">David L.  Banach</span>, <span class="hlFld-ContribAuthor ">Bryan A.  Fiamengo</span>, <span class="hlFld-ContribAuthor ">Sage E.  Foley</span>, <span class="hlFld-ContribAuthor ">Kristine E.  Frank</span>, <span class="hlFld-ContribAuthor ">Jonathan S.  George</span>, <span class="hlFld-ContribAuthor ">Christopher M.  Harris</span>, <span class="hlFld-ContribAuthor ">Adrian D.  Hobson</span>, <span class="hlFld-ContribAuthor ">David C.  Ihle</span>, <span class="hlFld-ContribAuthor ">Douglas  Marcotte</span>, <span class="hlFld-ContribAuthor ">Philip J.  Merta</span>, <span class="hlFld-ContribAuthor ">Mark E.  Michalak</span>, <span class="hlFld-ContribAuthor ">Sara E.  Murdock</span>, <span class="hlFld-ContribAuthor ">Medha J.  Tomlinson</span>, <span class="hlFld-ContribAuthor ">Jeffrey W.  Voss</span>. </span><span class="cited-content_cbyCitation_article-title">Tricyclic Covalent Inhibitors Selectively Target Jak3 through an Active Site Thiol. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biological Chemistry</span><span> <strong>2015,</strong> <em>290 </em>
                                    (8)
                                     , 4573-4589. <a href="https://doi.org/10.1074/jbc.M114.595181" title="DOI URL">https://doi.org/10.1074/jbc.M114.595181</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1074/jbc.M114.595181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1074%2Fjbc.M114.595181%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biological%2520Chemistry%26atitle%3DTricyclic%252BCovalent%252BInhibitors%252BSelectively%252BTarget%252BJak3%252Bthrough%252Ban%252BActive%252BSite%252BThiol%26aulast%3DGoedken%26aufirst%3DEric%2BR.%26date%3D2015%26volume%3D290%26issue%3D8%26spage%3D4573%26epage%3D4589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christel J  Menet</span>, <span class="hlFld-ContribAuthor ">Oscar  Mammoliti</span>, <span class="hlFld-ContribAuthor ">Miriam  López-Ramos</span>. </span><span class="cited-content_cbyCitation_article-title">Progress toward JAK1-selective inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2015,</strong> <em>7 </em>
                                    (2)
                                     , 203-235. <a href="https://doi.org/10.4155/fmc.14.149" title="DOI URL">https://doi.org/10.4155/fmc.14.149</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.14.149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.14.149%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DProgress%252Btoward%252BJAK1-selective%252Binhibitors%26aulast%3DMenet%26aufirst%3DChristel%2BJ%26date%3D2015%26volume%3D7%26issue%3D2%26spage%3D203%26epage%3D235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kazuhiro  Kobayashi</span>, <span class="hlFld-ContribAuthor ">Kazuya  Nakazawa</span>, <span class="hlFld-ContribAuthor ">Shohei  Yuba</span>, <span class="hlFld-ContribAuthor ">Hidetaka  Hiyoshi</span>, <span class="hlFld-ContribAuthor ">Kazuto  Umezu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 7-Alkyl-6-amino-7H-pyrrolo[2,3-d]pyrimidine-6-carbonitriles by the Copper-Catalyzed Reaction of 4-(Alkylamino)-5-iodopyrimidines with Propanedinitrile. </span><span class="cited-content_cbyCitation_journal-name">HETEROCYCLES</span><span> <strong>2015,</strong> <em>90 </em>
                                    (1)
                                     , 216. <a href="https://doi.org/10.3987/COM-14-S(K)5" title="DOI URL">https://doi.org/10.3987/COM-14-S(K)5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3987/COM-14-S(K)5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3987%2FCOM-14-S%28K%295%26sid%3Dliteratum%253Aachs%26jtitle%3DHETEROCYCLES%26atitle%3DSynthesis%252Bof%252B7-Alkyl-6-amino-7H-pyrrolo%25255B2%25252C3-d%25255Dpyrimidine-6-carbonitriles%252Bby%252Bthe%252BCopper-Catalyzed%252BReaction%252Bof%252B4-%252528Alkylamino%252529-5-iodopyrimidines%252Bwith%252BPropanedinitrile%26aulast%3DKobayashi%26aufirst%3DKazuhiro%26date%3D2015%26volume%3D90%26issue%3D1%26spage%3D216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mi Kyoung  Kim</span>, <span class="hlFld-ContribAuthor ">Kyung Do  Kim</span>, <span class="hlFld-ContribAuthor ">Youhoon  Chong</span>. </span><span class="cited-content_cbyCitation_article-title">De Novo Design of 2-Amino-4-Alkylaminoquinazoline-7-Carboxamides as Potential Scaffold for JAK1-Selective Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bulletin of the Korean Chemical Society</span><span> <strong>2014,</strong> <em>35 </em>
                                    (11)
                                     , 3377-3380. <a href="https://doi.org/10.5012/bkcs.2014.35.11.3377" title="DOI URL">https://doi.org/10.5012/bkcs.2014.35.11.3377</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.5012/bkcs.2014.35.11.3377&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.5012%2Fbkcs.2014.35.11.3377%26sid%3Dliteratum%253Aachs%26jtitle%3DBulletin%2520of%2520the%2520Korean%2520Chemical%2520Society%26atitle%3DDe%252BNovo%252BDesign%252Bof%252B2-Amino-4-Alkylaminoquinazoline-7-Carboxamides%252Bas%252BPotential%252BScaffold%252Bfor%252BJAK1-Selective%252BInhibitors%26aulast%3DKim%26aufirst%3DMi%2BKyoung%26date%3D2014%26volume%3D35%26issue%3D11%26spage%3D3377%26epage%3D3380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthias  Gehringer</span>, <span class="hlFld-ContribAuthor ">Michael  Forster</span>, <span class="hlFld-ContribAuthor ">Ellen  Pfaffenrot</span>, <span class="hlFld-ContribAuthor ">Silke M.  Bauer</span>, <span class="hlFld-ContribAuthor ">Stefan A.  Laufer</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Hinge-Binding Motifs for Janus Kinase 3 Inhibitors: A Comprehensive Structure-Activity Relationship Study on Tofacitinib Bioisosteres. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2014,</strong> <em>9 </em>
                                    (11)
                                     , 2516-2527. <a href="https://doi.org/10.1002/cmdc.201402252" title="DOI URL">https://doi.org/10.1002/cmdc.201402252</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201402252&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201402252%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DNovel%252BHinge-Binding%252BMotifs%252Bfor%252BJanus%252BKinase%2525E2%252580%2525853%252BInhibitors%25253A%252BA%252BComprehensive%252BStructure-Activity%252BRelationship%252BStudy%252Bon%252BTofacitinib%252BBioisosteres%26aulast%3DGehringer%26aufirst%3DMatthias%26date%3D2014%26date%3D2014%26volume%3D9%26issue%3D11%26spage%3D2516%26epage%3D2527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Javier  de Vicente</span>, <span class="hlFld-ContribAuthor ">Remy  Lemoine</span>, <span class="hlFld-ContribAuthor ">Mark  Bartlett</span>, <span class="hlFld-ContribAuthor ">Johannes C.  Hermann</span>, <span class="hlFld-ContribAuthor ">Mohammad  Hekmat-Nejad</span>, <span class="hlFld-ContribAuthor ">Robert  Henningsen</span>, <span class="hlFld-ContribAuthor ">Sue  Jin</span>, <span class="hlFld-ContribAuthor ">Andreas  Kuglstatter</span>, <span class="hlFld-ContribAuthor ">Hongju  Li</span>, <span class="hlFld-ContribAuthor ">Allen J.  Lovey</span>, <span class="hlFld-ContribAuthor ">John  Menke</span>, <span class="hlFld-ContribAuthor ">Linghao  Niu</span>, <span class="hlFld-ContribAuthor ">Vaishali  Patel</span>, <span class="hlFld-ContribAuthor ">Ann  Petersen</span>, <span class="hlFld-ContribAuthor ">Lina  Setti</span>, <span class="hlFld-ContribAuthor ">Ada  Shao</span>, <span class="hlFld-ContribAuthor ">Parcharee  Tivitmahaisoon</span>, <span class="hlFld-ContribAuthor ">Minh Diem  Vu</span>, <span class="hlFld-ContribAuthor ">Michael  Soth</span>. </span><span class="cited-content_cbyCitation_article-title">Scaffold hopping towards potent and selective JAK3 inhibitors: Discovery of novel C-5 substituted pyrrolopyrazines. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (21)
                                     , 4969-4975. <a href="https://doi.org/10.1016/j.bmcl.2014.09.031" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.09.031</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.09.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.09.031%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DScaffold%252Bhopping%252Btowards%252Bpotent%252Band%252Bselective%252BJAK3%252Binhibitors%25253A%252BDiscovery%252Bof%252Bnovel%252BC-5%252Bsubstituted%252Bpyrrolopyrazines%26aulast%3Dde%2BVicente%26aufirst%3DJavier%26date%3D2014%26volume%3D24%26issue%3D21%26spage%3D4969%26epage%3D4975" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mi Kyoung  Kim</span>, <span class="hlFld-ContribAuthor ">Onnuri  Bae</span>, <span class="hlFld-ContribAuthor ">Youhoon  Chong</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Molecular Docking Study of Flavonol Derivatives as Selective JAK1 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bulletin of the Korean Chemical Society</span><span> <strong>2014,</strong> <em>35 </em>
                                    (8)
                                     , 2581-2584. <a href="https://doi.org/10.5012/bkcs.2014.35.8.2581" title="DOI URL">https://doi.org/10.5012/bkcs.2014.35.8.2581</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.5012/bkcs.2014.35.8.2581&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.5012%2Fbkcs.2014.35.8.2581%26sid%3Dliteratum%253Aachs%26jtitle%3DBulletin%2520of%2520the%2520Korean%2520Chemical%2520Society%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BMolecular%252BDocking%252BStudy%252Bof%252BFlavonol%252BDerivatives%252Bas%252BSelective%252BJAK1%252BInhibitors%26aulast%3DKim%26aufirst%3DMi%2BKyoung%26date%3D2014%26volume%3D35%26issue%3D8%26spage%3D2581%26epage%3D2584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">H.  Jasuja</span>, <span class="hlFld-ContribAuthor ">N.  Chadha</span>, <span class="hlFld-ContribAuthor ">M.  Kaur</span>, <span class="hlFld-ContribAuthor ">O.  Silakari</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacophore and docking-based virtual screening approach for the design of new dual inhibitors of Janus kinase 1 and Janus kinase 2. </span><span class="cited-content_cbyCitation_journal-name">SAR and QSAR in Environmental Research</span><span> <strong>2014,</strong> <em>25 </em>
                                    (8)
                                     , 617-636. <a href="https://doi.org/10.1080/1062936X.2014.884163" title="DOI URL">https://doi.org/10.1080/1062936X.2014.884163</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/1062936X.2014.884163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F1062936X.2014.884163%26sid%3Dliteratum%253Aachs%26jtitle%3DSAR%2520and%2520QSAR%2520in%2520Environmental%2520Research%26atitle%3DPharmacophore%252Band%252Bdocking-based%252Bvirtual%252Bscreening%252Bapproach%252Bfor%252Bthe%252Bdesign%252Bof%252Bnew%252Bdual%252Binhibitors%252Bof%252BJanus%252Bkinase%252B1%252Band%252BJanus%252Bkinase%252B2%26aulast%3DJasuja%26aufirst%3DH.%26date%3D2014%26date%3D2014%26volume%3D25%26issue%3D8%26spage%3D617%26epage%3D636" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter  Norman</span>. </span><span class="cited-content_cbyCitation_article-title">Selective JAK inhibitors in development for rheumatoid arthritis. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Investigational Drugs</span><span> <strong>2014,</strong> <em>23 </em>
                                    (8)
                                     , 1067-1077. <a href="https://doi.org/10.1517/13543784.2014.918604" title="DOI URL">https://doi.org/10.1517/13543784.2014.918604</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543784.2014.918604&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543784.2014.918604%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Investigational%2520Drugs%26atitle%3DSelective%252BJAK%252Binhibitors%252Bin%252Bdevelopment%252Bfor%252Brheumatoid%252Barthritis%26aulast%3DNorman%26aufirst%3DPeter%26date%3D2014%26date%3D2014%26volume%3D23%26issue%3D8%26spage%3D1067%26epage%3D1077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brian W  Dymock</span>, <span class="hlFld-ContribAuthor ">Eugene Guorong  Yang</span>, <span class="hlFld-ContribAuthor ">Yuyi  Chu-Farseeva</span>, <span class="hlFld-ContribAuthor ">Lianbin  Yao</span>. </span><span class="cited-content_cbyCitation_article-title">Selective JAK inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2014,</strong> <em>6 </em>
                                    (12)
                                     , 1439-1471. <a href="https://doi.org/10.4155/fmc.14.92" title="DOI URL">https://doi.org/10.4155/fmc.14.92</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.14.92&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.14.92%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DSelective%252BJAK%252Binhibitors%26aulast%3DDymock%26aufirst%3DBrian%2BW%26date%3D2014%26volume%3D6%26issue%3D12%26spage%3D1439%26epage%3D1471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christel J  Menet</span>. </span><span class="cited-content_cbyCitation_article-title">Toward selective TYK2 inhibitors as therapeutic agents for the treatment of inflammatory diseases. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceutical Patent Analyst</span><span> <strong>2014,</strong> <em>3 </em>
                                    (4)
                                     , 449-466. <a href="https://doi.org/10.4155/ppa.14.23" title="DOI URL">https://doi.org/10.4155/ppa.14.23</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/ppa.14.23&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Fppa.14.23%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceutical%2520Patent%2520Analyst%26atitle%3DToward%252Bselective%252BTYK2%252Binhibitors%252Bas%252Btherapeutic%252Bagents%252Bfor%252Bthe%252Btreatment%252Bof%252Binflammatory%252Bdiseases%26aulast%3DMenet%26aufirst%3DChristel%2BJ%26date%3D2014%26volume%3D3%26issue%3D4%26spage%3D449%26epage%3D466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qiang  Liu</span>, <span class="hlFld-ContribAuthor ">Wei  Fan</span>, <span class="hlFld-ContribAuthor ">Hongqi  Tian</span>. </span><span class="cited-content_cbyCitation_article-title">A highly efficient TfOH-assisted alkylation of azaindoles with α-phenylethanols. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2014,</strong> <em>55 </em>
                                    (16)
                                     , 2745-2748. <a href="https://doi.org/10.1016/j.tetlet.2014.03.059" title="DOI URL">https://doi.org/10.1016/j.tetlet.2014.03.059</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2014.03.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2014.03.059%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DA%252Bhighly%252Befficient%252BTfOH-assisted%252Balkylation%252Bof%252Bazaindoles%252Bwith%252B%2525CE%2525B1-phenylethanols%26aulast%3DLiu%26aufirst%3DQiang%26date%3D2014%26volume%3D55%26issue%3D16%26spage%3D2745%26epage%3D2748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthias  Gehringer</span>, <span class="hlFld-ContribAuthor ">Ellen  Pfaffenrot</span>, <span class="hlFld-ContribAuthor ">Silke  Bauer</span>, <span class="hlFld-ContribAuthor ">Stefan A.  Laufer</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of Tricyclic JAK3 Inhibitors with Picomolar Affinities as Novel Molecular Probes. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2014,</strong> <em>9 </em>
                                    (2)
                                     , 277-281. <a href="https://doi.org/10.1002/cmdc.201300520" title="DOI URL">https://doi.org/10.1002/cmdc.201300520</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201300520&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201300520%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252BTricyclic%252BJAK3%252BInhibitors%252Bwith%252BPicomolar%252BAffinities%252Bas%252BNovel%252BMolecular%252BProbes%26aulast%3DGehringer%26aufirst%3DMatthias%26date%3D2014%26date%3D2014%26volume%3D9%26issue%3D2%26spage%3D277%26epage%3D281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mi Kyoung  Kim</span>, <span class="hlFld-ContribAuthor ">Heerim  Shin</span>, <span class="hlFld-ContribAuthor ">Seo Young  Cho</span>, <span class="hlFld-ContribAuthor ">Youhoon  Chong</span>. </span><span class="cited-content_cbyCitation_article-title">Linear propargylic alcohol functionality attached to the indazole-7-carboxamide as a JAK1-specific linear probe group. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2014,</strong> <em>22 </em>
                                    (3)
                                     , 1156-1162. <a href="https://doi.org/10.1016/j.bmc.2013.12.033" title="DOI URL">https://doi.org/10.1016/j.bmc.2013.12.033</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2013.12.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2013.12.033%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DLinear%252Bpropargylic%252Balcohol%252Bfunctionality%252Battached%252Bto%252Bthe%252Bindazole-7-carboxamide%252Bas%252Ba%252BJAK1-specific%252Blinear%252Bprobe%252Bgroup%26aulast%3DKim%26aufirst%3DMi%2BKyoung%26date%3D2014%26volume%3D22%26issue%3D3%26spage%3D1156%26epage%3D1162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark E.  McDonnell</span>, <span class="hlFld-ContribAuthor ">Haiyan  Bian</span>, <span class="hlFld-ContribAuthor ">Jay  Wrobel</span>, <span class="hlFld-ContribAuthor ">Garry R.  Smith</span>, <span class="hlFld-ContribAuthor ">Shuguang  Liang</span>, <span class="hlFld-ContribAuthor ">Haiching  Ma</span>, <span class="hlFld-ContribAuthor ">Allen B.  Reitz</span>. </span><span class="cited-content_cbyCitation_article-title">Anilino-monoindolylmaleimides as potent and selective JAK3 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (4)
                                     , 1116-1121. <a href="https://doi.org/10.1016/j.bmcl.2014.01.001" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.01.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.01.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.01.001%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DAnilino-monoindolylmaleimides%252Bas%252Bpotent%252Band%252Bselective%252BJAK3%252Binhibitors%26aulast%3DMcDonnell%26aufirst%3DMark%2BE.%26date%3D2014%26volume%3D24%26issue%3D4%26spage%3D1116%26epage%3D1121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xuebing  Chen</span>, <span class="hlFld-ContribAuthor ">Li  Zhu</span>, <span class="hlFld-ContribAuthor ">Li  Fang</span>, <span class="hlFld-ContribAuthor ">Shengjiao  Yan</span>, <span class="hlFld-ContribAuthor ">Jun  Lin</span>. </span><span class="cited-content_cbyCitation_article-title">Catalyst-free concise synthesis of imidazo[1,2-a]pyrrolo[3,4-e]pyridine derivatives. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2014,</strong> <em>4 </em>
                                    (20)
                                     , 9926. <a href="https://doi.org/10.1039/c3ra45485a" title="DOI URL">https://doi.org/10.1039/c3ra45485a</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c3ra45485a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc3ra45485a%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DCatalyst-free%252Bconcise%252Bsynthesis%252Bof%252Bimidazo%25255B1%25252C2-a%25255Dpyrrolo%25255B3%25252C4-e%25255Dpyridine%252Bderivatives%26aulast%3DChen%26aufirst%3DXuebing%26date%3D2014%26volume%3D4%26issue%3D20%26spage%3D9926" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adolfo  Maricán</span>, <span class="hlFld-ContribAuthor ">Mario J.  Simirgiotis</span>, <span class="hlFld-ContribAuthor ">Leonardo S.  Santos</span>. </span><span class="cited-content_cbyCitation_article-title">Asymmetric total synthesis of Tofacitinib. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2013,</strong> <em>54 </em>
                                    (37)
                                     , 5096-5098. <a href="https://doi.org/10.1016/j.tetlet.2013.07.042" title="DOI URL">https://doi.org/10.1016/j.tetlet.2013.07.042</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2013.07.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2013.07.042%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DAsymmetric%252Btotal%252Bsynthesis%252Bof%252BTofacitinib%26aulast%3DMaric%25C3%25A1n%26aufirst%3DAdolfo%26date%3D2013%26volume%3D54%26issue%3D37%26spage%3D5096%26epage%3D5098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher A.  Hurley</span>, <span class="hlFld-ContribAuthor ">Wade S.  Blair</span>, <span class="hlFld-ContribAuthor ">Richard J.  Bull</span>, <span class="hlFld-ContribAuthor ">Christine  Chang</span>, <span class="hlFld-ContribAuthor ">Peter H.  Crackett</span>, <span class="hlFld-ContribAuthor ">Gauri  Deshmukh</span>, <span class="hlFld-ContribAuthor ">Hazel J.  Dyke</span>, <span class="hlFld-ContribAuthor ">Rina  Fong</span>, <span class="hlFld-ContribAuthor ">Nico  Ghilardi</span>, <span class="hlFld-ContribAuthor ">Paul  Gibbons</span>, <span class="hlFld-ContribAuthor ">Peter R.  Hewitt</span>, <span class="hlFld-ContribAuthor ">Adam  Johnson</span>, <span class="hlFld-ContribAuthor ">Tony  Johnson</span>, <span class="hlFld-ContribAuthor ">Jane R.  Kenny</span>, <span class="hlFld-ContribAuthor ">Pawan Bir  Kohli</span>, <span class="hlFld-ContribAuthor ">Janusz J.  Kulagowski</span>, <span class="hlFld-ContribAuthor ">Marya  Liimatta</span>, <span class="hlFld-ContribAuthor ">Patrick J.  Lupardus</span>, <span class="hlFld-ContribAuthor ">Robert J.  Maxey</span>, <span class="hlFld-ContribAuthor ">Rohan  Mendonca</span>, <span class="hlFld-ContribAuthor ">Raman  Narukulla</span>, <span class="hlFld-ContribAuthor ">Rebecca  Pulk</span>, <span class="hlFld-ContribAuthor ">Savita  Ubhayakar</span>, <span class="hlFld-ContribAuthor ">Anne  van Abbema</span>, <span class="hlFld-ContribAuthor ">Stuart I.  Ward</span>, <span class="hlFld-ContribAuthor ">Bohdan  Waszkowycz</span>, <span class="hlFld-ContribAuthor ">Mark  Zak</span>. </span><span class="cited-content_cbyCitation_article-title">Novel triazolo-pyrrolopyridines as inhibitors of Janus kinase 1. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (12)
                                     , 3592-3598. <a href="https://doi.org/10.1016/j.bmcl.2013.04.018" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.04.018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.04.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.04.018%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DNovel%252Btriazolo-pyrrolopyridines%252Bas%252Binhibitors%252Bof%252BJanus%252Bkinase%252B1%26aulast%3DHurley%26aufirst%3DChristopher%2BA.%26date%3D2013%26volume%3D23%26issue%3D12%26spage%3D3592%26epage%3D3598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stacy  Van Epps</span>, <span class="hlFld-ContribAuthor ">Bryan  Fiamengo</span>, <span class="hlFld-ContribAuthor ">Jeremy  Edmunds</span>, <span class="hlFld-ContribAuthor ">Anna  Ericsson</span>, <span class="hlFld-ContribAuthor ">Kristine  Frank</span>, <span class="hlFld-ContribAuthor ">Michael  Friedman</span>, <span class="hlFld-ContribAuthor ">Dawn  George</span>, <span class="hlFld-ContribAuthor ">Jonathan  George</span>, <span class="hlFld-ContribAuthor ">Eric  Goedken</span>, <span class="hlFld-ContribAuthor ">Brian  Kotecki</span>, <span class="hlFld-ContribAuthor ">Gloria  Martinez</span>, <span class="hlFld-ContribAuthor ">Philip  Merta</span>, <span class="hlFld-ContribAuthor ">Michael  Morytko</span>, <span class="hlFld-ContribAuthor ">Shashank  Shekhar</span>, <span class="hlFld-ContribAuthor ">Barbara  Skinner</span>, <span class="hlFld-ContribAuthor ">Kent  Stewart</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Voss</span>, <span class="hlFld-ContribAuthor ">Grier  Wallace</span>, <span class="hlFld-ContribAuthor ">Lu  Wang</span>, <span class="hlFld-ContribAuthor ">Lu  Wang</span>, <span class="hlFld-ContribAuthor ">Neil  Wishart</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of tricyclic cores for kinase inhibition. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (3)
                                     , 693-698. <a href="https://doi.org/10.1016/j.bmcl.2012.11.108" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.11.108</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.11.108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.11.108%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Btricyclic%252Bcores%252Bfor%252Bkinase%252Binhibition%26aulast%3DVan%2BEpps%26aufirst%3DStacy%26date%3D2013%26volume%3D23%26issue%3D3%26spage%3D693%26epage%3D698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christel J.  Menet</span>, <span class="hlFld-ContribAuthor ">Luc Van  Rompaey</span>, <span class="hlFld-ContribAuthor ">Raphaël  Geney</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in the Discovery of Selective JAK Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 153-223. <a href="https://doi.org/10.1016/B978-0-444-62652-3.00004-1" title="DOI URL">https://doi.org/10.1016/B978-0-444-62652-3.00004-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-444-62652-3.00004-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-444-62652-3.00004-1%26sid%3Dliteratum%253Aachs%26atitle%3DAdvances%252Bin%252Bthe%252BDiscovery%252Bof%252BSelective%252BJAK%252BInhibitors%26aulast%3DMenet%26aufirst%3DChristel%2BJ.%26date%3D2013%26spage%3D153%26epage%3D223%26pub%3DElsevier%26date%3D2013%26volume%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sharada  Labadie</span>, <span class="hlFld-ContribAuthor ">Peter S.  Dragovich</span>, <span class="hlFld-ContribAuthor ">Kathy  Barrett</span>, <span class="hlFld-ContribAuthor ">Wade S.  Blair</span>, <span class="hlFld-ContribAuthor ">Philippe  Bergeron</span>, <span class="hlFld-ContribAuthor ">Christine  Chang</span>, <span class="hlFld-ContribAuthor ">Gauri  Deshmukh</span>, <span class="hlFld-ContribAuthor ">Charles  Eigenbrot</span>, <span class="hlFld-ContribAuthor ">Nico  Ghilardi</span>, <span class="hlFld-ContribAuthor ">Paul  Gibbons</span>, <span class="hlFld-ContribAuthor ">Christopher A.  Hurley</span>, <span class="hlFld-ContribAuthor ">Adam  Johnson</span>, <span class="hlFld-ContribAuthor ">Jane R.  Kenny</span>, <span class="hlFld-ContribAuthor ">Pawan Bir  Kohli</span>, <span class="hlFld-ContribAuthor ">Janusz J.  Kulagowski</span>, <span class="hlFld-ContribAuthor ">Marya  Liimatta</span>, <span class="hlFld-ContribAuthor ">Patrick J.  Lupardus</span>, <span class="hlFld-ContribAuthor ">Rohan  Mendonca</span>, <span class="hlFld-ContribAuthor ">Jeremy M.  Murray</span>, <span class="hlFld-ContribAuthor ">Rebecca  Pulk</span>, <span class="hlFld-ContribAuthor ">Steven  Shia</span>, <span class="hlFld-ContribAuthor ">Micah  Steffek</span>, <span class="hlFld-ContribAuthor ">Savita  Ubhayakar</span>, <span class="hlFld-ContribAuthor ">Mark  Ultsch</span>, <span class="hlFld-ContribAuthor ">Anne  van Abbema</span>, <span class="hlFld-ContribAuthor ">Stuart  Ward</span>, <span class="hlFld-ContribAuthor ">Mark  Zak</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based discovery of C-2 substituted imidazo-pyrrolopyridine JAK1 inhibitors with improved selectivity over JAK2. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (24)
                                     , 7627-7633. <a href="https://doi.org/10.1016/j.bmcl.2012.10.008" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.10.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.10.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.10.008%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructure-based%252Bdiscovery%252Bof%252BC-2%252Bsubstituted%252Bimidazo-pyrrolopyridine%252BJAK1%252Binhibitors%252Bwith%252Bimproved%252Bselectivity%252Bover%252BJAK2%26aulast%3DLabadie%26aufirst%3DSharada%26date%3D2012%26volume%3D22%26issue%3D24%26spage%3D7627%26epage%3D7633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ellen  Pfaffenrot</span>, <span class="hlFld-ContribAuthor ">Dieter  Schollmeyer</span>, <span class="hlFld-ContribAuthor ">Stefan  Laufer</span>. </span><span class="cited-content_cbyCitation_article-title">1-[(3
              RS
              ,4
              RS
              )-1-Benzyl-4-methylpiperidin-3-yl]-1,6-dihydroimidazo[4,5-
              d
              ]pyrrolo[2,3-
              b
              ]pyridine hemihydrate. </span><span class="cited-content_cbyCitation_journal-name">Acta Crystallographica Section E Structure Reports Online</span><span> <strong>2012,</strong> <em>68 </em>
                                    (10)
                                     , o3052-o3052. <a href="https://doi.org/10.1107/S1600536812039980" title="DOI URL">https://doi.org/10.1107/S1600536812039980</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1107/S1600536812039980&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1107%2FS1600536812039980%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Crystallographica%2520Section%2520E%2520Structure%2520Reports%2520Online%26atitle%3D1-%25255B%2525283%252BRS%252B%25252C4%252BRS%252B%252529-1-Benzyl-4-methylpiperidin-3-yl%25255D-1%25252C6-dihydroimidazo%25255B4%25252C5-%252Bd%252B%25255Dpyrrolo%25255B2%25252C3-%252Bb%252B%25255Dpyridine%252Bhemihydrate%26aulast%3DPfaffenrot%26aufirst%3DEllen%26date%3D2012%26date%3D2012%26volume%3D68%26issue%3D10%26spage%3Do3052%26epage%3Do3052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter  Norman</span>. </span><span class="cited-content_cbyCitation_article-title">Selective JAK1 inhibitor and selective Tyk2 inhibitor patents. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2012,</strong> <em>22 </em>
                                    (10)
                                     , 1233-1249. <a href="https://doi.org/10.1517/13543776.2012.723693" title="DOI URL">https://doi.org/10.1517/13543776.2012.723693</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2012.723693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2012.723693%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DSelective%252BJAK1%252Binhibitor%252Band%252Bselective%252BTyk2%252Binhibitor%252Bpatents%26aulast%3DNorman%26aufirst%3DPeter%26date%3D2012%26date%3D2012%26volume%3D22%26issue%3D10%26spage%3D1233%26epage%3D1249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter  Norman</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluation of WO2012037132 – a novel scaffold for selective JAK1 inhibition. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2012,</strong> <em>22 </em>
                                    (9)
                                     , 1105-1109. <a href="https://doi.org/10.1517/13543776.2012.707647" title="DOI URL">https://doi.org/10.1517/13543776.2012.707647</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2012.707647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2012.707647%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DEvaluation%252Bof%252BWO2012037132%252B%2525E2%252580%252593%252Ba%252Bnovel%252Bscaffold%252Bfor%252Bselective%252BJAK1%252Binhibition%26aulast%3DNorman%26aufirst%3DPeter%26date%3D2012%26date%3D2012%26volume%3D22%26issue%3D9%26spage%3D1105%26epage%3D1109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/medium/jm-2012-00438j_0026.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/large/jm-2012-00438j_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300438j&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/medium/jm-2012-00438j_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/large/jm-2012-00438j_0002.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. JAK inhibitors in advanced clinical evaluation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/large/jm-2012-00438j_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300438j&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/medium/jm-2012-00438j_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/large/jm-2012-00438j_0003.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Generation of tricyclic inhibitor scaffold <b>3</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/large/jm-2012-00438j_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300438j&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/medium/jm-2012-00438j_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/large/jm-2012-00438j_0004.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Synthetic precursor to <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/large/jm-2012-00438j_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300438j&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/medium/jm-2012-00438j_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/large/jm-2012-00438j_0013.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Comparison of the X-ray structures of <b>1</b> complexed with JAK1 (white carbon atoms; PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3EYG">3EYG</a><a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a>) and JAK2 (cyan carbon atoms; PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3FUP">3FUP</a>), showing the conserved binding mode of the ligand and the overall similarity in tertiary structure of the JAK isoforms. The phosphate-binding loop (P-loop), activation loop (A-loop), and hinge region are labeled. Residue differences between JAK1 and JAK2 that are located close to the ATP-binding site are shown in thin stick format. Residue numbers refer to JAK1. Figure was generated with Pymol.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/large/jm-2012-00438j_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300438j&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/medium/jm-2012-00438j_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/large/jm-2012-00438j_0014.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Comparison of the X-ray structures of <b>1</b> complexed with JAK1 (white carbon atoms; PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3EYG">3EYG</a><a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a>) and <b>7</b> complexed with a JAK2 triple mutant (green carbon atoms) showing the conserved binding mode. The phosphate-binding loop (P-loop), activation loop (A-loop), and hinge region are labeled. Residue numbers refer to JAK1. Figure generated with Pymol.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/large/jm-2012-00438j_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300438j&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/medium/jm-2012-00438j_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/large/jm-2012-00438j_0015.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Comparison of the X-ray structures of <b>7</b> (green carbon atoms) and <b>12</b> (orange carbon atoms), both complexed with a JAK2 triple mutant, highlighting movement of the P-loop to accommodate the benzyl substituent of <b>12</b>. Residue labels refer to JAK1 numbering.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/large/jm-2012-00438j_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300438j&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/medium/jm-2012-00438j_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/large/jm-2012-00438j_0016.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Electrostatic potential representations for the X-ray structure of <b>26</b> bound to JAK1 (left) and an <i>in silico</i> model of <b>26</b> bound to a JAK1-E883K mutant (right). Ligands are displayed in stick format with green carbon atoms. Surfaces colored by electrostatic potential from red (negative) to blue (positive). A similar orientation of each protein is shown. Surfaces and images were generated with Pymol’s protein contact potential algorithm which approximates the potential that would be felt by a point-charge one solvent radius above the protein surface (Schrödinger, Inc.).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/large/jm-2012-00438j_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300438j&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/medium/jm-2012-00438j_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/large/jm-2012-00438j_0017.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Comparison of the X-ray structures of <b>12</b> in JAK2 triple mutant (orange carbon atoms) and <b>30</b> in JAK1 (white carbon atoms), highlighting different piperidine rotamers due to 4-methylation in <b>30</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/large/jm-2012-00438j_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300438j&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/medium/jm-2012-00438j_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/large/jm-2012-00438j_0018.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Comparison of the X-ray structures of <b>30</b> bound to JAK1 (white carbon atoms) and JAK2 (cyan carbon atoms), highlighting a shift in the binding mode and significant movement of the P-loop.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/large/jm-2012-00438j_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300438j&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/medium/jm-2012-00438j_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/large/jm-2012-00438j_0019.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Comparison of the X-ray structures of <b>7</b> bound to JAK2 triple mutant (green carbon atoms) and <b>49</b> bound to JAK1 (white carbon atoms) to demonstrate the different vectors adopted by the substituents on the 3-piperidinyl and cyclopentyl rings, respectively. A potential hydrogen bond is highlighted between <b>49</b> and D1021 (yellow dotted line).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/large/jm-2012-00438j_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300438j&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/medium/jm-2012-00438j_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/large/jm-2012-00438j_0020.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Preparation of Heterocycloamine Derivatives of <b>3</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/large/jm-2012-00438j_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300438j&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) PhSO<sub>2</sub>Cl, DMAP (cat.), NEt<sub>3</sub>, DCM, rt, overnight, 83%; (ii) <i>n</i>-Bu<sub>4</sub>N<sup>+</sup>NO<sub>3</sub><sup>–</sup>, TFAA, DCM, −5 °C-rt, overnight, 79%; (iii) R′NH<sub>2</sub>, EtN(<i>i</i>-Pr)<sub>2</sub>, <i>i</i>-PrOH, 120 °C in microwave, 11–20 min, 80–100%; (iv) Fe, NH<sub>4</sub>Cl, EtOH, H<sub>2</sub>O, reflux, 70–99%; (v) (EtO)<sub>3</sub>CH, <i>p</i>-TsOH (cat.), PhMe, reflux, 18 h, 81–100%; (vi) NaOH, MeOH, H<sub>2</sub>O, rt, 7 h, 72–98%; (vii) Pd(OH)<sub>2</sub> on C, NH<sub>4</sub>HCO<sub>2</sub>, MeOH, reflux; (viii) NCCH<sub>2</sub>CO<sub>2</sub>H, HOBT, DMAP, EDCl, DCM, rt, 24 h, 11–48% 2 steps; (ix) Pd on C, H<sub>2</sub>, THF; (x) TFA, DCM, 94%, then PhCHO, Na(OAc)<sub>3</sub>BH, AcOH, DCE, MeOH, rt, 91%.</p></p></figure><figure data-id="sch2" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/medium/jm-2012-00438j_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/large/jm-2012-00438j_0021.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Preparation of 4-Piperidinyl Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/large/jm-2012-00438j_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300438j&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) Pd(OH)<sub>2</sub> on C, NH<sub>4</sub>HCO<sub>2</sub>, MeOH, reflux, 52%; (ii) Na(OAc)<sub>3</sub>BH, AcOH, DCE, MeOH, rt, 57–68%; (iii) <b>15</b>, <b>16</b>, X = OH HOBT, DMAP, EDCl, DCM, rt, 32–57%; <b>17</b>, X = Cl NEt<sub>3</sub>, DCM, rt, 52%; <b>23</b>, <b>25</b>–<b>27</b>, X = OH HATU, EtN(<i>i</i>-Pr)<sub>2</sub>, DMF; <b>24</b>, then TFA, DCM, then HCHO, Na(OAc)<sub>3</sub>BH, AcOH, DCE; (iv) EtN(<i>i</i>-Pr)<sub>2</sub>, DMF, THF, 13–18%; (v) NEt<sub>3</sub>, DCM, DMF, rt, 46%; (vi) EtOH, reflux, 87%.</p></p></figure><figure data-id="sch3" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/medium/jm-2012-00438j_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/large/jm-2012-00438j_0022.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Preparation of 4-Methyl Piperidinyl Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/large/jm-2012-00438j_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300438j&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) Ph<sub>2</sub>P(O)N<sub>3</sub>, NEt<sub>3</sub>, PhCH<sub>2</sub>OH, PhMe, reflux; (ii) Pd on C, H<sub>2</sub>, EtOH, 47% 2 steps; (iii) <b>52</b>, EtN(<i>i</i>-Pr)<sub>2</sub>, <i>i</i>-PrOH, reflux, 65 h, 79%; (iv) Fe, NH<sub>4</sub>Cl, MeOH, H<sub>2</sub>O, reflux, 84%; (v) (EtO)<sub>3</sub>CH, <i>p</i>-TsOH (cat.), PhMe, reflux, 86%; (vi) NaOH, MeOH, H<sub>2</sub>O, rt, 98%; (vii) TFA, DCM, rt, 98%; (viii) pyrimidine-5-carboxaldehyde, Na(OAc)<sub>3</sub>BH, AcOH, mol. sieves, DCE, rt, 47%; (ix) MeSO<sub>2</sub>Cl, NEt<sub>3</sub>, DCM, rt, 58%; (x) TfOCH<sub>2</sub>CF<sub>3</sub>, NEt<sub>3</sub>, DCM, DMF, rt, 87%; (xi) acrylonitrile, EtOH, reflux, 57%.</p></p></figure><figure data-id="sch4" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/medium/jm-2012-00438j_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/large/jm-2012-00438j_0023.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Preparation of 4-Cyclohexylamine Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/large/jm-2012-00438j_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300438j&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) <b>52</b>, EtN(<i>i</i>-Pr)<sub>2</sub>, <i>i</i>-PrOH, reflux, 1 h, 80%; (ii) Fe, NH<sub>4</sub>Cl, MeOH, H<sub>2</sub>O, reflux, 80%; (iii) (EtO)<sub>3</sub>CH, <i>p</i>-TsOH (cat.), PhMe, reflux, 88%; (iv) NaOH, MeOH, THF, rt, 81%; (v) TFA, DCM, rt, 1 h, 95%; (vi) <b>62</b>, <i>iso</i>butyryl chloride, EtN(<i>i</i>-Pr)<sub>2</sub>, DMAP, DCM, rt, then NaOH, MeOH, rt, 30%; (vii) <b>62</b>, cyclopropylcarboxaldehyde, Na(OAc)<sub>3</sub>BH, MeOH, rt, then NaOH, MeOH, rt, 44%; (viii) <b>35</b>, acrylonitrile, EtOH, reflux, 36%; (ix) <b>35</b>, 3-cyanobenzaldehyde, Na(OAc)<sub>3</sub>BH, AcOH, mol. sieves, DCE, rt, 24%; (x) <b>35</b>, MeSO<sub>2</sub>Cl, NEt<sub>3</sub>, DCM, rt, 38%; (xi) <b>62</b>, 4-nitrophenyl chloroformate, pyridine,0 °C, then NaOMe, MeOH, 100 °C in microwave, 10 min, 24%; (xii) <b>62</b>, Ac<sub>2</sub>O, HCO<sub>2</sub>H, THF, then BH<sub>3</sub>-THF, THF, 80 °C 86%; (xiii) methyl chloroformate, EtN(<i>i</i>-Pr)<sub>2</sub>, DCM, then NaOH, THF, MeOH, H<sub>2</sub>O, rt, 55%.</p></p></figure><figure data-id="sch5" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/medium/jm-2012-00438j_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/large/jm-2012-00438j_0024.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Preparation of Morpholine Derivatives <b>37</b> and <b>38</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/large/jm-2012-00438j_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300438j&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) <b>52</b>, EtN(<i>i</i>-Pr)<sub>2</sub>, <i>i</i>-PrOH, reflux, 2 h, quant.; (ii) Fe, NH<sub>4</sub>Cl, EtOH, H<sub>2</sub>O, reflux, 2 h, 52%; (iii) (EtO)<sub>3</sub>CH, AcOH, 110 °C, 0. 25 h, then rt, 82%; (iv) Dess–Martin periodinane, DCM, 0 °C-rt, 89%; (v) morpholine, Na(OAc)<sub>3</sub>BH, AcOH, THF, rt, 20 h, then chromatographic separation, <i>trans</i>: 19%, <i>cis</i>: 23%; (vi) NaOH, MeOH, H<sub>2</sub>O, <i>trans</i>, 67%.</p></p></figure><figure data-id="sch6" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/medium/jm-2012-00438j_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/large/jm-2012-00438j_0025.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Preparation of Cyclopentylamine Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-12/jm300438j/production/images/large/jm-2012-00438j_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300438j&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) Pd on C, H<sub>2</sub>, EtOH, 97%; (ii) Raney Ni, H<sub>2</sub>, EtOH, 75%; (iii) diisopropyl azodicarboxylate, PPh<sub>3</sub>, AcOH, THF, 0 °C-rt, then NaOH, MeOH, THF, H<sub>2</sub>O, rt, 76% 2 steps; (iv) MsCl, Et<sub>3</sub>N, acetone, 0 °C, 98%; (v) NaN<sub>3</sub>, DMF, H<sub>2</sub>O, 100 °C, 77–97%; (vi) PPh<sub>3</sub>, THF, H<sub>2</sub>O, 55 °C, 87–91%; (vii) <b>52</b>, EtN(<i>i</i>-Pr)<sub>2</sub>, <i>i</i>-PrOH, 120 °C in microwave, 10 min, 87%-quant. ; (viii) Fe, NH<sub>4</sub>Cl, EtOH, H<sub>2</sub>O, reflux, 70%; (ix) (EtO)<sub>3</sub>CH, <i>p</i>-TsOH (cat.), PhMe, reflux, 77%; (x) TFA, DCM, rt, 86%; (xi) MeO<sub>2</sub>CCl, EtN(<i>i</i>-Pr)<sub>2</sub>, DCM, quant.; (xii) NaOH, THF, MeOH, H<sub>2</sub>O, 89%; (xiii) SFC resolution.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i70">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55848" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55848" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 47 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Song, L.; Schindler, C.</span><span> </span><span class="NLM_article-title">JAK-STAT Signalling</span>. In  <span class="citation_source-book">The Handbook of Cell Signalling</span>. <span class="NLM_edition">2</span>nd ed.; <span class="NLM_contrib-group">Bradshaw, R. A., Dennis, E. A.</span>, Eds.; <span class="NLM_publisher-name">Elsevier Inc.</span>: <span class="NLM_publisher-loc">San Diego, CA</span>,<span class="NLM_x"> </span><span class="NLM_year">2010</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">3</span>, pp  <span class="NLM_fpage">2041</span><span class="NLM_x">–</span> <span class="NLM_lpage">2048</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Fjm300438j&amp;key=10.1016%2FB978-0-12-374145-5.00249-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&pages=2041-2048&author=L.+Song&author=C.+Schindlerauthor=R.+A.+Bradshaw&author=E.+A.+Dennis&title=The+Handbook+of+Cell+Signalling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-374145-5.00249-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-0-12-374145-5.00249-7%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DL.%26atitle%3DJAK-STAT%2520Signalling%26btitle%3DThe%2520Handbook%2520of%2520Cell%2520Signalling%26aulast%3DBradshaw%26aufirst%3DR.%2BA.%26pub%3DElsevier%2520Inc%26date%3D2010%26volume%3D3%26spage%3D2041%26epage%3D2048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Shuai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, B.</span><span> </span><span class="NLM_article-title">Regulation of JAK-STAT Signalling in the Immune System</span> <span class="citation_source-journal">Nat. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">900</span><span class="NLM_x">–</span> <span class="NLM_lpage">911</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Fjm300438j&amp;key=10.1038%2Fnri1226" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Fjm300438j&amp;key=14668806" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Fjm300438j&amp;key=1%3ACAS%3A528%3ADC%252BD3sXptFCltbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=900-911&author=K.+Shuaiauthor=B.+Liu&title=Regulation+of+JAK-STAT+Signalling+in+the+Immune+System"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of JAK-STAT signalling in the immune system</span></div><div class="casAuthors">Shuai, Ke; Liu, Bin</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">900-911</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The cytokine-activated Janus kinase (JAK)-signal transducer and activator of transcription (STAT) pathway has an important role in the control of immune responses.  Dysregulation of JAK-STAT signalling is assocd. with various immune disorders.  The signalling strength kinetics and specificity of the JAK-STAT pathway are modulated at many levels by distinct regulatory proteins.  Here, we review recent studies on the regulation of the JAK-STAT pathway that will enhance our ability to design rational therapeutic strategies for immune diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDG-MzyqAi4bVg90H21EOLACvtfcHk0lgqiaRQR0xCVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXptFCltbc%253D&md5=cb04239e0d430052a975e930c656e31d</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1038%2Fnri1226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri1226%26sid%3Dliteratum%253Aachs%26aulast%3DShuai%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DB.%26atitle%3DRegulation%2520of%2520JAK-STAT%2520Signalling%2520in%2520the%2520Immune%2520System%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2003%26volume%3D3%26spage%3D900%26epage%3D911" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Ghoreschi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laurence, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Shea, J. J.</span><span> </span><span class="NLM_article-title">Janus Kinases in Immune Cell Signalling</span> <span class="citation_source-journal">Immunol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">228</span><span class="NLM_x">, </span> <span class="NLM_fpage">273</span><span class="NLM_x">–</span> <span class="NLM_lpage">287</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=16&amp;doi=10.1021%2Fjm300438j&amp;key=10.1111%2Fj.1600-065X.2008.00754.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=8&amp;doi=10.1021%2Fjm300438j&amp;key=19290934" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=32&amp;doi=10.1021%2Fjm300438j&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGls7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=228&publication_year=2009&pages=273-287&author=K.+Ghoreschiauthor=A.+Laurenceauthor=J.+J.+O%E2%80%99Shea&title=Janus+Kinases+in+Immune+Cell+Signalling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1cR"><div class="casContent"><span class="casTitleNuber">1c</span><div class="casTitle"><span class="NLM_cas:atitle">Janus kinases in immune cell signaling</span></div><div class="casAuthors">Ghoreschi, Kamran; Laurence, Arian; O'Shea, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">228</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">273-287</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">1600-065X</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  The Janus family kinases (Jaks), Jak1, Jak2, Jak3, and Tyk2, form one subgroup of the non-receptor protein tyrosine kinases.  They are involved in cell growth, survival, development, and differentiation of a variety of cells but are critically important for immune cells and hematopoietic cells.  Data from exptl. mice and clin. observations have unraveled multiple signaling events mediated by Jaks in innate and adaptive immunity.  Deficiency of Jak3 or Tyk2 results in defined clin. disorders, which are also evident in mouse models.  A striking phenotype assocd. with inactivating Jak3 mutations is severe combined immunodeficiency syndrome, whereas mutation of Tyk2 results in another primary immunodeficiency termed autosomal recessive hyperimmunoglobulin E syndrome.  By contrast, complete deletion of Jak1 or Jak2 in the mouse are not compatible with life and, unsurprisingly, do not have counterparts in human disease.  However, activating mutations of each of the Jaks are found in assocn. with malignant transformation, the most common being gain-of-function mutations of Jak2 in polycythemia vera and other myeloproliferative disorders.  Our existing knowledge on Jak signaling pathways and fundamental work on their biochem. structure and intracellular interactions allow us to develop new strategies for controlling autoimmune diseases or malignancies by developing selective Jak inhibitors, which are now coming into clin. use.  Despite the fact that Jaks were discovered only a little more than a decade ago, at the time of writing there are 20 clin. trials underway testing the safely and efficacy of Jak inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp23ncK0nYqpbVg90H21EOLACvtfcHk0lgqiaRQR0xCVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGls7vJ&md5=adc282a9ad381ee18abe57a82c921f65</span></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-065X.2008.00754.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-065X.2008.00754.x%26sid%3Dliteratum%253Aachs%26aulast%3DGhoreschi%26aufirst%3DK.%26aulast%3DLaurence%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26atitle%3DJanus%2520Kinases%2520in%2520Immune%2520Cell%2520Signalling%26jtitle%3DImmunol.%2520Rev.%26date%3D2009%26volume%3D228%26spage%3D273%26epage%3D287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Levy, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darnell, J. E.,  Jr.</span><span> </span><span class="NLM_article-title">STATS: Transcriptional Control and Biological Impact</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">651</span><span class="NLM_x">–</span> <span class="NLM_lpage">662</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Fjm300438j&amp;key=10.1038%2Fnrm909" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Fjm300438j&amp;key=12209125" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Fjm300438j&amp;key=1%3ACAS%3A528%3ADC%252BD38Xmslansrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2002&pages=651-662&author=D.+E.+Levyauthor=J.+E.+Darnell&title=STATS%3A+Transcriptional+Control+and+Biological+Impact"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Stats: transcriptional control and biological impact</span></div><div class="casAuthors">Levy, David E.; Darnell, J. E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">651-662</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Extracellular proteins bound to cell-surface receptors can change nuclear gene expression patterns in minutes, with far-reaching consequences for development, cell growth, and homeostasis.  The signal transducer and activator of transcription (STAT) proteins are among the most well studied of the latent cytoplasmic signal-dependent transcription factor pathways.  In addn. to several roles in normal cell decisions, dysregulation of STAT function contributes to human disease, making the study of these proteins an important topic of current research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGqYF32j262LVg90H21EOLACvtfcHk0liiaueeL4h0iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xmslansrw%253D&md5=4a04359c59e54b12d8a67efb6ef42e4c</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1038%2Fnrm909&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm909%26sid%3Dliteratum%253Aachs%26aulast%3DLevy%26aufirst%3DD.%2BE.%26aulast%3DDarnell%26aufirst%3DJ.%2BE.%26atitle%3DSTATS%253A%2520Transcriptional%2520Control%2520and%2520Biological%2520Impact%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2002%26volume%3D3%26spage%3D651%26epage%3D662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kisseleva, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braunstein, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schindler, C. W.</span><span> </span><span class="NLM_article-title">Signalling Through the JAK/STAT Pathway, Recent Advances and Future Challenges</span> <span class="citation_source-journal">Gene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2002&pages=1-24&author=T.+Kisselevaauthor=S.+Bhattacharyaauthor=J.+Braunsteinauthor=C.+W.+Schindler&title=Signalling+Through+the+JAK%2FSTAT+Pathway%2C+Recent+Advances+and+Future+Challenges"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKisseleva%26aufirst%3DT.%26aulast%3DBhattacharya%26aufirst%3DS.%26aulast%3DBraunstein%26aufirst%3DJ.%26aulast%3DSchindler%26aufirst%3DC.%2BW.%26atitle%3DSignalling%2520Through%2520the%2520JAK%252FSTAT%2520Pathway%252C%2520Recent%2520Advances%2520and%2520Future%2520Challenges%26jtitle%3DGene%26date%3D2002%26volume%3D285%26spage%3D1%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Schindler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, T.</span><span> </span><span class="NLM_article-title">JAK-STAT Signaling: From Interferons to Cytokines</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">20059</span><span class="NLM_x">–</span> <span class="NLM_lpage">20063</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=20059-20063&author=C.+Schindlerauthor=D.+E.+Levyauthor=T.+Decker&title=JAK-STAT+Signaling%3A+From+Interferons+to+Cytokines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchindler%26aufirst%3DC.%26aulast%3DLevy%26aufirst%3DD.%2BE.%26aulast%3DDecker%26aufirst%3DT.%26atitle%3DJAK-STAT%2520Signaling%253A%2520From%2520Interferons%2520to%2520Cytokines%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D20059%26epage%3D20063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Quintas-Cardama, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kantarjian, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verstovsek, S.</span><span> </span><span class="NLM_article-title">Janus Kinase Inhibitors for the Treatment of Myeloproliferative Neoplasias and Beyond</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">140</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=127-140&author=A.+Quintas-Cardamaauthor=H.+Kantarjianauthor=J.+Cortesauthor=S.+Verstovsek&title=Janus+Kinase+Inhibitors+for+the+Treatment+of+Myeloproliferative+Neoplasias+and+Beyond"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DQuintas-Cardama%26aufirst%3DA.%26aulast%3DKantarjian%26aufirst%3DH.%26aulast%3DCortes%26aufirst%3DJ.%26aulast%3DVerstovsek%26aufirst%3DS.%26atitle%3DJanus%2520Kinase%2520Inhibitors%2520for%2520the%2520Treatment%2520of%2520Myeloproliferative%2520Neoplasias%2520and%2520Beyond%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D127%26epage%3D140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Watford, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Shea, J. J.</span><span> </span><span class="NLM_article-title">Human TYK2 Kinase Deficiency: Another Primary Immunodeficiency Syndrome</span> <span class="citation_source-journal">Immunity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">695</span><span class="NLM_x">–</span> <span class="NLM_lpage">697</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=695-697&author=W.+T.+Watfordauthor=J.+J.+O%E2%80%99Shea&title=Human+TYK2+Kinase+Deficiency%3A+Another+Primary+Immunodeficiency+Syndrome"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWatford%26aufirst%3DW.%2BT.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26atitle%3DHuman%2520TYK2%2520Kinase%2520Deficiency%253A%2520Another%2520Primary%2520Immunodeficiency%2520Syndrome%26jtitle%3DImmunity%26date%3D2006%26volume%3D25%26spage%3D695%26epage%3D697" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">O’Shea, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gadina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, R. D.</span><span> </span><span class="NLM_article-title">Cytokine Signaling in 2002: New Surprises in the Jak/Stat Pathway</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl.</span><span class="NLM_x">) </span> <span class="NLM_fpage">S121</span><span class="NLM_x">–</span> <span class="NLM_lpage">S131</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2002&pages=S121-S131&issue=Suppl.&author=J.+J.+O%E2%80%99Sheaauthor=M.+Gadinaauthor=R.+D.+Schreiber&title=Cytokine+Signaling+in+2002%3A+New+Surprises+in+the+Jak%2FStat+Pathway"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26aulast%3DGadina%26aufirst%3DM.%26aulast%3DSchreiber%26aufirst%3DR.%2BD.%26atitle%3DCytokine%2520Signaling%2520in%25202002%253A%2520New%2520Surprises%2520in%2520the%2520Jak%252FStat%2520Pathway%26jtitle%3DCell%26date%3D2002%26volume%3D109%26issue%3DSuppl%26spage%3DS121%26epage%3DS131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">O’Shea, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borie, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Changelian, P. S.</span><span> </span><span class="NLM_article-title">A New Modality for Immunosuppression: Targeting the JAK/STAT Pathway</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">555</span><span class="NLM_x">–</span> <span class="NLM_lpage">564</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=555-564&author=J.+J.+O%E2%80%99Sheaauthor=M.+Pesuauthor=D.+C.+Borieauthor=P.+S.+Changelian&title=A+New+Modality+for+Immunosuppression%3A+Targeting+the+JAK%2FSTAT+Pathway"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26aulast%3DPesu%26aufirst%3DM.%26aulast%3DBorie%26aufirst%3DD.%2BC.%26aulast%3DChangelian%26aufirst%3DP.%2BS.%26atitle%3DA%2520New%2520Modality%2520for%2520Immunosuppression%253A%2520Targeting%2520the%2520JAK%252FSTAT%2520Pathway%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D555%26epage%3D564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wrobleski, S. T.; Pitts, W. J.</span><span> </span><span class="NLM_article-title">Advances in the Discovery of Small Molecule JAK3 Inhibitors</span>. In  <span class="citation_source-book">Annual Reports in Medicinal Chemistry</span>; <span class="NLM_contrib-group">Macor, J. E.</span>, Ed.: <span class="NLM_publisher-name">Elsevier Inc.</span>: <span class="NLM_publisher-loc">San Diego</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">44</span>, Chapter 12, pp  <span class="NLM_fpage">247</span><span class="NLM_x">–</span> <span class="NLM_lpage">264</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=247-264&author=S.+T.+Wrobleski&author=W.+J.+Pittsauthor=J.+E.+Macor&title=Annual+Reports+in+Medicinal+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DWrobleski%26aufirst%3DS.%2BT.%26atitle%3DAdvances%2520in%2520the%2520Discovery%2520of%2520Small%2520Molecule%2520JAK3%2520Inhibitors%26btitle%3DAnnual%2520Reports%2520in%2520Medicinal%2520Chemistry%26aulast%3DMacor%26aufirst%3DJ.%2BE.%26pub%3DElsevier%2520Inc%26date%3D2009%26volume%3D44%26spage%3D247%26epage%3D264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Changelian, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flanagan, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ball, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kent, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnuson, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzuti, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brissette, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCurdy, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudlacz, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conklyn, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koslov, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strelevitz, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whipple, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munchhof, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doty, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casavant, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blumenkopf, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hines, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lillie, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subramanyam, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shang-Poa, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milici, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beckius, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodworth, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaweco, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beals, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Littman, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zagouras, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magna, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saltarelli, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelms, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Des Etages, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawabata, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finco-Kent, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Si, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paniagua, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holm, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reitz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Shea, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borie, D. C.</span><span> </span><span class="NLM_article-title">Prevention of Organ Allograft Rejection by a Specific Janus Kinase 3 Inhibitor</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">302</span><span class="NLM_x">, </span> <span class="NLM_fpage">875</span><span class="NLM_x">–</span> <span class="NLM_lpage">878</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Fjm300438j&amp;key=10.1126%2Fscience.1087061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=8&amp;doi=10.1021%2Fjm300438j&amp;key=14593182" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Fjm300438j&amp;key=1%3ACAS%3A528%3ADC%252BD3sXos1Cmtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=302&publication_year=2003&pages=875-878&author=P.+S.+Changelianauthor=M.+E.+Flanaganauthor=D.+J.+Ballauthor=C.+R.+Kentauthor=K.+S.+Magnusonauthor=W.+H.+Martinauthor=B.+J.+Rizzutiauthor=P.+S.+Sawyerauthor=B.+D.+Perryauthor=W.+H.+Brissetteauthor=S.+P.+McCurdyauthor=E.+M.+Kudlaczauthor=M.+J.+Conklynauthor=E.+A.+Elliottauthor=E.+R.+Koslovauthor=M.+B.+Fisherauthor=T.+J.+Strelevitzauthor=K.+Yoonauthor=D.+A.+Whippleauthor=J.+Sunauthor=M.+J.+Munchhofauthor=J.+L.+Dotyauthor=J.+M.+Casavantauthor=T.+A.+Blumenkopfauthor=M.+Hinesauthor=M.+F.+Brownauthor=B.+M.+Lillieauthor=C.+Subramanyamauthor=C.+Shang-Poaauthor=A.+J.+Miliciauthor=G.+E.+Beckiusauthor=J.+D.+Moyerauthor=C.+Suauthor=T.+G.+Woodworthauthor=A.+S.+Gawecoauthor=C.+R.+Bealsauthor=B.+H.+Littmanauthor=D.+A.+Fisherauthor=J.+F.+Smithauthor=P.+Zagourasauthor=H.+A.+Magnaauthor=M.+J.+Saltarelliauthor=K.+S.+Johnsonauthor=L.+F.+Nelmsauthor=S.+G.+Des+Etagesauthor=L.+S.+Hayesauthor=T.+T.+Kawabataauthor=D.+Finco-Kentauthor=D.+L.+Bakerauthor=M.+Larsonauthor=M.+S.+Siauthor=R.+Paniaguaauthor=J.+Higginsauthor=B.+Holmauthor=B.+Reitzauthor=Y.+J.+Zhouauthor=R.+E.+Morrisauthor=J.+J.+O%E2%80%99Sheaauthor=D.+C.+Borie&title=Prevention+of+Organ+Allograft+Rejection+by+a+Specific+Janus+Kinase+3+Inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">Prevention of Organ Allograft Rejection by a Specific Janus Kinase 3 Inhibitor</span></div><div class="casAuthors">Changelian, Paul S.; Flanagan, Mark E.; Ball, Douglas J.; Kent, Craig R.; Magnuson, Kelly S.; Martin, William H.; Rizzuti, Bonnie J.; Sawyer, Perry S.; Perry, Bret D.; Brissette, William H.; McCurdy, Sandra P.; Kudlacz, Elizabeth M.; Conklyn, Maryrose J.; Elliott, Eileen A.; Koslov, Erika R.; Fisher, Michael B.; Strelevitz, Timothy J.; Yoon, Kwansik; Whipple, David A.; Sun, Jianmin; Munchhof, Michael J.; Doty, John L.; Casavant, Jeffrey M.; Blumenkopf, Todd A.; Hines, Michael; Brown, Matthew F.; Lillie, Brett M.; Subramanyam, Chakrapani; Chang, Shang-Poa; Milici, Anthony J.; Beckius, Gretchen E.; Moyer, James D.; Su, Chunyan; Woodworth, Thasia G.; Gaweco, Anderson S.; Beals, Chan R.; Littman, Bruce H.; Fisher, Douglas A.; Smith, James F.; Zagouras, Panayiotis; Magna, Holly A.; Saltarelli, Mary J.; Johnson, Kimberly S.; Nelms, Linda F.; Des Etages, Shelley G.; Hayes, Lisa S.; Kawabata, Thomas T.; Finco-Kent, Deborah; Baker, Deanna L.; Larson, Michael; Si, Ming-Sing; Paniagua, Ricardo; Higgins, John; Holm, Bari; Reitz, Bruce; Zhou, Yong-Jie; Morris, Randall E.; O'Shea, John J.; Borie, Dominic C.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">302</span>
        (<span class="NLM_cas:issue">5646</span>),
    <span class="NLM_cas:pages">875-878</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Because of its requirement for signaling by multiple cytokines, Janus kinase 3 (JAK3) is an excellent target for clin. immunosuppression.  The authors report the development of a specific, orally active inhibitor of JAK3, CP-690,550, that significantly prolonged survival in a murine model of heart transplantation and in cynomolgus monkeys receiving kidney transplants.  CP-690,550 treatment was not assocd. with hypertension, hyperlipidemia, or lymphoproliferative disease.  On the basis of these preclin. results, the authors believe JAK3 blockade by CP-690,550 has potential for therapeutically desirable immunosuppression in human organ transplantation and in other clin. settings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNoo8qryWWkbVg90H21EOLACvtfcHk0liz9l6iHYBfig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXos1Cmtrg%253D&md5=85b6ea64a6711f95fc28408d42ce9c49</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1126%2Fscience.1087061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1087061%26sid%3Dliteratum%253Aachs%26aulast%3DChangelian%26aufirst%3DP.%2BS.%26aulast%3DFlanagan%26aufirst%3DM.%2BE.%26aulast%3DBall%26aufirst%3DD.%2BJ.%26aulast%3DKent%26aufirst%3DC.%2BR.%26aulast%3DMagnuson%26aufirst%3DK.%2BS.%26aulast%3DMartin%26aufirst%3DW.%2BH.%26aulast%3DRizzuti%26aufirst%3DB.%2BJ.%26aulast%3DSawyer%26aufirst%3DP.%2BS.%26aulast%3DPerry%26aufirst%3DB.%2BD.%26aulast%3DBrissette%26aufirst%3DW.%2BH.%26aulast%3DMcCurdy%26aufirst%3DS.%2BP.%26aulast%3DKudlacz%26aufirst%3DE.%2BM.%26aulast%3DConklyn%26aufirst%3DM.%2BJ.%26aulast%3DElliott%26aufirst%3DE.%2BA.%26aulast%3DKoslov%26aufirst%3DE.%2BR.%26aulast%3DFisher%26aufirst%3DM.%2BB.%26aulast%3DStrelevitz%26aufirst%3DT.%2BJ.%26aulast%3DYoon%26aufirst%3DK.%26aulast%3DWhipple%26aufirst%3DD.%2BA.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DMunchhof%26aufirst%3DM.%2BJ.%26aulast%3DDoty%26aufirst%3DJ.%2BL.%26aulast%3DCasavant%26aufirst%3DJ.%2BM.%26aulast%3DBlumenkopf%26aufirst%3DT.%2BA.%26aulast%3DHines%26aufirst%3DM.%26aulast%3DBrown%26aufirst%3DM.%2BF.%26aulast%3DLillie%26aufirst%3DB.%2BM.%26aulast%3DSubramanyam%26aufirst%3DC.%26aulast%3DShang-Poa%26aufirst%3DC.%26aulast%3DMilici%26aufirst%3DA.%2BJ.%26aulast%3DBeckius%26aufirst%3DG.%2BE.%26aulast%3DMoyer%26aufirst%3DJ.%2BD.%26aulast%3DSu%26aufirst%3DC.%26aulast%3DWoodworth%26aufirst%3DT.%2BG.%26aulast%3DGaweco%26aufirst%3DA.%2BS.%26aulast%3DBeals%26aufirst%3DC.%2BR.%26aulast%3DLittman%26aufirst%3DB.%2BH.%26aulast%3DFisher%26aufirst%3DD.%2BA.%26aulast%3DSmith%26aufirst%3DJ.%2BF.%26aulast%3DZagouras%26aufirst%3DP.%26aulast%3DMagna%26aufirst%3DH.%2BA.%26aulast%3DSaltarelli%26aufirst%3DM.%2BJ.%26aulast%3DJohnson%26aufirst%3DK.%2BS.%26aulast%3DNelms%26aufirst%3DL.%2BF.%26aulast%3DDes%2BEtages%26aufirst%3DS.%2BG.%26aulast%3DHayes%26aufirst%3DL.%2BS.%26aulast%3DKawabata%26aufirst%3DT.%2BT.%26aulast%3DFinco-Kent%26aufirst%3DD.%26aulast%3DBaker%26aufirst%3DD.%2BL.%26aulast%3DLarson%26aufirst%3DM.%26aulast%3DSi%26aufirst%3DM.%2BS.%26aulast%3DPaniagua%26aufirst%3DR.%26aulast%3DHiggins%26aufirst%3DJ.%26aulast%3DHolm%26aufirst%3DB.%26aulast%3DReitz%26aufirst%3DB.%26aulast%3DZhou%26aufirst%3DY.%2BJ.%26aulast%3DMorris%26aufirst%3DR.%2BE.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26aulast%3DBorie%26aufirst%3DD.%2BC.%26atitle%3DPrevention%2520of%2520Organ%2520Allograft%2520Rejection%2520by%2520a%2520Specific%2520Janus%2520Kinase%25203%2520Inhibitor%26jtitle%3DScience%26date%3D2003%26volume%3D302%26spage%3D875%26epage%3D878" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">West, K.</span><span> </span><span class="NLM_article-title">CP-690550, a JAK3 Inhibitor as an Immunosuppressant for the Treatment of Rheumatoid Arthritis, Transplant Rejection, Psoriasis and Other Immune-mediated Disorders</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">491</span><span class="NLM_x">–</span> <span class="NLM_lpage">504</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=491-504&author=K.+West&title=CP-690550%2C+a+JAK3+Inhibitor+as+an+Immunosuppressant+for+the+Treatment+of+Rheumatoid+Arthritis%2C+Transplant+Rejection%2C+Psoriasis+and+Other+Immune-mediated+Disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWest%26aufirst%3DK.%26atitle%3DCP-690550%252C%2520a%2520JAK3%2520Inhibitor%2520as%2520an%2520Immunosuppressant%2520for%2520the%2520Treatment%2520of%2520Rheumatoid%2520Arthritis%252C%2520Transplant%2520Rejection%252C%2520Psoriasis%2520and%2520Other%2520Immune-mediated%2520Disorders%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2009%26volume%3D10%26spage%3D491%26epage%3D504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Verstovsek, S.</span><span> </span><span class="NLM_article-title">Janus-Activated Kinase 2 Inhibitors: A New Era of Targeted Therapies Providing Significant Clinical Benefit for Philadelphia Chromosome–Negative Myeloproliferative Neoplasms</span> <span class="citation_source-journal">J. Clin. Oncology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">781</span><span class="NLM_x">–</span> <span class="NLM_lpage">788</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=16&amp;doi=10.1021%2Fjm300438j&amp;key=10.1200%2FJCO.2010.33.4508" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=8&amp;doi=10.1021%2Fjm300438j&amp;key=21220594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Fjm300438j&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktlelsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=781-788&author=S.+Verstovsek&title=Janus-Activated+Kinase+2+Inhibitors%3A+A+New+Era+of+Targeted+Therapies+Providing+Significant+Clinical+Benefit+for+Philadelphia+Chromosome%E2%80%93Negative+Myeloproliferative+Neoplasms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">Janus-activated kinase 2 inhibitors: a new era of targeted therapies providing significant clinical benefit for Philadelphia chromosome-negative myeloproliferative neoplasms</span></div><div class="casAuthors">Verstovsek, Srdan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">781-788</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">A review covers the role of Janus activated kinase 2 (JAK2) in the pathogenesis of myeloproliferative neoplasm (MPN), including JAK2V617F and JAK2 exon 12 mutations, thrombopoietin receptor mutations, and mutations in the adapter protein LNK.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKong4ZeEVSbVg90H21EOLACvtfcHk0liz9l6iHYBfig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktlelsL4%253D&md5=46cf6565241b648b80031a23da5df9e5</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1200%2FJCO.2010.33.4508&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2010.33.4508%26sid%3Dliteratum%253Aachs%26aulast%3DVerstovsek%26aufirst%3DS.%26atitle%3DJanus-Activated%2520Kinase%25202%2520Inhibitors%253A%2520A%2520New%2520Era%2520of%2520Targeted%2520Therapies%2520Providing%2520Significant%2520Clinical%2520Benefit%2520for%2520Philadelphia%2520Chromosome%25E2%2580%2593Negative%2520Myeloproliferative%2520Neoplasms%26jtitle%3DJ.%2520Clin.%2520Oncology%26date%3D2011%26volume%3D29%26spage%3D781%26epage%3D788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Vijayakrishnan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkataramanan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gulati, P.</span><span> </span><span class="NLM_article-title">Treating Inflammation with the Janus Kinase Inhibitor CP-690,550</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">25</span><span class="NLM_x">–</span> <span class="NLM_lpage">34</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2011&pages=25-34&author=L.+Vijayakrishnanauthor=R.+Venkataramananauthor=P.+Gulati&title=Treating+Inflammation+with+the+Janus+Kinase+Inhibitor+CP-690%2C550"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVijayakrishnan%26aufirst%3DL.%26aulast%3DVenkataramanan%26aufirst%3DR.%26aulast%3DGulati%26aufirst%3DP.%26atitle%3DTreating%2520Inflammation%2520with%2520the%2520Janus%2520Kinase%2520Inhibitor%2520CP-690%252C550%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2011%26volume%3D32%26spage%3D25%26epage%3D34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Meyer, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jesson, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elrick, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funckes-Shippy, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warner, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowty, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramaiah, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabbye, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barks, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kishore, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, D. L.</span><span> </span><span class="NLM_article-title">Anti-Inflammatory Activity and Neutrophil Reductions Mediated by the JAK1/JAK3 Inhibitor, CP-690,550, in Rat Adjuvant-Induced Arthritis</span> <span class="citation_source-journal">J. Inflamm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm300438j&amp;key=10.1186%2F1476-9255-7-41" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm300438j&amp;key=1%3ACAS%3A280%3ADC%252BC3cjnsVWktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2010&pages=41&author=D.+M.+Meyerauthor=M.+I.+Jessonauthor=X.+Liauthor=M.+M.+Elrickauthor=C.+L.+Funckes-Shippyauthor=J.+D.+Warnerauthor=C.+J.+Grossauthor=M.+E.+Dowtyauthor=S.+K.+Ramaiahauthor=J.+L.+Hirschauthor=M.+J.+Sabbyeauthor=J.+L.+Barksauthor=N.+Kishoreauthor=D.+L.+Morris&title=Anti-Inflammatory+Activity+and+Neutrophil+Reductions+Mediated+by+the+JAK1%2FJAK3+Inhibitor%2C+CP-690%2C550%2C+in+Rat+Adjuvant-Induced+Arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-inflammatory activity and neutrophil reductions mediated by the JAK1/JAK3 inhibitor, CP-690,550, in rat adjuvant-induced arthritis</span></div><div class="casAuthors">Meyer Debra M; Jesson Michael I; Li Xiong; Elrick Mollisa M; Funckes-Shippy Christie L; Warner James D; Gross Cindy J; Dowty Martin E; Ramaiah Shashi K; Hirsch Jeffrey L; Saabye Matthew J; Barks Jennifer L; Kishore Nandini; Morris Dale L</div><div class="citationInfo"><span class="NLM_cas:title">Journal of inflammation (London, England)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">41</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  The Janus kinase (JAK) family of tyrosine kinases includes JAK1, JAK2, JAK3 and TYK2, and is required for signaling through Type I and Type II cytokine receptors.  CP-690,550 is a potent and selective JAK inhibitor currently in clinical trials for rheumatoid arthritis (RA) and other autoimmune disease indications.  In RA trials, dose-dependent decreases in neutrophil counts (PBNC) were observed with CP-690,550 treatment.  These studies were undertaken to better understand the relationship between JAK selectivity and PBNC decreases observed with CP-690,550 treatment.  METHODS:  Potency and selectivity of CP-690,550 for mouse, rat and human JAKs was evaluated in a panel of in vitro assays.  The effect of CP-690,550 on granulopoiesis from progenitor cells was also assessed in vitro using colony forming assays.  In vivo the potency of orally administered CP-690,550 on arthritis (paw edema), plasma cytokines, PBNC and bone marrow differentials were evaluated in the rat adjuvant-induced arthritis (AIA) model.  RESULTS:  CP-690,550 potently inhibited signaling through JAK1 and JAK3 with 5-100 fold selectivity over JAK2 in cellular assays, despite inhibiting all four JAK isoforms with nM potency in in vitro enzyme assays.  Dose-dependent inhibition of paw edema was observed in vivo with CP-690,550 treatment.  Plasma cytokines (IL-6 and IL-17), PBNC, and bone marrow myeloid progenitor cells were elevated in the context of AIA disease.  At efficacious exposures, CP-690,550 returned all of these parameters to pre-disease levels.  The plasma concentration of CP-690,550 at efficacious doses was above the in vitro whole blood IC50 of JAK1 and JAK3 inhibition, but not that of JAK2.  CONCLUSION:  Results from this investigation suggest that CP-690,550 is a potent inhibitor of JAK1 and JAK3 with potentially reduced cellular potency for JAK2.  In rat AIA, as in the case of human RA, PBNC were decreased at efficacious exposures of CP-690,550.  Inflammatory end points were similarly reduced, as judged by attenuation of paw edema and cytokines IL-6 and IL-17.  Plasma concentration at these exposures was consistent with inhibition of JAK1 and JAK3 but not JAK2.  Decreases in PBNC following CP-690,550 treatment may thus be related to attenuation of inflammation and are likely not due to suppression of granulopoiesis through JAK2 inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR-l9vqy6452oNpW7w2tapOfW6udTcc2eYJys7K8hutQLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cjnsVWktA%253D%253D&md5=1190d7c5509fde79a7b56024a3aec9d9</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1186%2F1476-9255-7-41&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1476-9255-7-41%26sid%3Dliteratum%253Aachs%26aulast%3DMeyer%26aufirst%3DD.%2BM.%26aulast%3DJesson%26aufirst%3DM.%2BI.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DElrick%26aufirst%3DM.%2BM.%26aulast%3DFunckes-Shippy%26aufirst%3DC.%2BL.%26aulast%3DWarner%26aufirst%3DJ.%2BD.%26aulast%3DGross%26aufirst%3DC.%2BJ.%26aulast%3DDowty%26aufirst%3DM.%2BE.%26aulast%3DRamaiah%26aufirst%3DS.%2BK.%26aulast%3DHirsch%26aufirst%3DJ.%2BL.%26aulast%3DSabbye%26aufirst%3DM.%2BJ.%26aulast%3DBarks%26aufirst%3DJ.%2BL.%26aulast%3DKishore%26aufirst%3DN.%26aulast%3DMorris%26aufirst%3DD.%2BL.%26atitle%3DAnti-Inflammatory%2520Activity%2520and%2520Neutrophil%2520Reductions%2520Mediated%2520by%2520the%2520JAK1%252FJAK3%2520Inhibitor%252C%2520CP-690%252C550%252C%2520in%2520Rat%2520Adjuvant-Induced%2520Arthritis%26jtitle%3DJ.%2520Inflamm.%26date%3D2010%26volume%3D7%26spage%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lucia, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recchia, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gentile, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bossio, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vigna, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzone, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madeo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morabito, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gigliotti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeStefano, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caruso, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Servillo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franzese, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisconte, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gentile, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morabito, F.</span><span> </span><span class="NLM_article-title">Janus Kinase 2 Inhibitors in Myeloproliferative Disorders</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">59</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2011&pages=41-59&author=E.+Luciaauthor=A.+G.+Recchiaauthor=M.+Gentileauthor=S.+Bossioauthor=E.+Vignaauthor=C.+Mazzoneauthor=A.+Madeoauthor=L.+Morabitoauthor=V.+Gigliottiauthor=L.+DeStefanoauthor=N.+Carusoauthor=P.+Servilloauthor=F.+Franzeseauthor=M.+G.+Bisconteauthor=C.+Gentileauthor=F.+Morabito&title=Janus+Kinase+2+Inhibitors+in+Myeloproliferative+Disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLucia%26aufirst%3DE.%26aulast%3DRecchia%26aufirst%3DA.%2BG.%26aulast%3DGentile%26aufirst%3DM.%26aulast%3DBossio%26aufirst%3DS.%26aulast%3DVigna%26aufirst%3DE.%26aulast%3DMazzone%26aufirst%3DC.%26aulast%3DMadeo%26aufirst%3DA.%26aulast%3DMorabito%26aufirst%3DL.%26aulast%3DGigliotti%26aufirst%3DV.%26aulast%3DDeStefano%26aufirst%3DL.%26aulast%3DCaruso%26aufirst%3DN.%26aulast%3DServillo%26aufirst%3DP.%26aulast%3DFranzese%26aufirst%3DF.%26aulast%3DBisconte%26aufirst%3DM.%2BG.%26aulast%3DGentile%26aufirst%3DC.%26aulast%3DMorabito%26aufirst%3DF.%26atitle%3DJanus%2520Kinase%25202%2520Inhibitors%2520in%2520Myeloproliferative%2520Disorders%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2011%26volume%3D20%26spage%3D41%26epage%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ghoreschi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laurence, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Shea, J. J.</span><span> </span><span class="NLM_article-title">Selectivity and Therapeutic Inhibition of Kinases: To Be or Not To Be?</span> <span class="citation_source-journal">Nat. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">356</span><span class="NLM_x">–</span> <span class="NLM_lpage">360</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=16&amp;doi=10.1021%2Fjm300438j&amp;key=10.1038%2Fni.1701" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=356-360&author=K.+Ghoreschiauthor=A.+Laurenceauthor=J.+J.+O%E2%80%99Shea&title=Selectivity+and+Therapeutic+Inhibition+of+Kinases%3A+To+Be+or+Not+To+Be%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1038%2Fni.1701&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni.1701%26sid%3Dliteratum%253Aachs%26aulast%3DGhoreschi%26aufirst%3DK.%26aulast%3DLaurence%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26atitle%3DSelectivity%2520and%2520Therapeutic%2520Inhibition%2520of%2520Kinases%253A%2520To%2520Be%2520or%2520Not%2520To%2520Be%253F%26jtitle%3DNat.%2520Immunol.%26date%3D2009%26volume%3D4%26spage%3D356%26epage%3D360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Mesa, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasothan, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirkpatrick, P.</span><span> </span><span class="NLM_article-title">Ruxolitinib</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">103</span><span class="NLM_x">–</span> <span class="NLM_lpage">104</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=103-104&author=R.+A.+Mesaauthor=U.+Yasothanauthor=P.+Kirkpatrick&title=Ruxolitinib"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMesa%26aufirst%3DR.%2BA.%26aulast%3DYasothan%26aufirst%3DU.%26aulast%3DKirkpatrick%26aufirst%3DP.%26atitle%3DRuxolitinib%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2012%26volume%3D11%26spage%3D103%26epage%3D104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Moreland, L.</span> <span class="citation_source-book">A Randomized Placebo-Controlled Study of INCB018424, a Selective Janus Kinase 1& 2 (JAK1&2) Inhibitor in Rheumatoid Arthritis (RA)</span>. Annual Scientific Meeting of the American College of Rheumatology, San Francisco, CA, Oct 24–29,<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">; </span>John Wiley & Sons: Chichester, UK; Abstract 714.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=L.+Moreland&title=A+Randomized+Placebo-Controlled+Study+of+INCB018424%2C+a+Selective+Janus+Kinase+1%26+2+%28JAK1%262%29+Inhibitor+in+Rheumatoid+Arthritis+%28RA%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DMoreland%26aufirst%3DL.%26btitle%3DA%2520Randomized%2520Placebo-Controlled%2520Study%2520of%2520INCB018424%252C%2520a%2520Selective%2520Janus%2520Kinase%25201%2526%25202%2520%2528JAK1%25262%2529%2520Inhibitor%2520in%2520Rheumatoid%2520Arthritis%2520%2528RA%2529%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Quintas-Cardama, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaddi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manshouri, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherle, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caulder, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waeltz, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rupar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burn, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Covington, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shepard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodgers, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kantarjian, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridman, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verstovsek, S.</span><span> </span><span class="NLM_article-title">Preclinical Characterization of the Selective JAK1/2 Inhibitor INCB01424: Therapeutic Implications for the Treatment of Myeloproliferative Neoplasms</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">3109</span><span class="NLM_x">–</span> <span class="NLM_lpage">3117</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2010&pages=3109-3117&author=A.+Quintas-Cardamaauthor=K.+Vaddiauthor=P.+Liuauthor=T.+Manshouriauthor=J.+Liauthor=P.+A.+Scherleauthor=E.+Caulderauthor=X.+Wenauthor=Y.+Liauthor=P.+Waeltzauthor=M.+Ruparauthor=T.+Burnauthor=Y.+Loauthor=J.+Kelleyauthor=M.+Covingtonauthor=S.+Shepardauthor=J.+D.+Rodgersauthor=P.+Haleyauthor=H.+Kantarjianauthor=J.+S.+Fridmanauthor=S.+Verstovsek&title=Preclinical+Characterization+of+the+Selective+JAK1%2F2+Inhibitor+INCB01424%3A+Therapeutic+Implications+for+the+Treatment+of+Myeloproliferative+Neoplasms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DQuintas-Cardama%26aufirst%3DA.%26aulast%3DVaddi%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DManshouri%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DScherle%26aufirst%3DP.%2BA.%26aulast%3DCaulder%26aufirst%3DE.%26aulast%3DWen%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DWaeltz%26aufirst%3DP.%26aulast%3DRupar%26aufirst%3DM.%26aulast%3DBurn%26aufirst%3DT.%26aulast%3DLo%26aufirst%3DY.%26aulast%3DKelley%26aufirst%3DJ.%26aulast%3DCovington%26aufirst%3DM.%26aulast%3DShepard%26aufirst%3DS.%26aulast%3DRodgers%26aufirst%3DJ.%2BD.%26aulast%3DHaley%26aufirst%3DP.%26aulast%3DKantarjian%26aufirst%3DH.%26aulast%3DFridman%26aufirst%3DJ.%2BS.%26aulast%3DVerstovsek%26aufirst%3DS.%26atitle%3DPreclinical%2520Characterization%2520of%2520the%2520Selective%2520JAK1%252F2%2520Inhibitor%2520INCB01424%253A%2520Therapeutic%2520Implications%2520for%2520the%2520Treatment%2520of%2520Myeloproliferative%2520Neoplasms%26jtitle%3DBlood%26date%3D2010%26volume%3D115%26spage%3D3109%26epage%3D3117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Haan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rolvering, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raulf, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapp, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Druckes, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thoma, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behrmann, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zerwes, H.-G.</span><span> </span><span class="NLM_article-title">Jak1 Has a Dominant Role over Jak3 in Signal Transduction through γc-Containing Cytokine Receptors</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">314</span><span class="NLM_x">–</span> <span class="NLM_lpage">323</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm300438j&amp;key=10.1016%2Fj.chembiol.2011.01.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm300438j&amp;key=21439476" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm300438j&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvFSrtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=314-323&author=C.+Haanauthor=C.+Rolveringauthor=F.+Raulfauthor=M.+Kappauthor=P.+Druckesauthor=G.+Thomaauthor=I.+Behrmannauthor=H.-G.+Zerwes&title=Jak1+Has+a+Dominant+Role+over+Jak3+in+Signal+Transduction+through+%CE%B3c-Containing+Cytokine+Receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Jak1 Has a Dominant Role over Jak3 in Signal Transduction through γc-Containing Cytokine Receptors</span></div><div class="casAuthors">Haan, Claude; Rolvering, Catherine; Raulf, Friedrich; Kapp, Manuela; Drueckes, Peter; Thoma, Gebhard; Behrmann, Iris; Zerwes, Hans-Guenter</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">314-323</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Genetic deficiency of Jak3 leads to abrogation of signal transduction through the common gamma chain (γc) and thus to immunodeficiency suggesting that specific inhibition of Jak3 kinase may result in immunosuppression.  Jak1 cooperates with Jak3 in signaling through γc-contg. receptors.  Unexpectedly, a Jak3-selective inhibitor was less efficient in abolishing STAT5 phosphorylation than pan-Jak inhibitors.  We therefore explored the roles of Jak1 and Jak3 kinase functionality in signaling using a reconstituted system.  The presence of kinase-inactive Jak1 but not kinase-inactive Jak3 resulted in complete abolishment of STAT5 phosphorylation.  Specific inhibition of the "analog-sensitive" mutant AS-Jak1 but not AS-Jak3 by the ATP-competitive analog 1NM-PP1 abrogated IL-2 signaling, corroborating the data with the selective Jak3 inhibitor.  Jak1 thus plays a dominant role over Jak3 and these data challenge the notion that selective ATP-competitive Jak3 kinase inhibitors will be effective.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUv04vX29Zk7Vg90H21EOLACvtfcHk0ljQUmIAwOGdpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvFSrtrw%253D&md5=0109f316cfe0bee40f80a79f244e6ba5</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2011.01.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2011.01.012%26sid%3Dliteratum%253Aachs%26aulast%3DHaan%26aufirst%3DC.%26aulast%3DRolvering%26aufirst%3DC.%26aulast%3DRaulf%26aufirst%3DF.%26aulast%3DKapp%26aufirst%3DM.%26aulast%3DDruckes%26aufirst%3DP.%26aulast%3DThoma%26aufirst%3DG.%26aulast%3DBehrmann%26aufirst%3DI.%26aulast%3DZerwes%26aufirst%3DH.-G.%26atitle%3DJak1%2520Has%2520a%2520Dominant%2520Role%2520over%2520Jak3%2520in%2520Signal%2520Transduction%2520through%2520%25CE%25B3c-Containing%2520Cytokine%2520Receptors%26jtitle%3DChem.%2520Biol.%26date%3D2011%26volume%3D18%26spage%3D314%26epage%3D323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Rodig, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meraz, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lampe, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riley, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arthur, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheehan, K. C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennica, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, E. M.,  Jr</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, R. D.</span><span> </span><span class="NLM_article-title">Disruption of the JAK1 Gene Demonstrates Obligatory and Nonredundant Roles of the JAKs in Cytokine-Induced Biologic Responses</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">373</span><span class="NLM_x">–</span> <span class="NLM_lpage">383</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1998&pages=373-383&author=S.+J.+Rodigauthor=M.+A.+Merazauthor=J.+M.+Whiteauthor=P.+A.+Lampeauthor=J.+K.+Rileyauthor=C.+D.+Arthurauthor=K.+L.+Kingauthor=K.+C.+F.+Sheehanauthor=L.+Yinauthor=D.+Pennicaauthor=E.+M.+Johnsonauthor=R.+D.+Schreiber&title=Disruption+of+the+JAK1+Gene+Demonstrates+Obligatory+and+Nonredundant+Roles+of+the+JAKs+in+Cytokine-Induced+Biologic+Responses"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRodig%26aufirst%3DS.%2BJ.%26aulast%3DMeraz%26aufirst%3DM.%2BA.%26aulast%3DWhite%26aufirst%3DJ.%2BM.%26aulast%3DLampe%26aufirst%3DP.%2BA.%26aulast%3DRiley%26aufirst%3DJ.%2BK.%26aulast%3DArthur%26aufirst%3DC.%2BD.%26aulast%3DKing%26aufirst%3DK.%2BL.%26aulast%3DSheehan%26aufirst%3DK.%2BC.%2BF.%26aulast%3DYin%26aufirst%3DL.%26aulast%3DPennica%26aufirst%3DD.%26aulast%3DJohnson%26aufirst%3DE.%2BM.%26aulast%3DSchreiber%26aufirst%3DR.%2BD.%26atitle%3DDisruption%2520of%2520the%2520JAK1%2520Gene%2520Demonstrates%2520Obligatory%2520and%2520Nonredundant%2520Roles%2520of%2520the%2520JAKs%2520in%2520Cytokine-Induced%2520Biologic%2520Responses%26jtitle%3DCell%26date%3D1998%26volume%3D93%26spage%3D373%26epage%3D383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Parganas, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stravopodis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Topham, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marine, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teglund, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanin, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bodner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colamonici, O. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Deursen, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosveld, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ihle, J. N.</span><span> </span><span class="NLM_article-title">JAK2 Is Essential for Signaling Through a Variety of Cytokine Receptors</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">385</span><span class="NLM_x">–</span> <span class="NLM_lpage">395</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1998&pages=385-395&author=E.+Parganasauthor=D.+Wangauthor=D.+Stravopodisauthor=D.+J.+Tophamauthor=J.-C.+Marineauthor=S.+Teglundauthor=E.+F.+Vaninauthor=S.+Bodnerauthor=O.+R.+Colamoniciauthor=J.+M.+van+Deursenauthor=G.+Grosveldauthor=J.+N.+Ihle&title=JAK2+Is+Essential+for+Signaling+Through+a+Variety+of+Cytokine+Receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DParganas%26aufirst%3DE.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DStravopodis%26aufirst%3DD.%26aulast%3DTopham%26aufirst%3DD.%2BJ.%26aulast%3DMarine%26aufirst%3DJ.-C.%26aulast%3DTeglund%26aufirst%3DS.%26aulast%3DVanin%26aufirst%3DE.%2BF.%26aulast%3DBodner%26aufirst%3DS.%26aulast%3DColamonici%26aufirst%3DO.%2BR.%26aulast%3Dvan%2BDeursen%26aufirst%3DJ.%2BM.%26aulast%3DGrosveld%26aufirst%3DG.%26aulast%3DIhle%26aufirst%3DJ.%2BN.%26atitle%3DJAK2%2520Is%2520Essential%2520for%2520Signaling%2520Through%2520a%2520Variety%2520of%2520Cytokine%2520Receptors%26jtitle%3DCell%26date%3D1998%26volume%3D93%26spage%3D385%26epage%3D395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Shimoda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyamoto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shibamori, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Numata, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takase, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shibata, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gondo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sekiguchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niho, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, K.</span><span> </span><span class="NLM_article-title">TYK2 Plays a Restricted Role in IFNα Signaling, Although it is Required for IL-12-Mediated T Cell Function</span> <span class="citation_source-journal">Immunity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">561</span><span class="NLM_x">–</span> <span class="NLM_lpage">571</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2000&pages=561-571&author=K.+Shimodaauthor=K.+Katoauthor=K.+Aokiauthor=T.+Matsudaauthor=A.+Miyamotoauthor=M.+Shibamoriauthor=M.+Yamashitaauthor=A.+Numataauthor=K.+Takaseauthor=S.+Kobayashiauthor=S.+Shibataauthor=Y.+Asanoauthor=H.+Gondoauthor=K.+Sekiguchiauthor=K.+Nakayamaauthor=T.+Nakayamaauthor=T.+Okamuraauthor=S.+Okamuraauthor=Y.+Nihoauthor=K.+Nakayama&title=TYK2+Plays+a+Restricted+Role+in+IFN%CE%B1+Signaling%2C+Although+it+is+Required+for+IL-12-Mediated+T+Cell+Function"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShimoda%26aufirst%3DK.%26aulast%3DKato%26aufirst%3DK.%26aulast%3DAoki%26aufirst%3DK.%26aulast%3DMatsuda%26aufirst%3DT.%26aulast%3DMiyamoto%26aufirst%3DA.%26aulast%3DShibamori%26aufirst%3DM.%26aulast%3DYamashita%26aufirst%3DM.%26aulast%3DNumata%26aufirst%3DA.%26aulast%3DTakase%26aufirst%3DK.%26aulast%3DKobayashi%26aufirst%3DS.%26aulast%3DShibata%26aufirst%3DS.%26aulast%3DAsano%26aufirst%3DY.%26aulast%3DGondo%26aufirst%3DH.%26aulast%3DSekiguchi%26aufirst%3DK.%26aulast%3DNakayama%26aufirst%3DK.%26aulast%3DNakayama%26aufirst%3DT.%26aulast%3DOkamura%26aufirst%3DT.%26aulast%3DOkamura%26aufirst%3DS.%26aulast%3DNiho%26aufirst%3DY.%26aulast%3DNakayama%26aufirst%3DK.%26atitle%3DTYK2%2520Plays%2520a%2520Restricted%2520Role%2520in%2520IFN%25CE%25B1%2520Signaling%252C%2520Although%2520it%2520is%2520Required%2520for%2520IL-12-Mediated%2520T%2520Cell%2520Function%26jtitle%3DImmunity%26date%3D2000%26volume%3D13%26spage%3D561%26epage%3D571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Patel, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreland, L. W.</span><span> </span><span class="NLM_article-title">Interleukin-6 Inhibition for Treatment of Rheumatoid Arthritis: A Review of Tocilizumab Therapy</span> <span class="citation_source-journal">Drug Des. Dev. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">263</span><span class="NLM_x">–</span> <span class="NLM_lpage">278</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm300438j&amp;key=10.2147%2FDDDT.S14099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm300438j&amp;key=21116333" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm300438j&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVWks7rO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2010&pages=263-278&author=A.+M.+Patelauthor=L.+W.+Moreland&title=Interleukin-6+Inhibition+for+Treatment+of+Rheumatoid+Arthritis%3A+A+Review+of+Tocilizumab+Therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Interleukin-6 inhibition for treatment of rheumatoid arthritis: a review of tocilizumab therapy</span></div><div class="casAuthors">Patel, Aarat M.; Moreland, Larry W.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Design, Development and Therapy</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">263-278</span>CODEN:
                <span class="NLM_cas:coden">DDDTAQ</span>;
        ISSN:<span class="NLM_cas:issn">1177-8881</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">A review.  The dawn of the biol. era has been an exciting period for clin. research and patient care in rheumatoid arthritis (RA).  Targeted biol. therapies have changed the outcome of this disease and made remission a realistic outcome for many patients.  Tocilizumab (TCZ, Actemra), is a humanized monoclonal antibody against the interleukin 6 receptor and has been approved in many countries for the treatment of moderate to severe RA.  There have been a no. of important clin. trials demonstrating the efficacy of TCZ in active rheumatoid arthritis.  This review summarizes the data on efficacy, patient-reported outcomes, adverse events, and safety from some of these trials.  Current trends in clin. practice will be discussed.  It is difficult to place TCZ and many new medications in the algorithm of treatment at present.  However, the next few years will hopefully reveal their role as we better define abnormal immune processes in individuals with RA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSQBaSb6OpuLVg90H21EOLACvtfcHk0ljAdVH3WNoNbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVWks7rO&md5=ec9c2425184f453195e64fe225f66417</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.2147%2FDDDT.S14099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FDDDT.S14099%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DA.%2BM.%26aulast%3DMoreland%26aufirst%3DL.%2BW.%26atitle%3DInterleukin-6%2520Inhibition%2520for%2520Treatment%2520of%2520Rheumatoid%2520Arthritis%253A%2520A%2520Review%2520of%2520Tocilizumab%2520Therapy%26jtitle%3DDrug%2520Des.%2520Dev.%2520Ther.%26date%3D2010%26volume%3D4%26spage%3D263%26epage%3D278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Baslund, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tvede, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danneskiold-Samsoe, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panavi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beurskens, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuuman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van de Winkel, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parren, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gracie, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jongbloed, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liew, F. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McInnes, I. B.</span><span> </span><span class="NLM_article-title">Targeting Interleukin-15 in Patients With Rheumatoid Arthritis: A Proof-of-Concept Study</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">2686</span><span class="NLM_x">–</span> <span class="NLM_lpage">2692</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm300438j&amp;key=10.1002%2Fart.21249" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm300438j&amp;key=16142748" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm300438j&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFeltrjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2005&pages=2686-2692&author=B.+Baslundauthor=N.+Tvedeauthor=B.+Danneskiold-Samsoeauthor=P.+Larssonauthor=G.+Panaviauthor=J.+Petersenauthor=L.+J.+Petersenauthor=F.+J.+Beurskensauthor=J.+Schuumanauthor=J.+G.+van+de+Winkelauthor=P.+W.+Parrenauthor=J.+A.+Gracieauthor=S.+Jongbloedauthor=F.+Y.+Liewauthor=I.+B.+McInnes&title=Targeting+Interleukin-15+in+Patients+With+Rheumatoid+Arthritis%3A+A+Proof-of-Concept+Study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting interleukin-15 in patients with rheumatoid arthritis. A proof-of-concept study</span></div><div class="casAuthors">Baslund, Bo; Tvede, Niels; Danneskiold-Samsoe, Bente; Larsson, Per; Panayi, Gabriel; Petersen, Joergen; Petersen, Lars J.; Beurskens, Frank J. M.; Schuurman, Janine; van de Winkel, Jan G. J.; Parren, Paul W. H. I.; Gracie, J. Alastair; Jongbloed, Sarah; Liew, Foo Y.; McInnes, Iain B.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2686-2692</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective. Interleukin-15 (IL-15) is a proinflammatory, innate response cytokine that mediates pleiotropic effector function in rheumatoid arthritis (RA) inflammatory synovitis.  Our objective was to study the ability of HuMax-IL15, a human IgG1 anti-IL-15 monoclonal antibody, to neutralize exogenous and endogenous IL-15 activity in vitro and to perform a phase I-II dose-escalation trial with HuMax-IL15 in patients with active RA.  Methods. Mononuclear cells from blood and synovial fluid (SF) of RA patients were isolated and cultured in vitro under exptl. conditions involving the addn. of HuMax-IL15.  HuMax-IL15 was administered to 30 RA patients who received no other disease-modifying antirheumatic drugs in a 12-wk, dose-ascending, placebo-controlled, double-blind, phase I-II proof-of-concept study.  Results. In vitro studies showed that HuMax-IL15 suppressed proliferation and induced apoptosis in an IL-15-dependent cell line, BDB2, and was capable of suppressing the release of interferon-γ by synovial fluid mononuclear cell (SFMC) cultures induced by exogenous IL-15.  Furthermore, HuMax-IL15 F(ab')2 fragments suppressed exogenous IL-15-induced CD69 expression in RA peripheral blood mononuclear cells and SFMCs, which indicates that HuMax-IL15 can specifically neutralize several biol. effects of IL-15 in synovial tissue in vitro.  In a phase I-II clin. trial, HuMax-IL15 was well tolerated clin., with no significant effects on T lymphocyte subset and natural killer cell nos.  Substantial improvements in disease activity were obsd. according to the American College of Rheumatol. criteria for 20% improvement (63% of patients), 50% improvement (38%), and 70% improvement (25%).  Conclusion. These clin. data suggest for the first time that IL-15 could represent a novel therapeutic target in RA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogAvhCWrkc8bVg90H21EOLACvtfcHk0ljAdVH3WNoNbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFeltrjP&md5=5e9ada4f9e9649a6d048fe68c421d2cb</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1002%2Fart.21249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.21249%26sid%3Dliteratum%253Aachs%26aulast%3DBaslund%26aufirst%3DB.%26aulast%3DTvede%26aufirst%3DN.%26aulast%3DDanneskiold-Samsoe%26aufirst%3DB.%26aulast%3DLarsson%26aufirst%3DP.%26aulast%3DPanavi%26aufirst%3DG.%26aulast%3DPetersen%26aufirst%3DJ.%26aulast%3DPetersen%26aufirst%3DL.%2BJ.%26aulast%3DBeurskens%26aufirst%3DF.%2BJ.%26aulast%3DSchuuman%26aufirst%3DJ.%26aulast%3Dvan%2Bde%2BWinkel%26aufirst%3DJ.%2BG.%26aulast%3DParren%26aufirst%3DP.%2BW.%26aulast%3DGracie%26aufirst%3DJ.%2BA.%26aulast%3DJongbloed%26aufirst%3DS.%26aulast%3DLiew%26aufirst%3DF.%2BY.%26aulast%3DMcInnes%26aufirst%3DI.%2BB.%26atitle%3DTargeting%2520Interleukin-15%2520in%2520Patients%2520With%2520Rheumatoid%2520Arthritis%253A%2520A%2520Proof-of-Concept%2520Study%26jtitle%3DArthritis%2520Rheum.%26date%3D2005%26volume%3D52%26spage%3D2686%26epage%3D2692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Yamaoka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kubo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sonomoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeshima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, Y.</span><span> </span><span class="NLM_article-title">JAK Inhibitor: Tofacitinib, a New Disease Modifying Anti-Rheumatic Drug</span> <span class="citation_source-journal">Inflammation Regener.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">349</span><span class="NLM_x">–</span> <span class="NLM_lpage">353</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=16&amp;doi=10.1021%2Fjm300438j&amp;key=10.2492%2Finflammregen.31.349" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=32&amp;doi=10.1021%2Fjm300438j&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlSrtb%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=349-353&author=K.+Yamaokaauthor=S.+Kuboauthor=K.+Sonomotoauthor=K.+Maeshimaauthor=Y.+Tanaka&title=JAK+Inhibitor%3A+Tofacitinib%2C+a+New+Disease+Modifying+Anti-Rheumatic+Drug"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21aR"><div class="casContent"><span class="casTitleNuber">21a</span><div class="casTitle"><span class="NLM_cas:atitle">JAK inhibitor: tofacitinib, a new disease modifying anti-rheumatic drug</span></div><div class="casAuthors">Yamaoka, Kunihiro; Kubo, Satoshi; Sonomoto, Koshiro; Maeshima, Keisuke; Tanaka, Yoshiya</div><div class="citationInfo"><span class="NLM_cas:title">Inflammation and Regeneration</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">349-353</span>CODEN:
                <span class="NLM_cas:coden">IRNECG</span>;
        ISSN:<span class="NLM_cas:issn">1880-9693</span>.
    
            (<span class="NLM_cas:orgname">Nippon Ensho/Saisei Igakkai</span>)
        </div><div class="casAbstract">Treatment of rheumatoid arthritis (RA) with biol. agents targeting inflammatory cytokines and cell surface mols. such as tumor necrosis factor and Interleukin-6 is generally more efficacious than traditional disease-modifying antirheumatic drugs when combined with MTX.  However, not only do ∼30% of patients poorly respond to treatment but also parenteral mode of administration and expense are issues to be solved.  Recently, a kinase inhibitor targeting Janus kinases (JAKs), has shown high efficacy in active RA in clin. trials.  Among several JAK inhibitors in clin. trials for RA, tofacitinib is a step ahead for use in clin. practice.  Kinase inhibitors are orally available, which is a major advantage over biol. agents, in addn. to being less expensive.  This review describes recent advance in JAK inhibitors for RA and its possible mechanism of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3A1aier6Px7Vg90H21EOLACvtfcHk0ljAdVH3WNoNbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlSrtb%252FN&md5=33059f4ce0e6b80984903eb0f0f3e3f9</span></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=10.2492%2Finflammregen.31.349&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2492%252Finflammregen.31.349%26sid%3Dliteratum%253Aachs%26aulast%3DYamaoka%26aufirst%3DK.%26aulast%3DKubo%26aufirst%3DS.%26aulast%3DSonomoto%26aufirst%3DK.%26aulast%3DMaeshima%26aufirst%3DK.%26aulast%3DTanaka%26aufirst%3DY.%26atitle%3DJAK%2520Inhibitor%253A%2520Tofacitinib%252C%2520a%2520New%2520Disease%2520Modifying%2520Anti-Rheumatic%2520Drug%26jtitle%3DInflammation%2520Regener.%26date%3D2011%26volume%3D31%26spage%3D349%26epage%3D353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit21b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Fleischmann, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cutolo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genovese, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanik, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connell, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruben, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnaswami, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallenstein, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkinson, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwillich, S. H.</span><span> </span><span class="NLM_article-title">Phase 2B Dose-Ranging Study of the Oral JAK Inhibitor Tofacitinib (CP-690,550) or Adalimumab Monotherapy Versus Placebo in Patients with Active Rheumatoid Arthritis with an Inadequate Response to DMARDs</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">617</span><span class="NLM_x">–</span> <span class="NLM_lpage">629</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=16&amp;doi=10.1021%2Fjm300438j&amp;key=10.1002%2Fart.33383" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=8&amp;doi=10.1021%2Fjm300438j&amp;key=21952978" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=32&amp;doi=10.1021%2Fjm300438j&amp;key=1%3ACAS%3A528%3ADC%252BC38XivVGjurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2012&pages=617-629&author=R.+Fleischmannauthor=M.+Cutoloauthor=M.+C.+Genoveseauthor=E.+B.+Leeauthor=K.+S.+Kanikauthor=S.+Sadisauthor=C.+A.+Connellauthor=D.+Grubenauthor=S.+Krishnaswamiauthor=G.+Wallensteinauthor=B.+E.+Wilkinsonauthor=S.+H.+Zwillich&title=Phase+2B+Dose-Ranging+Study+of+the+Oral+JAK+Inhibitor+Tofacitinib+%28CP-690%2C550%29+or+Adalimumab+Monotherapy+Versus+Placebo+in+Patients+with+Active+Rheumatoid+Arthritis+with+an+Inadequate+Response+to+DMARDs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21bR"><div class="casContent"><span class="casTitleNuber">21b</span><div class="casTitle"><span class="NLM_cas:atitle">Phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) or adalimumab monotherapy versus placebo in patients with active rheumatoid arthritis with an inadequate response to disease-modifying antirheumatic drugs</span></div><div class="casAuthors">Fleischmann, Roy; Cutolo, Maurizio; Genovese, Mark C.; Lee, Eun Bong; Kanik, Keith S.; Sadis, Seth; Connell, Carol A.; Gruben, David; Krishnaswami, Sriram; Wallenstein, Gene; Wilkinson, Bethanie E.; Zwillich, Samuel H.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">617-629</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective : To compare the efficacy, safety, and tolerability of 5 doses of oral tofacitinib (CP-690,550) or adalimumab monotherapy with placebo for the treatment of active rheumatoid arthritis (RA) in patients with an inadequate response to disease-modifying antirheumatic drugs.  Methods : In this 24-wk, double-blind, phase IIb study, patients with RA (n = 384) were randomized to receive placebo, tofacitinib at 1, 3, 5, 10, or 15 mg administered orally twice a day, or adalimumab at 40 mg injected s.c. every 2 wk (total of 6 injections) followed by oral tofacitinib at 5 mg twice a day for 12 wk.  The primary end point was the responder rate according to the American College of Rheumatol. 20% improvement criteria (ACR20) at week 12.  Results : Treatment with tofacitinib at a dose of ≥3 mg twice a day resulted in a rapid response with significant efficacy when compared to placebo, as indicated by the primary end point (ACR20 response at week 12), achieved in 39.2% (3 mg; P ≤ 0.05), 59.2% (5 mg; P < 0.0001), 70.5% (10 mg; P < 0.0001), and 71.9% (15 mg; P < 0.0001) in the tofacitinib group and 35.9% of patients in the adalimumab group (P = 0.105), compared with 22.0% of patients receiving placebo.  Improvements were sustained at week 24, according to the ACR20, ACR50, and ACR70 response rates as well as classifications of remission according to the 3-variable Disease Activity Score in 28 joints (DAS28) using C-reactive protein and the 4-variable DAS28 using the erythrocyte sedimentation rate.  The most common treatment-emergent adverse events (AEs) in patients across all tofacitinib treatment arms (n = 272) were urinary tract infection (7.7%), diarrhea (4.8%), headache (4.8%), and bronchitis (4.8%).  Conclusion : Tofacitinib monotherapy at ≥3 mg twice a day was efficacious in the treatment of patients with active RA over 24 wk and demonstrated a manageable safety profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuu7Uf_SwBXbVg90H21EOLACvtfcHk0lg1cI2JosubXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XivVGjurs%253D&md5=99d7be4fd115ffa87410dcbd6c6ea860</span></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=10.1002%2Fart.33383&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.33383%26sid%3Dliteratum%253Aachs%26aulast%3DFleischmann%26aufirst%3DR.%26aulast%3DCutolo%26aufirst%3DM.%26aulast%3DGenovese%26aufirst%3DM.%2BC.%26aulast%3DLee%26aufirst%3DE.%2BB.%26aulast%3DKanik%26aufirst%3DK.%2BS.%26aulast%3DSadis%26aufirst%3DS.%26aulast%3DConnell%26aufirst%3DC.%2BA.%26aulast%3DGruben%26aufirst%3DD.%26aulast%3DKrishnaswami%26aufirst%3DS.%26aulast%3DWallenstein%26aufirst%3DG.%26aulast%3DWilkinson%26aufirst%3DB.%2BE.%26aulast%3DZwillich%26aufirst%3DS.%2BH.%26atitle%3DPhase%25202B%2520Dose-Ranging%2520Study%2520of%2520the%2520Oral%2520JAK%2520Inhibitor%2520Tofacitinib%2520%2528CP-690%252C550%2529%2520or%2520Adalimumab%2520Monotherapy%2520Versus%2520Placebo%2520in%2520Patients%2520with%2520Active%2520Rheumatoid%2520Arthritis%2520with%2520an%2520Inadequate%2520Response%2520to%2520DMARDs%26jtitle%3DArthritis%2520Rheum.%26date%3D2012%26volume%3D64%26spage%3D617%26epage%3D629" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit21c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Kremer, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkinson, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connell, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">French, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez-Reino, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruben, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanik, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnaswami, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pascuala-Ramos, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallenstein, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwillich, S. H.</span><span> </span><span class="NLM_article-title">A Phase 2B Dose-Ranging Study of the Oral JAK Inhibitor Tofacitinib (CP-690,550) Versus Placebo in Combination with Background Methotrexate in Patients with Active Rheumatoid Arthritis and Inadequate Response to Methotrexate Alone</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">970</span><span class="NLM_x">–</span> <span class="NLM_lpage">981</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21c&amp;dbid=16&amp;doi=10.1021%2Fjm300438j&amp;key=10.1002%2Fart.33419" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21c&amp;dbid=8&amp;doi=10.1021%2Fjm300438j&amp;key=22006202" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21c&amp;dbid=32&amp;doi=10.1021%2Fjm300438j&amp;key=1%3ACAS%3A528%3ADC%252BC38XmvVygt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2012&pages=970-981&author=J.+M.+Kremerauthor=S.+Cohenauthor=B.+E.+Wilkinsonauthor=C.+A.+Connellauthor=J.+L.+Frenchauthor=J.+Gomez-Reinoauthor=D.+Grubenauthor=K.+S.+Kanikauthor=S.+Krishnaswamiauthor=V.+Pascuala-Ramosauthor=G.+Wallensteinauthor=S.+H.+Zwillich&title=A+Phase+2B+Dose-Ranging+Study+of+the+Oral+JAK+Inhibitor+Tofacitinib+%28CP-690%2C550%29+Versus+Placebo+in+Combination+with+Background+Methotrexate+in+Patients+with+Active+Rheumatoid+Arthritis+and+Inadequate+Response+to+Methotrexate+Alone"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21cR"><div class="casContent"><span class="casTitleNuber">21c</span><div class="casTitle"><span class="NLM_cas:atitle">A phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) versus placebo in combination with background methotrexate in patients with active rheumatoid arthritis and an inadequate response to methotrexate alone</span></div><div class="casAuthors">Kremer, Joel M.; Cohen, Stanley; Wilkinson, Bethanie E.; Connell, Carol A.; French, Jonathan L.; Gomez-Reino, Juan; Gruben, David; Kanik, Keith S.; Krishnaswami, Sriram; Pascual-Ramos, Virginia; Wallenstein, Gene; Zwillich, Samuel H.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">970-981</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective. To compare the efficacy, safety, and tolerability of 6 dosages of oral tofacitinib (CP-690,550) with placebo for the treatment of active rheumatoid arthritis (RA) in patients receiving a stable background regimen of methotrexate (MTX) who have an inadequate response to MTX monotherapy.  Methods. In this 24-wk, double-blind, phase IIb study, patients with active RA (n = 507) were randomized to receive placebo or tofacitinib (20 mg/day, 1 mg twice daily, 3 mg twice daily, 5 mg twice daily, 10 mg twice daily, or 15 mg twice daily).  All patients continued to receive a stable dosage of MTX.  The primary end point was the American College of Rheumatol. 20% improvement criteria (ACR20) response rate at week 12.  Results. At week 12, ACR20 response rates for patients receiving all tofacitinib dosages ≥3 mg twice daily (52.9% for 3 mg twice daily, 50.7% for 5 mg twice daily, 58.1% for 10 mg twice daily, 56.0% for 15 mg twice daily, and 53.8% for 20 mg/day) were significantly (P ≤ 0.05) greater than those for placebo (33.3%).  Improvements were sustained at week 24 for the ACR20, ACR50, and ACR70 responses, scores for the Health Assessment Questionnaire disability index, the 3-variable Disease Activity Score in 28 joints using the C-reactive protein level (DAS28-CRP), and a 3-variable DAS28-CRP of <2.6.  The most common treatment-emergent adverse events occurring in >10% of patients in any tofacitinib group were diarrhea, upper respiratory tract infection, and headache; 21 patients (4.1%) experienced serious adverse events.  Sporadic increases in transaminase levels, increases in cholesterol and serum creatinine levels, and decreases in neutrophil and Hb levels were obsd.  Conclusion. In patients with active RA in whom the response to MTX has been inadequate, the addn. of tofacitinib at a dosage ≥3 mg twice daily showed sustained efficacy and a manageable safety profile over 24 wk.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGQK92I8twr7Vg90H21EOLACvtfcHk0lg1cI2JosubXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmvVygt78%253D&md5=69d74dbdde12d7d1b45fa3d3a413645a</span></div><a href="/servlet/linkout?suffix=cit21c&amp;dbid=16384&amp;doi=10.1002%2Fart.33419&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.33419%26sid%3Dliteratum%253Aachs%26aulast%3DKremer%26aufirst%3DJ.%2BM.%26aulast%3DCohen%26aufirst%3DS.%26aulast%3DWilkinson%26aufirst%3DB.%2BE.%26aulast%3DConnell%26aufirst%3DC.%2BA.%26aulast%3DFrench%26aufirst%3DJ.%2BL.%26aulast%3DGomez-Reino%26aufirst%3DJ.%26aulast%3DGruben%26aufirst%3DD.%26aulast%3DKanik%26aufirst%3DK.%2BS.%26aulast%3DKrishnaswami%26aufirst%3DS.%26aulast%3DPascuala-Ramos%26aufirst%3DV.%26aulast%3DWallenstein%26aufirst%3DG.%26aulast%3DZwillich%26aufirst%3DS.%2BH.%26atitle%3DA%2520Phase%25202B%2520Dose-Ranging%2520Study%2520of%2520the%2520Oral%2520JAK%2520Inhibitor%2520Tofacitinib%2520%2528CP-690%252C550%2529%2520Versus%2520Placebo%2520in%2520Combination%2520with%2520Background%2520Methotrexate%2520in%2520Patients%2520with%2520Active%2520Rheumatoid%2520Arthritis%2520and%2520Inadequate%2520Response%2520to%2520Methotrexate%2520Alone%26jtitle%3DArthritis%2520Rheum.%26date%3D2012%26volume%3D64%26spage%3D970%26epage%3D981" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Jatiani, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, E. P.</span><span> </span><span class="NLM_article-title">JAK/STAT Pathways in Cytokine Signaling and Myeloproliferative Disorders: Approaches for Targeted Therapies</span> <span class="citation_source-journal">Genes Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">979</span><span class="NLM_x">–</span> <span class="NLM_lpage">993</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=16&amp;doi=10.1021%2Fjm300438j&amp;key=10.1177%2F1947601910397187" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=8&amp;doi=10.1021%2Fjm300438j&amp;key=21442038" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=32&amp;doi=10.1021%2Fjm300438j&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisF2nsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=979-993&author=S.+S.+Jatianiauthor=S.+J.+Bakerauthor=L.+R.+Silvermanauthor=E.+P.+Reddy&title=JAK%2FSTAT+Pathways+in+Cytokine+Signaling+and+Myeloproliferative+Disorders%3A+Approaches+for+Targeted+Therapies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22aR"><div class="casContent"><span class="casTitleNuber">22a</span><div class="casTitle"><span class="NLM_cas:atitle">JAK/STAT pathways in cytokine signaling and myeloproliferative disorders: approaches for targeted therapies</span></div><div class="casAuthors">Jatiani, Shashidhar S.; Baker, Stacey J.; Silverman, Lewis R.; Reddy, E. Premkumar</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">979-993</span>CODEN:
                <span class="NLM_cas:coden">GCEAAY</span>;
        ISSN:<span class="NLM_cas:issn">1947-6019</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">A review.  Hematopoiesis is the cumulative result of intricately regulated signaling pathways that are mediated by cytokines and their receptors.  Studies conducted over the past 10 to 15 years have revealed that hematopoietic cytokine receptor signaling is largely mediated by a family of tyrosine kinases termed Janus kinases (JAKs) and their downstream transcription factors, termed STATs (signal transducers and activators of transcription).  Aberrations in these pathways, such as those caused by the recently identified JAK2V617F mutation and translocations of the JAK2 gene, are underlying causes of leukemias and other myeloproliferative disorders.  This review discusses the role of JAK/STAT signaling in normal hematopoiesis as well as genetic abnormalities assocd. with myeloproliferative and myelodisplastic syndromes.  This review also summarizes the status of several small mol. JAK2 inhibitors that are currently at various stages of clin. development Several of these compds. appear to improve the quality of life of patients with myeloproliferative disorders by palliation of disease-related symptoms.  However, to date, these agents do not seem to significantly affect bone marrow fibrosis, alter marrow histopathol., reverse cytopenias, reduce red cell transfusion requirements, or significantly reduce allele burden.  These results suggest the possibility that addnl. mutational events might be assocd. with the development of these neoplasms, and indicate the need for combination therapies as the nature and significance of these addnl. mol. events is better understood.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoG-L7_08PNubVg90H21EOLACvtfcHk0lg1cI2JosubXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisF2nsrs%253D&md5=c0837365f2a21a48053b2e8093465848</span></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=10.1177%2F1947601910397187&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1947601910397187%26sid%3Dliteratum%253Aachs%26aulast%3DJatiani%26aufirst%3DS.%2BS.%26aulast%3DBaker%26aufirst%3DS.%2BJ.%26aulast%3DSilverman%26aufirst%3DL.%2BR.%26aulast%3DReddy%26aufirst%3DE.%2BP.%26atitle%3DJAK%252FSTAT%2520Pathways%2520in%2520Cytokine%2520Signaling%2520and%2520Myeloproliferative%2520Disorders%253A%2520Approaches%2520for%2520Targeted%2520Therapies%26jtitle%3DGenes%2520Cancer%26date%3D2010%26volume%3D1%26spage%3D979%26epage%3D993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit22b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Verstovsek, S.; Passamonti, F.; Rambaldi, A.; Barosi, G.; Rosen, P.; Levy, R.; Bradley, E. C.; Schacter, L.; Garrett, W. M.; Vaddi, K.; Contel, N.; Rumi, E.; Gattoni, E.; Cazzola, M.; Kantarjian, H.; Barbui, T.; Vannucchi, A.</span> <span class="citation_source-book">A Phase 2 Study of INCB018424, an Oral, Selective JAK1/JAK2 Inhibitor, in Patients with Advanced Polycythemia Vera (PV) and Essential Thrombocythemia (ET) Refractory to Hydroxyurea</span>; 51st American Society of Hematology Annual Meeting and Exposition, New Orleans, LA, Dec 5–8,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span>American Society of Hematology: Washington, DC; Abstract 311.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=S.+Verstovsek&author=F.+Passamonti&author=A.+Rambaldi&author=G.+Barosi&author=P.+Rosen&author=R.+Levy&author=E.+C.+Bradley&author=L.+Schacter&author=W.+M.+Garrett&author=K.+Vaddi&author=N.+Contel&author=E.+Rumi&author=E.+Gattoni&author=M.+Cazzola&author=H.+Kantarjian&author=T.+Barbui&author=A.+Vannucchi&title=A+Phase+2+Study+of+INCB018424%2C+an+Oral%2C+Selective+JAK1%2FJAK2+Inhibitor%2C+in+Patients+with+Advanced+Polycythemia+Vera+%28PV%29+and+Essential+Thrombocythemia+%28ET%29+Refractory+to+Hydroxyurea"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DVerstovsek%26aufirst%3DS.%26btitle%3DA%2520Phase%25202%2520Study%2520of%2520INCB018424%252C%2520an%2520Oral%252C%2520Selective%2520JAK1%252FJAK2%2520Inhibitor%252C%2520in%2520Patients%2520with%2520Advanced%2520Polycythemia%2520Vera%2520%2528PV%2529%2520and%2520Essential%2520Thrombocythemia%2520%2528ET%2529%2520Refractory%2520to%2520Hydroxyurea%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Neubauer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huffstadt, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfeffer, K.</span><span> </span><span class="NLM_article-title">Jak2 Deficiency Defines an Essential Developmental Checkpoint in Definitive Hematopoiesis</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">397</span><span class="NLM_x">–</span> <span class="NLM_lpage">409</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1998&pages=397-409&author=H.+Neubauerauthor=A.+Cumanoauthor=M.+Mullerauthor=H.+Wuauthor=U.+Huffstadtauthor=K.+Pfeffer&title=Jak2+Deficiency+Defines+an+Essential+Developmental+Checkpoint+in+Definitive+Hematopoiesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNeubauer%26aufirst%3DH.%26aulast%3DCumano%26aufirst%3DA.%26aulast%3DMuller%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DHuffstadt%26aufirst%3DU.%26aulast%3DPfeffer%26aufirst%3DK.%26atitle%3DJak2%2520Deficiency%2520Defines%2520an%2520Essential%2520Developmental%2520Checkpoint%2520in%2520Definitive%2520Hematopoiesis%26jtitle%3DCell%26date%3D1998%26volume%3D93%26spage%3D397%26epage%3D409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Garber, K.</span><span> </span><span class="NLM_article-title">Pfizer’s JAK Inhibitor Sails Through Phase 3 in Rheumatoid Arthritis</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">467</span><span class="NLM_x">–</span> <span class="NLM_lpage">468</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=467-468&author=K.+Garber&title=Pfizer%E2%80%99s+JAK+Inhibitor+Sails+Through+Phase+3+in+Rheumatoid+Arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGarber%26aufirst%3DK.%26atitle%3DPfizer%25E2%2580%2599s%2520JAK%2520Inhibitor%2520Sails%2520Through%2520Phase%25203%2520in%2520Rheumatoid%2520Arthritis%26jtitle%3DNat.%2520Biotechnol.%26date%3D2011%26volume%3D29%26spage%3D467%26epage%3D468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Jiang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghoreschi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deflorian, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perreira, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, D.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leister, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costanzi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Shea, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, J. T.</span><span> </span><span class="NLM_article-title">Examining the Chirality, Conformation and Selective Kinase Inhibition of 3-((3<i>R</i>,4<i>R</i>)-4-methyl-3-(methyl(7H-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile (CP-690,550)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">8012</span><span class="NLM_x">–</span> <span class="NLM_lpage">8018</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801142b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=8012-8018&author=J.+Jiangauthor=K.+Ghoreschiauthor=F.+Deflorianauthor=Z.+Chenauthor=M.+Perreiraauthor=M.+Pesuauthor=J.+Smithauthor=D.-C.+Nguyenauthor=E.+H.+Liuauthor=W.+Leisterauthor=S.+Costanziauthor=J.+J.+O%E2%80%99Sheaauthor=J.+T.+Thomas&title=Examining+the+Chirality%2C+Conformation+and+Selective+Kinase+Inhibition+of+3-%28%283R%2C4R%29-4-methyl-3-%28methyl%287H-pyrrolo%5B2%2C3-d%5Dpyrimidin-4-yl%29amino%29piperidin-1-yl%29-3-oxopropanenitrile+%28CP-690%2C550%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm801142b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801142b%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DGhoreschi%26aufirst%3DK.%26aulast%3DDeflorian%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DPerreira%26aufirst%3DM.%26aulast%3DPesu%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DJ.%26aulast%3DNguyen%26aufirst%3DD.-C.%26aulast%3DLiu%26aufirst%3DE.%2BH.%26aulast%3DLeister%26aufirst%3DW.%26aulast%3DCostanzi%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26aulast%3DThomas%26aufirst%3DJ.%2BT.%26atitle%3DExamining%2520the%2520Chirality%252C%2520Conformation%2520and%2520Selective%2520Kinase%2520Inhibition%2520of%25203-%2528%25283R%252C4R%2529-4-methyl-3-%2528methyl%25287H-pyrrolo%255B2%252C3-d%255Dpyrimidin-4-yl%2529amino%2529piperidin-1-yl%2529-3-oxopropanenitrile%2520%2528CP-690%252C550%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D8012%26epage%3D8018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Flanagan, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blumenkopf, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brissette, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casavant, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shang-Poa, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doty, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hines, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kent, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudlacz, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lillie, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnuson, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCurdy, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munchhof, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strelevitz, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subramanyam, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whipple, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Changelian, P. S.</span><span> </span><span class="NLM_article-title">Discovery of CP-690,550: A Potent and Selective Janus Kinase (JAK) Inhibitor for the Treatment of Autoimmune Diseases and Organ Transplant Rejection</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">8468</span><span class="NLM_x">–</span> <span class="NLM_lpage">8484</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1004286" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm300438j&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVOgt7vP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=8468-8484&author=M.+E.+Flanaganauthor=T.+A.+Blumenkopfauthor=W.+H.+Brissetteauthor=M.+F.+Brownauthor=J.+M.+Casavantauthor=C.+Shang-Poaauthor=J.+L.+Dotyauthor=E.+A.+Elliottauthor=M.+B.+Fisherauthor=M.+Hinesauthor=C.+Kentauthor=E.+M.+Kudlaczauthor=B.+M.+Lillieauthor=K.+S.+Magnusonauthor=S.+P.+McCurdyauthor=M.+J.+Munchhofauthor=B.+D.+Perryauthor=P.+S.+Sawyerauthor=T.+J.+Strelevitzauthor=C.+Subramanyamauthor=J.+Sunauthor=D.+A.+Whippleauthor=P.+S.+Changelian&title=Discovery+of+CP-690%2C550%3A+A+Potent+and+Selective+Janus+Kinase+%28JAK%29+Inhibitor+for+the+Treatment+of+Autoimmune+Diseases+and+Organ+Transplant+Rejection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of CP-690,550: A Potent and Selective Janus Kinase (JAK) Inhibitor for the Treatment of Autoimmune Diseases and Organ Transplant Rejection</span></div><div class="casAuthors">Flanagan, Mark E.; Blumenkopf, Todd A.; Brissette, William H.; Brown, Matthew F.; Casavant, Jeffrey M.; Chang, Shang-Poa; Doty, Jonathan L.; Elliott, Eileen A.; Fisher, Michael B.; Hines, Michael; Kent, Craig; Kudlacz, Elizabeth M.; Lillie, Brett M.; Magnuson, Kelly S.; McCurdy, Sandra P.; Munchhof, Michael J.; Perry, Bret D.; Sawyer, Perry S.; Strelevitz, Timothy J.; Subramanyam, Chakrapani; Sun, Jianmin; Whipple, David A.; Changelian, Paul S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8468-8484</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">There is a crit. need for safer and more convenient treatments for organ transplant rejection and autoimmune disorders such as rheumatoid arthritis.  Janus tyrosine kinases (JAK1, JAK3) are expressed in lymphoid cells and are involved in the signaling of multiple cytokines important for various T cell functions.  Blockade of the JAK1/JAK3-STAT pathway with a small mol. was anticipated to provide therapeutic immunosuppression/immunomodulation.  The Pfizer compd. library was screened against the catalytic domain of JAK3 resulting in the identification of a pyrrolopyrimidine-based series of inhibitors represented by the hexahydrocarbazolyl pyrrolopyrimidine CP-352,664.  Synthetic analogs of CP-352,664 were screened against the JAK enzymes and evaluated in an IL-2 induced T cell blast proliferation assay.  Select compds. were evaluated in rodent efficacy models of allograft rejection and destructive inflammatory arthritis.  Optimization within this chem. series led to identification of the cyanoacetylpiperidinylamino pyrrolopyrimidine CP-690,550, a potential first-in-class JAK inhibitor for treatment of autoimmune diseases and organ transplant rejection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbFS_8DSHkDbVg90H21EOLACvtfcHk0lgtdh5OldvYDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVOgt7vP&md5=c1d31ce42ab3f1c1f3029c6f4f48df1a</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm1004286&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1004286%26sid%3Dliteratum%253Aachs%26aulast%3DFlanagan%26aufirst%3DM.%2BE.%26aulast%3DBlumenkopf%26aufirst%3DT.%2BA.%26aulast%3DBrissette%26aufirst%3DW.%2BH.%26aulast%3DBrown%26aufirst%3DM.%2BF.%26aulast%3DCasavant%26aufirst%3DJ.%2BM.%26aulast%3DShang-Poa%26aufirst%3DC.%26aulast%3DDoty%26aufirst%3DJ.%2BL.%26aulast%3DElliott%26aufirst%3DE.%2BA.%26aulast%3DFisher%26aufirst%3DM.%2BB.%26aulast%3DHines%26aufirst%3DM.%26aulast%3DKent%26aufirst%3DC.%26aulast%3DKudlacz%26aufirst%3DE.%2BM.%26aulast%3DLillie%26aufirst%3DB.%2BM.%26aulast%3DMagnuson%26aufirst%3DK.%2BS.%26aulast%3DMcCurdy%26aufirst%3DS.%2BP.%26aulast%3DMunchhof%26aufirst%3DM.%2BJ.%26aulast%3DPerry%26aufirst%3DB.%2BD.%26aulast%3DSawyer%26aufirst%3DP.%2BS.%26aulast%3DStrelevitz%26aufirst%3DT.%2BJ.%26aulast%3DSubramanyam%26aufirst%3DC.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DWhipple%26aufirst%3DD.%2BA.%26aulast%3DChangelian%26aufirst%3DP.%2BS.%26atitle%3DDiscovery%2520of%2520CP-690%252C550%253A%2520A%2520Potent%2520and%2520Selective%2520Janus%2520Kinase%2520%2528JAK%2529%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520Autoimmune%2520Diseases%2520and%2520Organ%2520Transplant%2520Rejection%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D8468%26epage%3D8484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Williams, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamert, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walden, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fantino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossjohn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucet, I. S.</span><span> </span><span class="NLM_article-title">Dissecting Specificity in the Janus Kinases: The Structures of JAK-Specific Inhibitors Complexed to the JAK1 and JAK2 Protein Tyrosine Kinase Domain</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">387</span><span class="NLM_x">, </span> <span class="NLM_fpage">219</span><span class="NLM_x">–</span> <span class="NLM_lpage">232</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=387&publication_year=2009&pages=219-232&author=N.+K.+Williamsauthor=R.+S.+Bamertauthor=O.+Patelauthor=C.+Wangauthor=P.+M.+Waldenauthor=E.+Fantinoauthor=J.+Rossjohnauthor=I.+S.+Lucet&title=Dissecting+Specificity+in+the+Janus+Kinases%3A+The+Structures+of+JAK-Specific+Inhibitors+Complexed+to+the+JAK1+and+JAK2+Protein+Tyrosine+Kinase+Domain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DN.%2BK.%26aulast%3DBamert%26aufirst%3DR.%2BS.%26aulast%3DPatel%26aufirst%3DO.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DWalden%26aufirst%3DP.%2BM.%26aulast%3DFantino%26aufirst%3DE.%26aulast%3DRossjohn%26aufirst%3DJ.%26aulast%3DLucet%26aufirst%3DI.%2BS.%26atitle%3DDissecting%2520Specificity%2520in%2520the%2520Janus%2520Kinases%253A%2520The%2520Structures%2520of%2520JAK-Specific%2520Inhibitors%2520Complexed%2520to%2520the%2520JAK1%2520and%2520JAK2%2520Protein%2520Tyrosine%2520Kinase%2520Domain%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2009%26volume%3D387%26spage%3D219%26epage%3D232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="note"><p class="first last">Prior to the commencement of this work, a series of related, imidazolone-containing compounds had been described as JAK3 inhibitors:</p></div><div class="NLM_citation" id="rightTab-cit28a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Inoue, T.; Tanaka, A.; Nakai, K.; Sasaki, H.; Takahashi, F.; Shirakami, S.; Hatanaka, K.; Nakajima, Y.; Mukoyoshi, K.; Hamaguchi, H.; Kunikawa, S.; Higashi, Y.</span><span> </span><span class="NLM_article-title">Heterocyclic Janus Kinase 3 Inhibitors</span>. WO2007077949,<span class="NLM_x"> </span><span class="NLM_year">2007</span>. <div class="note"><p class="first last">More recently, during the course of this work, patent applications have appeared describing other tricyclic, azaindole-containing scaffolds as JAK inhibitors. These include azaindole annelated by pyrrole, </p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=T.+Inoue&author=A.+Tanaka&author=K.+Nakai&author=H.+Sasaki&author=F.+Takahashi&author=S.+Shirakami&author=K.+Hatanaka&author=Y.+Nakajima&author=K.+Mukoyoshi&author=H.+Hamaguchi&author=S.+Kunikawa&author=Y.+Higashi&title=Heterocyclic+Janus+Kinase+3+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DInoue%26aufirst%3DT.%26atitle%3DHeterocyclic%2520Janus%2520Kinase%25203%2520Inhibitors%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit28b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Shirakami, S.; Nakajima, Y.; Maeda, J.; Tominaga, H.; Yamagishi, H.; Hondo, T.; Inami, M.; Morio, H.; Inoue, T.; Mizutani, T.; Ishioka, H.</span><span> </span><span class="NLM_article-title">Fused Pyrrolopyridine Derivative</span>. WO2010119875,<span class="NLM_x"> </span><span class="NLM_year">2010</span><span class="NLM_x">; </span><div class="note"><p class="first last">by pyrrole, pyrazole, and isoxazole,</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=S.+Shirakami&author=Y.+Nakajima&author=J.+Maeda&author=H.+Tominaga&author=H.+Yamagishi&author=T.+Hondo&author=M.+Inami&author=H.+Morio&author=T.+Inoue&author=T.+Mizutani&author=H.+Ishioka&title=Fused+Pyrrolopyridine+Derivative"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DShirakami%26aufirst%3DS.%26atitle%3DFused%2520Pyrrolopyridine%2520Derivative%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit28c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Wishart, N.; Argiriadi, M.; Calderwood, D. J.; Ericsson, A. M.; Fiamengo, B. A.; Frank, K. E.; Friedman, M.; George, D. M.; Goedken, E. R.; Josephsohn, N. S.; Li, B. C.; Morytko, M. J.; Stewart, K. D.; Voss, J. W.; Wallace, G. A.; Wang, L.; Woller, K. R.</span><span> </span><span class="NLM_article-title">Novel Tricyclic Compounds</span>. WO2009152133,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span><div class="note"><p class="first last">by isothiazole, triazole, and imidazole, as in <b>3</b>,</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=N.+Wishart&author=M.+Argiriadi&author=D.+J.+Calderwood&author=A.+M.+Ericsson&author=B.+A.+Fiamengo&author=K.+E.+Frank&author=M.+Friedman&author=D.+M.+George&author=E.+R.+Goedken&author=N.+S.+Josephsohn&author=B.+C.+Li&author=M.+J.+Morytko&author=K.+D.+Stewart&author=J.+W.+Voss&author=G.+A.+Wallace&author=L.+Wang&author=K.+R.+Woller&title=Novel+Tricyclic+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWishart%26aufirst%3DN.%26atitle%3DNovel%2520Tricyclic%2520Compounds%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit28d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Wishart, N.; Argiriadi, M.; Breinlinger, E. C.; Calderwood, D. J.; Ericsson, A. M.; Fiamengo, B. A.; Frank, K. E.; Friedman, M.; George, D. M.; Goedken, E. R.; Josephsohn, N. S.; Li, B. C.; Morytko, M. J.; Mullen, K. D.; Somal, G.; Stewart, K. D.; Voss, J. W.; Wallace, G. A.; Wang, L.; Woller, K. R.</span><span> </span><span class="NLM_article-title">Novel Tricyclic Compounds</span>. WO2011068899,<span class="NLM_x"> </span><span class="NLM_year">2011</span>. <div class="note"><p class="first last">Tricycles corresponding to <b>3</b> but having distinct substitution and probably employing an alternative hinge-binding mode have recently appeared as JAK2 inhibitors:</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=N.+Wishart&author=M.+Argiriadi&author=E.+C.+Breinlinger&author=D.+J.+Calderwood&author=A.+M.+Ericsson&author=B.+A.+Fiamengo&author=K.+E.+Frank&author=M.+Friedman&author=D.+M.+George&author=E.+R.+Goedken&author=N.+S.+Josephsohn&author=B.+C.+Li&author=M.+J.+Morytko&author=K.+D.+Mullen&author=G.+Somal&author=K.+D.+Stewart&author=J.+W.+Voss&author=G.+A.+Wallace&author=L.+Wang&author=K.+R.+Woller&title=Novel+Tricyclic+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWishart%26aufirst%3DN.%26atitle%3DNovel%2520Tricyclic%2520Compounds%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit28e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Purandare, A. V.; Grebinski, J. W.; Hart, A.; Inghrim, J.; Schroeder, G.; Wan, H.</span><span> </span><span class="NLM_article-title">JAK2 Inhibitors and Their Use for the Treatment of Myeloproliferative Diseases and Cancer</span>. WO2011028864,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=A.+V.+Purandare&author=J.+W.+Grebinski&author=A.+Hart&author=J.+Inghrim&author=G.+Schroeder&author=H.+Wan&title=JAK2+Inhibitors+and+Their+Use+for+the+Treatment+of+Myeloproliferative+Diseases+and+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DPurandare%26aufirst%3DA.%2BV.%26atitle%3DJAK2%2520Inhibitors%2520and%2520Their%2520Use%2520for%2520the%2520Treatment%2520of%2520Myeloproliferative%2520Diseases%2520and%2520Cancer%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="note"><p class="first last">Analogues of <b>1</b> substituted with pendent sulfonamides are described to have binding selectivity for JAK1 over JAK2 and JAK3: </p></div><div class="NLM_citation" id="rightTab-cit29a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Acker, B. A.; Hartmann, S. J.; Huang, H.-C.; Jacobsen, E. J.; Promo, M. A.; Wolfson, S. G.; Xie, J.</span><span> </span><span class="NLM_article-title">Pyrrolo[2,3-d]pyrimidine Compounds</span>. WO2011045702,<span class="NLM_x"> </span><span class="NLM_year">2011</span><span class="NLM_x">, </span>and</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=B.+A.+Acker&author=S.+J.+Hartmann&author=H.-C.+Huang&author=E.+J.+Jacobsen&author=M.+A.+Promo&author=S.+G.+Wolfson&author=J.+Xie&title=Pyrrolo%5B2%2C3-d%5Dpyrimidine+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAcker%26aufirst%3DB.%2BA.%26atitle%3DPyrrolo%255B2%252C3-d%255Dpyrimidine%2520Compounds%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit29b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Xie, J.; Promo, M. A.; Jacobsen, E. J.; Huang, H.-C.; Maddux, T.</span><span> </span><span class="NLM_article-title">Pyrrolo[2,3-D]pyrimidine Compounds</span>. WO2011075334,<span class="NLM_x"> </span><span class="NLM_year">2011</span>. <div class="note"><p class="first last">Also claimed as JAK1 selective inhibitors are derivatives of <b>2</b>:</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=J.+Xie&author=M.+A.+Promo&author=E.+J.+Jacobsen&author=H.-C.+Huang&author=T.+Maddux&title=Pyrrolo%5B2%2C3-D%5Dpyrimidine+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DJ.%26atitle%3DPyrrolo%255B2%252C3-D%255Dpyrimidine%2520Compounds%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit29c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Huang, T.; Xue, C.-B.; Wang, A.; Kong, L.; Ye, H. F.; Yao, W.; Rodgers, J. D.; Shepard, S.; Wang, H.; Shao, L.; Li, H.-Y.; Li, Q.</span><span> </span><span class="NLM_article-title">Piperidin-4-yl Azetidine Derivatives as JAK1 Inhibitors</span>. WO2011112662,<span class="NLM_x"> </span><span class="NLM_year">2011</span><span class="NLM_x">; </span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=T.+Huang&author=C.-B.+Xue&author=A.+Wang&author=L.+Kong&author=H.+F.+Ye&author=W.+Yao&author=J.+D.+Rodgers&author=S.+Shepard&author=H.+Wang&author=L.+Shao&author=H.-Y.+Li&author=Q.+Li&title=Piperidin-4-yl+Azetidine+Derivatives+as+JAK1+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DT.%26atitle%3DPiperidin-4-yl%2520Azetidine%2520Derivatives%2520as%2520JAK1%2520Inhibitors%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit29d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Rodgers, J. D.; Li, Y.-L.; Shepard, S.; Wang, H.</span><span> </span><span class="NLM_article-title">Heterocyclic Derivatives of Pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines as Janus Kinase Inhibitors</span>. WO2011028685,<span class="NLM_x"> </span><span class="NLM_year">2011</span><span class="NLM_x">; </span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=J.+D.+Rodgers&author=Y.-L.+Li&author=S.+Shepard&author=H.+Wang&title=Heterocyclic+Derivatives+of+Pyrazol-4-yl-pyrrolo%5B2%2C3-d%5Dpyrimidines+as+Janus+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRodgers%26aufirst%3DJ.%2BD.%26atitle%3DHeterocyclic%2520Derivatives%2520of%2520Pyrazol-4-yl-pyrrolo%255B2%252C3-d%255Dpyrimidines%2520as%2520Janus%2520Kinase%2520Inhibitors%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit29e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Li, Y.-L.; Rodgers, J. D.</span><span> </span><span class="NLM_article-title">3-[4-(7<i>H</i>-Pyrrolo[2,3-d]pyrimidin-4-yl)-1<i>H</i>-pyrazol-1-yl]octane- or Heptane-nitrile As JAK Inhibitors</span>. WO2010135621,<span class="NLM_x"> </span><span class="NLM_year">2010</span><span class="NLM_x">, </span><div class="note"><p class="first last">along with a polyaryl macrocycle:</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=Y.-L.+Li&author=J.+D.+Rodgers&title=3-%5B4-%287H-Pyrrolo%5B2%2C3-d%5Dpyrimidin-4-yl%29-1H-pyrazol-1-yl%5Doctane-+or+Heptane-nitrile+As+JAK+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.-L.%26atitle%3D3-%255B4-%25287H-Pyrrolo%255B2%252C3-d%255Dpyrimidin-4-yl%2529-1H-pyrazol-1-yl%255Doctane-%2520or%2520Heptane-nitrile%2520As%2520JAK%2520Inhibitors%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit29f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Combs, A. P.; Sparks, R. B.; Yue, E. W.; Feng, H.; Bower, M. J.; Zhu, W.</span><span> </span><span class="NLM_article-title">Macrocyclic Compounds and Their Use as Kinase Inhibitors</span>. WO2009132202,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=A.+P.+Combs&author=R.+B.+Sparks&author=E.+W.+Yue&author=H.+Feng&author=M.+J.+Bower&author=W.+Zhu&title=Macrocyclic+Compounds+and+Their+Use+as+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCombs%26aufirst%3DA.%2BP.%26atitle%3DMacrocyclic%2520Compounds%2520and%2520Their%2520Use%2520as%2520Kinase%2520Inhibitors%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Van’t Klooster, G.; Van Rompaey, L.; Menet, C.; Namour, F.; Vanhoutte, F.; van der Aar, E.; Clément-Lacroix, P.; Gallien, R.; Nelles, L.; Guérin, C.; Smets, B.; Brys, R.; Feyen, J.; Wigerinck, P.</span> <span class="citation_source-book">Preclinical Pharmacology and Early Clinical Evaluation of GLPG0634, a Selective JAK1 Inhibitor for the Treatment of Rheumatoid Arthritis</span>. EULAR Annual European Congress of Rheumatology, London, May 25–28,<span class="NLM_x"> </span><span class="NLM_year">2011</span><span class="NLM_x">; </span>BMJ Publishing Group Ltd.: London; Abstract 251.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=G.+Van%E2%80%99t+Klooster&author=L.+Van+Rompaey&author=C.+Menet&author=F.+Namour&author=F.+Vanhoutte&author=E.+van+der+Aar&author=P.+Cl%C3%A9ment-Lacroix&author=R.+Gallien&author=L.+Nelles&author=C.+Gu%C3%A9rin&author=B.+Smets&author=R.+Brys&author=J.+Feyen&author=P.+Wigerinck&title=Preclinical+Pharmacology+and+Early+Clinical+Evaluation+of+GLPG0634%2C+a+Selective+JAK1+Inhibitor+for+the+Treatment+of+Rheumatoid+Arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DVan%25E2%2580%2599t%2BKlooster%26aufirst%3DG.%26btitle%3DPreclinical%2520Pharmacology%2520and%2520Early%2520Clinical%2520Evaluation%2520of%2520GLPG0634%252C%2520a%2520Selective%2520JAK1%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520Rheumatoid%2520Arthritis%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span> </span><span class="NLM_article-title">Galapagos' GLPG0634 Shows Excellent Efficacy and Safety in Rheumatoid Arthritis Phase II Study</span>. <span class="NLM_publisher-name">Galapagos NV</span>: <span class="NLM_publisher-loc">Mechelen, Belgium</span>, Press Release November 22,<span class="NLM_x"> </span><span class="NLM_year">2011</span>. Available at <a href="http://www.glpg.com/" class="extLink">http://www.glpg.com/</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Galapagos%27+GLPG0634+Shows+Excellent+Efficacy+and+Safety+in+Rheumatoid+Arthritis+Phase+II+Study.+Galapagos+NV%3A+Mechelen%2C+Belgium%2C+Press+Release+November+22%2C+2011.+Available+at+http%3A%2F%2Fwww.glpg.com%2F."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26atitle%3DGalapagos%2527%2520GLPG0634%2520Shows%2520Excellent%2520Efficacy%2520and%2520Safety%2520in%2520Rheumatoid%2520Arthritis%2520Phase%2520II%2520Study%26pub%3DGalapagos%2520NV%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Malerich, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fine, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klebansky, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanga, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Andrea, A.</span><span> </span><span class="NLM_article-title">Diamino-1,2,4-triazole Derivatives Are Selective Inhibitors of TYK2 and JAK1 Over JAK2 and JAK3</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">7454</span><span class="NLM_x">–</span> <span class="NLM_lpage">7457</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=7454-7457&author=J.+P.+Malerichauthor=J.+S.+Lamauthor=B.+Hartauthor=R.+M.+Fineauthor=B.+Klebanskyauthor=M.+J.+Tangaauthor=A.+D%E2%80%99Andrea&title=Diamino-1%2C2%2C4-triazole+Derivatives+Are+Selective+Inhibitors+of+TYK2+and+JAK1+Over+JAK2+and+JAK3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMalerich%26aufirst%3DJ.%2BP.%26aulast%3DLam%26aufirst%3DJ.%2BS.%26aulast%3DHart%26aufirst%3DB.%26aulast%3DFine%26aufirst%3DR.%2BM.%26aulast%3DKlebansky%26aufirst%3DB.%26aulast%3DTanga%26aufirst%3DM.%2BJ.%26aulast%3DD%25E2%2580%2599Andrea%26aufirst%3DA.%26atitle%3DDiamino-1%252C2%252C4-triazole%2520Derivatives%2520Are%2520Selective%2520Inhibitors%2520of%2520TYK2%2520and%2520JAK1%2520Over%2520JAK2%2520and%2520JAK3%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D7454%26epage%3D7457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Karaman, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrgard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallant, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atteridge, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cicero, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edeen, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faraoni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockhart, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milanov, Z. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallares, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pritchard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wodicka, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinkar, P. P.</span><span> </span><span class="NLM_article-title">A Quantitative Analysis of Kinase Inhibitor Selectivity</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm300438j&amp;key=10.1038%2Fnbt1358" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm300438j&amp;key=18183025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm300438j&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisFGlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2008&pages=127-132&author=M.+W.+Karamanauthor=S.+Herrgardauthor=D.+K.+Treiberauthor=P.+Gallantauthor=C.+E.+Atteridgeauthor=B.+T.+Campbellauthor=K.+W.+Chanauthor=P.+Ciceroauthor=M.+I.+Davisauthor=P.+T.+Edeenauthor=R.+Faraoniauthor=M.+Floydauthor=J.+P.+Huntauthor=D.+J.+Lockhartauthor=Z.+V.+Milanovauthor=M.+J.+Morrisonauthor=G.+Pallaresauthor=H.+K.+Patelauthor=S.+Pritchardauthor=L.+M.+Wodickaauthor=P.+P.+Zarrinkar&title=A+Quantitative+Analysis+of+Kinase+Inhibitor+Selectivity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">A quantitative analysis of kinase inhibitor selectivity</span></div><div class="casAuthors">Karaman, Mazen W.; Herrgard, Sanna; Treiber, Daniel K.; Gallant, Paul; Atteridge, Corey E.; Campbell, Brian T.; Chan, Katrina W.; Ciceri, Pietro; Davis, Mindy I.; Edeen, Philip T.; Faraoni, Raffaella; Floyd, Mark; Hunt, Jeremy P.; Lockhart, Daniel J.; Milanov, Zdravko V.; Morrison, Michael J.; Pallares, Gabriel; Patel, Hitesh K.; Pritchard, Stephanie; Wodicka, Lisa M.; Zarrinkar, Patrick P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">127-132</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets.  The biol. consequences of multikinase activity are poorly defined, and an important step toward understanding the relationship between selectivity, efficacy and safety is the exploration of how inhibitors interact with the human kinome.  The authors present interaction maps for 38 kinase inhibitors across a panel of 317 kinases representing >50% of the predicted human protein kinome.  The data constitute the most comprehensive study of kinase inhibitor selectivity to date and reveal a wide diversity of interaction patterns.  To enable a global anal. of the results, the authors introduce the concept of a selectivity score as a general tool to quantify and differentiate the obsd. interaction patterns.  The authors further investigate the impact of panel size and find that small assay panels do not provide a robust measure of selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiArJSq2_lPrVg90H21EOLACvtfcHk0ljKaED1h_xCAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisFGlsQ%253D%253D&md5=346265d412853ced636ad4128ed8a76f</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1038%2Fnbt1358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt1358%26sid%3Dliteratum%253Aachs%26aulast%3DKaraman%26aufirst%3DM.%2BW.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DGallant%26aufirst%3DP.%26aulast%3DAtteridge%26aufirst%3DC.%2BE.%26aulast%3DCampbell%26aufirst%3DB.%2BT.%26aulast%3DChan%26aufirst%3DK.%2BW.%26aulast%3DCicero%26aufirst%3DP.%26aulast%3DDavis%26aufirst%3DM.%2BI.%26aulast%3DEdeen%26aufirst%3DP.%2BT.%26aulast%3DFaraoni%26aufirst%3DR.%26aulast%3DFloyd%26aufirst%3DM.%26aulast%3DHunt%26aufirst%3DJ.%2BP.%26aulast%3DLockhart%26aufirst%3DD.%2BJ.%26aulast%3DMilanov%26aufirst%3DZ.%2BV.%26aulast%3DMorrison%26aufirst%3DM.%2BJ.%26aulast%3DPallares%26aufirst%3DG.%26aulast%3DPatel%26aufirst%3DH.%2BK.%26aulast%3DPritchard%26aufirst%3DS.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26atitle%3DA%2520Quantitative%2520Analysis%2520of%2520Kinase%2520Inhibitor%2520Selectivity%26jtitle%3DNat.%2520Biotechnol.%26date%3D2008%26volume%3D26%26spage%3D127%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Van Abbema, A.; Kanada, H.; Chang, C.; Bir Kohli, P.; Smith, J.; Barrett, K.; Lewin-Koh, N.; Johnson, A. R.; Ghilardi, N.; Blair, W.</span><span> </span><span class="NLM_article-title">Determination of the JAK-Dependence of Cytokine Pathways Using Small Molecule Inhibitors</span>, unpublished results.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Van+Abbema%2C+A.%3B+Kanada%2C+H.%3B+Chang%2C+C.%3B+Bir+Kohli%2C+P.%3B+Smith%2C+J.%3B+Barrett%2C+K.%3B+Lewin-Koh%2C+N.%3B+Johnson%2C+A.+R.%3B+Ghilardi%2C+N.%3B+Blair%2C+W.+Determination+of+the+JAK-Dependence+of+Cytokine+Pathways+Using+Small+Molecule+Inhibitors%2C+unpublished+results."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BAbbema%26aufirst%3DA.%26atitle%3DDetermination%2520of%2520the%2520JAK-Dependence%2520of%2520Cytokine%2520Pathways%2520Using%2520Small%2520Molecule%2520Inhibitors" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="note"><p class="first last">EC<sub>50</sub> values for compounds that do not achieve at least 50% inhibition at the highest concentration tested (10 μM) in the cell based assays are considered to be noncalculable and are reported as >10 μM. Owing to normal run-to-run variability, some weakly potent compounds achieve >50% inhibition in some, but not all, of the replicate runs. In these cases, we report EC<sub>50</sub> > X, where X is the arithmetic mean of all the individual EC<sub>50</sub> values, both calculable and noncalculable. For example, compound <b>13</b> displayed replicate EC<sub>50</sub> values of 6.3 μM, >10 μM, and >10 μM in the pSTAT5-EPO assay; thus, the average JAK2 cell EC<sub>50</sub> was reported as >8.8 μM, giving a JAK2/JAK1 cell selectivity of >6.3-fold.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Chrencik, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patny, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, I. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korniski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emmons, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinberg, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gormley, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiefer, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leone, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sommers, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tenbrink, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomasselli, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benson, T. E.</span><span> </span><span class="NLM_article-title">Structural and Thermodynamic Characterization of the TYK2 and JAK3 Kinase Domains in Complex with CP690550 and CMP-6</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">400</span><span class="NLM_x">, </span> <span class="NLM_fpage">413</span><span class="NLM_x">–</span> <span class="NLM_lpage">433</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=400&publication_year=2010&pages=413-433&author=J.+E.+Chrencikauthor=A.+Patnyauthor=I.+K.+Leungauthor=B.+Korniskiauthor=T.+L.+Emmonsauthor=T.+Hallauthor=R.+A.+Weinbergauthor=J.+A.+Gormleyauthor=J.+M.+Williamsauthor=J.+E.+Dayauthor=J.+L.+Hirschauthor=J.+R.+Kieferauthor=J.+W.+Leoneauthor=H.+D.+Fischerauthor=C.+D.+Sommersauthor=H.-C.+Huangauthor=E.+J.+Jacobsenauthor=R.+E.+Tenbrinkauthor=A.+G.+Tomasselliauthor=T.+E.+Benson&title=Structural+and+Thermodynamic+Characterization+of+the+TYK2+and+JAK3+Kinase+Domains+in+Complex+with+CP690550+and+CMP-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChrencik%26aufirst%3DJ.%2BE.%26aulast%3DPatny%26aufirst%3DA.%26aulast%3DLeung%26aufirst%3DI.%2BK.%26aulast%3DKorniski%26aufirst%3DB.%26aulast%3DEmmons%26aufirst%3DT.%2BL.%26aulast%3DHall%26aufirst%3DT.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26aulast%3DGormley%26aufirst%3DJ.%2BA.%26aulast%3DWilliams%26aufirst%3DJ.%2BM.%26aulast%3DDay%26aufirst%3DJ.%2BE.%26aulast%3DHirsch%26aufirst%3DJ.%2BL.%26aulast%3DKiefer%26aufirst%3DJ.%2BR.%26aulast%3DLeone%26aufirst%3DJ.%2BW.%26aulast%3DFischer%26aufirst%3DH.%2BD.%26aulast%3DSommers%26aufirst%3DC.%2BD.%26aulast%3DHuang%26aufirst%3DH.-C.%26aulast%3DJacobsen%26aufirst%3DE.%2BJ.%26aulast%3DTenbrink%26aufirst%3DR.%2BE.%26aulast%3DTomasselli%26aufirst%3DA.%2BG.%26aulast%3DBenson%26aufirst%3DT.%2BE.%26atitle%3DStructural%2520and%2520Thermodynamic%2520Characterization%2520of%2520the%2520TYK2%2520and%2520JAK3%2520Kinase%2520Domains%2520in%2520Complex%2520with%2520CP690550%2520and%2520CMP-6%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2010%26volume%3D400%26spage%3D413%26epage%3D433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="note"><p class="first last">As crystallization of JAK1 proved difficult during the early stages of this program, the cocrystalization of several compounds reported below was solved using a JAK2 triple mutant surrogate, in which three residues adjacent to the ligand binding site were mutated to the respective JAK1 residues (i.e., Q853R, Y931F, and D939E using JAK2 numbering) in order to explore potential binding interactions between these residues and the ligand. Later compounds in the series were successfully cocrystalized with wild type JAK1.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit47"><span>The Pymol Molecular Graphics System, version 1.3; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York</span> (<a href="http://www.pymol.org" class="extLink">http://www.pymol.org</a>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+Pymol+Molecular+Graphics+System%2C+version+1.3%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York+%28http%3A%2F%2Fwww.pymol.org%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Pymol%2520Molecular%2520Graphics%2520System%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crockett, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reider, P. A</span><span> </span><span class="NLM_article-title">Practical Synthesis of 2-((1<i>H</i>-Pyrrolo[2,3-b]pyridine-4-yl)methylamino)-5-fluoronicotinic Acid</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">4021</span><span class="NLM_x">–</span> <span class="NLM_lpage">4023</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo0602571" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2006&pages=4021-4023&author=X.+Wangauthor=B.+Zhiauthor=J.+Baumauthor=Y.+Chenauthor=R.+Crockettauthor=L.+Huangauthor=S.+Eisenbergauthor=J.+Ngauthor=R.+Larsenauthor=M.+Martinelliauthor=P.+A+Reider&title=Practical+Synthesis+of+2-%28%281H-Pyrrolo%5B2%2C3-b%5Dpyridine-4-yl%29methylamino%29-5-fluoronicotinic+Acid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjo0602571&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo0602571%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DZhi%26aufirst%3DB.%26aulast%3DBaum%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DCrockett%26aufirst%3DR.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DEisenberg%26aufirst%3DS.%26aulast%3DNg%26aufirst%3DJ.%26aulast%3DLarsen%26aufirst%3DR.%26aulast%3DMartinelli%26aufirst%3DM.%26aulast%3DReider%26aufirst%3DP.%2BA%26atitle%3DPractical%2520Synthesis%2520of%25202-%2528%25281H-Pyrrolo%255B2%252C3-b%255Dpyridine-4-yl%2529methylamino%2529-5-fluoronicotinic%2520Acid%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2006%26volume%3D71%26spage%3D4021%26epage%3D4023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Vanotti, E.; Angelucci, F.; Bargiotti, A.; Brasca, M. G.; Menichincheri, M.</span><span> </span><span class="NLM_article-title">Pyrrolopyridines as Kinase Inhibitors</span>. WO2007054508,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=E.+Vanotti&author=F.+Angelucci&author=A.+Bargiotti&author=M.+G.+Brasca&author=M.+Menichincheri&title=Pyrrolopyridines+as+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DVanotti%26aufirst%3DE.%26atitle%3DPyrrolopyridines%2520as%2520Kinase%2520Inhibitors%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Brown Ripin, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abele, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blumenkopf, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casavant, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doty, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flanagan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koecher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laue, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meltz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munchhof, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pouwer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sha, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teixeira, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vries, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whipple, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilcox, G.</span><span> </span><span class="NLM_article-title">Development of a Scaleable Route for the Production of <i>cis</i>-<i>N</i>-Benzyl-3-methylamino-4-methylpiperidine</span> <span class="citation_source-journal">Org. Process Res. Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">115</span><span class="NLM_x">–</span> <span class="NLM_lpage">120</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2003&pages=115-120&author=D.+H.+Brown+Ripinauthor=S.+Abeleauthor=W.+Caiauthor=T.+Blumenkopfauthor=J.+M.+Casavantauthor=J.+L.+Dotyauthor=M.+Flanaganauthor=C.+Koecherauthor=K.+W.+Laueauthor=K.+McCarthyauthor=C.+Meltzauthor=M.+J.+Munchhofauthor=K.+Pouwerauthor=B.+Shaauthor=J.+Sunauthor=J.+Teixeiraauthor=T.+Vriesauthor=D.+A.+Whippleauthor=G.+Wilcox&title=Development+of+a+Scaleable+Route+for+the+Production+of+cis-N-Benzyl-3-methylamino-4-methylpiperidine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%2BRipin%26aufirst%3DD.%2BH.%26aulast%3DAbele%26aufirst%3DS.%26aulast%3DCai%26aufirst%3DW.%26aulast%3DBlumenkopf%26aufirst%3DT.%26aulast%3DCasavant%26aufirst%3DJ.%2BM.%26aulast%3DDoty%26aufirst%3DJ.%2BL.%26aulast%3DFlanagan%26aufirst%3DM.%26aulast%3DKoecher%26aufirst%3DC.%26aulast%3DLaue%26aufirst%3DK.%2BW.%26aulast%3DMcCarthy%26aufirst%3DK.%26aulast%3DMeltz%26aufirst%3DC.%26aulast%3DMunchhof%26aufirst%3DM.%2BJ.%26aulast%3DPouwer%26aufirst%3DK.%26aulast%3DSha%26aufirst%3DB.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DTeixeira%26aufirst%3DJ.%26aulast%3DVries%26aufirst%3DT.%26aulast%3DWhipple%26aufirst%3DD.%2BA.%26aulast%3DWilcox%26aufirst%3DG.%26atitle%3DDevelopment%2520of%2520a%2520Scaleable%2520Route%2520for%2520the%2520Production%2520of%2520cis-N-Benzyl-3-methylamino-4-methylpiperidine%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2003%26volume%3D7%26spage%3D115%26epage%3D120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Ramadas, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srinivasan, N.</span><span> </span><span class="NLM_article-title">Iron-Ammonium Chloride: A Convenient and Inexpensive Reductant</span> <span class="citation_source-journal">Synth. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">3189</span><span class="NLM_x">–</span> <span class="NLM_lpage">3195</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm300438j&amp;key=10.1080%2F00397919208021132" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm300438j&amp;key=1%3ACAS%3A528%3ADyaK3sXhs1ykt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1992&pages=3189-3195&author=K.+Ramadasauthor=N.+Srinivasan&title=Iron-Ammonium+Chloride%3A+A+Convenient+and+Inexpensive+Reductant"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Iron-ammonium chloride - a convenient and inexpensive reductant</span></div><div class="casAuthors">Ramadas, Krishnamurthy; Srinivasan, Natarajan</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">3189-95</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    </div><div class="casAbstract">The redn. of nitro arom. compds., I (R1 = H, NH2, Me, Cl, R2 = H, NH2, NO2, R3 = H, CH2CN, CH2CO2H, Me, OH, NHAc, Br, Cl, NH2, R4 = NO2), contg. other susceptible groups is reinvestigated to provide a viable economic route from the point of view of quant. transformation, reduced reaction times, and simple work up using iron powder and ammonium chloride soln. in neutral medium.  Thus, using Fe/NH4Cl on I gave I (R4 = NH2) in 67-90% yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqD_QX8c0Gcx7Vg90H21EOLACvtfcHk0lhCcnWsdcoCMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXhs1ykt7k%253D&md5=7b3830ad2efaf09a30cbff04b89eb32a</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1080%2F00397919208021132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397919208021132%26sid%3Dliteratum%253Aachs%26aulast%3DRamadas%26aufirst%3DK.%26aulast%3DSrinivasan%26aufirst%3DN.%26atitle%3DIron-Ammonium%2520Chloride%253A%2520A%2520Convenient%2520and%2520Inexpensive%2520Reductant%26jtitle%3DSynth.%2520Commun.%26date%3D1992%26volume%3D22%26spage%3D3189%26epage%3D3195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Li, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brogan, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gage, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. J.</span><span> </span><span class="NLM_article-title">Chemoenzymatic Synthesis and Synthetic Application of Enantiopure Aminocyclopentenols: Total Synthesis of Carbocyclic (+)-Uracil Polyoxin C and Its α-Epimer</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">4538</span><span class="NLM_x">–</span> <span class="NLM_lpage">4540</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo0496796" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2004&pages=4538-4540&author=F.+Liauthor=J.+B.+Broganauthor=J.+L.+Gageauthor=D.+Zhangauthor=M.+J.+Miller&title=Chemoenzymatic+Synthesis+and+Synthetic+Application+of+Enantiopure+Aminocyclopentenols%3A+Total+Synthesis+of+Carbocyclic+%28%2B%29-Uracil+Polyoxin+C+and+Its+%CE%B1-Epimer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjo0496796&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo0496796%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DF.%26aulast%3DBrogan%26aufirst%3DJ.%2BB.%26aulast%3DGage%26aufirst%3DJ.%2BL.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DMiller%26aufirst%3DM.%2BJ.%26atitle%3DChemoenzymatic%2520Synthesis%2520and%2520Synthetic%2520Application%2520of%2520Enantiopure%2520Aminocyclopentenols%253A%2520Total%2520Synthesis%2520of%2520Carbocyclic%2520%2528%252B%2529-Uracil%2520Polyoxin%2520C%2520and%2520Its%2520%25CE%25B1-Epimer%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2004%26volume%3D69%26spage%3D4538%26epage%3D4540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Ranganathan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, K. S.</span><span> </span><span class="NLM_article-title">2-Aza-3-oxabicyclo[2.2.1]heptane Hydrochloride: An Exceptionally Versatile Synthon For Carbocyclic Sugars and Nucleosides</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">3347</span><span class="NLM_x">–</span> <span class="NLM_lpage">3362</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1997&pages=3347-3362&author=S.+Ranganathanauthor=K.+S.+George&title=2-Aza-3-oxabicyclo%5B2.2.1%5Dheptane+Hydrochloride%3A+An+Exceptionally+Versatile+Synthon+For+Carbocyclic+Sugars+and+Nucleosides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRanganathan%26aufirst%3DS.%26aulast%3DGeorge%26aufirst%3DK.%2BS.%26atitle%3D2-Aza-3-oxabicyclo%255B2.2.1%255Dheptane%2520Hydrochloride%253A%2520An%2520Exceptionally%2520Versatile%2520Synthon%2520For%2520Carbocyclic%2520Sugars%2520and%2520Nucleosides%26jtitle%3DTetrahedron%26date%3D1997%26volume%3D53%26spage%3D3347%26epage%3D3362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Gregson, M.; Ayres, B. E.; Ewan, G. B.; Ellis, F.; Knight, J.</span><span> </span><span class="NLM_article-title">2,6-Diaminopurine Derivatives</span>. WO199417090,<span class="NLM_x"> </span><span class="NLM_year">1994</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1994&author=M.+Gregson&author=B.+E.+Ayres&author=G.+B.+Ewan&author=F.+Ellis&author=J.+Knight&title=2%2C6-Diaminopurine+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGregson%26aufirst%3DM.%26atitle%3D2%252C6-Diaminopurine%2520Derivatives%26date%3D1994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Erickson, S. D.; Qian, Y.; Tilley, J. W.</span><span> </span><span class="NLM_article-title">Diaminocyclohexane and Diaminocyclopentane Derivatives</span>. WO2008065021,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=S.+D.+Erickson&author=Y.+Qian&author=J.+W.+Tilley&title=Diaminocyclohexane+and+Diaminocyclopentane+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DErickson%26aufirst%3DS.%2BD.%26atitle%3DDiaminocyclohexane%2520and%2520Diaminocyclopentane%2520Derivatives%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Morrison, J. F.</span><span> </span><span class="NLM_article-title">Kinetics of the Reversible Inhibition of Enzyme-Catalyzed Reactions by Tight-binding Inhibitors</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1969</span><span class="NLM_x">, </span> <span class="NLM_volume">185</span><span class="NLM_x">, </span> <span class="NLM_fpage">269</span><span class="NLM_x">–</span> <span class="NLM_lpage">296</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=185&publication_year=1969&pages=269-296&author=J.+F.+Morrison&title=Kinetics+of+the+Reversible+Inhibition+of+Enzyme-Catalyzed+Reactions+by+Tight-binding+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMorrison%26aufirst%3DJ.%2BF.%26atitle%3DKinetics%2520of%2520the%2520Reversible%2520Inhibition%2520of%2520Enzyme-Catalyzed%2520Reactions%2520by%2520Tight-binding%2520Inhibitors%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D1969%26volume%3D185%26spage%3D269%26epage%3D296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit47b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">William, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, J. F.</span><span> </span><span class="NLM_article-title">The Kinetics of Reversible Tight-binding Inhibition</span> <span class="citation_source-journal">Methods Enzymol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">437</span><span class="NLM_x">–</span> <span class="NLM_lpage">467</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1979&pages=437-467&author=J.+W.+Williamauthor=J.+F.+Morrison&title=The+Kinetics+of+Reversible+Tight-binding+Inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilliam%26aufirst%3DJ.%2BW.%26aulast%3DMorrison%26aufirst%3DJ.%2BF.%26atitle%3DThe%2520Kinetics%2520of%2520Reversible%2520Tight-binding%2520Inhibition%26jtitle%3DMethods%2520Enzymol.%26date%3D1979%26volume%3D63%26spage%3D437%26epage%3D467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3EYG" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3EYG','PDB','3EYG'); return false;">PDB: 3EYG</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3FUP" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3FUP','PDB','3FUP'); return false;">PDB: 3FUP</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-3"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i64"><a href="/doi/suppl/10.1021/jm300438j">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_67263"></div></div></div></div></div><hr /></hr><p class="last">Details of crystallographic methods and procedures: analytical LCMS methods; experimental LogD measurement procedures; <i>in vitro</i> and <i>in vivo</i> ADME experimental procedures; details of molecular modeling calculations and methods; preparation and characterization of <b>7</b>–<b>11</b>, <b>14</b>–<b>18</b>, <b>20</b>, <b>21</b>, <b>23</b>–<b>25</b>, <b>27</b>, <b>29</b>, <b>31</b>, <b>32</b>, <b>34</b>, <b>36</b>–<b>40</b>, <b>42</b>–<b>46</b>, <b>48</b>, <b>54b</b>–<b>d</b>, <b>54g</b>, <b>62</b>, <b>64</b>–<b>66</b>, <b>71</b>, <b>73</b>, and <b>74</b>. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm300438j/suppl_file/jm300438j_si_001.pdf">jm300438j_si_001.pdf (662.56 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">PDB nos.: 4E6D for <b>7</b> complexed with JAK2TM, 4E6Q for <b>12</b> complexed with JAK2TM, 4E5W for <b>26</b> complexed with JAK1, 4E4L for <b>30</b> complexed with JAK1, 4E4M for <b>30</b> complexed with JAK2, and 4E4N for <b>49</b> complexed with JAK1.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm300438j&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Fjm300438j%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2012.55.issue-12%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm300438j" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"66e0f0db9a7c198b","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.6.0","si":10}'></script>
</body>
</html>
